UCP4	B-Gene_or_gene_product
,	O
a	O
novel	O
brain	O
-	O
specific	O
mitochondrial	O
protein	B-Gene_or_gene_product
that	O
reduces	O
membrane	O
potential	O
in	O
mammalian	O
cells	O
.	O

Uncoupling	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
(	O
UCPs	B-Gene_or_gene_product
)	O
are	O
a	O
family	O
of	O
mitochondrial	O
transporter	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
that	O
have	O
been	O
implicated	O
in	O
thermoregulatory	O
heat	O
production	O
and	O
maintenance	O
of	O
the	O
basal	O
metabolic	O
rate	O
.	O

We	O
have	O
identified	O
and	O
partially	O
characterized	O
a	O
novel	O
member	O
of	O
the	O
human	O
uncoupling	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
family	O
,	O
termed	O
uncoupling	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
(	O
UCP4	B-Gene_or_gene_product
)	O
.	O

Protein	B-Gene_or_gene_product
sequence	O
analyses	O
showed	O
that	O
UCP4	B-Gene_or_gene_product
is	O
most	O
related	O
to	O
UCP3	B-Gene_or_gene_product
and	O
possesses	O
features	O
characteristic	O
of	O
mitochondrial	O
transporter	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Unlike	O
other	O
known	O
UCPs	B-Gene_or_gene_product
,	O
UCP4	B-Gene_or_gene_product
transcripts	O
are	O
exclusively	O
expressed	O
in	O
both	O
fetal	O
and	O
adult	O
brain	O
tissues	O
.	O

UCP4	B-Gene_or_gene_product
maps	O
to	O
human	O
chromosome	O
6p11	O
.	O
2	O
-	O
q12	O
.	O

Consistent	O
with	O
its	O
potential	O
role	O
as	O
an	O
uncoupling	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
UCP4	B-Gene_or_gene_product
is	O
localized	O
to	O
the	O
mitochondria	O
and	O
its	O
ectopic	O
expression	O
in	O
mammalian	O
cells	O
reduces	O
mitochondrial	O
membrane	O
potential	O
.	O

These	O
findings	O
suggest	O
that	O
UCP4	B-Gene_or_gene_product
may	O
be	O
involved	O
in	O
thermoregulatory	O
heat	O
production	O
and	O
metabolism	O
in	O
the	O
brain	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
angiopoietin	B-Gene_or_gene_product
family	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
angiopoietin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
.	O

Using	O
homology	O
-	O
based	O
PCR	O
,	O
we	O
have	O
isolated	O
cDNA	O
encoding	O
a	O
novel	O
member	O
(	O
491	O
amino	O
acids	O
)	O
of	O
the	O
angiopoietin	B-Gene_or_gene_product
(	O
Ang	B-Gene_or_gene_product
)	O
family	O
from	O
human	O
adult	O
heart	O
cDNA	O
and	O
have	O
designated	O
it	O
angiopoietin	O
-	O
3	O
(	O
Ang3	B-Gene_or_gene_product
)	O
.	O

The	O
NH2	O
-	O
terminal	O
and	O
COOH	O
-	O
terminal	O
portions	O
of	O
Ang	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
contain	O
the	O
characteristic	O
coiled	O
-	O
coil	O
domain	O
and	O
fibrinogen	O
-	O
like	O
domain	O
that	O
are	O
conserved	O
in	O
other	O
known	O
Angs	B-Gene_or_gene_product
.	O

Ang3	B-Gene_or_gene_product
has	O
a	O
highly	O
hydrophobic	O
region	O
at	O
the	O
N	O
-	O
terminus	O
(	O
approximately	O
21	O
amino	O
acids	O
)	O
that	O
is	O
typical	O
of	O
a	O
signal	O
sequence	O
for	O
protein	O
secretion	O
.	O

Ang3	B-Gene_or_gene_product
mRNA	O
is	O
most	O
abundant	O
in	O
adrenal	O
gland	O
,	O
placenta	O
,	O
thyroid	O
gland	O
,	O
heart	O
and	O
small	O
intestine	O
in	O
human	O
adult	O
tissues	O
.	O

Additionally	O
,	O
Ang3	B-Gene_or_gene_product
is	O
a	O
secretory	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
but	O
is	O
not	O
a	O
mitogen	B-Gene_or_gene_product
in	O
endothelial	O
cells	O
.	O

Purification	O
and	O
identification	O
of	O
a	O
novel	O
subunit	O
of	O
protein	O
serine	O
/	O
threonine	O
phosphatase	O
4	O
.	O

The	O
catalytic	O
subunit	O
of	O
protein	O
serine	O
/	O
threonine	O
phosphatase	O
4	O
(	O
PP4C	O
)	O
has	O
greater	O
than	O
65	O
%	O
amino	O
acid	O
identity	O
to	O
the	O
catalytic	O
subunit	O
of	O
protein	O
phosphatase	O
2A	O
(	O
PP2AC	O
)	O
.	O

Despite	O
this	O
high	O
homology	O
,	O
PP4	O
does	O
not	O
appear	O
to	O
associate	O
with	O
known	O
PP2A	O
regulatory	O
subunits	O
.	O

As	O
a	O
first	O
step	O
toward	O
characterization	O
of	O
PP4	O
holoenzymes	O
and	O
identification	O
of	O
putative	O
PP4	O
regulatory	O
subunits	O
,	O
PP4	O
was	O
purified	O
from	O
bovine	O
testis	O
soluble	O
extracts	O
.	O

PP4	O
existed	O
in	O
two	O
complexes	O
of	O
approximately	O
270	O
-	O
300	O
and	O
400	O
-	O
450	O
kDa	O
as	O
determined	O
by	O
gel	O
filtration	O
chromatography	O
.	O

The	O
smaller	O
PP4	O
complex	O
was	O
purified	O
by	O
sequential	O
phenyl	O
-	O
Sepharose	O
,	O
Source	O
15Q	O
,	O
DEAE2	O
,	O
and	O
Superdex	O
200	O
gel	O
filtration	O
chromatographies	O
.	O

The	O
final	O
product	O
contained	O
two	O
major	O
proteins	B-Gene_or_gene_product
:	O
the	O
PP4	O
catalytic	O
subunit	O
plus	O
a	O
protein	B-Gene_or_gene_product
that	O
migrated	O
as	O
a	O
doublet	O
of	O
120	O
-	O
125	O
kDa	O
on	O
SDS	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
.	O

The	O
associated	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
termed	O
PP4R1	O
,	O
and	O
PP4C	O
also	O
bound	O
to	O
microcystin	O
-	O
Sepharose	O
.	O

Mass	O
spectrometry	O
analysis	O
of	O
the	O
purified	O
complex	O
revealed	O
two	O
major	O
peaks	O
,	O
at	O
35	O
(	O
PP4C	O
)	O
and	O
105	O
kDa	O
(	O
PP4R1	O
)	O
.	O

Amino	O
acid	O
sequence	O
information	O
of	O
several	O
peptides	O
derived	O
from	O
the	O
105	O
kDa	O
protein	B-Gene_or_gene_product
was	O
utilized	O
to	O
isolate	O
a	O
human	O
cDNA	O
clone	O
.	O

Analysis	O
of	O
the	O
predicted	O
amino	O
acid	O
sequence	O
revealed	O
13	O
nonidentical	O
repeats	O
similar	O
to	O
repeats	O
found	O
in	O
the	O
A	O
subunit	O
of	O
PP2A	B-Gene_or_gene_product
(	O
PP2AA	O
)	O
.	O

The	O
PP4R1	O
cDNA	O
clone	O
engineered	O
with	O
an	O
N	O
-	O
terminal	O
Myc	O
tag	O
was	O
expressed	O
in	O
COS	O
M6	O
cells	O
and	O
PP4C	B-Gene_or_gene_product
co	O
-	O
immunoprecipitated	O
with	O
Myc	O
-	O
tagged	O
PP4R1	B-Gene_or_gene_product
.	O

These	O
data	O
indicate	O
that	O
one	O
form	O
of	O
PP4	O
is	O
similar	O
to	O
the	O
core	O
complex	O
of	O
PP2A	O
in	O
that	O
it	O
consists	O
of	O
a	O
catalytic	O
subunit	O
and	O
a	O
"	O
PP2AA	O
-	O
like	O
"	O
structural	O
subunit	O
.	O

Conserved	O
residues	O
of	O
human	O
XPG	O
protein	O
important	O
for	O
nuclease	O
activity	O
and	O
function	O
in	O
nucleotide	O
excision	O
repair	O
.	O

The	O
human	O
XPG	O
endonuclease	O
cuts	O
on	O
the	O
3	O
'	O
side	O
of	O
a	O
DNA	O
lesion	O
during	O
nucleotide	O
excision	O
repair	O
.	O

Mutations	O
in	O
XPG	O
can	O
lead	O
to	O
the	O
disorders	O
xeroderma	O
pigmentosum	O
(	O
XP	O
)	O
and	O
Cockayne	O
syndrome	O
.	O

XPG	O
shares	O
sequence	O
similarities	O
in	O
two	O
regions	O
with	O
a	O
family	O
of	O
structure	O
-	O
specific	O
nucleases	O
and	O
exonucleases	O
.	O

To	O
begin	O
defining	O
its	O
catalytic	O
mechanism	O
,	O
we	O
changed	O
highly	O
conserved	O
residues	O
and	O
determined	O
the	O
effects	O
on	O
the	O
endonuclease	O
activity	O
of	O
isolated	O
XPG	O
,	O
its	O
function	O
in	O
open	O
complex	O
formation	O
and	O
dual	O
incision	O
reconstituted	O
with	O
purified	O
proteins	B-Gene_or_gene_product
,	O
and	O
its	O
ability	O
to	O
restore	O
cellular	O
resistance	O
to	O
UV	O
light	O
.	O

The	O
substitution	O
A792V	O
present	O
in	O
two	O
XP	O
complementation	O
group	O
G	O
(	O
XP	O
-	O
G	O
)	O
individuals	O
reduced	O
but	O
did	O
not	O
abolish	O
endonuclease	O
activity	O
,	O
explaining	O
their	O
mild	O
clinical	O
phenotype	O
.	O

Isolated	O
XPG	O
proteins	O
with	O
Asp	O
-	O
77	O
or	O
Glu	O
-	O
791	O
substitutions	O
did	O
not	O
cleave	O
DNA	O
.	O

In	O
the	O
reconstituted	O
repair	O
system	O
,	O
alanine	O
substitutions	O
at	O
these	O
positions	O
permitted	O
open	O
complex	O
formation	O
but	O
were	O
inactive	O
for	O
3	O
'	O
cleavage	O
,	O
whereas	O
D77E	O
and	O
E791D	O
proteins	O
retained	O
considerable	O
activity	O
.	O

The	O
function	O
of	O
each	O
mutant	O
protein	O
in	O
the	O
reconstituted	O
system	O
was	O
mirrored	O
by	O
its	O
ability	O
to	O
restore	O
UV	O
resistance	O
to	O
XP	O
-	O
G	O
cell	O
lines	O
.	O

Hydrodynamic	O
measurements	O
indicated	O
that	O
XPG	O
exists	O
as	O
a	O
monomer	O
in	O
high	O
salt	O
conditions	O
,	O
but	O
immunoprecipitation	O
of	O
intact	O
and	O
truncated	O
XPG	O
proteins	O
showed	O
that	O
XPG	O
polypeptides	O
can	O
interact	O
with	O
each	O
other	O
,	O
suggesting	O
dimerization	O
as	O
an	O
element	O
of	O
XPG	O
function	O
.	O

The	O
mutation	O
results	O
define	O
critical	O
residues	O
in	O
the	O
catalytic	O
center	O
of	O
XPG	O
and	O
strongly	O
suggest	O
that	O
key	O
features	O
of	O
the	O
strand	O
cleavage	O
mechanism	O
and	O
active	O
site	O
structure	O
are	O
shared	O
by	O
members	O
of	O
the	O
nuclease	O
family	O
.	O

Mapping	O
the	O
functional	O
domains	O
of	O
BRCA1	B-Gene_or_gene_product
.	O

Interaction	O
of	O
the	O
ring	O
finger	O
domains	O
of	O
BRCA1	B-Gene_or_gene_product
and	O
BARD1	B-Gene_or_gene_product
.	O

Breast	O
cancer	O
1	O
(	O
BRCA1	B-Gene_or_gene_product
)	O
and	O
BRCA1	O
-	O
associated	O
RING	O
domain	O
1	O
(	O
BARD1	B-Gene_or_gene_product
)	O
are	O
multidomain	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
that	O
interact	O
in	O
vivo	O
via	O
their	O
N	O
-	O
terminal	O
RING	O
finger	O
motif	O
regions	O
.	O

To	O
characterize	O
functional	O
aspects	O
of	O
the	O
BRCA1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
BARD1	I-Gene_or_gene_product
interaction	O
,	O
we	O
have	O
defined	O
the	O
structural	O
domains	O
required	O
for	O
the	O
interaction	O
,	O
as	O
well	O
as	O
their	O
oligomerization	O
state	O
,	O
relative	O
stability	O
,	O
and	O
possible	O
nucleic	O
acid	O
binding	O
activity	O
.	O

We	O
have	O
found	O
that	O
the	O
RING	O
finger	O
motifs	O
do	O
not	O
themselves	O
constitute	O
stable	O
structural	O
domains	O
but	O
are	O
instead	O
part	O
of	O
larger	O
domains	O
comprising	O
residues	O
1	O
-	O
109	O
of	O
BRCA1	B-Gene_or_gene_product
and	O
residues	O
26	O
-	O
119	O
of	O
BARD1	B-Gene_or_gene_product
.	O

These	O
domains	O
exist	O
as	O
homodimers	O
and	O
preferentially	O
form	O
a	O
stable	O
heterodimer	O
.	O

Shorter	O
BRCA1	B-Gene_or_gene_product
RING	O
finger	O
constructs	O
do	O
not	O
interact	O
with	O
BARD1	B-Gene_or_gene_product
or	O
with	O
longer	O
BRCA1	B-Gene_or_gene_product
constructs	I-Gene_or_gene_product
,	O
indicating	O
that	O
the	O
heterodimeric	O
and	O
homodimer	O
interactions	O
are	O
mediated	O
by	O
regions	O
outside	O
the	O
canonical	O
RING	O
finger	O
motif	O
.	O

Nucleic	O
acid	O
binding	O
is	O
a	O
generally	O
proposed	O
function	O
of	O
RING	O
finger	O
domains	O
.	O

We	O
show	O
that	O
neither	O
the	O
homodimers	O
nor	O
the	O
heterodimer	O
displays	O
affinity	O
for	O
nucleic	O
acids	O
,	O
indicating	O
that	O
the	O
proposed	O
roles	O
of	O
BRCA1	B-Gene_or_gene_product
and	O
BARD1	B-Gene_or_gene_product
in	O
DNA	O
repair	O
and	O
/	O
or	O
transcriptional	O
activation	O
must	O
be	O
mediated	O
either	O
by	O
other	O
regions	O
of	O
the	O
proteins	B-Gene_or_gene_product
or	O
by	O
additional	O
cofactors	O
.	O

Characterization	O
of	O
a	O
mutant	O
pancreatic	O
eIF	O
-	O
2alpha	O
kinase	O
,	O
PEK	O
,	O
and	O
co	O
-	O
localization	O
with	O
somatostatin	B-Gene_or_gene_product
in	O
islet	O
delta	O
cells	O
.	O

Phosphorylation	O
of	O
eukaryotic	O
translation	O
initiation	O
factor	O
-	O
2alpha	O
(	O
eIF	O
-	O
2alpha	O
)	O
is	O
one	O
of	O
the	O
key	O
steps	O
where	O
protein	O
synthesis	O
is	O
regulated	O
in	O
response	O
to	O
changes	O
in	O
environmental	O
conditions	O
.	O

The	O
phosphorylation	O
is	O
carried	O
out	O
in	O
part	O
by	O
three	O
distinct	O
eIF	O
-	O
2alpha	O
kinases	O
including	O
mammalian	O
double	O
-	O
stranded	O
RNA	O
-	O
dependent	O
eIF	O
-	O
2alpha	O
kinase	O
(	O
PKR	O
)	O
and	O
heme	O
-	O
regulated	O
inhibitor	O
kinase	O
(	O
HRI	O
)	O
,	O
and	O
yeast	O
GCN2	O
.	O

We	O
report	O
the	O
identification	O
and	O
characterization	O
of	O
a	O
related	O
kinase	O
,	O
PEK	O
,	O
which	O
shares	O
common	O
features	O
with	O
other	O
eIF	O
-	O
2alpha	O
kinases	O
including	O
phosphorylation	O
of	O
eIF	O
-	O
2alpha	O
in	O
vitro	O
.	O

We	O
show	O
that	O
human	O
PEK	O
is	O
regulated	O
by	O
different	O
mechanisms	O
than	O
PKR	O
or	O
HRI	O
.	O

In	O
contrast	O
to	O
PKR	O
or	O
HRI	O
,	O
which	O
are	O
dependent	O
on	O
autophosphorylation	O
for	O
their	O
kinase	O
activity	O
,	O
a	O
point	O
mutation	O
that	O
replaced	O
the	O
conserved	O
Lys	O
-	O
614	O
with	O
an	O
alanine	O
completely	O
abolished	O
the	O
eIF	O
-	O
2alpha	O
kinase	O
activity	O
,	O
whereas	O
the	O
mutant	O
PEK	O
was	O
still	O
autophosphorylated	O
when	O
expressed	O
in	O
Sf	O
-	O
9	O
cells	O
.	O

Northern	O
blot	O
analysis	O
indicates	O
that	O
PEK	O
mRNA	O
was	O
predominantly	O
expressed	O
in	O
pancreas	O
,	O
though	O
low	O
expression	O
was	O
also	O
present	O
in	O
several	O
tissues	O
.	O

Consistent	O
with	O
the	O
high	O
levels	O
of	O
mRNA	O
in	O
pancreas	O
,	O
the	O
PEK	O
protein	O
was	O
only	O
detected	O
in	O
human	O
pancreatic	O
islets	O
,	O
and	O
the	O
kinase	O
co	O
-	O
localized	O
with	O
somatostatin	O
,	O
a	O
pancreatic	O
delta	O
cell	O
-	O
specific	O
hormone	O
.	O

Thus	O
PEK	O
is	O
believed	O
to	O
play	O
an	O
important	O
role	O
in	O
regulating	O
protein	O
synthesis	O
in	O
the	O
pancreatic	O
islet	O
,	O
especially	O
in	O
islet	O
delta	O
cells	O
.	O

Cell	O
adhesion	O
regulates	O
the	O
interaction	O
between	O
the	O
docking	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
p130	I-Gene_or_gene_product
(	I-Gene_or_gene_product
Cas	I-Gene_or_gene_product
)	I-Gene_or_gene_product
and	O
the	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Integrin	B-Gene_or_gene_product
ligand	O
binding	O
induces	O
a	O
signaling	O
complex	O
formation	O
via	O
the	O
direct	O
association	O
of	O
the	O
docking	O
protein	O
p130	O
(	O
Cas	O
)	O
(	O
Cas	B-Gene_or_gene_product
)	O
with	O
diverse	O
molecules	O
.	O

We	O
report	O
here	O
that	O
the	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3zeta	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
interacts	O
with	O
Cas	B-Gene_or_gene_product
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
assay	O
.	O

We	O
also	O
found	O
that	O
the	O
two	O
proteins	B-Gene_or_gene_product
associate	O
in	O
mammalian	O
cells	O
and	O
that	O
this	O
interaction	O
takes	O
place	O
in	O
a	O
phosphoserine	O
-	O
dependent	O
manner	O
,	O
because	O
treatment	O
of	O
Cas	B-Gene_or_gene_product
with	O
a	O
serine	O
phosphatase	O
greatly	O
reduced	O
its	O
ability	O
to	O
bind	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3zeta	I-Gene_or_gene_product
.	O

Furthermore	O
,	O
the	O
Cas	B-Gene_or_gene_product
-	I-Gene_or_gene_product
14	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3zeta	I-Gene_or_gene_product
interaction	O
was	O
found	O
to	O
be	O
regulated	O
by	O
integrin	B-Gene_or_gene_product
-	O
mediated	O
cell	O
adhesion	O
.	O

Thus	O
,	O
when	O
cells	O
are	O
detached	O
from	O
the	O
extracellular	O
matrix	O
,	O
the	O
binding	O
of	O
Cas	B-Gene_or_gene_product
to	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3zeta	I-Gene_or_gene_product
is	O
greatly	O
diminished	O
,	O
whereas	O
replating	O
the	O
cells	O
onto	O
fibronectin	O
rapidly	O
induces	O
the	O
association	O
.	O

Consistent	O
with	O
these	O
results	O
,	O
we	O
found	O
that	O
the	O
subcellular	O
localization	O
of	O
Cas	B-Gene_or_gene_product
and	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
is	O
also	O
regulated	O
by	O
integrin	B-Gene_or_gene_product
ligand	O
binding	O
and	O
that	O
the	O
two	O
proteins	B-Gene_or_gene_product
display	O
a	O
significant	O
co	O
-	O
localization	O
during	O
cell	O
attachment	O
to	O
the	O
extracellular	O
matrix	O
.	O

In	O
conclusion	O
,	O
our	O
results	O
demonstrate	O
that	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
participate	O
in	O
integrin	B-Gene_or_gene_product
-	O
activated	O
signaling	O
pathways	O
through	O
their	O
interaction	O
with	O
Cas	B-Gene_or_gene_product
,	O
which	O
,	O
in	O
turn	O
,	O
may	O
contribute	O
to	O
important	O
biological	O
responses	O
regulated	O
by	O
cell	O
adhesion	O
to	O
the	O
extracellular	O
matrix	O
.	O

A	O
novel	O
PDZ	O
domain	O
containing	O
guanine	B-Gene_or_gene_product
nucleotide	I-Gene_or_gene_product
exchange	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
links	O
heterotrimeric	B-Gene_or_gene_product
G	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
to	O
Rho	B-Gene_or_gene_product
.	O

Small	B-Gene_or_gene_product
GTP	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
of	O
the	O
Rho	B-Gene_or_gene_product
family	O
play	O
a	O
critical	O
role	O
in	O
signal	O
transduction	O
.	O

However	O
,	O
there	O
is	O
still	O
very	O
limited	O
information	O
on	O
how	O
they	O
are	O
activated	O
by	O
cell	O
surface	O
receptors	B-Gene_or_gene_product
.	O

Here	O
,	O
we	O
used	O
a	O
consensus	O
sequence	O
for	O
Dbl	O
domains	O
of	O
Rho	B-Gene_or_gene_product
guanine	I-Gene_or_gene_product
nucleotide	I-Gene_or_gene_product
exchange	I-Gene_or_gene_product
factors	I-Gene_or_gene_product
(	O
GEFs	B-Gene_or_gene_product
)	O
to	O
search	O
DNA	O
data	O
bases	O
,	O
and	O
identified	O
a	O
novel	O
human	O
GEF	B-Gene_or_gene_product
for	O
Rho	B-Gene_or_gene_product
-	O
related	O
GTPases	O
harboring	O
structural	O
features	O
indicative	O
of	O
its	O
possible	O
regulatory	O
mechanism	O
(	O
s	O
)	O
.	O

This	O
protein	B-Gene_or_gene_product
contained	O
a	O
tandem	O
DH	O
/	O
PH	O
domain	O
closely	O
related	O
to	O
those	O
of	O
Rho	B-Gene_or_gene_product
-	O
specific	O
GEFs	B-Gene_or_gene_product
,	O
a	O
PDZ	O
domain	O
,	O
a	O
proline	O
-	O
rich	O
domain	O
,	O
and	O
an	O
area	O
of	O
homology	O
to	O
Lsc	B-Gene_or_gene_product
,	O
p115	B-Gene_or_gene_product
-	I-Gene_or_gene_product
RhoGEF	I-Gene_or_gene_product
,	O
and	O
a	O
Drosophila	O
RhoGEF	B-Gene_or_gene_product
that	O
was	O
termed	O
Lsc	O
-	O
homology	O
(	O
LH	O
)	O
domain	O
.	O

This	O
novel	O
molecule	O
,	O
designated	O
PDZ	B-Gene_or_gene_product
-	I-Gene_or_gene_product
RhoGEF	I-Gene_or_gene_product
,	O
activated	O
biological	O
and	O
biochemical	O
pathways	O
specific	O
for	O
Rho	B-Gene_or_gene_product
,	O
and	O
activation	O
of	O
these	O
pathways	O
required	O
an	O
intact	O
DH	O
and	O
PH	O
domain	O
.	O

However	O
,	O
the	O
PDZ	O
domain	O
was	O
dispensable	O
for	O
these	O
functions	O
,	O
and	O
mutants	O
lacking	O
the	O
LH	O
domain	O
were	O
more	O
active	O
,	O
suggesting	O
a	O
negative	O
regulatory	O
role	O
for	O
the	O
LH	O
domain	O
.	O

A	O
search	O
for	O
additional	O
molecules	O
exhibiting	O
an	O
LH	O
domain	O
revealed	O
a	O
limited	O
homology	O
with	O
the	O
catalytic	O
region	O
of	O
a	O
newly	O
identified	O
GTPase	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activating	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
for	O
heterotrimeric	B-Gene_or_gene_product
G	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
RGS14	B-Gene_or_gene_product
.	O

This	O
prompted	O
us	O
to	O
investigate	O
whether	O
PDZ	B-Gene_or_gene_product
-	I-Gene_or_gene_product
RhoGEF	I-Gene_or_gene_product
could	O
interact	O
with	O
representative	O
members	O
of	O
each	O
G	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
family	O
.	O

We	O
found	O
that	O
PDZ	B-Gene_or_gene_product
-	I-Gene_or_gene_product
RhoGEF	I-Gene_or_gene_product
was	O
able	O
to	O
form	O
,	O
in	O
vivo	O
,	O
stable	O
complexes	O
with	O
two	O
members	O
of	O
the	O
Galpha12	B-Gene_or_gene_product
family	O
,	O
Galpha12	B-Gene_or_gene_product
and	O
Galpha13	B-Gene_or_gene_product
,	O
and	O
that	O
this	O
interaction	O
was	O
mediated	O
by	O
the	O
LH	O
domain	O
.	O

Furthermore	O
,	O
we	O
obtained	O
evidence	O
to	O
suggest	O
that	O
PDZ	B-Gene_or_gene_product
-	I-Gene_or_gene_product
RhoGEF	I-Gene_or_gene_product
mediates	O
the	O
activation	O
of	O
Rho	B-Gene_or_gene_product
by	O
Galpha12	B-Gene_or_gene_product
and	O
Galpha13	B-Gene_or_gene_product
.	O

Together	O
,	O
these	O
findings	O
suggest	O
the	O
existence	O
of	O
a	O
novel	O
mechanism	O
whereby	O
the	O
large	O
family	O
of	O
cell	O
surface	O
receptors	B-Gene_or_gene_product
that	O
transmit	O
signals	O
through	O
heterotrimeric	B-Gene_or_gene_product
G	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
activate	O
Rho	O
-	O
dependent	O
pathways	O
:	O
by	O
stimulating	O
the	O
activity	O
of	O
members	O
of	O
the	O
Galpha12	B-Gene_or_gene_product
family	O
which	O
,	O
in	O
turn	O
,	O
activate	O
an	O
exchange	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
acting	O
on	O
Rho	B-Gene_or_gene_product
.	O

Human	O
geranylgeranyl	O
diphosphate	O
synthase	O
.	O

cDNA	O
cloning	O
and	O
expression	O
.	O

Geranylgeranyl	O
diphosphate	O
(	O
GGPP	O
)	O
synthase	O
(	O
GGPPSase	O
)	O
catalyzes	O
the	O
synthesis	O
of	O
GGPP	O
,	O
which	O
is	O
an	O
important	O
molecule	O
responsible	O
for	O
the	O
C20	B-Gene_or_gene_product
-	I-Gene_or_gene_product
prenylated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
biosynthesis	O
and	O
for	O
the	O
regulation	O
of	O
a	O
nuclear	O
hormone	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
LXR	O
.	O
RXR	O
)	O
.	O

The	O
human	O
GGPPSase	O
cDNA	O
encodes	O
a	O
protein	B-Gene_or_gene_product
of	O
300	O
amino	O
acids	O
which	O
shows	O
16	O
%	O
sequence	O
identity	O
with	O
the	O
known	O
human	O
farnesyl	O
diphosphate	O
(	O
FPP	O
)	O
synthase	O
(	O
FPPSase	O
)	O
.	O

The	O
GGPPSase	O
expressed	O
in	O
Escherichia	O
coli	O
catalyzes	O
the	O
GGPP	O
formation	O
(	O
240	O
nmol	O
/	O
min	O
/	O
mg	O
)	O
from	O
FPP	O
and	O
isopentenyl	O
diphosphate	O
.	O

The	O
human	O
GGPPSase	O
behaves	O
as	O
an	O
oligomeric	O
molecule	O
with	O
280	O
kDa	O
on	O
a	O
gel	O
filtration	O
column	O
and	O
cross	O
-	O
reacts	O
with	O
an	O
antibody	O
directed	O
against	O
bovine	O
brain	O
GGPPSase	O
,	O
which	O
differs	O
immunochemically	O
from	O
bovine	O
brain	O
FPPSase	O
.	O

Northern	O
blot	O
analysis	O
indicates	O
the	O
presence	O
of	O
two	O
forms	O
of	O
the	O
mRNA	O
.	O

Skeletal	B-Gene_or_gene_product
muscle	I-Gene_or_gene_product
type	I-Gene_or_gene_product
ryanodine	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
is	O
involved	O
in	O
calcium	O
signaling	O
in	O
human	O
B	O
lymphocytes	O
.	O

The	O
regulation	O
of	O
intracellular	O
free	O
Ca2	O
+	O
concentration	O
(	O
[	O
Ca2	O
+	O
]	O
i	O
)	O
in	O
B	O
cells	O
remains	O
poorly	O
understood	O
and	O
is	O
presently	O
explained	O
almost	O
solely	O
by	O
inositol	O
1	O
,	O
4	O
,	O
5	O
-	O
triphosphate	O
(	O
IP3	O
)	O
-	O
mediated	O
Ca2	O
+	O
release	O
,	O
followed	O
by	O
activation	O
of	O
a	O
store	O
-	O
operated	O
channel	O
mechanism	O
.	O

In	O
fact	O
,	O
there	O
are	O
reports	O
indicating	O
that	O
IP3	O
production	O
does	O
not	O
always	O
correlate	O
with	O
the	O
magnitude	O
of	O
Ca2	O
+	O
release	O
.	O

We	O
demonstrate	O
here	O
that	O
human	O
B	O
cells	O
express	O
a	O
ryanodine	O
receptor	O
(	O
RYR	B-Gene_or_gene_product
)	O
that	O
functions	O
as	O
a	O
Ca2	O
+	O
release	O
channel	B-Gene_or_gene_product
during	O
the	O
B	O
cell	O
antigen	O
receptor	O
(	O
BCR	B-Gene_or_gene_product
)	O
-	O
stimulated	O
Ca2	O
+	O
signaling	O
process	O
.	O

Immunoblotting	O
studies	O
showed	O
that	O
both	O
human	O
primary	O
CD19	O
(	O
+	O
)	O
B	O
and	O
DAKIKI	O
cells	O
express	O
a	O
565	O
-	O
kDa	O
immunoreactive	O
protein	B-Gene_or_gene_product
that	O
is	O
indistinguishable	O
in	O
molecular	O
size	O
and	O
immunoreactivity	O
from	O
the	O
RYR	B-Gene_or_gene_product
.	O

Selective	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
,	O
restriction	O
fragment	O
length	O
polymorphism	O
,	O
and	O
sequencing	O
of	O
cloned	O
cDNA	O
indicated	O
that	O
the	O
major	O
isoform	O
of	O
the	O
RYR	B-Gene_or_gene_product
expressed	O
in	O
primary	O
CD19	O
(	O
+	O
)	O
B	O
and	O
DAKIKI	O
cells	O
is	O
identical	O
to	O
the	O
skeletal	O
muscle	O
type	O
(	O
RYR1	B-Gene_or_gene_product
)	O
.	O

Saturation	O
analysis	O
of	O
[	O
3H	O
]	O
ryanodine	O
binding	O
yielded	O
Bmax	O
=	O
150	O
fmol	O
/	O
mg	O
of	O
protein	B-Gene_or_gene_product
and	O
Kd	O
=	O
110	O
nM	O
in	O
DAKIKI	O
cells	O
.	O

In	O
fluo	O
-	O
3	O
-	O
loaded	O
CD19	O
(	O
+	O
)	O
B	O
and	O
DAKIKI	O
cells	O
,	O
4	O
-	O
chloro	O
-	O
m	O
-	O
cresol	O
,	O
a	O
potent	O
activator	O
of	O
Ca2	O
+	O
release	O
mediated	O
by	O
the	O
ryanodine	O
-	O
sensitive	O
Ca2	O
+	O
release	O
channel	B-Gene_or_gene_product
,	O
induced	O
Ca2	O
+	O
release	O
in	O
a	O
dose	O
-	O
dependent	O
and	O
ryanodine	O
-	O
sensitive	O
fashion	O
.	O

Furthermore	O
,	O
BCR	B-Gene_or_gene_product
-	O
mediated	O
Ca2	O
+	O
release	O
in	O
CD19	O
(	O
+	O
)	O
B	O
cells	O
was	O
significantly	O
altered	O
by	O
4	O
-	O
chloro	O
-	O
m	O
-	O
cresol	O
and	O
ryanodine	O
.	O

These	O
results	O
indicate	O
that	O
RYR1	B-Gene_or_gene_product
functions	O
as	O
a	O
Ca2	O
+	O
release	O
channel	B-Gene_or_gene_product
during	O
BCR	B-Gene_or_gene_product
-	O
stimulated	O
Ca2	O
+	O
signaling	O
and	O
suggest	O
that	O
complex	O
Ca2	O
+	O
signals	O
that	O
control	O
the	O
cellular	O
activities	O
of	O
B	O
cells	O
may	O
be	O
generated	O
by	O
cooperation	O
of	O
the	O
IP3	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
and	O
RYR1	B-Gene_or_gene_product
.	O

Zinc	O
-	O
binding	O
site	O
of	O
an	O
S100	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
revealed	O
.	O

Two	O
crystal	O
structures	O
of	O
Ca2	O
+	O
-	O
bound	O
human	O
psoriasin	B-Gene_or_gene_product
(	O
S100A7	B-Gene_or_gene_product
)	O
in	O
the	O
Zn2	O
+	O
-	O
loaded	O
and	O
Zn2	O
+	O
-	O
free	O
states	O
.	O

The	O
crystal	O
structure	O
of	O
human	O
psoriasin	B-Gene_or_gene_product
(	O
S100A7	B-Gene_or_gene_product
)	O
in	O
the	O
native	O
,	O
calcium	O
-	O
bound	O
form	O
has	O
been	O
determined	O
from	O
two	O
crystal	O
forms	O
of	O
the	O
protein	B-Gene_or_gene_product
crystallized	O
with	O
and	O
without	O
divalent	O
zinc	O
.	O

The	O
overall	O
structures	O
of	O
the	O
dimeric	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
closely	O
resemble	O
the	O
previously	O
determined	O
holmium	O
-	O
substituted	O
structure	O
.	O

The	O
structures	O
also	O
reveal	O
a	O
zinc	O
-	O
binding	O
site	O
of	O
the	O
protein	B-Gene_or_gene_product
,	O
which	O
is	O
formed	O
by	O
three	O
histidines	O
and	O
an	O
aspartate	O
residue	O
.	O

Together	O
,	O
these	O
residues	O
coordinate	O
the	O
zinc	O
ion	O
in	O
a	O
way	O
similar	O
to	O
the	O
pattern	O
seen	O
in	O
certain	O
metalloproteases	O
and	O
in	O
particular	O
the	O
collagenase	O
family	O
of	O
proteins	B-Gene_or_gene_product
.	O

Sequence	O
comparison	O
suggests	O
that	O
this	O
zinc	O
site	O
is	O
present	O
in	O
a	O
number	O
of	O
the	O
remaining	O
members	O
of	O
the	O
S100	B-Gene_or_gene_product
family	O
.	O

The	O
structure	O
of	O
S100A7	B-Gene_or_gene_product
crystallized	O
in	O
the	O
absence	O
of	O
zinc	O
further	O
shows	O
that	O
loss	O
of	O
zinc	O
results	O
in	O
a	O
reorganization	O
of	O
the	O
adjacent	O
empty	O
and	O
distorted	O
EF	O
-	O
hand	O
loop	O
,	O
causing	O
it	O
to	O
resemble	O
a	O
calcium	O
-	O
loaded	O
EF	O
-	O
hand	O
.	O

Formiminotransferase	O
cyclodeaminase	O
is	O
an	O
organ	B-Gene_or_gene_product
-	I-Gene_or_gene_product
specific	I-Gene_or_gene_product
autoantigen	I-Gene_or_gene_product
recognized	O
by	O
sera	O
of	O
patients	O
with	O
autoimmune	O
hepatitis	O
.	O

Anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
liver	I-Gene_or_gene_product
cytosol	I-Gene_or_gene_product
type	I-Gene_or_gene_product
1	I-Gene_or_gene_product
autoantibodies	I-Gene_or_gene_product
have	O
been	O
reported	O
in	O
association	O
with	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
liver	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kidney	I-Gene_or_gene_product
microsome	I-Gene_or_gene_product
type	I-Gene_or_gene_product
1	I-Gene_or_gene_product
autoantibodies	I-Gene_or_gene_product
in	O
30	O
%	O
of	O
patients	O
with	O
autoimmune	O
hepatitis	O
type	O
II	O
.	O

In	O
10	O
%	O
of	O
cases	O
,	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
liver	I-Gene_or_gene_product
cytosol	I-Gene_or_gene_product
type	I-Gene_or_gene_product
1	I-Gene_or_gene_product
antibodies	I-Gene_or_gene_product
are	O
the	O
only	O
liver	O
-	O
related	O
circulating	O
autoantibodies	B-Gene_or_gene_product
.	O

The	O
liver	B-Gene_or_gene_product
cytosol	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
is	O
a	O
liver	O
-	O
specific	O
62	O
-	O
kilodalton	O
protein	O
present	O
in	O
the	O
cell	O
as	O
an	O
oligomer	O
of	O
approximately	O
240	O
kilodaltons	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
antigen	O
recognized	O
by	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
liver	I-Gene_or_gene_product
cytosol	I-Gene_or_gene_product
antibody	I-Gene_or_gene_product
.	O

To	O
identify	O
the	O
liver	B-Gene_or_gene_product
cytosol	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
,	O
an	O
anti	O
-	O
liver	O
cytosol	O
type	O
1	O
-	O
positive	O
serum	O
was	O
used	O
for	O
the	O
screening	O
of	O
a	O
complementary	O
DNA	O
library	O
from	O
HepG2	O
cells	O
.	O

Double	O
immunodiffusion	O
method	O
was	O
used	O
to	O
show	O
the	O
identity	O
between	O
the	O
cytosolic	O
and	O
the	O
cloned	O
protein	O
.	O

The	O
sequence	O
of	O
two	O
isolated	O
clones	O
showed	O
85	O
.	O
2	O
%	O
homology	O
with	O
the	O
formiminotransferase	O
cyclodeaminase	O
(	O
FTCD	O
)	O
enzyme	O
from	O
pig	O
liver	O
.	O

Antibodies	B-Gene_or_gene_product
purified	O
by	O
affinity	O
with	O
the	O
recombinant	O
protein	O
and	O
sera	O
from	O
mice	O
immunized	O
with	O
FTCD	O
recognized	O
a	O
62	O
-	O
kilodalton	O
human	O
cytosolic	O
protein	O
when	O
tested	O
by	O
immunoblot	O
.	O

The	O
identity	O
of	O
precipitation	O
lines	O
was	O
found	O
between	O
the	O
cytosolic	O
antigen	O
and	O
FTCD	O
.	O

This	O
enzyme	O
is	O
a	O
liver	B-Gene_or_gene_product
-	I-Gene_or_gene_product
specific	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
recognized	O
by	O
the	O
sera	O
of	O
patients	O
with	O
autoimmune	O
hepatitis	O
.	O

Identification	O
of	O
a	O
human	O
HECT	B-Gene_or_gene_product
family	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
with	O
homology	O
to	O
the	O
Drosophila	O
tumor	B-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
hyperplastic	B-Gene_or_gene_product
discs	I-Gene_or_gene_product
.	O

Use	O
of	O
the	O
differential	O
display	O
technique	O
to	O
isolate	O
progestin	O
-	O
regulated	O
genes	B-Gene_or_gene_product
in	O
T	O
-	O
47D	O
human	O
breast	O
cancer	O
cells	O
led	O
to	O
identification	O
of	O
a	O
novel	O
gene	O
,	O
EDD	B-Gene_or_gene_product
.	O

The	O
cDNA	O
sequence	O
contains	O
a	O
2799	O
amino	O
acid	O
open	O
reading	O
frame	O
sharing	O
40	O
%	O
identity	O
with	O
the	O
predicted	O
2894	O
amino	O
acid	O
product	O
of	O
the	O
Drosophila	O
melanogaster	O
tumor	B-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
hyperplastic	B-Gene_or_gene_product
discs	I-Gene_or_gene_product
,	O
while	O
the	O
carboxy	O
-	O
terminal	O
889	O
amino	O
acids	O
show	O
96	O
%	O
identity	O
to	O
a	O
rat	O
100	O
kDa	O
HECT	B-Gene_or_gene_product
domain	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

EDD	O
mRNA	O
was	O
progestin	O
-	O
induced	O
in	O
T	O
-	O
47D	O
cells	O
and	O
was	O
highly	O
abundant	O
in	O
testes	O
and	O
expressed	O
at	O
moderately	O
high	O
levels	O
in	O
other	O
tissues	O
,	O
suggesting	O
a	O
broad	O
role	O
for	O
EDD	B-Gene_or_gene_product
.	O

Anti	O
-	O
EDD	O
antibodies	O
immunoprecipitated	O
an	O
approximately	O
300	O
kDa	O
protein	B-Gene_or_gene_product
from	O
T	O
-	O
47D	O
cell	O
lysates	O
.	O

HECT	B-Gene_or_gene_product
family	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
function	O
as	O
E3	O
ubiquitin	O
-	O
protein	O
ligases	O
,	O
targeting	O
specific	O
proteins	O
for	O
ubiquitin	B-Gene_or_gene_product
-	O
mediated	O
proteolysis	O
.	O

EDD	B-Gene_or_gene_product
is	O
likely	O
to	O
function	O
as	O
an	O
E3	O
as	O
in	O
vitro	O
translated	O
protein	O
bound	O
ubiquitin	B-Gene_or_gene_product
reversibly	O
through	O
a	O
conserved	O
HECT	O
domain	O
cysteine	O
residue	O
.	O

EDD	B-Gene_or_gene_product
was	O
localized	O
by	O
FISH	O
to	O
chromosome	O
8q22	O
,	O
a	O
locus	O
disrupted	O
in	O
a	O
variety	O
of	O
cancers	O
.	O

Given	O
the	O
homology	O
between	O
EDD	B-Gene_or_gene_product
and	O
the	O
hyperplastic	B-Gene_or_gene_product
discs	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
which	O
is	O
required	O
for	O
control	O
of	O
imaginal	O
disc	O
growth	O
in	O
Drosophila	O
,	O
EDD	B-Gene_or_gene_product
potentially	O
has	O
a	O
role	O
in	O
regulation	O
of	O
cell	O
proliferation	O
or	O
differentiation	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
human	O
homologue	O
of	O
the	O
latrophilin	B-Gene_or_gene_product
gene	B-Gene_or_gene_product
from	O
a	O
region	O
of	O
1p31	O
.	O
1	O
implicated	O
in	O
breast	O
cancer	O
.	O

We	O
have	O
identified	O
a	O
region	O
of	O
chromosome	O
1p31	O
.	O
1	O
that	O
shows	O
high	O
frequency	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
in	O
human	O
breast	O
cancer	O
.	O

This	O
region	O
forms	O
part	O
of	O
a	O
7	O
Mb	O
YAC	O
/	O
BAC	O
contig	O
.	O

In	O
order	O
to	O
identify	O
candidate	O
sequences	O
,	O
mutation	O
of	O
which	O
might	O
contribute	O
to	O
the	O
development	O
of	O
disease	O
,	O
we	O
have	O
carried	O
out	O
mapping	O
studies	O
of	O
ESTs	O
localized	O
to	O
1p31	O
.	O
1	O
.	O

This	O
analysis	O
,	O
coupled	O
with	O
library	O
screening	O
and	O
a	O
modified	O
5	O
'	O
RACE	O
-	O
PCR	O
strategy	O
,	O
resulted	O
in	O
the	O
identification	O
and	O
characterization	O
of	O
a	O
novel	O
gene	B-Gene_or_gene_product
(	O
LPHH1	B-Gene_or_gene_product
)	O
which	O
is	O
located	O
adjacent	O
to	O
the	O
smallest	O
region	O
of	O
overlapping	O
loss	O
(	O
SRO	O
)	O
seen	O
in	O
tumours	O
.	O

The	O
4209	O
bp	O
open	O
reading	O
frame	O
of	O
the	O
7	O
kb	O
LPHH1	B-Gene_or_gene_product
transcript	O
encodes	O
a	O
peptide	O
which	O
shows	O
approximately	O
65	O
%	O
identity	O
to	O
rat	O
latrophilin	B-Gene_or_gene_product
,	O
a	O
G	O
-	O
coupled	O
,	O
seven	O
span	O
transmembrane	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
which	O
binds	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
latrotoxin	I-Gene_or_gene_product
.	O

In	O
the	O
human	O
sequence	O
,	O
whilst	O
conservation	O
of	O
the	O
transmembrane	O
domain	O
is	O
high	O
,	O
the	O
intra	O
-	O
and	O
extracellular	O
domains	O
show	O
two	O
regions	O
of	O
variable	O
structure	O
,	O
which	O
are	O
presumably	O
generated	O
by	O
alternative	O
splicing	O
.	O

Surprisingly	O
,	O
while	O
expression	O
of	O
the	O
rat	O
gene	B-Gene_or_gene_product
is	O
tightly	O
restricted	O
to	O
neurological	O
and	O
perhaps	O
some	O
endocrine	O
cells	O
,	O
the	O
human	O
sequence	O
appears	O
to	O
be	O
expressed	O
very	O
widely	O
in	O
all	O
normal	O
tissues	O
tested	O
.	O

Northern	O
and	O
RT	O
-	O
PCR	O
analysis	O
of	O
a	O
panel	O
of	O
tumour	O
cell	O
lines	O
showed	O
that	O
LPHH1	B-Gene_or_gene_product
expression	O
was	O
variable	O
,	O
apparently	O
elevated	O
in	O
some	O
lines	O
and	O
absent	O
or	O
markedly	O
reduced	O
in	O
others	O
.	O

Furthermore	O
,	O
characterization	O
of	O
the	O
range	O
of	O
transcripts	O
encoded	O
in	O
a	O
breast	O
tumour	O
cell	O
line	O
,	O
compared	O
to	O
normal	O
breast	O
,	O
suggested	O
that	O
gene	O
product	O
variability	O
was	O
higher	O
in	O
the	O
tumour	O
.	O

Discovery	O
of	O
three	O
novel	O
orphan	O
G	B-Gene_or_gene_product
-	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
coupled	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O

We	O
have	O
discovered	O
three	O
novel	O
human	O
genes	B-Gene_or_gene_product
,	O
GPR34	B-Gene_or_gene_product
,	O
GPR44	B-Gene_or_gene_product
,	O
and	O
GPR45	B-Gene_or_gene_product
,	O
encoding	O
family	O
A	O
G	B-Gene_or_gene_product
-	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
coupled	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
(	O
GPCRs	B-Gene_or_gene_product
)	O
.	O

The	O
receptor	B-Gene_or_gene_product
encoded	O
by	O
GPR34	B-Gene_or_gene_product
is	O
most	O
similar	O
to	O
the	O
P2Y	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
subfamily	I-Gene_or_gene_product
,	O
while	O
the	O
receptor	B-Gene_or_gene_product
encoded	O
by	O
GPR44	B-Gene_or_gene_product
is	O
most	O
similar	O
to	O
chemoattractant	B-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O

The	O
receptor	B-Gene_or_gene_product
encoded	O
by	O
GPR45	B-Gene_or_gene_product
is	O
the	O
mammalian	O
orthologue	O
of	O
a	O
putative	O
lysophosphatidic	B-Gene_or_gene_product
acid	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
from	O
Xenopus	O
laevis	O
.	O

Partial	O
sequence	O
of	O
GPR34	B-Gene_or_gene_product
was	O
discovered	O
during	O
a	O
search	O
of	O
the	O
GenBank	O
database	O
of	O
expressed	O
sequence	O
tags	O
(	O
ESTs	O
)	O
.	O

This	O
sequence	O
information	O
was	O
used	O
both	O
to	O
isolate	O
the	O
full	O
-	O
length	O
translational	O
open	O
reading	O
frame	O
from	O
a	O
human	O
genomic	O
library	O
and	O
to	O
assemble	O
a	O
contig	O
from	O
additional	O
GPR34	B-Gene_or_gene_product
EST	O
cDNAs	O
.	O

Northern	O
blot	O
and	O
in	O
situ	O
hybridization	O
analyses	O
revealed	O
GPR34	B-Gene_or_gene_product
mRNA	O
transcripts	O
in	O
several	O
human	O
and	O
rat	O
brain	O
regions	O
.	O

Also	O
,	O
we	O
used	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
to	O
amplify	O
human	O
genomic	O
DNA	O
using	O
degenerate	O
oligonucleotides	O
designed	O
from	O
sequences	O
encoding	O
transmembrane	O
domains	O
3	O
and	O
7	O
of	O
opioid	B-Gene_or_gene_product
and	I-Gene_or_gene_product
somatostatin	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O

Two	O
PCR	O
products	O
partially	O
encoding	O
novel	O
GPCRs	B-Gene_or_gene_product
,	O
named	O
GPR44	B-Gene_or_gene_product
and	O
GPR45	B-Gene_or_gene_product
,	O
were	O
discovered	O
and	O
used	O
to	O
isolate	O
the	O
full	O
-	O
length	O
translational	O
open	O
reading	O
frames	O
from	O
a	O
human	O
genomic	O
library	O
.	O

Both	O
GPR44	B-Gene_or_gene_product
and	O
GPR45	B-Gene_or_gene_product
are	O
expressed	O
in	O
the	O
central	O
nervous	O
system	O
and	O
periphery	O
.	O

For	O
chromosomal	O
localization	O
,	O
fluorescence	O
in	O
situ	O
hybridization	O
analysis	O
was	O
performed	O
to	O
assign	O
GPR34	B-Gene_or_gene_product
to	O
chromosomes	O
4p12	O
and	O
Xp11	O
.	O

3	O
,	O
GPR44	B-Gene_or_gene_product
to	O
chromosome	O
11q12	O
-	O
q13	O
.	O
3	O
,	O
and	O
GPR45	B-Gene_or_gene_product
to	O
chromosome	O
2q11	O
.	O

1	O
-	O
q12	O
.	O

A	O
gene	B-Gene_or_gene_product
upregulated	O
in	O
the	O
acoustically	O
damaged	O
chick	O
basilar	O
papilla	O
encodes	O
a	O
novel	O
WD40	B-Gene_or_gene_product
repeat	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

The	O
chick	O
WDR1	B-Gene_or_gene_product
gene	O
is	O
expressed	O
at	O
higher	O
levels	O
in	O
the	O
chick	O
basilar	O
papilla	O
after	O
acoustic	O
overstimulation	O
.	O

The	O
3	O
.	O
3	O
-	O
kb	O
WDR1	O
cDNA	O
encodes	O
a	O
novel	O
67	O
-	O
kDa	O
protein	B-Gene_or_gene_product
containing	O
nine	O
WD40	O
repeats	O
,	O
motifs	O
that	O
mediate	O
protein	O
-	O
protein	O
interactions	O
.	O

The	O
predicted	O
WDR1	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
has	O
high	O
sequence	O
identity	O
to	O
WD40	B-Gene_or_gene_product
-	I-Gene_or_gene_product
repeat	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
in	O
budding	O
yeast	O
(	O
Saccharomyces	O
cerevisiae	O
)	O
,	O
two	O
slime	O
molds	O
(	O
Dictyostelium	O
discoideum	O
and	O
Physarum	O
polycephalum	O
)	O
,	O
and	O
the	O
roundworm	O
(	O
Caenorhabditis	O
elegans	O
)	O
.	O

The	O
yeast	O
and	O
P	O
.	O
polycephalum	O
proteins	B-Gene_or_gene_product
bind	O
actin	B-Gene_or_gene_product
,	O
suggesting	O
that	O
the	O
novel	O
chick	O
protein	B-Gene_or_gene_product
may	O
be	O
an	O
actin	B-Gene_or_gene_product
-	O
binding	O
protein	O
.	O

Sequence	O
database	O
comparisons	O
identified	O
mouse	O
and	O
human	O
cDNAs	O
with	O
high	O
sequence	O
identity	O
to	O
the	O
chick	O
WDR1	O
cDNA	O
.	O

The	O
mouse	O
Wdr1	B-Gene_or_gene_product
and	O
human	O
WDR1	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
showed	O
95	O
%	O
sequence	O
identity	O
to	O
each	O
other	O
and	O
86	O
%	O
identity	O
to	O
the	O
chick	O
WDR1	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

Northern	O
blot	O
analysis	O
of	O
total	O
RNA	O
from	O
the	O
chick	O
basilar	O
papilla	O
after	O
noise	O
trauma	O
revealed	O
increased	O
levels	O
of	O
a	O
3	O
.	O
1	O
-	O
kb	O
transcript	O
in	O
the	O
lesioned	O
area	O
.	O

The	O
WDR1	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
was	O
mapped	O
to	O
human	O
chromosome	O
4	O
,	O
between	O
22	O
and	O
24	O
cM	O
from	O
the	O
telomere	O
of	O
4p	O
.	O

DCAMKL1	B-Gene_or_gene_product
,	O
a	O
brain	O
-	O
specific	O
transmembrane	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
on	O
13q12	O
.	O
3	O
that	O
is	O
similar	O
to	O
doublecortin	B-Gene_or_gene_product
(	O
DCX	B-Gene_or_gene_product
)	O
.	O

Mutations	O
in	O
the	O
human	O
doublecortin	B-Gene_or_gene_product
(	O
DCX	B-Gene_or_gene_product
)	O
,	O
a	O
brain	O
-	O
specific	O
putative	O
signaling	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
cause	O
X	O
-	O
linked	O
lissencephaly	O
and	O
subcortical	O
band	O
heterotopia	O
.	O

A	O
predicted	O
740	O
-	O
amino	O
-	O
acid	O
protein	B-Gene_or_gene_product
from	O
human	O
brain	O
has	O
two	O
distinct	O
regions	O
,	O
an	O
N	O
-	O
terminal	O
345	O
-	O
amino	O
-	O
acid	O
region	O
78	O
%	O
similar	O
to	O
the	O
DCX	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
and	O
a	O
C	O
-	O
terminal	O
427	O
-	O
amino	O
-	O
acid	O
region	O
that	O
contains	O
two	O
transmembrane	O
domains	O
and	O
is	O
98	O
%	O
homologous	O
to	O
a	O
rat	O
Ca2	O
+	O
/	O
calmodulin	O
-	O
dependent	O
protein	O
kinase	O
.	O

We	O
have	O
designated	O
this	O
protein	B-Gene_or_gene_product
DCAMKL1	B-Gene_or_gene_product
.	O

It	O
maps	O
to	O
chromosome	O
13q12	O
.	O
3	O
-	O
q13	O
,	O
within	O
a	O
540	O
-	O
kb	O
YAC	O
clone	O
containing	O
markers	O
D13S805	O
and	O
D13S1164	O
.	O

Northern	O
analysis	O
detected	O
three	O
major	O
transcript	O
isoforms	O
of	O
the	O
DCAMKL1	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
expressed	O
differentially	O
and	O
predominantly	O
in	O
human	O
fetal	O
and	O
adult	O
brain	O
and	O
during	O
mouse	O
embryogenesis	O
(	O
11	O
-	O
17	O
dpc	O
)	O
.	O

These	O
results	O
and	O
its	O
homology	O
with	O
the	O
DCX	B-Gene_or_gene_product
and	O
Ca2	B-Gene_or_gene_product
+	I-Gene_or_gene_product
/	I-Gene_or_gene_product
calmodulin	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
suggest	O
a	O
likely	O
role	O
for	O
DCAMKL1	B-Gene_or_gene_product
transmembrane	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
in	O
developing	O
and	O
adult	O
brain	O
,	O
possibly	O
in	O
a	O
pathway	O
of	O
cortical	O
development	O
.	O

The	O
human	O
POP2	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
:	O
identification	O
,	O
sequencing	O
,	O
and	O
mapping	O
to	O
the	O
critical	O
region	O
of	O
the	O
5q	O
-	O
syndrome	O
.	O

ARF6	O
requirement	O
for	O
Rac	O
ruffling	O
suggests	O
a	O
role	O
for	O
membrane	O
trafficking	O
in	O
cortical	B-Gene_or_gene_product
actin	I-Gene_or_gene_product
rearrangements	O
.	O

The	O
ARF6	O
GTPase	O
regulates	O
a	O
novel	O
endosomal	O
-	O
plasma	O
membrane	O
recycling	O
pathway	O
and	O
influences	O
cortical	B-Gene_or_gene_product
actin	I-Gene_or_gene_product
remodeling	O
.	O

Here	O
we	O
examined	O
the	O
relationship	O
between	O
ARF6	O
and	O
Rac1	O
,	O
a	O
Rho	O
family	O
GTPase	O
,	O
implicated	O
in	O
cortical	B-Gene_or_gene_product
actin	I-Gene_or_gene_product
rearrangements	O
.	O

Endogenous	O
Rac1	O
colocalized	O
with	O
ARF6	O
at	O
the	O
plasma	O
membrane	O
and	O
on	O
the	O
ARF6	O
recycling	O
endosome	O
in	O
untransfected	O
HeLa	O
and	O
primary	O
human	O
fibroblast	O
cells	O
.	O

In	O
transfected	O
HeLa	O
cells	O
Rac1	O
and	O
ARF6	O
also	O
colocalized	O
.	O

Cells	O
expressing	O
wild	O
-	O
type	O
ARF6	O
or	O
Rac1	O
formed	O
actin	O
-	O
containing	O
surface	O
protrusions	O
and	O
membrane	O
ruffles	O
,	O
respectively	O
,	O
upon	O
treatment	O
with	O
the	O
G	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
activator	O
aluminum	O
fluoride	O
.	O

Aluminum	O
fluoride	O
-	O
treatment	O
of	O
cells	O
transfected	O
with	O
equivalent	O
amounts	O
of	O
plasmid	O
resulted	O
in	O
enhanced	O
membrane	O
ruffling	O
,	O
with	O
protrusions	O
appearing	O
as	O
Rac	O
expression	O
was	O
lowered	O
.	O

Co	O
-	O
expression	O
of	O
the	O
dominant	O
negative	O
,	O
GTP	O
binding	O
-	O
defective	O
ARF6	O
T27N	O
mutant	O
inhibited	O
the	O
aluminum	O
fluoride	O
-	O
induced	O
ruffling	O
observed	O
in	O
cells	O
expressing	O
Rac1	O
,	O
and	O
the	O
constitutive	O
ruffling	O
observed	O
in	O
cells	O
expressing	O
the	O
activated	O
Rac1	O
Q61L	O
mutant	O
.	O

In	O
contrast	O
,	O
co	O
-	O
expression	O
of	O
the	O
GTP	O
-	O
binding	O
-	O
defective	O
,	O
T17N	O
mutant	O
of	O
either	O
Rac1	O
or	O
Cdc42	O
with	O
ARF6	O
did	O
not	O
inhibit	O
the	O
aluminum	O
fluoride	O
-	O
induced	O
surface	O
protrusions	O
,	O
nor	O
did	O
inactivation	O
of	O
Rho	O
with	O
C3	O
-	O
transferase	O
.	O

These	O
observations	O
suggest	O
that	O
ARF6	O
,	O
a	O
non	O
-	O
Rho	O
family	O
GTPase	O
,	O
can	O
,	O
by	O
itself	O
,	O
alter	O
cortical	B-Gene_or_gene_product
actin	I-Gene_or_gene_product
and	O
can	O
influence	O
the	O
ability	O
of	O
Rac1	O
to	O
form	O
lamellipodia	O
,	O
in	O
part	O
,	O
by	O
regulating	O
its	O
trafficking	O
to	O
the	O
plasma	O
membrane	O
.	O

Function	O
of	O
WW	O
domains	O
as	O
phosphoserine	O
-	O
or	O
phosphothreonine	O
-	O
binding	O
modules	O
.	O

Protein	O
-	O
interacting	O
modules	O
help	O
determine	O
the	O
specificity	O
of	O
signal	O
transduction	O
events	O
,	O
and	O
protein	B-Gene_or_gene_product
phosphorylation	O
can	O
modulate	O
the	O
assembly	O
of	O
such	O
modules	O
into	O
specific	O
signaling	O
complexes	O
.	O

Although	O
phosphotyrosine	O
-	O
binding	O
modules	O
have	O
been	O
well	O
-	O
characterized	O
,	O
phosphoserine	O
-	O
or	O
phosphothreonine	O
-	O
binding	O
modules	O
have	O
not	O
been	O
described	O
.	O

WW	O
domains	O
are	O
small	O
protein	B-Gene_or_gene_product
modules	O
found	O
in	O
various	O
proteins	B-Gene_or_gene_product
that	O
participate	O
in	O
cell	O
signaling	O
or	O
regulation	O
.	O

WW	O
domains	O
of	O
the	O
essential	O
mitotic	O
prolyl	O
isomerase	O
Pin1	O
and	O
the	O
ubiquitin	O
ligase	O
Nedd4	O
bound	O
to	O
phosphoproteins	O
,	O
including	O
physiological	O
substrates	O
of	O
enzymes	O
,	O
in	O
a	O
phosphorylation	O
-	O
dependent	O
manner	O
.	O

The	O
Pin1	O
WW	O
domain	O
functioned	O
as	O
a	O
phosphoserine	O
-	O
or	O
phosphothreonine	O
-	O
binding	O
module	O
,	O
with	O
properties	O
similar	O
to	O
those	O
of	O
SRC	O
homology	O
2	O
domains	O
.	O

Phosphoserine	O
-	O
or	O
phosphothreonine	O
-	O
binding	O
activity	O
was	O
required	O
for	O
Pin1	O
to	O
interact	O
with	O
its	O
substrates	O
in	O
vitro	O
and	O
to	O
perform	O
its	O
essential	O
function	O
in	O
vivo	O
.	O

Molecular	O
cloning	O
and	O
functional	O
characterization	O
of	O
a	O
new	O
Cap	O
'	O
n	O
'	O
collar	O
family	O
transcription	O
factor	O
Nrf3	O
.	O

The	O
NF	O
-	O
E2	O
-	O
binding	O
sites	O
or	O
Maf	O
recognition	O
elements	O
(	O
MARE	O
)	O
are	O
essential	O
cis	O
-	O
acting	O
elements	O
in	O
the	O
regulatory	O
regions	O
of	O
erythroid	O
-	O
specific	O
genes	B-Gene_or_gene_product
recognized	O
by	O
the	O
erythroid	O
transcription	O
factor	O
NF	O
-	O
E2	O
,	O
composed	O
of	O
p45	O
and	O
MafK	O
.	O

Recently	O
,	O
two	O
p45	O
-	O
related	O
factors	O
Nrf1	O
and	O
Nrf2	O
were	O
isolated	O
,	O
and	O
they	O
are	O
now	O
collectively	O
grouped	O
as	O
the	O
Cap	O
'	O
n	O
'	O
collar	O
(	O
CNC	O
)	O
family	O
.	O

CNC	O
factors	O
bind	O
to	O
MARE	O
through	O
heterodimer	O
formation	O
with	O
small	O
Maf	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

We	O
report	O
here	O
the	O
identification	O
and	O
characterization	O
of	O
a	O
novel	O
CNC	O
factor	O
,	O
Nrf3	B-Gene_or_gene_product
,	O
encoding	O
a	O
predicted	O
73	O
-	O
kDa	O
protein	B-Gene_or_gene_product
with	O
a	O
basic	O
region	O
-	O
leucine	O
zipper	O
domain	O
highly	O
homologous	O
to	O
those	O
of	O
other	O
CNC	O
proteins	O
.	O

In	O
vitro	O
and	O
in	O
vivo	O
analyses	O
showed	O
that	O
Nrf3	O
can	O
heterodimerize	O
with	O
MafK	O
and	O
that	O
this	O
complex	O
binds	O
to	O
the	O
MARE	O
in	O
the	O
chicken	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
globin	I-Gene_or_gene_product
enhancer	O
and	O
can	O
activate	O
transcription	O
.	O

Nrf3	O
mRNA	O
is	O
highly	O
expressed	O
in	O
human	O
placenta	O
and	O
B	O
cell	O
and	O
monocyte	O
lineage	O
.	O

Chromosomal	O
localization	O
of	O
human	O
Nrf3	O
is	O
7p14	O
-	O
15	O
,	O
which	O
lies	O
near	O
the	O
hoxA	O
gene	O
locus	O
.	O

As	O
the	O
genetic	O
loci	O
of	O
p45	O
,	O
nrf1	O
,	O
and	O
nrf2	O
have	O
been	O
mapped	O
close	O
to	O
those	O
of	O
hoxC	O
,	O
hoxB	O
,	O
and	O
hoxD	O
,	O
respectively	O
,	O
the	O
present	O
study	O
strongly	O
argues	O
for	O
the	O
idea	O
that	O
a	O
single	O
ancestral	O
gene	B-Gene_or_gene_product
for	O
the	O
CNC	O
family	O
members	O
may	O
have	O
been	O
localized	O
near	O
the	O
ancestral	O
Hox	O
cluster	O
and	O
have	O
diverged	O
to	O
give	O
rise	O
to	O
four	O
closely	O
related	O
CNC	O
factors	O
through	O
chromosome	O
duplication	O
.	O

Molecular	O
characterization	O
of	O
a	O
third	O
member	O
of	O
the	O
guanylyl	B-Gene_or_gene_product
cyclase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activating	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
subfamily	O
.	O

The	O
mammalian	O
retina	O
contains	O
at	O
least	O
two	O
guanylyl	O
cyclases	O
(	O
GC1	O
and	O
GC2	O
)	O
and	O
two	O
guanylyl	B-Gene_or_gene_product
cyclase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activating	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
(	O
GCAP1	B-Gene_or_gene_product
and	O
GCAP2	B-Gene_or_gene_product
)	O
.	O

Here	O
we	O
present	O
evidence	O
of	O
the	O
presence	O
of	O
a	O
new	O
photoreceptor	B-Gene_or_gene_product
-	O
specific	O
GCAP	B-Gene_or_gene_product
,	O
termed	O
GCAP3	B-Gene_or_gene_product
,	O
which	O
is	O
closely	O
related	O
to	O
GCAP1	B-Gene_or_gene_product
.	O

The	O
sequence	O
similarity	O
of	O
GCAP3	B-Gene_or_gene_product
with	O
GCAP1	B-Gene_or_gene_product
and	O
GCAP2	B-Gene_or_gene_product
is	O
57	O
and	O
49	O
%	O
,	O
respectively	O
.	O

Recombinant	O
GCAP3	B-Gene_or_gene_product
and	O
GCAP2	B-Gene_or_gene_product
stimulate	O
GC1	O
and	O
GC2	O
in	O
low	O
[	O
Ca2	O
+	O
]	O
free	O
and	O
inhibit	O
GCs	O
when	O
[	O
Ca2	O
+	O
]	O
free	O
is	O
elevated	O
,	O
unlike	O
GCAP1	B-Gene_or_gene_product
,	O
which	O
only	O
stimulates	O
GC1	O
.	O

GCAP3	B-Gene_or_gene_product
is	O
encoded	O
by	O
a	O
distinct	O
gene	B-Gene_or_gene_product
present	O
in	O
other	O
mammalian	O
species	O
but	O
could	O
not	O
be	O
detected	O
by	O
genomic	O
Southern	O
blotting	O
in	O
rodents	O
,	O
amphibians	O
,	O
and	O
lower	O
vertebrates	O
.	O

The	O
intron	O
/	O
exon	O
arrangement	O
of	O
the	O
GCAP3	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
identical	O
to	O
that	O
of	O
the	O
other	O
GCAP	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

While	O
the	O
GCAP1	B-Gene_or_gene_product
and	O
GCAP2	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
are	O
arranged	O
in	O
a	O
tail	O
-	O
to	O
-	O
tail	O
array	O
on	O
chromosome	O
6p	O
in	O
human	O
,	O
the	O
GCAP3	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
located	O
on	O
3q13	O
.	O
1	O
,	O
suggesting	O
an	O
ancestral	O
gene	B-Gene_or_gene_product
duplication	O
/	O
translocation	O
event	O
.	O

The	O
identification	O
of	O
multiple	O
Ca2	B-Gene_or_gene_product
+	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
that	O
interact	O
with	O
GC	O
is	O
suggestive	O
of	O
complex	O
regulatory	O
mechanisms	O
for	O
photoreceptor	B-Gene_or_gene_product
GC	O
.	O

Molecular	O
enzymology	O
of	O
mammalian	O
Delta1	O
-	O
pyrroline	O
-	O
5	O
-	O
carboxylate	O
synthase	O
.	O

Alternative	O
splice	O
donor	O
utilization	O
generates	O
isoforms	O
with	O
different	O
sensitivity	O
to	O
ornithine	O
inhibition	O
.	O

Delta1	O
-	O
Pyrroline	O
-	O
5	O
-	O
carboxylate	O
synthase	O
(	O
P5CS	O
;	O
EC	O
not	O
assigned	O
)	O
,	O
a	O
mitochondrial	O
inner	O
membrane	O
,	O
ATP	O
-	O
and	O
NADPH	O
-	O
dependent	O
,	O
bifunctional	O
enzyme	O
,	O
catalyzes	O
the	O
reduction	O
of	O
glutamate	O
to	O
Delta1	O
-	O
pyrroline	O
-	O
5	O
-	O
carboxylate	O
,	O
a	O
critical	O
step	O
in	O
the	O
de	O
novo	O
biosynthesis	O
of	O
proline	O
and	O
ornithine	O
.	O

We	O
utilized	O
published	O
plant	O
P5CS	O
sequence	O
to	O
search	O
the	O
expressed	O
sequence	O
tag	O
data	O
base	O
and	O
cloned	O
two	O
full	O
-	O
length	O
human	O
P5CS	O
cDNAs	O
differing	O
in	O
length	O
by	O
6	O
base	O
pairs	O
(	O
bp	O
)	O
in	O
the	O
open	O
reading	O
frame	O
.	O

The	O
short	O
cDNA	O
has	O
a	O
2379	O
-	O
bp	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	B-Gene_or_gene_product
of	O
793	O
residues	O
;	O
the	O
long	O
cDNA	O
,	O
generated	O
by	O
"	O
exon	O
sliding	O
,	O
"	O
a	O
form	O
of	O
alternative	O
splicing	O
,	O
contains	O
an	O
additional	O
6	O
-	O
bp	O
insert	O
following	O
bp	O
+	O
711	O
of	O
the	O
short	O
form	O
resulting	O
in	O
inclusion	O
of	O
two	O
additional	O
amino	O
acids	O
in	O
the	O
region	O
predicted	O
to	O
be	O
the	O
gamma	O
-	O
glutamyl	O
kinase	O
active	O
site	O
of	O
P5CS	O
.	O

The	O
long	O
form	O
predominates	O
in	O
all	O
tissues	O
examined	O
except	O
gut	O
.	O

We	O
also	O
isolated	O
the	O
corresponding	O
long	O
and	O
short	O
murine	O
P5CS	O
transcripts	O
.	O

To	O
confirm	O
the	O
identity	O
of	O
the	O
putative	O
P5CS	O
cDNAs	O
,	O
we	O
expressed	O
both	O
human	O
forms	O
in	O
gamma	O
-	O
glutamyl	O
kinase	O
-	O
and	O
gamma	O
-	O
glutamyl	O
phosphate	O
reductase	O
-	O
deficient	O
strains	O
of	O
Saccharomyces	O
cerevisiae	O
and	O
showed	O
that	O
they	O
conferred	O
the	O
proline	O
prototrophy	O
.	O

Additionally	O
,	O
we	O
found	O
expression	O
of	O
the	O
murine	O
putative	O
P5CS	O
cDNAs	O
conferred	O
proline	O
prototrophy	O
to	O
P5CS	O
-	O
deficient	O
Chinese	O
hamster	O
ovary	O
cells	O
(	O
CHO	O
-	O
K1	O
)	O
.	O

We	O
utilized	O
stable	O
CHO	O
-	O
K1	O
cell	O
transformants	O
to	O
compare	O
the	O
biochemical	O
characteristics	O
of	O
the	O
long	O
and	O
short	O
murine	O
P5CS	O
isoforms	O
.	O

We	O
found	O
that	O
both	O
confer	O
P5CS	O
activity	O
and	O
that	O
the	O
short	O
isoform	O
is	O
inhibited	O
by	O
L	O
-	O
ornithine	O
with	O
a	O
Ki	O
of	O
approximately	O
0	O
.	O
25	O
mM	O
.	O

Surprisingly	O
,	O
the	O
long	O
isoform	O
is	O
insensitive	O
to	O
ornithine	O
inhibition	O
.	O

Thus	O
,	O
the	O
two	O
amino	O
acid	O
insert	O
in	O
the	O
long	O
isoform	O
abolishes	O
feedback	O
inhibition	O
of	O
P5CS	O
activity	O
by	O
L	O
-	O
ornithine	O
.	O

LYVE	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
a	O
new	O
homologue	O
of	O
the	O
CD44	B-Gene_or_gene_product
glycoprotein	B-Gene_or_gene_product
,	O
is	O
a	O
lymph	O
-	O
specific	O
receptor	B-Gene_or_gene_product
for	O
hyaluronan	O
.	O

The	O
extracellular	O
matrix	O
glycosaminoglycan	O
hyaluronan	O
(	O
HA	O
)	O
is	O
an	O
abundant	O
component	O
of	O
skin	O
and	O
mesenchymal	O
tissues	O
where	O
it	O
facilitates	O
cell	O
migration	O
during	O
wound	O
healing	O
,	O
inflammation	O
,	O
and	O
embryonic	O
morphogenesis	O
.	O

Both	O
during	O
normal	O
tissue	O
homeostasis	O
and	O
particularly	O
after	O
tissue	O
injury	O
,	O
HA	O
is	O
mobilized	O
from	O
these	O
sites	O
through	O
lymphatic	O
vessels	O
to	O
the	O
lymph	O
nodes	O
where	O
it	O
is	O
degraded	O
before	O
entering	O
the	O
circulation	O
for	O
rapid	O
uptake	O
by	O
the	O
liver	O
.	O

Currently	O
,	O
however	O
,	O
the	O
identities	O
of	O
HA	O
binding	O
molecules	O
which	O
control	O
this	O
pathway	O
are	O
unknown	O
.	O

Here	O
we	O
describe	O
the	O
first	O
such	O
molecule	O
,	O
LYVE	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
which	O
we	O
have	O
identified	O
as	O
a	O
major	O
receptor	B-Gene_or_gene_product
for	O
HA	O
on	O
the	O
lymph	O
vessel	O
wall	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
LYVE	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
predicts	O
a	O
322	O
-	O
residue	O
type	O
I	O
integral	O
membrane	O
polypeptide	O
41	O
%	O
similar	O
to	O
the	O
CD44	B-Gene_or_gene_product
HA	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
with	O
a	O
212	O
-	O
residue	O
extracellular	O
domain	O
containing	O
a	O
single	O
Link	O
module	O
the	O
prototypic	O
HA	O
binding	O
domain	O
of	O
the	O
Link	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
superfamily	O
.	O

Like	O
CD44	B-Gene_or_gene_product
,	O
the	O
LYVE	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
molecule	I-Gene_or_gene_product
binds	O
both	O
soluble	O
and	O
immobilized	O
HA	O
.	O

However	O
,	O
unlike	O
CD44	B-Gene_or_gene_product
,	O
the	O
LYVE	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
molecule	I-Gene_or_gene_product
colocalizes	O
with	O
HA	O
on	O
the	O
luminal	O
face	O
of	O
the	O
lymph	O
vessel	O
wall	O
and	O
is	O
completely	O
absent	O
from	O
blood	O
vessels	O
.	O

Hence	O
,	O
LYVE	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
the	O
first	O
lymph	O
-	O
specific	O
HA	O
receptor	B-Gene_or_gene_product
to	O
be	O
characterized	O
and	O
is	O
a	O
uniquely	O
powerful	O
marker	O
for	O
lymph	O
vessels	O
themselves	O
.	O

Combining	O
SSH	O
and	O
cDNA	O
microarrays	O
for	O
rapid	O
identification	O
of	O
differentially	O
expressed	O
genes	B-Gene_or_gene_product
.	O

Comparing	O
patterns	O
of	O
gene	O
expression	O
in	O
cell	O
lines	O
and	O
tissues	O
has	O
important	O
applications	O
in	O
a	O
variety	O
of	O
biological	O
systems	O
.	O

In	O
this	O
study	O
we	O
have	O
examined	O
whether	O
the	O
emerging	O
technology	O
of	O
cDNA	O
microarrays	O
will	O
allow	O
a	O
high	O
throughput	O
analysis	O
of	O
expression	O
of	O
cDNA	O
clones	O
generated	O
by	O
suppression	O
subtractive	O
hybridization	O
(	O
SSH	O
)	O
.	O

A	O
set	O
of	O
cDNA	O
clones	O
including	O
332	O
SSH	O
inserts	O
amplified	O
by	O
PCR	O
was	O
arrayed	O
using	O
robotic	O
printing	O
.	O

The	O
cDNA	O
arrays	O
were	O
hybridized	O
with	O
fluorescent	O
labeled	O
probes	O
prepared	O
from	O
RNA	O
from	O
ER	B-Gene_or_gene_product
-	O
positive	O
(	O
MCF7	O
and	O
T47D	O
)	O
and	O
ER	O
-	O
negative	O
(	O
MDA	O
-	O
MB	O
-	O
231	O
and	O
HBL	O
-	O
100	O
)	O
breast	O
cancer	O
cell	O
lines	O
.	O

Ten	O
clones	O
were	O
identified	O
that	O
were	O
over	O
-	O
expressed	O
by	O
at	O
least	O
a	O
factor	O
of	O
five	O
in	O
the	O
ER	B-Gene_or_gene_product
-	O
positive	O
cell	O
lines	O
.	O

Northern	O
blot	O
analysis	O
confirmed	O
over	O
-	O
expression	O
of	O
these	O
10	O
cDNAs	O
.	O

Sequence	O
analysis	O
identified	O
four	O
of	O
these	O
clones	O
as	O
cytokeratin	B-Gene_or_gene_product
19	I-Gene_or_gene_product
,	O
GATA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
,	O
CD24	B-Gene_or_gene_product
and	O
glutathione	B-Gene_or_gene_product
-	I-Gene_or_gene_product
S	I-Gene_or_gene_product
-	I-Gene_or_gene_product
transferase	I-Gene_or_gene_product
mu	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
.	O

Of	O
the	O
remaining	O
six	O
cDNA	O
clones	O
,	O
four	O
clones	O
matched	O
EST	O
sequences	O
from	O
two	O
different	O
genes	O
and	O
two	O
clones	O
were	O
novel	O
sequences	O
.	O

Flow	O
cytometry	O
and	O
immunofluorescence	O
confirmed	O
that	O
CD24	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
was	O
over	O
-	O
expressed	O
in	O
the	O
ER	B-Gene_or_gene_product
-	O
positive	O
cell	O
lines	O
.	O

We	O
conclude	O
that	O
SSH	O
and	O
microarray	O
technology	O
can	O
be	O
successfully	O
applied	O
to	O
identify	O
differentially	O
expressed	O
genes	B-Gene_or_gene_product
.	O

This	O
approach	O
allowed	O
the	O
identification	O
of	O
differentially	O
expressed	O
genes	B-Gene_or_gene_product
without	O
the	O
need	O
to	O
obtain	O
previously	O
cloned	O
cDNAs	O
.	O

Characterization	O
of	O
a	O
novel	O
mouse	O
cDNA	O
,	O
ES18	O
,	O
involved	O
in	O
apoptotic	O
cell	O
death	O
of	O
T	O
-	O
cells	O
.	O

Using	O
the	O
modified	O
screening	O
approach	O
in	O
combination	O
with	O
expressed	O
sequence	O
tags	O
,	O
we	O
have	O
identified	O
several	O
novel	O
cDNAs	O
from	O
mouse	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
,	O
whose	O
expression	O
is	O
tissue	O
-	O
restricted	O
and	O
/	O
or	O
developmentally	O
regulated	O
.	O

One	O
of	O
the	O
cDNAs	O
,	O
ES18	O
,	O
is	O
preferentially	O
expressed	O
in	O
lymph	O
node	O
and	O
thymus	O
,	O
and	O
contains	O
noteworthy	O
features	O
of	O
transcriptional	O
regulator	O
.	O

The	O
expression	O
of	O
ES18	O
transcript	O
was	O
selectively	O
regulated	O
during	O
the	O
apoptosis	O
of	O
T	O
-	O
cell	O
thymoma	O
S49	O
.	O
1	O
induced	O
by	O
several	O
stimuli	O
.	O

Interestingly	O
,	O
the	O
ES18	O
transcript	O
was	O
differently	O
regulated	O
in	O
the	O
mutually	O
antagonistic	O
process	O
,	O
between	O
dexamethasone	O
-	O
and	O
A23187	O
-	O
induced	O
cell	O
death	O
of	O
T	O
-	O
cells	O
.	O

Moreover	O
,	O
the	O
message	O
level	O
of	O
ES18	O
was	O
selectively	O
enhanced	O
by	O
staurosporine	O
,	O
a	O
broad	O
protein	O
kinase	O
inhibitor	O
,	O
but	O
not	O
by	O
other	O
protein	O
kinase	O
inhibitors	O
such	O
as	O
GF109203X	O
and	O
H89	O
.	O

In	O
addition	O
,	O
ES18	O
transcript	O
was	O
induced	O
by	O
C2	O
-	O
ceramide	O
,	O
which	O
is	O
a	O
mediator	O
of	O
both	O
dexamethasone	O
-	O
and	O
staurosporine	O
-	O
induced	O
apoptotic	O
signaling	O
.	O

We	O
further	O
showed	O
that	O
transient	O
overexpression	O
of	O
ES18	O
in	O
mouse	O
T	O
-	O
cell	O
lymphoma	O
increased	O
the	O
apoptotic	O
cell	O
death	O
.	O

These	O
data	O
suggest	O
that	O
ES18	O
may	O
be	O
selectively	O
involved	O
in	O
specific	O
apoptotic	O
processes	O
in	O
mouse	O
T	O
-	O
cells	O
.	O

Crystal	O
structure	O
of	O
human	O
muscle	O
aldolase	O
complexed	O
with	O
fructose	O
1	O
,	O
6	O
-	O
bisphosphate	O
:	O
mechanistic	O
implications	O
.	O

Fructose	O
1	O
,	O
6	O
-	O
bisphosphate	O
aldolase	O
catalyzes	O
the	O
reversible	O
cleavage	O
of	O
fructose	O
1	O
,	O
6	O
-	O
bisphosphate	O
and	O
fructose	O
1	O
-	O
phosphate	O
to	O
dihydroxyacetone	O
phosphate	O
and	O
either	O
glyceraldehyde	O
3	O
-	O
phosphate	O
or	O
glyceraldehyde	O
,	O
respectively	O
.	O

Catalysis	O
involves	O
the	O
formation	O
of	O
a	O
Schiff	O
'	O
s	O
base	O
intermediate	O
formed	O
at	O
the	O
epsilon	O
-	O
amino	O
group	O
of	O
Lys229	O
.	O

The	O
existing	O
apo	O
-	O
enzyme	O
structure	O
was	O
refined	O
using	O
the	O
crystallographic	O
free	O
-	O
R	O
-	O
factor	O
and	O
maximum	O
likelihood	O
methods	O
that	O
have	O
been	O
shown	O
to	O
give	O
improved	O
structural	O
results	O
that	O
are	O
less	O
subject	O
to	O
model	O
bias	O
.	O

Crystals	O
were	O
also	O
soaked	O
with	O
the	O
natural	O
substrate	O
(	O
fructose	O
1	O
,	O
6	O
-	O
bisphosphate	O
)	O
,	O
and	O
the	O
crystal	O
structure	O
of	O
this	O
complex	O
has	O
been	O
determined	O
to	O
2	O
.	O
8	O
A	O
.	O

The	O
apo	O
structure	O
differs	O
from	O
the	O
previous	O
Brookhaven	O
-	O
deposited	O
structure	O
(	O
1ald	O
)	O
in	O
the	O
flexible	O
C	O
-	O
terminal	O
region	O
.	O

This	O
is	O
also	O
the	O
region	O
where	O
the	O
native	O
and	O
complex	O
structures	O
exhibit	O
differences	O
.	O

The	O
conformational	O
changes	O
between	O
native	O
and	O
complex	O
structure	O
are	O
not	O
large	O
,	O
but	O
the	O
observed	O
complex	O
does	O
not	O
involve	O
the	O
full	O
formation	O
of	O
the	O
Schiff	O
'	O
s	O
base	O
intermediate	O
,	O
and	O
suggests	O
a	O
preliminary	O
hydrogen	O
-	O
bonded	O
Michaelis	O
complex	O
before	O
the	O
formation	O
of	O
the	O
covalent	O
complex	O
.	O

Crystal	O
structure	O
of	O
the	O
FMN	O
-	O
binding	O
domain	O
of	O
human	O
cytochrome	O
P450	O
reductase	O
at	O
1	O
.	O
93	O
A	O
resolution	O
.	O

The	O
crystal	O
structure	O
of	O
the	O
FMN	O
-	O
binding	O
domain	O
of	O
human	O
NADPH	O
-	O
cytochrome	O
P450	O
reductase	O
(	O
P450R	O
-	O
FMN	O
)	O
,	O
a	O
key	O
component	O
in	O
the	O
cytochrome	O
P450	O
monooxygenase	O
system	O
,	O
has	O
been	O
determined	O
to	O
1	O
.	O
93	O
A	O
resolution	O
and	O
shown	O
to	O
be	O
very	O
similar	O
both	O
to	O
the	O
global	O
fold	O
in	O
solution	O
(	O
Barsukov	O
I	O
et	O
al	O
.	O
,	O
1997	O
,	O
J	O
Biomol	O
NMR	O
10	O
:	O
63	O
-	O
75	O
)	O
and	O
to	O
the	O
corresponding	O
domain	O
in	O
the	O
2	O
.	O
6	O
A	O
crystal	O
structure	O
of	O
intact	O
rat	O
P450R	O
(	O
Wang	O
M	O
et	O
al	O
.	O
,	O
1997	O
,	O
Proc	O
Nat	O
Acad	O
Sci	O
USA	O
94	O
:	O
8411	O
-	O
8416	O
)	O
.	O

The	O
crystal	O
structure	O
of	O
P450R	O
-	O
FMN	O
reported	O
here	O
confirms	O
the	O
overall	O
similarity	O
of	O
its	O
alpha	O
-	O
beta	O
-	O
alpha	O
architecture	O
to	O
that	O
of	O
the	O
bacterial	O
flavodoxins	O
,	O
but	O
reveals	O
differences	O
in	O
the	O
position	O
,	O
number	O
,	O
and	O
length	O
of	O
the	O
helices	O
relative	O
to	O
the	O
central	O
beta	O
-	O
sheet	O
.	O

The	O
marked	O
similarity	O
between	O
P450R	O
-	O
FMN	O
and	O
flavodoxins	O
in	O
the	O
interactions	O
between	O
the	O
FMN	O
and	O
the	O
protein	B-Gene_or_gene_product
,	O
indicate	O
a	O
striking	O
evolutionary	O
conservation	O
of	O
the	O
FMN	O
binding	O
site	O
.	O

The	O
P450R	O
-	O
FMN	O
molecule	O
has	O
an	O
unusual	O
surface	O
charge	O
distribution	O
,	O
leading	O
to	O
a	O
very	O
strong	O
dipole	O
,	O
which	O
may	O
be	O
involved	O
in	O
docking	O
cytochrome	O
P450	O
into	O
place	O
for	O
electron	O
transfer	O
near	O
the	O
FMN	O
.	O

Several	O
acidic	O
residues	O
near	O
the	O
FMN	O
are	O
identified	O
by	O
mutagenesis	O
experiments	O
to	O
be	O
important	O
for	O
electron	O
transfer	O
to	O
P4502D6	O
and	O
to	O
cytochrome	B-Gene_or_gene_product
c	I-Gene_or_gene_product
,	O
a	O
clear	O
indication	O
of	O
the	O
part	O
of	O
the	O
molecular	O
surface	O
that	O
is	O
likely	O
to	O
be	O
involved	O
in	O
substrate	O
binding	O
.	O

Somewhat	O
different	O
parts	O
are	O
found	O
to	O
be	O
involved	O
in	O
binding	O
cytochrome	B-Gene_or_gene_product
P450	I-Gene_or_gene_product
and	O
cytochrome	B-Gene_or_gene_product
c	I-Gene_or_gene_product
.	O

Ski	B-Gene_or_gene_product
is	O
a	O
component	O
of	O
the	O
histone	O
deacetylase	O
complex	O
required	O
for	O
transcriptional	O
repression	O
by	O
Mad	B-Gene_or_gene_product
and	O
thyroid	B-Gene_or_gene_product
hormone	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
.	O

The	O
N	O
-	O
CoR	O
/	O
SMRT	O
complex	O
containing	O
mSin3	B-Gene_or_gene_product
and	O
histone	O
deacetylase	O
(	O
HDAC	O
)	O
mediates	O
transcriptional	O
repression	O
by	O
nuclear	B-Gene_or_gene_product
hormone	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
and	O
Mad	B-Gene_or_gene_product
.	O

The	O
proteins	B-Gene_or_gene_product
encoded	O
by	O
the	O
ski	B-Gene_or_gene_product
proto	I-Gene_or_gene_product
-	I-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
family	O
directly	O
bind	O
to	O
N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CoR	I-Gene_or_gene_product
/	I-Gene_or_gene_product
SMRT	I-Gene_or_gene_product
and	O
mSin3A	B-Gene_or_gene_product
,	O
and	O
forms	O
a	O
complex	O
with	O
HDAC	O
.	O

c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Ski	I-Gene_or_gene_product
and	O
its	O
related	O
gene	O
product	O
Sno	B-Gene_or_gene_product
are	O
required	O
for	O
transcriptional	O
repression	O
by	O
Mad	B-Gene_or_gene_product
and	O
thyroid	B-Gene_or_gene_product
hormone	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
TRbeta	B-Gene_or_gene_product
)	O
.	O

The	O
oncogenic	O
form	O
,	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Ski	I-Gene_or_gene_product
,	O
which	O
lacks	O
the	O
mSin3A	B-Gene_or_gene_product
-	O
binding	O
domain	O
,	O
acts	O
in	O
a	O
dominant	O
-	O
negative	O
fashion	O
,	O
and	O
abrogates	O
transcriptional	O
repression	O
by	O
Mad	B-Gene_or_gene_product
and	O
TRbeta	B-Gene_or_gene_product
.	O

In	O
ski	B-Gene_or_gene_product
-	O
deficient	O
mouse	O
embryos	O
,	O
the	O
ornithine	O
decarboxylase	O
gene	B-Gene_or_gene_product
,	O
whose	O
expression	O
is	O
normally	O
repressed	O
by	O
Mad	B-Gene_or_gene_product
-	O
Max	B-Gene_or_gene_product
,	O
is	O
expressed	O
ectopically	O
.	O

These	O
results	O
show	O
that	O
Ski	B-Gene_or_gene_product
is	O
a	O
component	O
of	O
the	O
HDAC	O
complex	O
and	O
that	O
Ski	B-Gene_or_gene_product
is	O
required	O
for	O
the	O
transcriptional	O
repression	O
mediated	O
by	O
this	O
complex	O
.	O

The	O
involvement	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Ski	I-Gene_or_gene_product
in	O
the	O
HDAC	O
complex	O
indicates	O
that	O
the	O
function	O
of	O
the	O
HDAC	O
complex	O
is	O
important	O
for	O
oncogenesis	O
.	O

Cloning	O
and	O
characterization	O
of	O
two	O
cytoplasmic	O
dynein	B-Gene_or_gene_product
intermediate	I-Gene_or_gene_product
chain	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
in	O
mouse	O
and	O
human	O
.	O

Cytoplasmic	O
dynein	B-Gene_or_gene_product
is	O
a	O
large	O
multisubunit	O
microtubule	B-Gene_or_gene_product
-	O
based	O
motor	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
which	O
mediates	O
movement	O
of	O
numerous	O
intracellular	O
organelles	O
.	O

We	O
report	O
here	O
the	O
identification	O
of	O
the	O
human	O
homologue	O
of	O
cytoplasmic	O
dynein	O
intermediate	O
chain	O
1	O
gene	O
(	O
DNCI1	B-Gene_or_gene_product
)	O
located	O
on	O
human	O
chromosome	O
7q21	O
.	O
3	O
-	O
q22	O
.	O
1	O
.	O

The	O
mouse	O
orthologue	O
(	O
Dnci1	B-Gene_or_gene_product
)	O
was	O
identified	O
along	O
with	O
another	O
highly	O
related	O
gene	B-Gene_or_gene_product
,	O
Dnci2	B-Gene_or_gene_product
,	O
and	O
their	O
RNA	O
in	O
situ	O
expression	O
patterns	O
were	O
examined	O
during	O
mouse	O
embryogenesis	O
.	O

Dnci1	B-Gene_or_gene_product
was	O
found	O
to	O
have	O
a	O
highly	O
restricted	O
expression	O
domain	O
in	O
the	O
developing	O
forebrain	O
as	O
well	O
as	O
the	O
peripheral	O
nervous	O
system	O
(	O
PNS	O
)	O
,	O
while	O
Dnci2	B-Gene_or_gene_product
displayed	O
a	O
broad	O
expression	O
profile	O
throughout	O
the	O
entire	O
central	O
nervous	O
system	O
and	O
most	O
of	O
the	O
PNS	O
.	O

A	O
dynamic	O
expression	O
profile	O
was	O
also	O
found	O
for	O
Dnci2	B-Gene_or_gene_product
in	O
the	O
developing	O
mouse	O
limb	O
bud	O
.	O

The	O
data	O
presented	O
here	O
provide	O
a	O
framework	O
for	O
the	O
further	O
analysis	O
of	O
the	O
functional	O
role	O
of	O
Dnci1	B-Gene_or_gene_product
and	O
Dnci2	B-Gene_or_gene_product
in	O
mouse	O
and	O
DNCI1	B-Gene_or_gene_product
in	O
human	O
.	O

Identification	O
and	O
characterization	O
of	O
the	O
human	O
homologue	O
(	O
RAI2	B-Gene_or_gene_product
)	O
of	O
a	O
mouse	O
retinoic	B-Gene_or_gene_product
acid	I-Gene_or_gene_product
-	I-Gene_or_gene_product
induced	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
in	O
Xp22	O
.	O

We	O
have	O
identified	O
a	O
novel	O
human	O
gene	B-Gene_or_gene_product
during	O
studies	O
of	O
a	O
1	O
.	O
3	O
-	O
Mb	O
region	O
of	O
Xp22	O
between	O
DXS418	O
and	O
DXS999	O
.	O

A	O
PAC	O
contig	O
spanning	O
the	O
region	O
was	O
constructed	O
,	O
sequenced	O
,	O
and	O
analyzed	O
by	O
gene	B-Gene_or_gene_product
and	O
exon	O
prediction	O
programs	O
and	O
by	O
homology	O
searches	O
.	O

Further	O
investigation	O
of	O
predicted	O
exons	O
from	O
PAC	O
clone	O
389A20	O
led	O
to	O
the	O
identification	O
of	O
a	O
single	O
-	O
exon	O
gene	B-Gene_or_gene_product
,	O
designated	O
RAI2	B-Gene_or_gene_product
(	O
retinoic	B-Gene_or_gene_product
acid	I-Gene_or_gene_product
-	I-Gene_or_gene_product
induced	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
.	O

RAI2	B-Gene_or_gene_product
mapped	O
28	O
kb	O
centromeric	O
to	O
marker	O
DXS7996	O
,	O
between	O
DXS7996	O
and	O
DXS7997	O
,	O
and	O
was	O
transcribed	O
from	O
centromere	O
to	O
telomere	O
.	O

Northern	O
blot	O
analysis	O
and	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
analysis	O
revealed	O
expression	O
of	O
a	O
2	O
.	O
5	O
-	O
kb	O
transcript	O
in	O
four	O
fetal	O
tissues	O
(	O
brain	O
,	O
lung	O
,	O
kidney	O
,	O
and	O
heart	O
)	O
and	O
eight	O
adult	O
tissues	O
(	O
heart	O
,	O
brain	O
,	O
placenta	O
,	O
lung	O
,	O
skeletal	O
muscle	O
,	O
kidney	O
,	O
pancreas	O
,	O
and	O
retina	O
)	O
but	O
not	O
in	O
fetal	O
or	O
adult	O
liver	O
.	O

The	O
530	O
-	O
amino	O
-	O
acid	O
protein	B-Gene_or_gene_product
(	O
57	O
kDa	O
predicted	O
mass	O
)	O
displays	O
94	O
%	O
homology	O
with	O
a	O
mouse	O
retinoic	B-Gene_or_gene_product
acid	I-Gene_or_gene_product
-	I-Gene_or_gene_product
induced	I-Gene_or_gene_product
gene	O
product	O
and	O
contains	O
a	O
novel	O
proline	O
-	O
rich	O
(	O
39	O
%	O
)	O
domain	O
of	O
68	O
amino	O
acids	O
.	O

Retinoic	O
acid	O
is	O
involved	O
in	O
vertebrate	O
anteroposterior	O
axis	O
formation	O
and	O
cellular	O
differentiation	O
and	O
has	O
been	O
shown	O
to	O
modulate	O
gene	O
expression	O
controlling	O
early	O
embryonal	O
development	O
,	O
suggesting	O
a	O
developmental	O
role	O
for	O
RAI2	B-Gene_or_gene_product
.	O

RAI2	B-Gene_or_gene_product
remains	O
a	O
candidate	O
gene	B-Gene_or_gene_product
for	O
diseases	O
mapping	O
to	O
the	O
Xp22	O
region	O
.	O

GPR56	B-Gene_or_gene_product
,	O
a	O
novel	O
secretin	B-Gene_or_gene_product
-	O
like	O
human	O
G	B-Gene_or_gene_product
-	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
coupled	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

A	O
novel	O
gene	O
product	O
,	O
GPR56	B-Gene_or_gene_product
,	O
with	O
homology	O
to	O
the	O
seven	B-Gene_or_gene_product
transmembrane	I-Gene_or_gene_product
-	I-Gene_or_gene_product
domain	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
superfamily	O
,	O
has	O
been	O
cloned	O
by	O
PCR	O
amplification	O
using	O
degenerate	O
oligonucleotide	O
primers	O
and	O
subsequent	O
screening	O
of	O
a	O
human	O
heart	O
cDNA	O
library	O
.	O

The	O
isolated	O
2	O
.	O
8	O
-	O
kb	O
cDNA	O
clone	O
encodes	O
a	O
protein	B-Gene_or_gene_product
of	O
693	O
amino	O
acids	O
that	O
shows	O
highest	O
identity	O
(	O
32	O
%	O
)	O
to	O
HE6	B-Gene_or_gene_product
,	O
a	O
member	O
of	O
a	O
subclass	O
of	O
the	O
class	B-Gene_or_gene_product
B	I-Gene_or_gene_product
secretin	I-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
G	I-Gene_or_gene_product
-	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
coupled	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O

Northern	O
analysis	O
of	O
various	O
human	O
tissues	O
revealed	O
a	O
wide	O
distribution	O
of	O
the	O
transcript	O
with	O
highest	O
levels	O
found	O
in	O
thyroid	O
gland	O
,	O
brain	O
,	O
and	O
heart	O
.	O

In	O
situ	O
hybridization	O
analysis	O
of	O
human	O
thyroid	O
gland	O
as	O
well	O
as	O
rat	O
heart	O
and	O
brain	O
tissue	O
confirms	O
these	O
results	O
and	O
identifies	O
the	O
hippocampus	O
and	O
hypothalamic	O
nuclei	O
as	O
brain	O
areas	O
with	O
particularly	O
high	O
expression	O
of	O
GPR56	B-Gene_or_gene_product
mRNA	O
.	O

The	O
high	O
level	O
of	O
mRNA	O
expression	O
,	O
its	O
wide	O
distribution	O
,	O
and	O
the	O
mucin	B-Gene_or_gene_product
-	O
like	O
extracellular	O
domain	O
of	O
the	O
receptor	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
suggest	O
a	O
possible	O
role	O
for	O
this	O
receptor	B-Gene_or_gene_product
in	O
cell	O
-	O
cell	O
interaction	O
processes	O
.	O

The	O
human	O
gene	B-Gene_or_gene_product
for	O
GPR56	B-Gene_or_gene_product
has	O
been	O
isolated	O
and	O
its	O
exon	O
-	O
intron	O
structure	O
determined	O
.	O

The	O
total	O
length	O
of	O
the	O
human	O
GPR56	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
approximately	O
15	O
kb	O
,	O
and	O
it	O
consists	O
of	O
13	O
exons	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
,	O
PCR	O
analysis	O
of	O
somatic	O
cell	O
hybrids	O
,	O
and	O
interspecific	O
mouse	O
backcross	O
mapping	O
have	O
localized	O
the	O
genes	B-Gene_or_gene_product
to	O
human	O
chromosome	O
16q13	O
and	O
mouse	O
chromosome	O
8	O
.	O

The	O
LIM	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
FHL1	B-Gene_or_gene_product
and	O
FHL3	B-Gene_or_gene_product
are	O
expressed	O
differently	O
in	O
skeletal	O
muscle	O
.	O

We	O
have	O
determined	O
the	O
complete	O
mRNA	O
sequence	O
of	O
FHL3	B-Gene_or_gene_product
(	O
formerly	O
SLIM2	B-Gene_or_gene_product
)	O
.	O

We	O
have	O
confirmed	O
that	O
it	O
is	O
a	O
member	O
of	O
the	O
family	O
of	O
LIM	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
that	O
share	O
a	O
similar	O
secondary	O
protein	O
structure	O
,	O
renamed	O
as	O
Four	O
-	O
and	O
-	O
a	O
-	O
Half	O
-	O
LIM	O
domain	O
(	O
or	O
FHL	O
)	O
proteins	B-Gene_or_gene_product
in	O
accordance	O
with	O
this	O
structure	O
.	O

The	O
"	O
half	O
-	O
LIM	O
"	O
domain	O
is	O
a	O
single	O
zinc	O
finger	O
domain	O
that	O
may	O
represent	O
a	O
subfamily	O
of	O
LIM	O
domains	O
and	O
defines	O
this	O
particular	O
family	O
of	O
LIM	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

The	O
distribution	O
of	O
FHL	B-Gene_or_gene_product
mRNA	O
expression	O
within	O
a	O
variety	O
of	O
murine	O
tissues	O
is	O
complex	O
.	O

Both	O
FHL1	B-Gene_or_gene_product
and	O
FHL3	B-Gene_or_gene_product
were	O
expressed	O
in	O
a	O
number	O
of	O
skeletal	O
muscles	O
while	O
FHL2	B-Gene_or_gene_product
was	O
expressed	O
at	O
high	O
levels	O
in	O
cardiac	O
muscle	O
.	O

Localisation	O
of	O
FHL3	B-Gene_or_gene_product
to	O
human	O
chromosome	O
1	O
placed	O
this	O
gene	B-Gene_or_gene_product
in	O
the	O
proximity	O
of	O
,	O
but	O
not	O
overlapping	O
with	O
,	O
alleles	O
associated	O
with	O
muscle	O
diseases	O
.	O

FHL1	B-Gene_or_gene_product
and	O
FHL3	B-Gene_or_gene_product
mRNAs	O
were	O
reciprocally	O
expressed	O
in	O
the	O
murine	O
C2C12	O
skeletal	O
muscle	O
cell	O
line	O
and	O
this	O
suggested	O
that	O
the	O
pattern	O
of	O
expression	O
was	O
linked	O
to	O
key	O
events	O
in	O
myogenesis	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
two	O
novel	O
human	O
renal	O
organic	B-Gene_or_gene_product
anion	I-Gene_or_gene_product
transporters	I-Gene_or_gene_product
(	O
hOAT1	B-Gene_or_gene_product
and	O
hOAT3	B-Gene_or_gene_product
)	O
.	O

The	O
cloned	O
organic	B-Gene_or_gene_product
anion	I-Gene_or_gene_product
transporters	I-Gene_or_gene_product
from	O
rat	O
,	O
mouse	O
,	O
and	O
winter	O
flounder	O
(	O
rOAT1	B-Gene_or_gene_product
,	O
mOAT1	B-Gene_or_gene_product
,	O
fROAT	B-Gene_or_gene_product
)	O
mediate	O
the	O
coupled	O
exchange	O
of	O
alpha	O
-	O
ketoglutarate	O
with	O
multiple	O
organic	O
anions	O
,	O
including	O
p	O
-	O
aminohippurate	O
(	O
PAH	O
)	O
.	O

We	O
have	O
isolated	O
two	O
novel	O
gene	O
products	O
from	O
human	O
kidney	O
which	O
bear	O
significant	O
homology	O
to	O
the	O
known	O
OATs	B-Gene_or_gene_product
and	O
belong	O
to	O
the	O
amphiphilic	B-Gene_or_gene_product
solute	I-Gene_or_gene_product
facilitator	I-Gene_or_gene_product
(	O
ASF	B-Gene_or_gene_product
)	O
family	O
.	O

The	O
cDNAs	O
,	O
hOAT1	B-Gene_or_gene_product
and	O
hOAT3	B-Gene_or_gene_product
,	O
encode	O
for	O
550	O
-	O
and	O
568	O
-	O
amino	O
-	O
acid	O
residue	O
proteins	B-Gene_or_gene_product
,	O
respectively	O
.	O

hOAT1	B-Gene_or_gene_product
and	O
hOAT3	B-Gene_or_gene_product
mRNAs	O
are	O
expressed	O
strongly	O
in	O
kidney	O
and	O
weakly	O
in	O
brain	O
.	O

Both	O
genes	B-Gene_or_gene_product
map	O
to	O
chromosome	O
11	O
region	O
q11	O
.	O
7	O
.	O

PAH	O
uptake	O
by	O
Xenopus	O
laevis	O
oocytes	O
injected	O
with	O
hOAT1	B-Gene_or_gene_product
mRNA	O
is	O
increased	O
100	O
-	O
fold	O
compared	O
to	O
water	O
-	O
injected	O
oocytes	O
.	O

PAH	O
uptake	O
is	O
chloride	O
dependent	O
and	O
is	O
not	O
further	O
increased	O
by	O
preincubation	O
of	O
oocytes	O
in	O
5	O
mM	O
glutarate	O
.	O

Uptake	O
of	O
PAH	O
is	O
inhibited	O
by	O
probenicid	O
,	O
alpha	O
-	O
ketoglutarate	O
,	O
bumetanide	O
,	O
furosemide	O
,	O
and	O
losartan	O
,	O
but	O
not	O
by	O
salicylate	O
,	O
urate	O
,	O
choline	O
,	O
amilioride	O
,	O
and	O
hydrochlorothiazide	O
.	O

X11L2	B-Gene_or_gene_product
,	O
a	O
new	O
member	O
of	O
the	O
X11	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
family	O
,	O
interacts	O
with	O
Alzheimer	O
'	O
s	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
amyloid	I-Gene_or_gene_product
precursor	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

We	O
screened	O
proteins	B-Gene_or_gene_product
for	O
interaction	O
with	O
Alzheimer	O
'	O
s	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
amyloid	I-Gene_or_gene_product
precursor	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
APP	B-Gene_or_gene_product
)	O
and	O
cloned	O
a	O
new	O
member	O
of	O
the	O
X11	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
family	O
,	O
X11L2	B-Gene_or_gene_product
.	O

The	O
PID	O
/	O
PTB	O
element	O
of	O
X11L2	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
interacted	O
with	O
the	O
intracellular	O
domain	O
of	O
APP	B-Gene_or_gene_product
by	O
GST	O
binding	O
assay	O
,	O
and	O
in	O
vivo	O
interaction	O
was	O
confirmed	O
by	O
coimmunoprecipitation	O
from	O
cell	O
extracts	O
overexpressing	O
APP	B-Gene_or_gene_product
and	O
HA	O
-	O
tagged	O
X11L2	B-Gene_or_gene_product
.	O

This	O
gene	B-Gene_or_gene_product
encoded	O
575	O
amino	O
acids	O
and	O
the	O
deduced	O
amino	O
acid	O
sequence	O
was	O
highly	O
homologous	O
to	O
rat	O
Mint3	B-Gene_or_gene_product
.	O

Three	O
protein	O
-	O
protein	O
interaction	O
domains	O
,	O
a	O
PID	O
/	O
PTB	O
and	O
two	O
PDZ	O
elements	O
,	O
were	O
conserved	O
among	O
the	O
X11	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
family	O
,	O
and	O
the	O
N	O
-	O
terminal	O
region	O
of	O
X11L2	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
had	O
several	O
putative	O
SH3	O
binding	O
motifs	O
,	O
PXXP	O
.	O

Unlike	O
other	O
members	O
of	O
the	O
X11	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
family	O
,	O
X11L2	B-Gene_or_gene_product
mRNA	O
was	O
expressed	O
in	O
various	O
tissues	O
.	O

An	O
antisense	O
transcript	O
to	O
SMAD5	B-Gene_or_gene_product
expressed	O
in	O
fetal	O
and	O
tumor	O
tissues	O
.	O

SMAD5	B-Gene_or_gene_product
,	O
a	O
transducer	O
of	O
TGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
/	I-Gene_or_gene_product
BMP	I-Gene_or_gene_product
inhibitory	O
signals	O
and	O
a	O
tumor	B-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
candidate	O
,	O
localizes	O
to	O
the	O
region	O
of	O
invariant	O
loss	O
in	O
human	O
myeloid	O
neoplasms	O
,	O
on	O
chromosome	O
5q31	O
.	O
1	O
.	O

Recent	O
evidence	O
indicates	O
a	O
gene	B-Gene_or_gene_product
-	O
dosage	O
effect	O
along	O
the	O
TGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
/	I-Gene_or_gene_product
BMP	I-Gene_or_gene_product
signaling	O
pathways	O
.	O

We	O
have	O
identified	O
a	O
novel	O
transcript	O
designated	O
DAMS	B-Gene_or_gene_product
,	O
whose	O
3	O
'	O
exonic	O
sequences	O
contain	O
in	O
part	O
an	O
alternate	O
5	O
'	O
exon	O
of	O
SMAD5	B-Gene_or_gene_product
,	O
in	O
the	O
antisense	O
orientation	O
.	O

Expressed	O
sequenced	O
tags	O
(	O
ESTs	O
)	O
for	O
DAMS	B-Gene_or_gene_product
are	O
found	O
in	O
fetal	O
tissues	O
(	O
heart	O
,	O
adrenal	O
glands	O
,	O
and	O
total	O
fetus	O
)	O
and	O
pancreatic	O
tumor	O
cDNA	O
libraries	O
.	O

In	O
contrast	O
to	O
SMAD5	B-Gene_or_gene_product
,	O
DAMS	B-Gene_or_gene_product
expression	O
is	O
not	O
readily	O
detectable	O
in	O
adult	O
and	O
fetal	O
tissues	O
.	O

Semiquantitative	O
PCR	O
suggests	O
that	O
the	O
stoichiometry	O
between	O
SMAD5	B-Gene_or_gene_product
and	O
DAMS	B-Gene_or_gene_product
transcripts	O
ranges	O
between	O
15	O
and	O
120	O
in	O
normal	O
and	O
malignant	O
hematopoietic	O
cells	O
.	O

The	O
findings	O
raise	O
the	O
possibility	O
that	O
DAMS	B-Gene_or_gene_product
may	O
be	O
a	O
fail	O
-	O
safe	O
mechanism	O
for	O
precise	O
regulation	O
of	O
SMAD5	B-Gene_or_gene_product
transcript	O
levels	O
that	O
may	O
be	O
critical	O
in	O
maintaining	O
normal	O
homeostasis	O
.	O

Cloning	O
of	O
BRAK	B-Gene_or_gene_product
,	O
a	O
novel	O
divergent	O
CXC	B-Gene_or_gene_product
chemokine	I-Gene_or_gene_product
preferentially	O
expressed	O
in	O
normal	O
versus	O
malignant	O
cells	O
.	O

Chemokines	B-Gene_or_gene_product
are	O
a	O
family	O
of	O
related	O
proteins	B-Gene_or_gene_product
that	O
regulate	O
leukocyte	O
infiltration	O
into	O
inflamed	O
tissue	O
and	O
play	O
important	O
roles	O
in	O
many	O
disease	O
processes	O
.	O

Chemokines	B-Gene_or_gene_product
are	O
divided	O
into	O
two	O
major	O
groups	O
,	O
CC	B-Gene_or_gene_product
or	O
CXC	B-Gene_or_gene_product
,	O
based	O
on	O
their	O
sequence	O
around	O
the	O
amino	O
terminal	O
cysteines	O
.	O

We	O
report	O
the	O
PCR	O
cloning	O
of	O
a	O
novel	O
human	O
chemokine	B-Gene_or_gene_product
termed	O
BRAK	B-Gene_or_gene_product
for	O
its	O
initial	O
isolation	O
from	O
breast	O
and	O
kidney	O
cells	O
.	O

This	O
novel	O
chemokine	B-Gene_or_gene_product
is	O
distantly	O
related	O
to	O
other	O
CXC	B-Gene_or_gene_product
chemokines	I-Gene_or_gene_product
(	O
30	O
%	O
identity	O
with	O
MIP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2alpha	I-Gene_or_gene_product
and	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	O
and	O
shares	O
several	O
biological	O
activities	O
.	O

BRAK	B-Gene_or_gene_product
is	O
expressed	O
ubiquitously	O
and	O
highly	O
in	O
normal	O
tissue	O
.	O

However	O
,	O
it	O
was	O
expressed	O
in	O
only	O
2	O
of	O
18	O
cancer	O
cell	O
lines	O
.	O

BRAK	B-Gene_or_gene_product
is	O
located	O
on	O
human	O
chromosome	O
5q31	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
cDNA	O
encoding	O
a	O
novel	O
fibroblast	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
preferentially	O
expressed	O
in	O
human	O
heart	O
.	O

A	O
novel	O
human	O
fibroblast	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
hFGF	B-Gene_or_gene_product
)	O
,	O
which	O
shows	O
75	O
%	O
sequence	O
homology	O
with	O
fibroblast	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
,	O
was	O
isolated	O
in	O
random	O
sequencing	O
of	O
a	O
human	O
heart	O
cDNA	O
library	O
.	O

The	O
full	O
-	O
length	O
sequence	O
is	O
928	O
bp	O
,	O
the	O
encoded	O
protein	B-Gene_or_gene_product
is	O
composed	O
of	O
168	O
amino	O
acid	O
residues	O
,	O
and	O
its	O
pI	O
value	O
and	O
molecular	O
weight	O
were	O
estimated	O
to	O
be	O
8	O
.	O
13	O
and	O
19	O
.	O
1	O
kDa	O
,	O
respectively	O
.	O

RT	O
-	O
PCR	O
using	O
Marathon	O
human	O
heart	O
cDNA	O
shows	O
that	O
the	O
coding	O
region	O
is	O
approximately	O
507	O
bp	O
.	O

Southern	O
hybridization	O
showed	O
a	O
single	O
band	O
which	O
indicates	O
that	O
this	O
is	O
a	O
single	O
copy	O
gene	B-Gene_or_gene_product
.	O

Northern	O
hybridization	O
done	O
on	O
a	O
human	O
multiple	O
tissues	O
blot	O
showed	O
that	O
the	O
gene	B-Gene_or_gene_product
is	O
preferentially	O
expressed	O
in	O
human	O
heart	O
,	O
very	O
weakly	O
detectable	O
in	O
human	O
brain	O
and	O
not	O
detectable	O
in	O
18	O
other	O
different	O
human	O
tissues	O
.	O

Human	O
phenylalanyl	O
-	O
tRNA	O
synthetase	O
:	O
cloning	O
,	O
characterization	O
of	O
the	O
deduced	O
amino	O
acid	O
sequences	O
in	O
terms	O
of	O
the	O
structural	O
domains	O
and	O
coordinately	O
regulated	O
expression	O
of	O
the	O
alpha	O
and	O
beta	O
subunits	O
in	O
chronic	O
myeloid	O
leukemia	O
cells	O
.	O

Unlike	O
the	O
catalytic	O
alpha	O
-	O
subunit	O
,	O
the	O
beta	O
-	O
subunit	O
of	O
heterodimeric	O
(	O
alphabeta	O
)	O
2	O
phenylalanyl	O
-	O
tRNA	O
synthetase	O
(	O
PheRS	O
)	O
has	O
no	O
invariant	O
functional	O
amino	O
acids	O
directly	O
involved	O
in	O
the	O
aminoacylation	O
process	O
as	O
it	O
is	O
evident	O
from	O
the	O
crystal	O
structure	O
of	O
the	O
T	O
.	O
thermophilus	O
enzyme	O
complexed	O
with	O
tRNAPhe	O
.	O

Having	O
no	O
catalytic	O
function	O
,	O
the	O
prokaryotic	O
beta	O
-	O
subunit	O
comprises	O
OB	O
-	O
,	O
RNP	O
-	O
,	O
SH3	O
-	O
,	O
and	O
DNA	O
-	O
binding	O
-	O
like	O
domains	O
involved	O
in	O
a	O
variety	O
of	O
biological	O
functions	O
in	O
other	O
proteins	B-Gene_or_gene_product
.	O

It	O
was	O
shown	O
that	O
the	O
mRNA	O
of	O
the	O
human	O
alpha	O
-	O
subunit	O
overexpressed	O
in	O
the	O
tumorigenic	O
versus	O
the	O
nontumorigenic	O
variant	O
of	O
the	O
same	O
acute	O
-	O
phase	O
chronic	O
myeloid	O
leukemia	O
cell	O
line	O
(	O
CML	O
)	O
.	O

We	O
cloned	O
,	O
sequenced	O
,	O
and	O
expressed	O
human	O
PheRS	O
.	O

The	O
layout	O
of	O
the	O
human	O
sequence	O
indicates	O
that	O
the	O
general	O
tRNA	O
binding	O
mode	O
and	O
anticodon	O
recognition	O
differ	O
between	O
prokaryotes	O
and	O
eukaryotes	O
for	O
the	O
phenylalanine	O
system	O
.	O

Northern	O
blot	O
hybridization	O
analysis	O
from	O
malignant	O
and	O
normal	O
human	O
tissues	O
enabled	O
us	O
to	O
assess	O
the	O
relative	O
expression	O
levels	O
of	O
the	O
alpha	O
-	O
and	O
beta	O
-	O
subunits	O
independently	O
,	O
in	O
view	O
of	O
the	O
additional	O
cellular	O
role	O
proposed	O
for	O
the	O
beta	O
-	O
subunit	O
in	O
tumorigenic	O
events	O
.	O

The	O
levels	O
of	O
mRNA	O
corresponding	O
to	O
the	O
alpha	O
-	O
and	O
beta	O
-	O
subunits	O
were	O
remarkably	O
similar	O
in	O
all	O
cell	O
types	O
and	O
tissues	O
examined	O
,	O
thus	O
indicating	O
the	O
implication	O
of	O
the	O
entire	O
(	B-Gene_or_gene_product
alphabeta	I-Gene_or_gene_product
)	I-Gene_or_gene_product
2	I-Gene_or_gene_product
heterodimer	O
in	O
tumorigenic	O
events	O
.	O

Parathyroid	O
hormone	O
-	O
regulated	O
production	O
of	O
stem	B-Gene_or_gene_product
cell	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
in	O
human	O
osteoblasts	O
and	O
osteoblast	O
-	O
like	O
cells	O
.	O

We	O
investigated	O
stem	B-Gene_or_gene_product
cell	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
SCF	B-Gene_or_gene_product
)	O
expression	O
in	O
osteoblasts	O
because	O
mast	O
cells	O
,	O
which	O
occur	O
ectopically	O
in	O
hyperparathyroid	O
bone	O
,	O
are	O
induced	O
by	O
SCF	B-Gene_or_gene_product
.	O

Nontransformed	O
osteoblasts	O
and	O
Saos2	O
or	O
MG63	O
cells	O
expressed	O
SCF	B-Gene_or_gene_product
in	O
response	O
to	O
PTH	O
.	O

Western	O
analysis	O
showed	O
only	O
large	O
,	O
cell	O
-	O
associated	O
isoforms	O
,	O
Mrs	O
approximately	O
40	O
-	O
48	O
kD	O
.	O

Transfection	O
of	O
MG63	O
cells	O
with	O
plasmids	O
expressing	O
antisense	O
SCF	O
mRNA	O
eliminated	O
immunoreactive	O
SCF	B-Gene_or_gene_product
.	O

Sequencing	O
osteoblast	O
SCF	B-Gene_or_gene_product
cDNAs	O
showed	O
that	O
exon	O
6	O
was	O
omitted	O
.	O

mRNAs	O
without	O
exon	O
6	O
produce	O
membrane	O
-	O
associated	O
SCF	B-Gene_or_gene_product
isoforms	I-Gene_or_gene_product
in	O
rodents	O
,	O
suggesting	O
that	O
human	O
SCFs	B-Gene_or_gene_product
are	O
processed	O
similarly	O
.	O

The	O
major	O
osteoblastic	O
SCF	B-Gene_or_gene_product
mRNA	O
,	O
approximately	O
5	O
kB	O
,	O
was	O
augmented	O
by	O
PTH	O
.	O

Neither	O
protein	B-Gene_or_gene_product
or	O
mRNA	O
was	O
increased	O
by	O
vitamin	O
D	O
,	O
however	O
,	O
6	O
-	O
7	O
kB	O
transcripts	O
were	O
predominant	O
in	O
other	O
tissues	O
but	O
not	O
detectable	O
in	O
osteoblasts	O
.	O

We	O
conclude	O
that	O
osteoblasts	O
express	O
SCF	B-Gene_or_gene_product
in	O
response	O
to	O
PTH	O
,	O
with	O
mRNA	O
and	O
protein	B-Gene_or_gene_product
processing	O
differences	O
relative	O
to	O
other	O
cells	O
.	O

SCF	B-Gene_or_gene_product
stimulates	O
osteoclasts	O
,	O
suggesting	O
that	O
PTH	O
-	O
induced	O
osteoblastic	O
SCF	B-Gene_or_gene_product
functions	O
to	O
accelerate	O
bone	O
turnover	O
.	O

Mast	O
cells	O
may	O
occur	O
due	O
to	O
SCF	B-Gene_or_gene_product
overexpression	O
at	O
extreme	O
PTH	O
levels	O
.	O

NKp44	B-Gene_or_gene_product
,	O
a	O
triggering	O
receptor	B-Gene_or_gene_product
involved	O
in	O
tumor	O
cell	O
lysis	O
by	O
activated	O
human	O
natural	O
killer	O
cells	O
,	O
is	O
a	O
novel	O
member	O
of	O
the	O
immunoglobulin	B-Gene_or_gene_product
superfamily	O
.	O

Surface	O
receptors	B-Gene_or_gene_product
involved	O
in	O
natural	O
killer	O
(	O
NK	O
)	O
cell	O
triggering	O
during	O
the	O
process	O
of	O
tumor	O
cell	O
lysis	O
have	O
recently	O
been	O
identified	O
.	O

Of	O
these	O
receptors	B-Gene_or_gene_product
,	O
NKp44	B-Gene_or_gene_product
is	O
selectively	O
expressed	O
by	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	O
activated	O
NK	O
cells	O
and	O
may	O
contribute	O
to	O
the	O
increased	O
efficiency	O
of	O
activated	O
NK	O
cells	O
to	O
mediate	O
tumor	O
cell	O
lysis	O
.	O

Here	O
we	O
describe	O
the	O
molecular	O
cloning	O
of	O
NKp44	B-Gene_or_gene_product
.	O

Analysis	O
of	O
the	O
cloned	O
cDNA	O
indicated	O
that	O
NKp44	B-Gene_or_gene_product
is	O
a	O
novel	O
transmembrane	O
glycoprotein	B-Gene_or_gene_product
belonging	O
to	O
the	O
Immunoglobulin	B-Gene_or_gene_product
superfamily	O
characterized	O
by	O
a	O
single	O
extracellular	O
V	O
-	O
type	O
domain	O
.	O

The	O
charged	O
amino	O
acid	O
lysine	O
in	O
the	O
transmembrane	O
region	O
may	O
be	O
involved	O
in	O
the	O
association	O
of	O
NKp44	B-Gene_or_gene_product
with	O
the	O
signal	O
transducing	O
molecule	O
killer	O
activating	O
receptor	O
-	O
associated	O
polypeptide	O
(	B-Gene_or_gene_product
KARAP	I-Gene_or_gene_product
)	I-Gene_or_gene_product
/	I-Gene_or_gene_product
DAP12	I-Gene_or_gene_product
.	O

These	O
molecules	O
were	O
found	O
to	O
be	O
crucial	O
for	O
the	O
surface	O
expression	O
of	O
NKp44	B-Gene_or_gene_product
.	O

In	O
agreement	O
with	O
data	O
of	O
NKp44	B-Gene_or_gene_product
surface	O
expression	O
,	O
the	O
NKp44	B-Gene_or_gene_product
transcripts	O
were	O
strictly	O
confined	O
to	O
activated	O
NK	O
cells	O
and	O
to	O
a	O
minor	O
subset	O
of	O
TCR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
gamma	I-Gene_or_gene_product
/	I-Gene_or_gene_product
delta	I-Gene_or_gene_product
+	O
T	O
lymphocytes	O
.	O

Unlike	O
genes	B-Gene_or_gene_product
coding	O
for	O
other	O
receptors	B-Gene_or_gene_product
involved	O
in	O
NK	O
cell	O
triggering	O
or	O
inhibition	O
,	O
the	O
NKp44	B-Gene_or_gene_product
gene	B-Gene_or_gene_product
is	O
on	O
human	O
chromosome	O
6	O
.	O

Nuclear	O
and	O
nucleolar	O
targeting	O
of	O
human	O
ribosomal	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
S25	I-Gene_or_gene_product
:	O
common	O
features	O
shared	O
with	O
HIV	O
-	O
1	O
regulatory	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

The	O
nuclear	O
and	O
nucleolar	O
targeting	O
properties	O
of	O
human	O
ribosomal	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
S25	I-Gene_or_gene_product
(	O
RPS25	B-Gene_or_gene_product
)	O
were	O
analysed	O
by	O
the	O
expression	O
of	O
epitope	O
-	O
tagged	O
RPS25	B-Gene_or_gene_product
cDNAs	O
in	O
Cos	O
-	O
1	O
cells	O
.	O

The	O
tagged	O
RPS25	B-Gene_or_gene_product
was	O
localized	O
to	O
the	O
cell	O
nucleus	O
,	O
with	O
a	O
strong	O
predominance	O
in	O
the	O
nucleolus	O
.	O

At	O
the	O
amino	O
terminus	O
of	O
RPS25	B-Gene_or_gene_product
,	O
two	O
stretches	O
of	O
highly	O
basic	O
residues	O
juxtapose	O
.	O

This	O
configuration	O
shares	O
common	O
features	O
with	O
the	O
nucleolar	O
targeting	O
signals	O
(	O
NOS	O
)	O
of	O
lentiviral	O
RNA	O
-	O
binding	O
transactivators	O
,	O
including	O
human	O
immunodeficiency	O
viruses	O
'	O
(	O
HIV	O
)	O
Rev	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Deletion	O
and	O
site	O
-	O
directed	O
mutational	O
analyses	O
demonstrated	O
that	O
the	O
first	O
NOS	O
-	O
like	O
stretch	O
is	O
dispensable	O
for	O
both	O
nuclear	O
and	O
nucleolar	O
localization	O
of	O
RPS25	B-Gene_or_gene_product
,	O
and	O
that	O
the	O
nuclear	O
targeting	O
signal	O
is	O
located	O
within	O
the	O
second	O
NOS	O
-	O
like	O
stretch	O
.	O

It	O
has	O
also	O
been	O
suggested	O
that	O
a	O
set	O
of	O
continuous	O
basic	O
residues	O
and	O
the	O
total	O
number	O
of	O
basic	O
residues	O
should	O
be	O
required	O
for	O
nucleolar	O
targeting	O
.	O

Signal	O
-	O
mediated	O
nuclear	O
/	O
nucleolar	O
targeting	O
was	O
further	O
characterized	O
by	O
the	O
construction	O
and	O
expression	O
of	O
a	O
variety	O
of	O
chimeric	O
constructs	O
,	O
utilizing	O
three	O
different	O
backbones	O
with	O
RPS25	B-Gene_or_gene_product
cDNA	O
fragments	O
.	O

Immunofluorescence	O
analyses	O
demonstrated	O
a	O
17	O
residue	O
peptide	O
of	O
RPS25	B-Gene_or_gene_product
as	O
a	O
potential	O
nuclear	O
/	O
nucleolar	O
targeting	O
signal	O
.	O

The	O
identified	O
peptide	O
signal	O
may	O
belong	O
to	O
a	O
putative	O
subclass	O
of	O
NOS	O
,	O
characterized	O
by	O
compact	O
structure	O
,	O
together	O
with	O
lentiviral	O
RNA	O
-	O
binding	O
transactivators	O
.	O

Ma1	B-Gene_or_gene_product
,	O
a	O
novel	O
neuron	O
-	O
and	O
testis	O
-	O
specific	O
protein	B-Gene_or_gene_product
,	O
is	O
recognized	O
by	O
the	O
serum	O
of	O
patients	O
with	O
paraneoplastic	O
neurological	O
disorders	O
.	O

The	O
identification	O
of	O
antineuronal	O
antibodies	B-Gene_or_gene_product
has	O
facilitated	O
the	O
diagnosis	O
of	O
paraneoplastic	O
neurological	O
disorders	O
and	O
the	O
early	O
detection	O
of	O
the	O
associated	O
tumours	O
.	O

It	O
has	O
also	O
led	O
to	O
the	O
cloning	O
of	O
possibly	O
important	O
neuron	O
-	O
specific	O
proteins	B-Gene_or_gene_product
.	O

In	O
this	O
study	O
we	O
wanted	O
to	O
identify	O
novel	O
antineuronal	O
antibodies	B-Gene_or_gene_product
in	O
the	O
sera	O
of	O
patients	O
with	O
paraneoplastic	O
neurological	O
disorders	O
and	O
to	O
clone	O
the	O
corresponding	O
antigens	O
.	O

Serological	O
studies	O
of	O
1705	O
sera	O
from	O
patients	O
with	O
suspected	O
paraneoplastic	O
neurological	O
disorders	O
resulted	O
in	O
the	O
identification	O
of	O
four	O
patients	O
with	O
antibodies	B-Gene_or_gene_product
that	O
reacted	O
with	O
37	O
and	O
40	O
kDa	O
neuronal	O
proteins	B-Gene_or_gene_product
(	O
anti	O
-	O
Ma	O
antibodies	B-Gene_or_gene_product
)	O
.	O

Three	O
patients	O
had	O
brainstem	O
and	O
cerebellar	O
dysfunction	O
,	O
and	O
one	O
had	O
dysphagia	O
and	O
motor	O
weakness	O
.	O

Autopsy	O
of	O
two	O
patients	O
showed	O
loss	O
of	O
Purkinje	O
cells	O
,	O
Bergmann	O
gliosis	O
and	O
deep	O
cerebellar	O
white	O
matter	O
inflammatory	O
infiltrates	O
.	O

Extensive	O
neuronal	O
degeneration	O
,	O
gliosis	O
and	O
infiltrates	O
mainly	O
composed	O
of	O
CD8	B-Gene_or_gene_product
+	O
T	O
cells	O
were	O
also	O
found	O
in	O
the	O
brainstem	O
of	O
one	O
patient	O
.	O

In	O
normal	O
human	O
and	O
rat	O
tissues	O
,	O
the	O
anti	O
-	O
Ma	O
antibodies	B-Gene_or_gene_product
reacted	O
exclusively	O
with	O
neurons	O
and	O
with	O
testicular	O
germ	O
cells	O
;	O
the	O
reaction	O
was	O
mainly	O
with	O
subnuclear	O
elements	O
(	O
including	O
the	O
nucleoli	O
)	O
and	O
to	O
a	O
lesser	O
degree	O
the	O
cytoplasm	O
.	O

Anti	O
-	O
Ma	O
antibodies	B-Gene_or_gene_product
also	O
reacted	O
with	O
the	O
cancers	O
(	O
breast	O
,	O
colon	O
and	O
parotid	O
)	O
available	O
from	O
three	O
anti	O
-	O
Ma	O
patients	O
,	O
but	O
not	O
with	O
66	O
other	O
tumours	O
of	O
varying	O
histological	O
types	O
.	O

Preincubation	O
of	O
tissues	O
with	O
any	O
of	O
the	O
anti	O
-	O
Ma	O
sera	O
abrogated	O
the	O
reactivity	O
of	O
the	O
other	O
anti	O
-	O
Ma	O
immunoglobulins	B-Gene_or_gene_product
.	O

Probing	O
of	O
a	O
human	O
complementary	O
DNA	O
library	O
with	O
anti	O
-	O
Ma	O
serum	O
resulted	O
in	O
the	O
cloning	O
of	O
a	O
gene	B-Gene_or_gene_product
that	O
encodes	O
a	O
novel	O
37	O
kDa	O
protein	B-Gene_or_gene_product
(	O
Mal	B-Gene_or_gene_product
)	O
.	O

Recombinant	B-Gene_or_gene_product
Mal	I-Gene_or_gene_product
was	O
specifically	O
recognized	O
by	O
the	O
four	O
anti	O
-	O
Ma	O
sera	O
but	O
not	O
by	O
337	O
control	O
sera	O
,	O
including	O
those	O
from	O
52	O
normal	O
individuals	O
,	O
179	O
cancer	O
patients	O
without	O
paraneoplastic	O
neurological	O
symptoms	O
,	O
96	O
patients	O
with	O
paraneoplastic	O
syndromes	O
and	O
10	O
patients	O
with	O
non	O
-	O
cancer	O
-	O
related	O
neurological	O
disorders	O
.	O

The	O
expression	O
of	O
Mal	B-Gene_or_gene_product
mRNA	O
is	O
highly	O
restricted	O
to	O
the	O
brain	O
and	O
testis	O
.	O

Subsequent	O
analysis	O
suggested	O
that	O
Mal	B-Gene_or_gene_product
is	O
likely	O
to	O
be	O
a	O
phosphoprotein	B-Gene_or_gene_product
.	O

Our	O
study	O
demonstrates	O
that	O
some	O
patients	O
with	O
paraneoplastic	O
neurological	O
disorders	O
develop	O
antibodies	B-Gene_or_gene_product
against	O
Mal	B-Gene_or_gene_product
,	O
a	O
new	O
member	O
of	O
an	O
expanding	O
family	O
of	O
'	O
brain	O
/	O
testis	O
'	O
proteins	B-Gene_or_gene_product
.	O

Chromosomal	O
localization	O
of	O
three	O
human	O
genes	B-Gene_or_gene_product
encoding	O
bone	B-Gene_or_gene_product
morphogenetic	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O

Bone	B-Gene_or_gene_product
morphogenetic	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
(	O
BMPs	B-Gene_or_gene_product
)	O
are	O
members	O
of	O
the	O
TGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
superfamily	O
that	O
play	O
a	O
pivotal	O
role	O
in	O
bone	O
formation	O
during	O
embryogenesis	O
and	O
fracture	O
repair	O
.	O

BMP	B-Gene_or_gene_product
signaling	O
occurs	O
via	O
hetero	O
-	O
oligomeric	O
serine	O
/	O
threonine	O
kinase	O
complexes	O
of	O
BMP	B-Gene_or_gene_product
type	I-Gene_or_gene_product
I	I-Gene_or_gene_product
(	O
BMPR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IA	I-Gene_or_gene_product
or	O
BMPR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IB	I-Gene_or_gene_product
)	O
and	O
type	B-Gene_or_gene_product
II	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
(	O
BMPR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
II	I-Gene_or_gene_product
)	O
.	O

BMPR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IA	I-Gene_or_gene_product
and	O
IB	B-Gene_or_gene_product
are	O
closely	O
related	O
receptors	B-Gene_or_gene_product
,	O
with	O
sequence	O
differences	O
conserved	O
between	O
different	O
species	O
,	O
suggesting	O
that	O
they	O
serve	O
distinct	O
functions	O
.	O

Here	O
we	O
report	O
the	O
cDNA	O
cloning	O
of	O
human	O
BMPR1B	B-Gene_or_gene_product
and	O
the	O
chromosomal	O
localization	O
of	O
all	O
three	O
BMPR	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

Using	O
somatic	O
cell	O
hybrid	O
and	O
FISH	O
analyses	O
,	O
the	O
BMPR1A	B-Gene_or_gene_product
,	O
BMPR1B	B-Gene_or_gene_product
,	O
and	O
BMPR2	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
were	O
assigned	O
to	O
10q23	O
,	O
4q22	O
-	O
24	O
,	O
and	O
2q33	O
-	O
34	O
,	O
respectively	O
.	O

A	O
processed	O
BMPR1A	B-Gene_or_gene_product
pseudogene	I-Gene_or_gene_product
was	O
mapped	O
to	O
6q23	O
.	O

Genomic	O
structure	O
,	O
chromosomal	O
mapping	O
,	O
and	O
expression	O
pattern	O
of	O
human	O
DCAMKL1	B-Gene_or_gene_product
(	O
KIAA0369	B-Gene_or_gene_product
)	O
,	O
a	O
homologue	O
of	O
DCX	B-Gene_or_gene_product
(	O
XLIS	B-Gene_or_gene_product
)	O
.	O

Human	O
DCAMKL1	B-Gene_or_gene_product
,	O
also	O
known	O
as	O
KIAA0369	B-Gene_or_gene_product
,	O
is	O
a	O
homologue	O
of	O
DCX	B-Gene_or_gene_product
(	O
Xq22	O
.	O
3	O
)	O
,	O
a	O
gene	B-Gene_or_gene_product
associated	O
with	O
X	O
-	O
linked	O
lissencephaly	O
and	O
subcortical	O
band	O
heterotopia	O
.	O

This	O
suggests	O
that	O
DCAMKL1	B-Gene_or_gene_product
may	O
play	O
a	O
role	O
in	O
neuronal	O
migration	O
.	O

The	O
gene	B-Gene_or_gene_product
also	O
shows	O
similarity	O
to	O
Ca2	O
+	O
/	O
calmodulin	O
-	O
dependent	O
protein	O
kinases	O
.	O

We	O
have	O
determined	O
its	O
genomic	O
structure	O
,	O
regional	O
mapping	O
,	O
and	O
expression	O
pattern	O
in	O
human	O
tissues	O
.	O

DCAMKL1	B-Gene_or_gene_product
consists	O
of	O
at	O
least	O
18	O
exons	O
ranging	O
from	O
58	O
to	O
3359	O
bp	O
in	O
length	O
.	O

We	O
have	O
characterized	O
the	O
exon	O
/	O
intron	O
borders	O
,	O
and	O
primers	O
were	O
designed	O
to	O
amplify	O
each	O
individual	O
exon	O
for	O
mutation	O
analysis	O
.	O

DCAMKL1	B-Gene_or_gene_product
was	O
mapped	O
to	O
chromosome	O
13q13	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O

Northern	O
blot	O
analysis	O
showed	O
DCAMKL1	B-Gene_or_gene_product
to	O
be	O
predominantly	O
expressed	O
in	O
human	O
fetal	O
brain	O
as	O
a	O
major	O
transcript	O
of	O
about	O
5	O
.	O
8	O
kb	O
.	O

Structure	O
and	O
chromosomal	O
assignment	O
of	O
the	O
sterol	B-Gene_or_gene_product
12alpha	I-Gene_or_gene_product
-	I-Gene_or_gene_product
hydroxylase	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
(	O
CYP8B1	B-Gene_or_gene_product
)	O
in	O
human	O
and	O
mouse	O
:	O
eukaryotic	O
cytochrome	B-Gene_or_gene_product
P	I-Gene_or_gene_product
-	I-Gene_or_gene_product
450	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
devoid	O
of	O
introns	O
.	O

Sterol	O
12alpha	O
-	O
hydroxylase	O
(	O
CYP8B1	O
)	O
is	O
a	O
hepatic	O
cytochrome	B-Gene_or_gene_product
P	I-Gene_or_gene_product
-	I-Gene_or_gene_product
450	I-Gene_or_gene_product
that	O
controls	O
the	O
ratio	O
of	O
cholic	O
acid	O
over	O
chenodeoxycholic	O
acid	O
in	O
bile	O
and	O
thus	O
controls	O
the	O
solubility	O
of	O
cholesterol	O
.	O

Both	O
the	O
human	O
and	O
the	O
mouse	O
CYP8B1	B-Gene_or_gene_product
complementary	O
DNA	O
and	O
gene	B-Gene_or_gene_product
were	O
cloned	O
and	O
structurally	O
characterized	O
.	O

Surprisingly	O
,	O
the	O
genomic	O
DNA	O
from	O
both	O
species	O
was	O
found	O
to	O
lack	O
introns	O
.	O

The	O
major	O
transcript	O
of	O
the	O
human	O
gene	B-Gene_or_gene_product
was	O
estimated	O
to	O
be	O
3950	O
bp	O
,	O
and	O
the	O
putative	O
promoter	O
region	O
was	O
estimated	O
to	O
be	O
at	O
least	O
1360	O
bp	O
.	O

The	O
murine	O
structural	O
gene	B-Gene_or_gene_product
was	O
found	O
to	O
span	O
approximately	O
3	O
kb	O
.	O

By	O
using	O
FISH	O
and	O
radiation	O
hybrid	O
mapping	O
techniques	O
,	O
the	O
human	O
CYP8B1	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
was	O
located	O
to	O
chromosome	O
3p21	O
.	O
3	O
-	O
p22	O
,	O
whereas	O
FISH	O
mapped	O
the	O
murine	O
counterpart	O
to	O
chromosome	O
9qF4	O
,	O
a	O
region	O
that	O
is	O
homologous	O
to	O
the	O
third	O
human	O
chromosome	O
.	O

The	O
results	O
from	O
the	O
chromosome	O
mapping	O
and	O
Southern	O
blotting	O
indicated	O
that	O
the	O
gene	B-Gene_or_gene_product
is	O
present	O
in	O
a	O
single	O
copy	O
.	O

Transcription	O
of	O
the	O
mouse	O
and	O
human	O
CYP8B1	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
was	O
initiated	O
from	O
a	O
position	O
situated	O
51	O
and	O
35	O
bases	O
,	O
respectively	O
,	O
downstream	O
of	O
a	O
consensus	O
TATA	O
box	O
.	O

A	O
homology	O
of	O
21	O
%	O
for	O
the	O
promoter	O
regions	O
of	O
mouse	O
and	O
human	O
may	O
indicate	O
differences	O
in	O
transcriptional	O
regulation	O
.	O

Although	O
a	O
potent	O
induction	O
of	O
CYP8B1	B-Gene_or_gene_product
mRNA	O
was	O
observed	O
upon	O
starvation	O
of	O
mice	O
,	O
the	O
mechanism	O
behind	O
this	O
effect	O
was	O
not	O
revealed	O
by	O
analysis	O
of	O
the	O
promoter	O
for	O
potential	O
cis	O
-	O
acting	O
elements	O
.	O

In	O
the	O
human	O
promoter	O
,	O
several	O
possible	O
cis	O
-	O
acting	O
regions	O
were	O
identified	O
but	O
none	O
of	O
them	O
could	O
be	O
directly	O
related	O
to	O
bile	O
acid	O
metabolism	O
.	O

After	O
transfection	O
of	O
COS	O
cells	O
with	O
the	O
human	O
coding	O
region	O
,	O
mRNA	O
and	O
enzymatic	O
activity	O
for	O
the	O
12alpha	O
-	O
hydroxylase	O
were	O
identified	O
.	O

This	O
is	O
the	O
first	O
mammalian	O
cytochrome	B-Gene_or_gene_product
P	I-Gene_or_gene_product
-	I-Gene_or_gene_product
450	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
reported	O
to	O
lack	O
introns	O
.	O

The	O
importance	O
of	O
this	O
structural	O
feature	O
for	O
evolution	O
and	O
gene	B-Gene_or_gene_product
regulation	O
is	O
discussed	O
.	O

Three	O
distinct	O
anti	O
-	O
allergic	O
drugs	O
,	O
amlexanox	O
,	O
cromolyn	O
and	O
tranilast	O
,	O
bind	O
to	O
S100A12	B-Gene_or_gene_product
and	O
S100A13	B-Gene_or_gene_product
of	O
the	O
S100	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
family	O
.	O

To	O
investigate	O
the	O
roles	O
of	O
calcium	O
-	O
binding	O
proteins	B-Gene_or_gene_product
in	O
degranulation	O
,	O
we	O
used	O
three	O
anti	O
-	O
allergic	O
drugs	O
,	O
amlexanox	O
,	O
cromolyn	O
and	O
tranilast	O
,	O
which	O
inhibit	O
IgE	B-Gene_or_gene_product
-	O
mediated	O
degranulation	O
of	O
mast	O
cells	O
,	O
as	O
molecular	O
probes	O
in	O
affinity	O
chromatography	O
.	O

All	O
of	O
these	O
drugs	O
,	O
which	O
have	O
different	O
structures	O
but	O
similar	O
function	O
,	O
scarcely	O
bound	O
to	O
calmodulin	B-Gene_or_gene_product
in	O
bovine	O
lung	O
extract	O
,	O
but	O
bound	O
to	O
the	O
same	O
kinds	O
of	O
calcium	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
such	O
as	O
the	O
10	O
-	O
kDa	O
proteins	B-Gene_or_gene_product
isolated	O
in	O
this	O
study	O
,	O
calcyphosine	B-Gene_or_gene_product
and	O
annexins	B-Gene_or_gene_product
I	I-Gene_or_gene_product
-	I-Gene_or_gene_product
V	I-Gene_or_gene_product
.	O

The	O
10	O
-	O
kDa	O
proteins	B-Gene_or_gene_product
obtained	O
on	O
three	O
drug	O
-	O
coupled	O
resins	O
and	O
on	O
phenyl	O
-	O
Sepharose	O
were	O
analysed	O
by	O
reversed	O
-	O
phase	O
HPLC	O
.	O

It	O
was	O
found	O
that	O
two	O
characteristic	O
10	O
-	O
kDa	O
proteins	B-Gene_or_gene_product
,	O
one	O
polar	O
and	O
one	O
less	O
polar	O
,	O
were	O
bound	O
with	O
all	O
three	O
drugs	O
,	O
although	O
S100A2	B-Gene_or_gene_product
(	I-Gene_or_gene_product
S100L	I-Gene_or_gene_product
)	I-Gene_or_gene_product
,	O
of	O
the	O
S100	B-Gene_or_gene_product
family	O
,	O
was	O
bound	O
with	O
phenyl	O
-	O
Sepharose	O
.	O

The	O
cDNA	O
and	O
deduced	O
amino	O
acid	O
sequence	O
proved	O
our	O
major	O
polar	O
protein	B-Gene_or_gene_product
to	O
be	O
identical	O
with	O
the	O
calcium	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
in	O
bovine	O
amniotic	O
fluid	O
(	O
CAAF1	B-Gene_or_gene_product
,	O
S100A12	B-Gene_or_gene_product
)	O
.	O

The	O
cDNA	O
and	O
deduced	O
amino	O
acid	O
sequence	O
of	O
the	O
less	O
-	O
polar	O
protein	B-Gene_or_gene_product
shared	O
95	O
%	O
homology	O
with	O
human	O
and	O
mouse	O
S100A13	B-Gene_or_gene_product
.	O

In	O
addition	O
,	O
it	O
was	O
demonstrated	O
that	O
the	O
native	O
S100A12	B-Gene_or_gene_product
and	O
recombinant	O
S100A12	B-Gene_or_gene_product
and	O
S100A13	B-Gene_or_gene_product
bind	O
to	O
immobilized	O
amlexanox	O
.	O

On	O
the	O
basis	O
of	O
these	O
findings	O
,	O
we	O
speculate	O
that	O
the	O
three	O
anti	O
-	O
allergic	O
drugs	O
might	O
inhibit	O
degranulation	O
by	O
binding	O
with	O
S100A12	B-Gene_or_gene_product
and	O
S100A13	B-Gene_or_gene_product
.	O

Active	O
transcriptional	O
repression	O
by	O
the	O
Rb	B-Gene_or_gene_product
-	I-Gene_or_gene_product
E2F	I-Gene_or_gene_product
complex	I-Gene_or_gene_product
mediates	O
G1	O
arrest	O
triggered	O
by	O
p16INK4a	B-Gene_or_gene_product
,	O
TGFbeta	B-Gene_or_gene_product
,	O
and	O
contact	O
inhibition	O
.	O

Rb	B-Gene_or_gene_product
inhibits	O
progression	O
from	O
G1	O
to	O
S	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O

It	O
associates	O
with	O
a	O
number	O
of	O
cellular	O
proteins	B-Gene_or_gene_product
;	O
however	O
,	O
the	O
nature	O
of	O
these	O
interactions	O
and	O
their	O
relative	O
significance	O
in	O
cell	O
cycle	O
regulation	O
are	O
still	O
unclear	O
.	O

We	O
present	O
evidence	O
that	O
Rb	B-Gene_or_gene_product
must	O
normally	O
interact	O
with	O
the	O
E2F	O
family	O
of	O
transcription	O
factors	O
to	O
arrest	O
cells	O
in	O
G1	O
,	O
and	O
that	O
this	O
arrest	O
results	O
from	O
active	O
transcriptional	O
repression	O
by	O
the	O
Rb	O
-	O
E2F	O
complex	O
,	O
not	O
from	O
inactivation	O
of	O
E2F	O
.	O

Thus	O
,	O
a	O
major	O
role	O
of	O
E2F	O
in	O
cell	O
cycle	O
regulation	O
is	O
assembly	O
of	O
this	O
repressor	O
complex	O
.	O

We	O
demonstrate	O
that	O
active	O
repression	O
by	O
Rb	O
-	O
E2F	O
mediates	O
the	O
G1	O
arrest	O
triggered	O
by	O
TGFbeta	B-Gene_or_gene_product
,	O
p16INK4a	B-Gene_or_gene_product
,	O
and	O
contact	O
inhibition	O
.	O

A	O
novel	O
lipopolysaccharide	O
-	O
induced	O
transcription	O
factor	O
regulating	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
gene	O
expression	O
:	O
molecular	O
cloning	O
,	O
sequencing	O
,	O
characterization	O
,	O
and	O
chromosomal	O
assignment	O
.	O

Lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
a	O
potent	O
stimulator	O
of	O
monocytes	O
and	O
macrophages	O
,	O
causing	O
secretion	O
of	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
)	O
and	O
other	O
inflammatory	O
mediators	O
.	O

Given	O
the	O
deleterious	O
effects	O
to	O
the	O
host	O
of	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
it	O
has	O
been	O
postulated	O
that	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
gene	O
expression	O
must	O
be	O
tightly	O
regulated	O
.	O

The	O
nature	O
of	O
the	O
nuclear	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	I-Gene_or_gene_product
s	I-Gene_or_gene_product
)	I-Gene_or_gene_product
that	O
control	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
transcription	O
in	O
humans	O
remains	O
obscure	O
,	O
although	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
has	O
been	O
suggested	O
.	O

Our	O
previous	O
studies	O
pertaining	O
to	O
macrophage	O
response	O
to	O
LPS	O
identified	O
a	O
novel	O
DNA	O
-	O
binding	O
domain	O
located	O
from	O
-	O
550	O
to	O
-	O
487	O
in	O
the	O
human	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
promoter	O
that	O
contains	O
transcriptional	O
activity	O
,	O
but	O
lacks	O
any	O
known	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
-	O
binding	O
sites	O
.	O

We	O
have	O
used	O
this	O
DNA	O
fragment	O
to	O
isolate	O
and	O
purify	O
a	O
60	O
-	O
kDa	O
protein	B-Gene_or_gene_product
binding	O
to	O
this	O
fragment	O
and	O
obtained	O
its	O
amino	O
-	O
terminal	O
sequence	O
,	O
which	O
was	O
used	O
to	O
design	O
degenerate	O
probes	O
to	O
screen	O
a	O
cDNA	O
library	O
from	O
THP	O
-	O
1	O
cells	O
.	O

A	O
novel	O
cDNA	O
clone	O
(	O
1	O
.	O
8	O
kb	O
)	O
was	O
isolated	O
and	O
fully	O
sequenced	O
.	O

Characterization	O
of	O
this	O
cDNA	O
clone	O
revealed	O
that	O
its	O
induction	O
was	O
dependent	O
on	O
LPS	O
activation	O
of	O
THP	O
-	O
1	O
cells	O
;	O
hence	O
,	O
the	O
name	O
LPS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
induced	I-Gene_or_gene_product
TNF	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
LITAF	B-Gene_or_gene_product
)	O
.	O

Inhibition	O
of	O
LITAF	B-Gene_or_gene_product
mRNA	O
expression	O
in	O
THP	O
-	O
1	O
cells	O
resulted	O
in	O
a	O
reduction	O
of	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
transcripts	O
.	O

In	O
addition	O
,	O
high	O
level	O
of	O
expression	O
of	O
LITAF	B-Gene_or_gene_product
mRNA	O
was	O
observed	O
predominantly	O
in	O
the	O
placenta	O
,	O
peripheral	O
blood	O
leukocytes	O
,	O
lymph	O
nodes	O
,	O
and	O
the	O
spleen	O
.	O

Finally	O
,	O
chromosomal	O
localization	O
using	O
fluorescence	O
in	O
situ	O
hybridization	O
revealed	O
that	O
LITAF	B-Gene_or_gene_product
mapped	O
to	O
chromosome	O
16p12	O
-	O
16p13	O
.	O
3	O
.	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
LITAF	B-Gene_or_gene_product
plays	O
an	O
important	O
role	O
in	O
the	O
activation	O
of	O
the	O
human	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
and	O
proposes	O
a	O
new	O
mechanism	O
to	O
control	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
gene	O
expression	O
.	O

SHP2	O
-	O
interacting	O
transmembrane	O
adaptor	O
protein	O
(	O
SIT	B-Gene_or_gene_product
)	O
,	O
a	O
novel	O
disulfide	O
-	O
linked	O
dimer	O
regulating	O
human	O
T	O
cell	O
activation	O
.	O

T	O
lymphocytes	O
express	O
several	O
low	O
molecular	O
weight	O
transmembrane	B-Gene_or_gene_product
adaptor	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
that	O
recruit	O
src	O
homology	O
(	O
SH	O
)	O
2	O
domain	O
-	O
containing	O
intracellular	O
molecules	O
to	O
the	O
cell	O
membrane	O
via	O
tyrosine	O
-	O
based	O
signaling	O
motifs	O
.	O

We	O
describe	O
here	O
a	O
novel	O
molecule	O
of	O
this	O
group	O
termed	O
SIT	B-Gene_or_gene_product
(	O
SHP2	O
interacting	O
transmembrane	O
adaptor	O
protein	O
)	O
.	O

SIT	B-Gene_or_gene_product
is	O
a	O
disulfide	O
-	O
linked	O
homodimeric	O
glycoprotein	B-Gene_or_gene_product
that	O
is	O
expressed	O
in	O
lymphocytes	O
.	O

After	O
tyrosine	O
phosphorylation	O
by	O
src	B-Gene_or_gene_product
and	O
possibly	O
syk	O
protein	O
tyrosine	O
kinases	O
SIT	B-Gene_or_gene_product
recruits	O
the	O
SH2	O
domain	O
-	O
containing	O
tyrosine	O
phosphatase	O
SHP2	O
via	O
an	O
immunoreceptor	B-Gene_or_gene_product
tyrosine	O
-	O
based	O
inhibition	O
motif	O
.	O

Overexpression	O
of	O
SIT	B-Gene_or_gene_product
in	O
Jurkat	O
cells	O
downmodulates	O
T	O
cell	O
receptor	B-Gene_or_gene_product
-	O
and	O
phytohemagglutinin	B-Gene_or_gene_product
-	O
mediated	O
activation	O
of	O
the	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
AT	I-Gene_or_gene_product
)	O
by	O
interfering	O
with	O
signaling	O
processes	O
that	O
are	O
probably	O
located	O
upstream	O
of	O
activation	O
of	O
phospholipase	O
C	O
.	O

However	O
,	O
binding	O
of	O
SHP2	B-Gene_or_gene_product
to	O
SIT	B-Gene_or_gene_product
is	O
not	O
required	O
for	O
inhibition	O
of	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
AT	I-Gene_or_gene_product
induction	O
,	O
suggesting	O
that	O
SIT	B-Gene_or_gene_product
not	O
only	O
regulates	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
AT	I-Gene_or_gene_product
activity	O
but	O
also	O
controls	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
AT	I-Gene_or_gene_product
unrelated	O
pathways	O
of	O
T	O
cell	O
activation	O
involving	O
SHP2	B-Gene_or_gene_product
.	O

Rel	B-Gene_or_gene_product
/	I-Gene_or_gene_product
NF	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
can	O
trigger	O
the	O
Notch	B-Gene_or_gene_product
signaling	O
pathway	O
by	O
inducing	O
the	O
expression	O
of	O
Jagged1	O
,	O
a	O
ligand	O
for	O
Notch	B-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O

Jagged1	O
belongs	O
to	O
the	O
DSL	O
family	O
of	O
ligands	O
for	O
Notch	B-Gene_or_gene_product
receptors	I-Gene_or_gene_product
that	O
control	O
the	O
proliferation	O
and	O
differentiation	O
of	O
various	O
cell	O
lineages	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
transcription	O
factors	O
that	O
regulate	O
its	O
expression	O
.	O

Here	O
,	O
we	O
show	O
that	O
Jagged1	O
is	O
a	O
Rel	B-Gene_or_gene_product
/	I-Gene_or_gene_product
NF	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
-	O
responsive	O
gene	B-Gene_or_gene_product
.	O

Both	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
and	O
RelA	B-Gene_or_gene_product
induced	O
jagged1	O
gene	O
expression	O
,	O
whereas	O
a	O
mutant	O
defective	O
for	O
transactivation	O
did	O
not	O
.	O

Importantly	O
,	O
jagged1	O
transcripts	O
were	O
also	O
upregulated	O
by	O
endogenous	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
activation	O
and	O
this	O
effect	O
was	O
inhibited	O
by	O
a	O
dominant	O
mutant	O
of	O
IkappaBalpha	B-Gene_or_gene_product
,	O
a	O
physiological	O
inhibitor	O
of	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
.	O

Cell	O
surface	O
expression	O
of	O
Jagged1	O
in	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
-	O
expressing	O
cell	O
monolayers	O
led	O
to	O
a	O
functional	O
interaction	O
with	O
lymphocytes	O
expressing	O
the	O
Notch1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
TAN	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
.	O

This	O
correlated	O
with	O
the	O
initiation	O
of	O
signaling	O
downstream	O
of	O
Notch	B-Gene_or_gene_product
,	O
as	O
evidenced	O
by	O
increased	O
levels	O
of	O
HES	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
transcripts	O
in	O
co	O
-	O
cultivated	O
T	O
cells	O
and	O
of	O
CD23	B-Gene_or_gene_product
transcripts	O
in	O
co	O
-	O
cultivated	O
B	O
cells	O
.	O

Consistent	O
with	O
its	O
Rel	B-Gene_or_gene_product
/	I-Gene_or_gene_product
NF	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
-	O
dependent	O
induction	O
,	O
Jagged1	O
was	O
found	O
to	O
be	O
highly	O
expressed	O
in	O
splenic	O
B	O
cells	O
where	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
is	O
expressed	O
constitutively	O
.	O

These	O
results	O
demonstrate	O
that	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
can	O
trigger	O
the	O
Notch	B-Gene_or_gene_product
signaling	O
pathway	O
in	O
neighboring	O
cells	O
by	O
inducing	O
jagged1	O
gene	O
expression	O
,	O
and	O
suggest	O
a	O
role	O
for	O
Jagged1	O
in	O
B	O
-	O
cell	O
activation	O
,	O
differentiation	O
or	O
function	O
.	O

These	O
findings	O
also	O
highlight	O
the	O
potential	O
for	O
an	O
interplay	O
between	O
the	O
Notch	B-Gene_or_gene_product
and	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
signaling	O
pathways	O
in	O
the	O
immune	O
system	O
.	O

Host	O
defense	O
mechanisms	O
triggered	O
by	O
microbial	O
lipoproteins	B-Gene_or_gene_product
through	O
toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O

The	O
generation	O
of	O
cell	O
-	O
mediated	O
immunity	O
against	O
many	O
infectious	O
pathogens	O
involves	O
the	O
production	O
of	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
12	I-Gene_or_gene_product
(	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
12	I-Gene_or_gene_product
)	O
,	O
a	O
key	O
signal	O
of	O
the	O
innate	O
immune	O
system	O
.	O

Yet	O
,	O
for	O
many	O
pathogens	O
,	O
the	O
molecules	O
that	O
induce	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
12	I-Gene_or_gene_product
production	O
by	O
macrophages	O
and	O
the	O
mechanisms	O
by	O
which	O
they	O
do	O
so	O
remain	O
undefined	O
.	O

Here	O
it	O
is	O
shown	O
that	O
microbial	O
lipoproteins	B-Gene_or_gene_product
are	O
potent	O
stimulators	O
of	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
12	I-Gene_or_gene_product
production	O
by	O
human	O
macrophages	O
,	O
and	O
that	O
induction	O
is	O
mediated	O
by	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
(	O
TLRs	B-Gene_or_gene_product
)	O
.	O

Several	O
lipoproteins	B-Gene_or_gene_product
stimulated	O
TLR	B-Gene_or_gene_product
-	O
dependent	O
transcription	O
of	O
inducible	O
nitric	O
oxide	O
synthase	O
and	O
the	O
production	O
of	O
nitric	O
oxide	O
,	O
a	O
powerful	O
microbicidal	O
pathway	O
.	O

Activation	O
of	O
TLRs	B-Gene_or_gene_product
by	O
microbial	O
lipoproteins	B-Gene_or_gene_product
may	O
initiate	O
innate	O
defense	O
mechanisms	O
against	O
infectious	O
pathogens	O
.	O

Cell	O
activation	O
and	O
apoptosis	O
by	O
bacterial	O
lipoproteins	B-Gene_or_gene_product
through	O
toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O

Apoptosis	O
is	O
implicated	O
in	O
the	O
generation	O
and	O
resolution	O
of	O
inflammation	O
in	O
response	O
to	O
bacterial	O
pathogens	O
.	O

All	O
bacterial	O
pathogens	O
produce	O
lipoproteins	B-Gene_or_gene_product
(	O
BLPs	B-Gene_or_gene_product
)	O
,	O
which	O
trigger	O
the	O
innate	O
immune	O
response	O
.	O

BLPs	B-Gene_or_gene_product
were	O
found	O
to	O
induce	O
apoptosis	O
in	O
THP	O
-	O
1	O
monocytic	O
cells	O
through	O
human	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
hTLR2	B-Gene_or_gene_product
)	O
.	O

BLPs	B-Gene_or_gene_product
also	O
initiated	O
apoptosis	O
in	O
an	O
epithelial	O
cell	O
line	O
transfected	O
with	O
hTLR2	B-Gene_or_gene_product
.	O

In	O
addition	O
,	O
BLPs	B-Gene_or_gene_product
stimulated	O
nuclear	O
factor	O
-	O
kappaB	O
,	O
a	O
transcriptional	O
activator	O
of	O
multiple	O
host	O
defense	O
genes	B-Gene_or_gene_product
,	O
and	O
activated	O
the	O
respiratory	O
burst	O
through	O
hTLR2	B-Gene_or_gene_product
.	O

Thus	O
,	O
hTLR2	B-Gene_or_gene_product
is	O
a	O
molecular	O
link	O
between	O
microbial	O
products	O
,	O
apoptosis	O
,	O
and	O
host	O
defense	O
mechanisms	O
.	O

Isolation	O
and	O
characterization	O
of	O
ARA160	B-Gene_or_gene_product
as	O
the	O
first	O
androgen	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
coactivator	I-Gene_or_gene_product
in	O
human	O
prostate	O
cells	O
.	O

The	O
androgen	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
AR	B-Gene_or_gene_product
)	O
is	O
a	O
member	O
of	O
the	O
steroid	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
superfamily	I-Gene_or_gene_product
that	O
may	O
require	O
coactivators	B-Gene_or_gene_product
for	O
proper	O
or	O
maximal	O
transactivation	O
.	O

Using	O
a	O
purified	O
AR	B-Gene_or_gene_product
N	O
-	O
terminal	O
peptide	O
as	O
a	O
probe	O
to	O
screen	O
the	O
human	O
testis	O
expression	O
library	O
,	O
we	O
identified	O
an	O
androgen	O
-	O
enhanced	O
AR	B-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
ARA160	I-Gene_or_gene_product
,	O
which	O
consists	O
of	O
1	O
,	O
093	O
amino	O
acids	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
160	O
kDa	O
.	O

Sequence	O
comparison	O
in	O
GenBank	O
(	O
TM	O
)	O
reveals	O
that	O
ARA160	B-Gene_or_gene_product
shares	O
an	O
identical	O
sequence	O
with	O
a	O
HIV	O
-	O
1	O
TATA	O
element	O
modulatory	O
factor	O
,	O
TMF	O
.	O

The	O
far	O
-	O
Western	O
blotting	O
and	O
co	O
-	O
immunoprecipitation	O
assays	O
demonstrate	O
that	O
the	O
AR	B-Gene_or_gene_product
can	O
interact	O
directly	O
with	O
ARA160	B-Gene_or_gene_product
/	I-Gene_or_gene_product
TMF	I-Gene_or_gene_product
.	O

Affinity	O
gel	O
pull	O
-	O
down	O
and	O
mammalian	O
two	O
-	O
hybrid	O
assays	O
further	O
suggest	O
androgen	O
can	O
enhance	O
significantly	O
the	O
interaction	O
between	O
AR	B-Gene_or_gene_product
and	O
ARA160	B-Gene_or_gene_product
.	O

Transient	O
transfection	O
assays	O
demonstrated	O
that	O
ARA160	B-Gene_or_gene_product
might	O
function	O
as	O
a	O
coactivator	B-Gene_or_gene_product
for	O
AR	B-Gene_or_gene_product
-	O
mediated	O
transactivation	O
in	O
human	O
prostate	O
cancer	O
PC	O
-	O
3	O
cells	O
.	O

Our	O
data	O
further	O
suggest	O
that	O
this	O
AR	B-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
coactivator	I-Gene_or_gene_product
can	O
function	O
cooperatively	O
with	O
AR	B-Gene_or_gene_product
C	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
coactivator	I-Gene_or_gene_product
,	O
ARA70	B-Gene_or_gene_product
,	O
in	O
PC	O
-	O
3	O
cells	O
.	O

Together	O
,	O
our	O
data	O
demonstrate	O
that	O
ARA160	B-Gene_or_gene_product
might	O
represent	O
the	O
first	O
identified	O
androgen	O
-	O
enhanced	O
N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
coactivator	I-Gene_or_gene_product
for	O
the	O
AR	B-Gene_or_gene_product
.	O

Phosphorylation	O
of	O
SOX9	O
by	O
cyclic	O
AMP	O
-	O
dependent	O
protein	O
kinase	O
A	O
enhances	O
SOX9	O
'	O
s	O
ability	O
to	O
transactivate	O
a	O
Col2a1	B-Gene_or_gene_product
chondrocyte	O
-	O
specific	O
enhancer	O
.	O

Sox9	O
is	O
a	O
high	O
-	O
mobility	O
-	O
group	O
domain	O
-	O
containing	O
transcription	O
factor	O
required	O
for	O
chondrocyte	O
differentiation	O
and	O
cartilage	O
formation	O
.	O

We	O
used	O
a	O
yeast	O
two	O
-	O
hybrid	O
method	O
based	O
on	O
Son	B-Gene_or_gene_product
of	I-Gene_or_gene_product
Sevenless	I-Gene_or_gene_product
(	O
SOS	B-Gene_or_gene_product
)	O
recruitment	O
to	O
screen	O
a	O
chondrocyte	O
cDNA	O
library	O
and	O
found	O
that	O
the	O
catalytic	O
subunit	O
of	O
cyclic	O
AMP	O
(	O
cAMP	O
)	O
-	O
dependent	O
protein	O
kinase	O
A	O
(	O
PKA	O
-	O
Calpha	O
)	O
interacted	O
specifically	O
with	O
SOX9	O
.	O

Next	O
we	O
found	O
that	O
two	O
consensus	O
PKA	O
phosphorylation	O
sites	O
within	O
SOX9	O
could	O
be	O
phosphorylated	O
by	O
PKA	O
in	O
vitro	O
and	O
that	O
SOX9	O
could	O
be	O
phosphorylated	O
by	O
PKA	O
-	O
Calpha	O
in	O
vivo	O
.	O

In	O
COS	O
-	O
7	O
cells	O
cotransfected	O
with	O
PKA	O
-	O
Calpha	O
and	O
SOX9	O
expression	O
plasmids	O
,	O
PKA	O
enhanced	O
the	O
phosphorylation	O
of	O
wild	O
-	O
type	O
SOX9	O
but	O
did	O
not	O
affect	O
phosphorylation	O
of	O
a	O
SOX9	O
protein	O
in	O
which	O
the	O
two	O
PKA	O
phosphorylation	O
sites	O
(	O
S	O
(	O
64	O
)	O
and	O
S	O
(	O
211	O
)	O
)	O
were	O
mutated	O
.	O

Using	O
a	O
phosphospecific	O
antibody	O
that	O
specifically	O
recognized	O
SOX9	O
phosphorylated	O
at	O
serine	O
211	O
,	O
one	O
of	O
the	O
two	O
PKA	O
phosphorylation	O
sites	O
,	O
we	O
demonstrated	O
that	O
addition	O
of	O
cAMP	O
to	O
chondrocytes	O
strongly	O
increased	O
the	O
phosphorylation	O
of	O
endogenous	O
Sox9	O
.	O

In	O
addition	O
,	O
immunohistochemistry	O
of	O
mouse	O
embryo	O
hind	O
legs	O
showed	O
that	O
Sox9	O
phosphorylated	O
at	O
serine	O
211	O
was	O
principally	O
localized	O
in	O
the	O
prehypertrophic	O
zone	O
of	O
the	O
growth	O
plate	O
,	O
corresponding	O
to	O
the	O
major	O
site	O
of	O
expression	O
of	O
the	O
parathyroid	O
hormone	O
-	O
related	O
peptide	O
(	O
PTHrP	O
)	O
receptor	B-Gene_or_gene_product
.	O

Since	O
cAMP	O
has	O
previously	O
been	O
shown	O
to	O
effectively	O
increase	O
the	O
mRNA	O
levels	O
of	O
Col2a1	B-Gene_or_gene_product
and	O
other	O
specific	O
markers	O
of	O
chondrocyte	O
differentiation	O
in	O
culture	O
,	O
we	O
then	O
asked	O
whether	O
PKA	O
phosphorylation	O
could	O
modulate	O
the	O
activity	O
of	O
SOX9	O
.	O

Addition	O
of	O
8	O
-	O
bromo	O
-	O
cAMP	O
to	O
chondrocytes	O
in	O
culture	O
increased	O
the	O
activity	O
of	O
a	O
transiently	O
transfected	O
SOX9	O
-	O
dependent	O
48	O
-	O
bp	O
Col2a1	B-Gene_or_gene_product
chondrocyte	O
-	O
specific	O
enhancer	O
;	O
similarly	O
,	O
cotransfection	O
of	O
PKA	O
-	O
Calpha	O
increased	O
the	O
activity	O
of	O
this	O
enhancer	O
.	O

Mutations	O
of	O
the	O
two	O
PKA	O
phosphorylation	O
consensus	O
sites	O
of	O
SOX9	O
markedly	O
decreased	O
the	O
PKA	O
-	O
Calpha	O
activation	O
of	O
this	O
enhancer	O
by	O
SOX9	O
.	O

PKA	O
phosphorylation	O
and	O
the	O
mutations	O
in	O
the	O
consensus	O
PKA	O
phosphorylation	O
sites	O
of	O
SOX9	B-Gene_or_gene_product
did	O
not	O
alter	O
its	O
nuclear	O
localization	O
.	O

In	O
vitro	O
phosphorylation	O
of	O
SOX9	O
by	O
PKA	O
resulted	O
in	O
more	O
efficient	O
DNA	O
binding	O
.	O

We	O
conclude	O
that	O
SOX9	O
is	O
a	O
target	O
of	O
cAMP	O
signaling	O
and	O
that	O
phosphorylation	O
of	O
SOX9	O
by	O
PKA	O
enhances	O
its	O
transcriptional	O
and	O
DNA	O
-	O
binding	O
activity	O
.	O

Because	O
PTHrP	O
signaling	O
is	O
mediated	O
by	O
cAMP	O
,	O
our	O
results	O
support	O
the	O
hypothesis	O
that	O
Sox9	O
is	O
a	O
target	O
of	O
PTHrP	O
signaling	O
in	O
the	O
growth	O
plate	O
and	O
that	O
the	O
increased	O
activity	O
of	O
Sox9	O
might	O
mediate	O
the	O
effect	O
of	O
PTHrP	O
in	O
maintaining	O
the	O
cells	O
as	O
nonhypertrophic	O
chondrocytes	O
.	O

cDNA	O
cloning	O
,	O
tissue	O
expression	O
,	O
and	O
chromosome	O
mapping	O
of	O
human	O
homolog	O
of	O
SOX18	B-Gene_or_gene_product
.	O

The	O
SRY	B-Gene_or_gene_product
(	O
sex	O
-	O
determining	O
region	O
Y	O
)	O
gene	O
encodes	O
a	O
transcription	O
factor	O
characterized	O
by	O
a	O
DNA	O
-	O
binding	O
motif	O
termed	O
the	O
HMG	O
(	O
high	O
mobility	O
group	O
)	O
domain	O
.	O

The	O
SOX	B-Gene_or_gene_product
(	O
Sry	O
-	O
box	O
)	O
genes	O
comprise	O
a	O
large	O
family	O
related	O
by	O
homology	O
to	O
the	O
HMG	O
-	O
box	O
region	O
.	O

We	O
isolated	O
a	O
cDNA	O
clone	O
with	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
putative	O
protein	B-Gene_or_gene_product
of	O
384	O
amino	O
acids	O
,	O
which	O
shared	O
83	O
%	O
identity	O
to	O
the	O
mouse	O
Sox18	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

Northern	O
blot	O
analysis	O
revealed	O
that	O
a	O
1	O
.	O
9	O
-	O
kb	O
band	O
of	O
human	O
SOX18	B-Gene_or_gene_product
messenger	O
RNAs	O
was	O
predominantly	O
expressed	O
in	O
heart	O
,	O
although	O
weak	O
signals	O
were	O
seen	O
in	O
brain	O
,	O
liver	O
,	O
testis	O
,	O
and	O
leukocyte	O
.	O

By	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
-	O
based	O
analyses	O
with	O
both	O
a	O
human	O
/	O
rodent	O
monochromosomal	O
hybrid	O
cell	O
panel	O
and	O
a	O
radiation	O
hybrid	O
panel	O
,	O
the	O
gene	B-Gene_or_gene_product
was	O
mapped	O
to	O
the	O
chromosome	O
20q13	O
.	O
33	O
region	O
.	O

Human	O
Sug1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
p45	I-Gene_or_gene_product
is	O
involved	O
in	O
the	O
proteasome	O
-	O
dependent	O
degradation	O
of	O
Sp1	O
.	O

The	O
transcription	O
factor	O
Sp1	O
was	O
previously	O
shown	O
to	O
undergo	O
proteasome	O
-	O
dependent	O
degradation	O
when	O
cells	O
were	O
glucose	O
-	O
starved	O
and	O
stimulated	O
with	O
the	O
adenylate	O
cyclase	O
inducer	O
,	O
forskolin	O
.	O

However	O
,	O
the	O
control	O
of	O
the	O
Sp1	O
degradation	O
process	O
is	O
largely	O
unknown	O
.	O

Using	O
in	O
vitro	O
and	O
in	O
vivo	O
interaction	O
studies	O
,	O
we	O
show	O
in	O
the	O
present	O
study	O
that	O
Sp1	O
interacts	O
with	O
human	O
Sug1	B-Gene_or_gene_product
[	B-Gene_or_gene_product
hSug1	I-Gene_or_gene_product
,	O
also	O
known	O
as	O
p45	B-Gene_or_gene_product
or	O
thyroid	B-Gene_or_gene_product
-	I-Gene_or_gene_product
hormone	I-Gene_or_gene_product
-	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
interacting	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
'	O
TRIP1	B-Gene_or_gene_product
'	O
)	O
]	O
,	O
an	O
ATPase	O
subunit	O
of	O
the	O
26	O
S	O
proteasome	O
and	O
a	O
putative	O
transcriptional	O
modulator	O
.	O

This	O
interaction	O
with	O
Sp1	O
occurs	O
through	O
the	O
C	O
-	O
terminus	O
of	O
hSug1	B-Gene_or_gene_product
,	O
the	O
region	O
that	O
contains	O
the	O
conserved	O
ATPase	O
domain	O
in	O
this	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

Both	O
in	O
vitro	O
studies	O
,	O
in	O
reconstituted	O
degradation	O
assays	O
,	O
and	O
in	O
vivo	O
experiments	O
,	O
in	O
which	O
hSug1	B-Gene_or_gene_product
is	O
overexpressed	O
in	O
normal	O
rat	O
kidney	O
cells	O
,	O
show	O
that	O
full	B-Gene_or_gene_product
-	I-Gene_or_gene_product
length	I-Gene_or_gene_product
hSug1	I-Gene_or_gene_product
is	O
able	O
to	O
stimulate	O
the	O
proteasome	O
-	O
dependent	O
degradation	O
of	O
Sp1	O
.	O

However	O
,	O
hSug1	O
truncations	O
that	O
lack	O
either	O
the	O
N	O
-	O
or	O
C	O
-	O
terminal	O
domain	O
of	O
hSug1	B-Gene_or_gene_product
act	O
as	O
dominant	O
negatives	O
,	O
inhibiting	O
Sp1	O
degradation	O
in	O
vitro	O
.	O

Also	O
,	O
an	O
ATPase	O
mutant	O
of	O
hSug1	B-Gene_or_gene_product
,	O
while	O
still	O
able	O
to	O
bind	O
Sp1	O
,	O
acts	O
as	O
a	O
dominant	O
negative	O
,	O
blocking	O
Sp1	O
degradation	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

These	O
results	O
demonstrate	O
that	O
hSug1	B-Gene_or_gene_product
is	O
involved	O
in	O
the	O
degradation	O
of	O
Sp1	O
and	O
that	O
ATP	O
hydrolysis	O
by	O
hSug1	B-Gene_or_gene_product
is	O
necessary	O
for	O
this	O
process	O
.	O

Our	O
findings	O
indicate	O
that	O
hSug1	B-Gene_or_gene_product
is	O
an	O
exchangeable	O
proteasomal	O
component	O
that	O
plays	O
a	O
critical	O
regulatory	O
role	O
in	O
the	O
proteasome	O
-	O
dependent	O
degradation	O
of	O
Sp1	O
.	O

However	O
,	O
hSug1	B-Gene_or_gene_product
is	O
not	O
the	O
factor	O
limiting	O
Sp1	O
degradation	O
in	O
the	O
cells	O
treated	O
with	O
glucosamine	O
.	O

This	O
and	O
other	O
considerations	O
suggest	O
that	O
hSug1	B-Gene_or_gene_product
co	O
-	O
operation	O
with	O
other	O
molecules	O
is	O
necessary	O
to	O
target	O
Sp1	O
for	O
proteasome	O
degradation	O
.	O

Nuclear	O
distribution	O
of	O
prothymosin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
parathymosin	B-Gene_or_gene_product
:	O
evidence	O
that	O
prothymosin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
is	O
associated	O
with	O
RNA	O
synthesis	O
processing	O
and	O
parathymosin	B-Gene_or_gene_product
with	O
early	O
DNA	O
replication	O
.	O

Prothymosin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
parathymosin	B-Gene_or_gene_product
are	O
two	O
ubiquitous	O
small	O
acidic	O
nuclear	O
proteins	B-Gene_or_gene_product
that	O
are	O
thought	O
to	O
be	O
involved	O
in	O
cell	O
cycle	O
progression	O
,	O
proliferation	O
,	O
and	O
cell	O
differentiation	O
.	O

In	O
an	O
effort	O
to	O
investigate	O
the	O
molecular	O
function	O
of	O
the	O
two	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
we	O
studied	O
their	O
spatial	O
distribution	O
by	O
indirect	O
immunofluorescence	O
labeling	O
and	O
confocal	O
scanning	O
laser	O
microscopy	O
in	O
relation	O
to	O
nuclear	O
components	O
involved	O
in	O
transcription	O
,	O
translation	O
,	O
and	O
splicing	O
.	O

Results	O
indicate	O
that	O
both	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
exhibit	O
a	O
punctuated	O
nuclear	O
distribution	O
and	O
are	O
excluded	O
by	O
nucleoli	O
.	O

The	O
distribution	O
of	O
prothymosin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
in	O
the	O
nucleus	O
is	O
related	O
to	O
that	O
of	O
transcription	O
sites	O
,	O
whereas	O
the	O
distribution	O
of	O
parathymosin	B-Gene_or_gene_product
correlates	O
with	O
early	O
replication	O
sites	O
.	O

This	O
implies	O
that	O
prothymosin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
parathymosin	B-Gene_or_gene_product
are	O
involved	O
in	O
transcription	O
and	O
replication	O
,	O
respectively	O
.	O

In	O
addition	O
to	O
the	O
punctate	O
distribution	O
,	O
prothymosin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
also	O
is	O
found	O
concentrated	O
in	O
1	O
-	O
6	O
nuclear	O
domains	O
per	O
cell	O
.	O

These	O
domains	O
are	O
found	O
in	O
more	O
than	O
80	O
%	O
of	O
randomly	O
growing	O
T24	O
human	O
bladder	O
carcinoma	O
cells	O
.	O

They	O
have	O
a	O
diameter	O
of	O
0	O
.	O
2	O
-	O
2	O
.	O
5	O
microm	O
,	O
their	O
size	O
being	O
inversely	O
related	O
to	O
the	O
number	O
of	O
domains	O
per	O
cell	O
.	O

The	O
domains	O
disappear	O
during	O
mitosis	O
and	O
the	O
protein	B-Gene_or_gene_product
is	O
excluded	O
from	O
the	O
metaphase	O
chromosomes	O
.	O

Double	O
-	O
labeling	O
experiments	O
associate	O
these	O
prothymosin	O
alpha	O
domains	O
with	O
PML	B-Gene_or_gene_product
and	O
CstF64	B-Gene_or_gene_product
containing	O
nuclear	O
bodies	O
,	O
but	O
not	O
with	O
hnRNP	O
-	O
I	O
containing	O
domains	O
or	O
coiled	O
bodies	O
.	O

The	O
fragile	B-Gene_or_gene_product
X	I-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
FXR1P	I-Gene_or_gene_product
and	O
FXR2P	B-Gene_or_gene_product
contain	O
a	O
functional	O
nucleolar	O
-	O
targeting	O
signal	O
equivalent	O
to	O
the	O
HIV	O
-	O
1	O
regulatory	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Fragile	O
X	O
syndrome	O
is	O
caused	O
by	O
the	O
absence	O
of	O
the	O
fragile	B-Gene_or_gene_product
X	I-Gene_or_gene_product
mental	I-Gene_or_gene_product
-	I-Gene_or_gene_product
retardation	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
FMRP	B-Gene_or_gene_product
)	O
.	O

FMRP	B-Gene_or_gene_product
and	O
the	O
fragile	B-Gene_or_gene_product
X	I-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
FXR1P	B-Gene_or_gene_product
and	O
FXR2P	B-Gene_or_gene_product
)	O
form	O
a	O
gene	B-Gene_or_gene_product
family	I-Gene_or_gene_product
with	O
functional	O
similarities	O
,	O
such	O
as	O
RNA	O
binding	O
,	O
polyribosomal	O
association	O
and	O
nucleocytoplasmic	O
shuttling	O
.	O

In	O
a	O
previous	O
study	O
,	O
we	O
found	O
that	O
FMRP	B-Gene_or_gene_product
and	O
FXR1P	B-Gene_or_gene_product
shuttle	O
between	O
cytoplasm	O
and	O
nucleoplasm	O
,	O
while	O
FXR2P	B-Gene_or_gene_product
shuttles	O
between	O
cytoplasm	O
and	O
nucleolus	O
.	O

The	O
nuclear	O
and	O
nucleolar	O
-	O
targeting	O
properties	O
of	O
these	O
proteins	B-Gene_or_gene_product
were	O
investigated	O
further	O
.	O

Here	O
,	O
we	O
show	O
that	O
FXR2P	B-Gene_or_gene_product
contains	O
in	O
its	O
C	O
-	O
terminal	O
part	O
,	O
a	O
stretch	O
of	O
basic	O
amino	O
acids	O
'	O
RPQRRNRSRRRRFR	O
'	O
that	O
resemble	O
the	O
nucleolar	O
-	O
targeting	O
signal	O
(	O
NoS	O
)	O
of	O
the	O
viral	O
protein	B-Gene_or_gene_product
Rev	I-Gene_or_gene_product
.	O

This	O
particular	O
sequence	O
is	O
also	O
present	O
within	O
exon	O
15	O
of	O
the	O
FXR1	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

This	O
exon	O
undergoes	O
alternative	O
splicing	O
and	O
is	O
therefore	O
only	O
present	O
in	O
some	O
of	O
the	O
FXR1P	B-Gene_or_gene_product
isoforms	I-Gene_or_gene_product
.	O

We	O
investigated	O
the	O
intracellular	O
distribution	O
of	O
various	O
FXR1P	B-Gene_or_gene_product
isoforms	I-Gene_or_gene_product
with	O
(	O
iso	O
-	O
e	O
and	O
iso	O
-	O
f	O
)	O
and	O
without	O
(	O
iso	O
-	O
d	O
)	O
the	O
potential	O
NoS	O
in	O
transfected	O
COS	O
cells	O
treated	O
with	O
the	O
nuclear	O
export	O
inhibitor	O
leptomycin	O
-	O
B	O
.	O

Both	O
iso	B-Gene_or_gene_product
-	I-Gene_or_gene_product
e	I-Gene_or_gene_product
and	O
iso	B-Gene_or_gene_product
-	I-Gene_or_gene_product
f	I-Gene_or_gene_product
showed	O
a	O
nucleolar	O
localization	O
,	O
as	O
observed	O
for	O
FXR2P	B-Gene_or_gene_product
;	O
iso	B-Gene_or_gene_product
-	I-Gene_or_gene_product
d	I-Gene_or_gene_product
was	O
detected	O
in	O
the	O
nucleo	O
-	O
plasm	O
outside	O
the	O
nucleoli	O
.	O

Further	O
,	O
when	O
a	O
labelled	O
16	O
-	O
residue	O
synthetic	O
peptide	O
corresponding	O
to	O
the	O
NoS	O
of	O
FXR1P	B-Gene_or_gene_product
was	O
added	O
to	O
human	O
fibroblast	O
cultures	O
a	O
clear	O
nucleolar	O
signal	O
was	O
observed	O
.	O

Based	O
on	O
these	O
data	O
we	O
argue	O
that	O
the	O
intranuclear	O
distribution	O
of	O
FXR2P	B-Gene_or_gene_product
and	O
FXR1P	B-Gene_or_gene_product
isoforms	O
is	O
very	O
likely	O
to	O
be	O
mediated	O
by	O
a	O
similar	O
NoS	O
localized	O
in	O
their	O
C	O
-	O
terminal	O
region	O
.	O

This	O
domain	O
is	O
absent	O
in	O
some	O
FXR1P	B-Gene_or_gene_product
isoforms	I-Gene_or_gene_product
as	O
well	O
as	O
in	O
all	O
FMRP	B-Gene_or_gene_product
isoforms	I-Gene_or_gene_product
,	O
suggesting	O
functional	O
differences	O
for	O
this	O
family	B-Gene_or_gene_product
of	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
possibly	O
related	O
to	O
RNA	O
metabolism	O
in	O
different	O
tissues	O
.	O

Evidence	O
that	O
dynamin	O
-	O
2	O
functions	O
as	O
a	O
signal	O
-	O
transducing	O
GTPase	O
.	O

The	O
role	O
of	O
dynamin	O
GTPases	O
in	O
the	O
regulation	O
of	O
receptor	B-Gene_or_gene_product
-	O
mediated	O
endocytosis	O
is	O
well	O
established	O
.	O

Here	O
,	O
we	O
present	O
new	O
evidence	O
that	O
the	O
ubiquitously	O
expressed	O
isoform	O
dynamin	O
-	O
2	O
(	O
dyn2	O
)	O
can	O
also	O
function	O
in	O
a	O
signal	O
transduction	O
pathway	O
(	O
s	O
)	O
.	O

A	O
<	O
/	O
=	O
5	O
-	O
fold	O
increase	O
of	O
dyn2	O
relative	O
to	O
endogenous	O
levels	O
activates	O
the	O
transcription	O
factor	O
p53	O
and	O
induces	O
apoptosis	O
,	O
as	O
demonstrated	O
by	O
reduced	O
cell	O
proliferation	O
,	O
DNA	O
fragmentation	O
,	O
and	O
caspase	O
-	O
3	O
activation	O
.	O

Dyn2	O
-	O
triggered	O
apoptosis	O
occurs	O
only	O
in	O
dividing	O
cells	O
and	O
is	O
p53	O
dependent	O
.	O

A	O
mutant	O
defective	O
in	O
GTP	O
binding	O
does	O
not	O
trigger	O
apoptosis	O
,	O
indicating	O
that	O
increased	O
levels	O
of	O
dyn2	O
.	O
GTP	O
,	O
rather	O
than	O
protein	B-Gene_or_gene_product
levels	O
per	O
se	O
,	O
are	O
required	O
to	O
transduce	O
signals	O
that	O
activate	O
p53	O
.	O

A	O
truncated	O
dyn2	O
lacking	O
the	O
COOH	O
-	O
terminal	O
proline	O
/	O
arginine	O
-	O
rich	O
domain	O
(	O
PRD	O
)	O
,	O
which	O
interacts	O
with	O
many	O
SH3	O
domain	O
-	O
containing	O
partners	B-Gene_or_gene_product
implicated	O
in	O
both	O
endocytosis	O
and	O
signal	O
transduction	O
,	O
triggers	O
apoptosis	O
even	O
more	O
potently	O
than	O
the	O
wild	O
-	O
type	O
.	O

This	O
observation	O
provides	O
additional	O
support	O
for	O
the	O
importance	O
of	O
the	O
NH	O
(	O
2	O
)	O
-	O
terminal	O
GTPase	O
domain	O
for	O
the	O
apoptotic	O
phenotype	O
.	O

All	O
described	O
effects	O
are	O
dyn2	O
-	O
specific	O
because	O
>	O
200	O
-	O
fold	O
overexpression	O
of	O
dyn1	O
,	O
the	O
70	O
%	O
identical	O
neuronal	O
isoform	O
,	O
has	O
no	O
effect	O
.	O

Our	O
data	O
suggest	O
that	O
dyn2	O
can	O
act	O
as	O
a	O
signal	O
transducing	O
GTPase	O
affecting	O
transcriptional	O
regulation	O
.	O

RET	O
finger	O
protein	O
is	O
a	O
transcriptional	O
repressor	O
and	O
interacts	O
with	O
enhancer	B-Gene_or_gene_product
of	I-Gene_or_gene_product
polycomb	I-Gene_or_gene_product
that	O
has	O
dual	O
transcriptional	O
functions	O
.	O

RET	O
finger	O
protein	O
(	O
RFP	O
)	O
belongs	O
to	O
the	O
large	O
B	O
-	O
box	O
RING	O
finger	O
protein	O
family	O
and	O
is	O
known	O
to	O
become	O
oncogenic	O
by	O
fusion	O
with	O
RET	O
tyrosine	O
kinase	O
.	O

Although	O
RFP	O
is	O
reported	O
to	O
be	O
a	O
nuclear	O
protein	B-Gene_or_gene_product
that	O
is	O
present	O
in	O
the	O
nuclear	O
matrix	O
,	O
its	O
function	O
is	O
largely	O
unknown	O
.	O

Here	O
we	O
show	O
that	O
RFP	O
interacts	O
with	O
Enhancer	B-Gene_or_gene_product
of	I-Gene_or_gene_product
Polycomb	I-Gene_or_gene_product
(	O
EPC	B-Gene_or_gene_product
)	O
and	O
strongly	O
represses	O
the	O
gene	O
transcription	O
.	O

Yeast	O
two	O
-	O
hybrid	O
assays	O
revealed	O
that	O
the	O
coiled	O
-	O
coil	O
domain	O
of	O
RFP	B-Gene_or_gene_product
was	O
associated	O
with	O
the	O
EPcA	O
domain	O
and	O
the	O
carboxyl	O
-	O
terminal	O
region	O
of	O
EPC	B-Gene_or_gene_product
.	O

In	O
addition	O
,	O
both	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
were	O
co	O
-	O
precipitated	O
from	O
the	O
lysates	O
of	O
human	O
cells	O
and	O
mostly	O
colocalized	O
in	O
the	O
nucleus	O
.	O

Using	O
the	O
luciferase	O
reporter	O
-	O
gene	O
assay	O
,	O
we	O
found	O
that	O
they	B-Gene_or_gene_product
repress	O
the	O
gene	O
transcription	O
activity	O
independent	O
of	O
the	O
differences	O
of	O
enhancers	O
and	O
promoters	O
used	O
,	O
although	O
the	O
repressive	O
activity	O
of	O
RFP	B-Gene_or_gene_product
was	O
much	O
stronger	O
than	O
that	O
of	O
EPC	B-Gene_or_gene_product
.	O

The	O
coiled	O
-	O
coil	O
domain	O
of	O
RFP	B-Gene_or_gene_product
and	O
the	O
carboxyl	O
-	O
terminal	O
region	O
of	O
EPC	B-Gene_or_gene_product
were	O
most	O
important	O
for	O
the	O
repressive	O
activity	O
of	O
each	O
protein	B-Gene_or_gene_product
,	O
whereas	O
the	O
EPcA	O
domain	O
had	O
the	O
transcription	O
activating	O
ability	O
that	O
is	O
unique	O
as	O
the	O
Polycomb	B-Gene_or_gene_product
group	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
function	O
.	O

These	O
results	O
suggested	O
that	O
RFP	B-Gene_or_gene_product
may	O
be	O
involved	O
in	O
the	O
epigenetic	O
gene	O
silencing	O
mechanism	O
cooperating	O
with	O
Polycomb	B-Gene_or_gene_product
group	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
and	O
that	O
EPC	B-Gene_or_gene_product
is	O
a	O
unique	O
molecule	O
with	O
both	O
repressive	O
and	O
transactivating	O
activities	O
.	O

Electron	O
microscopic	O
in	O
situ	O
hybridization	O
study	O
of	O
simultaneous	O
expression	O
of	O
TNP1	B-Gene_or_gene_product
and	O
PRM1	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
in	O
human	O
spermatids	O
.	O

Nuclear	O
changes	O
in	O
the	O
basic	O
nucleoprotein	B-Gene_or_gene_product
complement	O
occur	O
during	O
human	O
spermiogenesis	O
.	O

Somatic	O
type	O
histones	O
are	O
displaced	O
by	O
transition	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
which	O
are	O
replaced	O
themselves	O
by	O
protamines	B-Gene_or_gene_product
,	O
the	O
major	O
nuclear	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
found	O
in	O
late	O
spermatids	O
and	O
spermatozoa	O
nuclei	O
.	O

Digoxigenin	O
or	O
Biotin	O
labeled	O
probes	O
,	O
coding	O
respectively	O
for	O
human	O
transition	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
TP1	B-Gene_or_gene_product
)	O
and	O
protamine	B-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
HP1	B-Gene_or_gene_product
)	O
,	O
were	O
used	O
for	O
double	O
EM	O
in	O
situ	O
hybridization	O
.	O

Immunodetection	O
of	O
hybrids	O
with	O
specific	O
antibodies	O
coupled	O
to	O
colloidal	O
gold	O
particles	O
of	O
different	O
size	O
(	O
10	O
nm	O
and	O
15	O
nm	O
)	O
was	O
performed	O
on	O
the	O
same	O
preparations	O
.	O

Quantitative	O
analysis	O
of	O
the	O
nuclear	O
and	O
cytoplasmic	O
labeling	O
densities	O
for	O
the	O
mRNAs	O
coding	O
for	O
TP1	B-Gene_or_gene_product
and	O
HP1	B-Gene_or_gene_product
showed	O
the	O
presence	O
of	O
transcripts	O
in	O
both	O
the	O
nucleus	O
and	O
cytoplasm	O
of	O
round	O
spermatids	O
until	O
the	O
elongation	O
phase	O
.	O

Transcripts	O
accumulated	O
in	O
the	O
spermatid	O
cytoplasm	O
without	O
any	O
particular	O
cellular	O
compartmentalization	O
.	O

At	O
the	O
end	O
of	O
the	O
spermatid	O
elongation	O
phase	O
,	O
the	O
disappearing	O
of	O
TP1	B-Gene_or_gene_product
and	O
HP1	B-Gene_or_gene_product
transcripts	O
may	O
be	O
related	O
to	O
the	O
arrest	O
of	O
transcriptional	O
activity	O
while	O
the	O
deposition	O
of	O
transition	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
and	O
protamines	B-Gene_or_gene_product
successively	O
occurs	O
within	O
spermatid	O
nuclei	O
.	O

Identification	O
of	O
functional	O
domains	O
involved	O
in	O
BTG1	B-Gene_or_gene_product
cell	O
localization	O
.	O

We	O
have	O
previously	O
shown	O
that	O
BTG1	B-Gene_or_gene_product
stimulates	O
myoblast	O
differentiation	O
.	O

In	O
addition	O
,	O
this	O
protein	B-Gene_or_gene_product
displays	O
a	O
major	O
nuclear	O
localization	O
in	O
confluent	O
myoblasts	O
,	O
decreasing	O
during	O
the	O
early	O
steps	O
of	O
differentiation	O
,	O
and	O
is	O
essentially	O
detected	O
in	O
the	O
cytoplasm	O
of	O
mature	O
myotubes	O
.	O

To	O
identify	O
the	O
domains	O
involved	O
in	O
the	O
cellular	O
trafficking	O
of	O
BTG1	B-Gene_or_gene_product
,	O
we	O
observed	O
the	O
localization	O
of	O
several	O
BTG1	B-Gene_or_gene_product
sequences	O
fused	O
to	O
betaGalactosidase	O
.	O

The	O
highly	O
conserved	O
B	O
box	O
among	O
all	O
members	O
of	O
the	O
BTG	B-Gene_or_gene_product
family	I-Gene_or_gene_product
induces	O
a	O
significant	O
nuclear	O
localization	O
of	O
the	O
betaGal	O
moiety	O
,	O
enhanced	O
by	O
presence	O
of	O
the	O
BTG1	B-Gene_or_gene_product
carboxy	O
-	O
terminal	O
sequence	O
.	O

In	O
addition	O
,	O
a	O
functional	O
Nuclear	O
Export	O
Signal	O
(	O
NES	O
)	O
overlaps	O
the	O
B	O
box	O
.	O

Moreover	O
,	O
presence	O
of	O
the	O
first	O
43	O
NH	O
(	O
2	O
)	O
-	O
terminal	O
amino	O
acids	O
reduced	O
the	O
nuclear	O
localization	O
of	O
each	O
chimeric	O
protein	B-Gene_or_gene_product
tested	O
.	O

Last	O
,	O
the	O
BTG1	B-Gene_or_gene_product
amino	O
-	O
terminal	O
domain	O
bears	O
an	O
LxxLL	O
motif	O
favouring	O
nuclear	O
accumulation	O
,	O
and	O
another	O
region	O
encompassing	O
the	O
A	O
box	O
inhibiting	O
nuclear	O
localization	O
.	O

In	O
contrast	O
to	O
a	O
BTG1	O
mutant	O
exclusively	O
localized	O
in	O
the	O
cytoplasm	O
,	O
transient	O
expression	O
of	O
a	O
mutant	O
displaying	O
a	O
nuclear	O
localization	O
enhanced	O
myoblasts	O
withdrawal	O
from	O
the	O
cell	O
cycle	O
and	O
terminal	O
differentiation	O
,	O
thus	O
mimicking	O
the	O
myogenic	O
influence	O
of	O
BTG1	B-Gene_or_gene_product
.	O

In	O
conclusion	O
,	O
several	O
regions	O
of	O
BTG1	B-Gene_or_gene_product
are	O
implicated	O
in	O
its	O
cellular	O
localization	O
,	O
and	O
BTG1	B-Gene_or_gene_product
myogenic	O
activity	O
is	O
induced	O
at	O
the	O
nuclear	O
level	O
.	O

Solution	O
structure	O
of	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
interleukin	B-Gene_or_gene_product
enhancer	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
FOXK1a	B-Gene_or_gene_product
)	O
.	O

Interleukin	B-Gene_or_gene_product
enhancer	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
ILF	B-Gene_or_gene_product
)	O
binds	O
to	O
the	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
promoter	O
and	O
regulates	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
gene	O
expression	O
.	O

In	O
this	O
study	O
,	O
the	O
3D	O
structure	O
of	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
ILF	B-Gene_or_gene_product
was	O
determined	O
by	O
multidimensional	O
NMR	O
spectroscopy	O
.	O

NMR	O
structure	O
analysis	O
revealed	O
that	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
ILF	B-Gene_or_gene_product
is	O
a	O
new	O
member	O
of	O
the	O
winged	O
helix	O
/	O
forkhead	O
family	O
,	O
and	O
that	O
its	O
wing	O
2	O
contains	O
an	O
extra	O
alpha	O
-	O
helix	O
.	O

This	O
is	O
the	O
first	O
study	O
to	O
report	O
the	O
presence	O
of	O
a	O
C	O
-	O
terminal	O
alpha	O
-	O
helix	O
in	O
place	O
of	O
a	O
typical	O
wing	O
2	O
in	O
a	O
member	O
of	O
this	B-Gene_or_gene_product
family	I-Gene_or_gene_product
.	O

This	O
structural	O
difference	O
may	O
be	O
responsible	O
for	O
the	O
different	O
DNA	O
-	O
binding	O
specificity	O
of	O
ILF	B-Gene_or_gene_product
compared	O
to	O
other	O
winged	O
helix	O
/	O
forkhead	O
proteins	O
.	O

Our	O
deletion	O
studies	O
of	O
the	O
fragments	O
of	O
ILF	B-Gene_or_gene_product
also	O
suggest	O
that	O
the	O
C	O
-	O
terminal	O
region	O
plays	O
a	O
regulatory	O
role	O
in	O
DNA	O
binding	O
.	O

Role	O
for	O
RFX	O
transcription	O
factors	O
in	O
non	O
-	O
neuronal	O
cell	O
-	O
specific	O
inactivation	O
of	O
the	O
microtubule	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
MAP1A	B-Gene_or_gene_product
promoter	O
.	O

Microtubule	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
MAP1A	B-Gene_or_gene_product
is	O
expressed	O
abundantly	O
in	O
mature	O
neurons	O
and	O
is	O
necessary	O
for	O
maintenance	O
of	O
neuronal	O
morphology	O
and	O
localization	O
of	O
some	O
molecules	O
in	O
association	O
with	O
the	O
microtubule	O
-	O
based	O
cytoskeleton	O
.	O

Previous	O
studies	O
indicated	O
that	O
its	B-Gene_or_gene_product
complementary	O
expression	O
together	O
with	O
MAP1B	B-Gene_or_gene_product
during	O
nervous	O
system	O
development	O
is	O
regulated	O
at	O
the	O
transcriptional	O
level	O
and	O
that	O
the	O
mouse	O
Map1A	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
transcribed	O
under	O
the	O
control	O
of	O
5	O
'	O
and	O
intronic	O
promoters	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
regulatory	O
mechanisms	O
that	O
govern	O
the	O
neuronal	O
cell	O
-	O
specific	O
activation	O
of	O
the	O
MAP1A	B-Gene_or_gene_product
5	O
'	O
promoter	O
.	O

We	O
found	O
that	O
two	O
regulatory	O
factor	O
for	O
X	O
box	O
(	O
RFX	O
)	O
binding	O
sites	O
in	O
exon1	O
of	O
both	O
the	O
mouse	O
and	O
human	O
genes	B-Gene_or_gene_product
are	O
important	O
for	O
effective	O
transcriptional	O
repression	O
observed	O
only	O
in	O
non	O
-	O
neuronal	O
cells	O
by	O
reporter	O
assays	O
.	O

Among	O
RFX	O
transcription	O
factor	O
family	O
members	O
,	O
RFX1	O
and	O
3	O
mainly	O
interact	O
with	O
repressive	O
elements	O
in	O
vitro	O
.	O

Cotransfection	O
studies	O
indicated	O
that	O
RFX1	O
,	O
which	O
is	O
expressed	O
ubiquitously	O
,	O
down	O
-	O
regulated	O
the	O
MAP1A	B-Gene_or_gene_product
5	O
'	O
promoter	O
activity	O
in	O
non	O
-	O
neuronal	O
cells	O
.	O

Unexpectedly	O
,	O
RFX3	O
,	O
which	O
is	O
abundantly	O
expressed	O
in	O
neuronal	O
cells	O
,	O
down	O
-	O
regulated	O
the	O
transactivity	O
as	O
well	O
,	O
when	O
it	O
was	O
expressed	O
in	O
non	O
-	O
neuronal	O
cells	O
.	O

Both	O
RFX1	O
and	O
3	O
did	O
not	O
down	O
-	O
regulate	O
the	O
transactivity	O
in	O
neuronal	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
RFX1	O
and	O
3	O
are	O
pivotal	O
factors	O
in	O
down	O
-	O
regulation	O
of	O
the	O
MAP1A	B-Gene_or_gene_product
5	O
'	O
promoter	O
in	O
non	O
-	O
neuronal	O
cells	O
.	O

The	O
cell	O
type	O
-	O
specific	O
down	O
-	O
regulation	O
,	O
however	O
,	O
does	O
not	O
depend	O
simply	O
on	O
which	O
RFX	O
interacts	O
with	O
the	O
elements	O
,	O
but	O
seems	O
to	O
depend	O
on	O
underlying	O
profound	O
mechanisms	O
.	O

Identification	O
of	O
a	O
functional	O
binding	O
site	O
for	O
activin	B-Gene_or_gene_product
on	O
the	O
type	B-Gene_or_gene_product
I	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
ALK4	I-Gene_or_gene_product
.	O

Activins	B-Gene_or_gene_product
,	O
like	O
other	O
members	O
of	O
the	O
transforming	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
(	O
TGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	O
superfamily	O
,	O
initiate	O
signaling	O
by	O
assembling	O
a	O
complex	O
of	O
two	O
types	O
of	O
transmembrane	O
serine	O
/	O
threonine	O
receptor	O
kinases	O
classified	O
as	O
type	O
II	O
(	O
ActRII	B-Gene_or_gene_product
or	O
ActRIIB	B-Gene_or_gene_product
)	O
and	O
type	O
I	O
(	O
ALK4	B-Gene_or_gene_product
)	O
.	O

A	O
kinase	O
-	O
deleted	O
version	O
of	O
ALK4	O
can	O
form	O
an	O
inactive	O
complex	O
with	O
activin	B-Gene_or_gene_product
and	O
ActRII	B-Gene_or_gene_product
/	I-Gene_or_gene_product
IIB	I-Gene_or_gene_product
and	O
thereby	O
acts	O
in	O
a	O
dominant	O
negative	O
manner	O
to	O
block	O
activin	B-Gene_or_gene_product
signaling	O
.	O

Using	O
the	O
complex	O
structure	O
of	O
bone	B-Gene_or_gene_product
morphogenetic	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
bound	O
to	O
its	O
type	B-Gene_or_gene_product
I	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
ALK3	B-Gene_or_gene_product
)	O
as	O
a	O
guide	O
,	O
we	O
introduced	O
extracellular	O
domain	O
mutations	O
in	O
the	O
context	O
of	O
the	O
truncated	O
ALK4	O
(	O
ALK4	O
-	O
trunc	O
)	O
construct	O
and	O
assessed	O
the	O
ability	O
of	O
the	O
mutants	O
to	O
inhibit	O
activin	B-Gene_or_gene_product
function	O
.	O

We	O
have	O
identified	O
five	O
hydrophobic	O
amino	O
acid	O
residues	O
on	O
the	O
ALK4	B-Gene_or_gene_product
extracellular	O
domain	O
(	O
Leu40	O
,	O
Ile70	O
,	O
Val73	O
,	O
Leu75	O
,	O
and	O
Pro77	O
)	O
that	O
,	O
when	O
mutated	O
to	O
alanine	O
,	O
have	O
substantial	O
effects	O
on	O
ALK4	O
-	O
trunc	O
dominant	O
negative	O
activity	O
.	O

In	O
addition	O
,	O
eleven	O
mutants	O
partially	O
affected	O
activin	B-Gene_or_gene_product
binding	O
to	O
ALK4	B-Gene_or_gene_product
.	O

Together	O
,	O
these	O
residues	O
likely	O
constitute	O
the	O
binding	O
surface	O
for	O
activin	B-Gene_or_gene_product
on	O
ALK4	B-Gene_or_gene_product
.	O

Cross	O
-	O
linking	O
studies	O
measuring	O
binding	O
of	O
125I	O
-	O
activin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A	I-Gene_or_gene_product
to	O
the	O
ALK4	O
-	O
trunc	O
mutants	O
in	O
the	O
presence	O
of	O
ActRII	B-Gene_or_gene_product
implicated	O
the	O
same	O
residues	O
.	O

Our	O
results	O
indicate	O
that	O
there	O
is	O
only	O
a	O
partial	O
overlap	O
of	O
the	O
binding	O
sites	O
on	O
ALK4	B-Gene_or_gene_product
and	O
ALK3	B-Gene_or_gene_product
for	O
activin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A	I-Gene_or_gene_product
and	O
bone	B-Gene_or_gene_product
morphogenetic	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
respectively	O
.	O

In	O
addition	O
three	O
of	O
the	O
residues	O
required	O
for	O
activin	B-Gene_or_gene_product
binding	O
to	O
ALK4	B-Gene_or_gene_product
are	O
conserved	O
on	O
the	O
type	B-Gene_or_gene_product
I	I-Gene_or_gene_product
TGF	I-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
ALK5	I-Gene_or_gene_product
,	O
suggesting	O
the	O
corresponding	O
region	O
on	O
ALK5	B-Gene_or_gene_product
may	O
be	O
important	O
for	O
TGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
binding	O
.	O

Identification	O
and	O
characterization	O
of	O
three	O
new	O
components	O
of	O
the	O
mSin3A	O
corepressor	O
complex	O
.	O

The	O
mSin3A	O
corepressor	O
complex	O
contains	O
7	O
to	O
10	O
tightly	O
associated	O
polypeptides	O
and	O
is	O
utilized	O
by	O
many	O
transcriptional	O
repressors	O
.	O

Much	O
of	O
the	O
corepressor	O
function	O
of	O
mSin3A	O
derives	O
from	O
associations	O
with	O
the	O
histone	O
deacetylases	O
HDAC1	O
and	O
HDAC2	O
;	O
however	O
,	O
the	O
contributions	O
of	O
the	O
other	O
mSin3A	O
-	O
associated	O
polypeptides	O
remain	O
largely	O
unknown	O
.	O

We	O
have	O
purified	O
an	O
mSin3A	O
complex	O
from	O
K562	O
erythroleukemia	O
cells	O
and	O
identified	O
three	O
new	O
mSin3A	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
(	O
SAP	B-Gene_or_gene_product
)	O
:	O
SAP180	B-Gene_or_gene_product
,	O
SAP130	B-Gene_or_gene_product
,	O
and	O
SAP45	B-Gene_or_gene_product
.	O

SAP180	B-Gene_or_gene_product
is	O
40	O
%	O
identical	O
to	O
a	O
previously	O
identified	O
mSin3A	O
-	O
associated	O
protein	B-Gene_or_gene_product
,	O
RBP1	B-Gene_or_gene_product
.	O

SAP45	B-Gene_or_gene_product
is	O
identical	O
to	O
mSDS3	B-Gene_or_gene_product
,	O
the	O
human	O
ortholog	O
of	O
the	O
SDS3p	B-Gene_or_gene_product
component	O
of	O
the	O
Saccharomyces	O
cerevisiae	O
Sin3p	O
-	O
Rpd3p	O
corepressor	O
complex	O
.	O

SAP130	O
does	O
not	O
have	O
detectable	O
homology	O
to	O
other	O
proteins	O
.	O

Coimmunoprecipitation	O
and	O
gel	O
filtration	O
data	O
suggest	O
that	O
the	O
new	O
SAPs	B-Gene_or_gene_product
are	O
,	O
at	O
the	O
very	O
least	O
,	O
components	O
of	O
the	O
same	O
mSin3A	O
complex	O
.	O

Each	O
new	O
SAP	B-Gene_or_gene_product
repressed	O
transcription	O
when	O
tethered	O
to	O
DNA	O
.	O

Furthermore	O
,	O
repression	O
correlated	O
with	O
mSin3A	O
binding	O
,	O
suggesting	O
that	O
the	O
new	O
SAPs	B-Gene_or_gene_product
are	O
components	O
of	O
functional	O
mSin3A	O
corepressor	O
complexes	O
.	O

SAP180	B-Gene_or_gene_product
has	O
two	O
repression	O
domains	O
:	O
a	O
C	O
-	O
terminal	O
domain	O
,	O
which	O
interacts	O
with	O
the	O
mSin3A	O
-	O
HDAC	O
complex	O
,	O
and	O
an	O
N	O
-	O
terminal	O
domain	O
,	O
which	O
functions	O
independently	O
of	O
mSin3A	O
-	O
HDAC	O
.	O

SAP130	B-Gene_or_gene_product
has	O
a	O
repression	O
domain	O
at	O
its	O
C	O
terminus	O
that	O
interacts	O
with	O
the	O
mSin3A	O
-	O
HDAC	O
complex	O
and	O
an	O
N	O
-	O
terminal	O
domain	O
that	O
probably	O
mediates	O
an	O
interaction	O
with	O
a	O
transcriptional	O
activator	O
.	O

Together	O
,	O
our	O
data	O
suggest	O
that	O
these	O
novel	O
SAPs	B-Gene_or_gene_product
function	O
in	O
the	O
assembly	O
and	O
/	O
or	O
enzymatic	O
activity	O
of	O
the	O
mSin3A	O
complex	O
or	O
in	O
mediating	O
interactions	O
between	O
the	O
mSin3A	O
complex	O
and	O
other	O
regulatory	O
complexes	O
.	O

Finally	O
,	O
all	O
three	O
SAPs	B-Gene_or_gene_product
bind	O
to	O
the	O
HDAC	O
-	O
interaction	O
domain	O
(	O
HID	O
)	O
of	O
mSin3A	O
,	O
suggesting	O
that	O
the	O
HID	O
functions	O
as	O
the	O
assembly	O
interface	O
for	O
the	O
mSin3A	O
corepressor	O
complex	O
.	O

Large	O
-	O
scale	O
identification	O
and	O
characterization	O
of	O
human	O
genes	B-Gene_or_gene_product
that	O
activate	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
and	O
MAPK	B-Gene_or_gene_product
signaling	O
pathways	O
.	O

We	O
have	O
carried	O
out	O
a	O
large	O
-	O
scale	O
identification	O
and	O
characterization	O
of	O
human	O
genes	B-Gene_or_gene_product
that	O
activate	O
the	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
and	O
MARK	B-Gene_or_gene_product
signaling	O
pathways	O
.	O

We	O
constructed	O
full	O
-	O
length	O
cDNA	O
libraries	O
using	O
the	O
oligo	O
-	O
capping	O
method	O
and	O
prepared	O
an	O
arrayed	O
cDNA	O
pool	O
consisting	O
of	O
150	O
000	O
cDNAs	O
randomly	O
isolated	O
from	O
the	O
libraries	O
.	O

For	O
analysis	O
of	O
the	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
signaling	O
pathway	O
,	O
we	O
introduced	O
each	O
of	O
the	O
cDNAs	O
into	O
human	O
embryonic	O
kidney	O
293	O
cells	O
and	O
examined	O
whether	O
it	O
activated	O
the	O
transcription	O
of	O
a	O
luciferase	O
reporter	O
gene	O
driven	O
by	O
a	O
promoter	O
containing	O
the	O
consensus	O
NF	O
-	O
kappaB	O
binding	O
sites	O
.	O

In	O
total	O
,	O
we	O
identified	O
299	O
cDNAs	O
that	O
activate	O
the	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
pathway	O
,	O
and	O
we	O
classified	O
them	O
into	O
83	O
genes	B-Gene_or_gene_product
,	O
including	O
30	O
characterized	O
activator	O
genes	B-Gene_or_gene_product
of	O
the	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
pathway	O
,	O
28	O
genes	B-Gene_or_gene_product
whose	O
involvement	O
in	O
the	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
pathways	O
have	O
not	O
been	O
characterized	O
and	O
25	O
novel	O
genes	B-Gene_or_gene_product
.	O

We	O
then	O
carried	O
out	O
a	O
similar	O
analysis	O
for	O
the	O
identification	O
of	O
genes	B-Gene_or_gene_product
that	O
activate	O
the	O
MARK	B-Gene_or_gene_product
pathway	O
,	O
utilizing	O
the	O
same	O
cDNA	O
resource	O
.	O

We	O
assayed	O
145	O
000	O
cDNAs	O
and	O
identified	O
57	O
genes	B-Gene_or_gene_product
that	O
activate	O
the	O
MARK	B-Gene_or_gene_product
pathway	O
.	O

Interestingly	O
,	O
27	O
genes	B-Gene_or_gene_product
were	O
overlapping	O
between	O
the	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
and	O
the	O
MAPK	B-Gene_or_gene_product
pathways	O
,	O
which	O
may	O
indicate	O
that	O
these	O
genes	B-Gene_or_gene_product
play	O
cross	O
-	O
talking	O
roles	O
between	O
these	O
two	O
pathways	O
.	O

The	O
upstream	O
region	O
of	O
the	O
human	O
homeobox	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
HOX3D	I-Gene_or_gene_product
is	O
a	O
target	O
for	O
regulation	O
by	O
retinoic	O
acid	O
and	O
HOX	O
homeoproteins	O
.	O

We	O
studied	O
the	O
structure	O
,	O
regulation	O
and	O
expression	O
of	O
HOX3D	B-Gene_or_gene_product
,	O
a	O
human	O
homeobox	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
located	O
in	O
the	O
HOX3	O
cluster	O
on	O
chromosome	O
12	O
.	O

HOX3D	B-Gene_or_gene_product
is	O
developmentally	O
regulated	O
during	O
embryogenesis	O
and	O
is	O
activated	O
by	O
retinoic	O
acid	O
(	O
RA	O
)	O
in	O
cultured	O
embryonal	O
carcinoma	O
(	O
EC	O
)	O
cells	O
.	O

Transfection	O
of	O
HOX3D	B-Gene_or_gene_product
upstream	O
genomic	O
sequences	O
linked	O
to	O
a	O
reporter	O
gene	O
allowed	O
the	O
functional	O
definition	O
of	O
its	O
promoter	O
,	O
containing	O
a	O
canonical	O
TATA	O
element	O
.	O

This	O
promoter	O
directs	O
the	O
expression	O
of	O
the	O
reporter	O
gene	O
in	O
EC	O
cells	O
after	O
induction	O
with	O
RA	O
,	O
and	O
binds	O
RA	O
-	O
induced	O
nuclear	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	I-Gene_or_gene_product
s	I-Gene_or_gene_product
)	I-Gene_or_gene_product
through	O
a	O
conserved	O
palindromic	O
sequence	O
located	O
approximately	O
100	O
bp	O
upstream	O
of	O
the	O
transcription	O
start	O
site	O
.	O

The	O
HOX3D	B-Gene_or_gene_product
promoter	O
is	O
transactivated	O
in	O
both	O
human	O
and	O
murine	O
cells	O
when	O
cotransfected	O
with	O
vectors	O
expressing	O
the	O
protein	B-Gene_or_gene_product
product	O
of	O
the	O
upstream	O
gene	O
HOX3C	B-Gene_or_gene_product
and	O
the	O
paralogs	B-Gene_or_gene_product
of	O
further	O
upstream	O
genes	O
in	O
the	O
HOX4	B-Gene_or_gene_product
cluster	O
(	O
i	O
.	O
e	O
.	O
HOX4D	B-Gene_or_gene_product
,	O
HOX4C	B-Gene_or_gene_product
and	O
the	O
murine	O
Hox	B-Gene_or_gene_product
4	I-Gene_or_gene_product
.	I-Gene_or_gene_product
3	I-Gene_or_gene_product
)	O
.	O

The	O
HOX3D	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
and	O
those	O
encoded	O
by	O
the	O
downstream	O
gene	O
HOX3E	B-Gene_or_gene_product
and	O
its	O
paralog	O
HOX4B	B-Gene_or_gene_product
are	O
instead	O
inactive	O
.	O

HOX4C	B-Gene_or_gene_product
and	O
HOX4D	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
synthesized	O
in	O
bacteria	O
bind	O
to	O
the	O
same	O
conserved	O
sequence	O
located	O
around	O
position	O
-	O
120	O
,	O
as	O
well	O
as	O
to	O
the	O
TATA	O
box	O
and	O
immediately	O
upstream	O
and	O
downstream	O
nucleotides	O
.	O

These	O
data	O
provide	O
evidence	O
that	O
cross	O
-	O
regulatory	O
interactions	O
between	O
mammalian	O
homeogenes	O
take	O
place	O
in	O
cultured	O
cells	O
,	O
thus	O
raising	O
the	O
possibility	O
that	O
a	O
regulatory	O
network	O
may	O
exist	O
in	O
vivo	O
.	O

The	O
sequences	O
on	O
the	O
HOX3D	B-Gene_or_gene_product
promoter	O
involved	O
in	O
cross	O
-	O
regulation	O
are	O
different	O
from	O
those	O
binding	O
nuclear	B-Gene_or_gene_product
factors	I-Gene_or_gene_product
induced	O
by	O
RA	O
.	O

DLX2	O
(	O
TES1	O
)	O
,	O
a	O
homeobox	O
gene	O
of	O
the	O
Distal	B-Gene_or_gene_product
-	I-Gene_or_gene_product
less	I-Gene_or_gene_product
family	I-Gene_or_gene_product
,	O
assigned	O
to	O
conserved	O
regions	O
on	O
human	O
and	O
mouse	O
chromosomes	O
2	O
.	O

Dlx	O
-	O
2	O
(	O
also	O
called	O
Tes	O
-	O
1	O
)	O
,	O
a	O
mammalian	O
member	O
of	O
the	O
Distal	B-Gene_or_gene_product
-	I-Gene_or_gene_product
less	I-Gene_or_gene_product
family	I-Gene_or_gene_product
of	O
homeobox	O
genes	O
,	O
is	O
expressed	O
during	O
murine	O
fetal	O
development	O
in	O
spatially	O
restricted	O
domains	O
of	O
the	O
forebrain	O
.	O

Searching	O
for	O
a	O
candidate	O
neurological	O
mutation	O
that	O
might	O
involve	O
this	O
gene	O
,	O
we	O
have	O
assigned	O
the	O
human	O
and	O
mouse	O
loci	O
to	O
regions	O
of	O
conserved	O
synteny	O
on	O
human	O
chromosome	O
2	O
,	O
region	O
cen	O
-	O
-	O
q33	O
,	O
and	O
mouse	O
chromosome	O
2	O
by	O
Southern	O
analysis	O
of	O
somatic	O
cell	O
hybrid	O
lines	O
.	O

An	O
EcoRI	O
dimorphism	O
,	O
discovered	O
in	O
common	O
inbred	O
laboratory	O
strains	O
,	O
was	O
used	O
for	O
recombinant	O
inbred	O
strain	O
mapping	O
.	O

The	O
results	O
place	O
Dlx	O
-	O
2	O
/	O
Tes	O
-	O
1	O
near	O
the	O
Hox	O
-	O
4	O
cluster	O
on	O
mouse	O
chromosome	O
2	O
.	O

A	O
region	O
of	O
antisense	O
RNA	O
from	O
human	O
p120	B-Gene_or_gene_product
cDNA	O
with	O
high	O
homology	O
to	O
mouse	O
p120	B-Gene_or_gene_product
cDNA	O
inhibits	O
NIH	O
3T3	O
proliferation	O
.	O

The	O
human	O
nucleolar	O
p120	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
is	O
a	O
proliferation	O
-	O
associated	O
antigen	O
which	O
is	O
expressed	O
in	O
G1	O
and	O
peaks	O
during	O
the	O
early	O
S	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O

Overexpression	O
of	O
the	O
human	O
p120	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
caused	O
the	O
transformation	O
of	O
NIH	O
3T3	O
cells	O
and	O
expression	O
of	O
an	O
antisense	O
p120	B-Gene_or_gene_product
construct	O
inhibited	O
the	O
growth	O
of	O
NIH	O
3T3	O
cells	O
(	O
Perlaky	O
et	O
al	O
.	O
,	O
Cancer	O
Res	O
.	O
,	O
52	O
:	O
428	O
-	O
436	O
,	O
1992	O
)	O
.	O

The	O
middle	O
region	O
of	O
the	O
antisense	O
p120	O
RNA	O
was	O
found	O
to	O
be	O
almost	O
as	O
inhibitory	O
as	O
the	O
full	O
length	O
antisense	O
construct	O
but	O
the	O
5	O
'	O
and	O
3	O
'	O
antisense	O
portions	O
did	O
not	O
affect	O
NIH	O
3T3	O
cell	O
proliferation	O
.	O

After	O
the	O
mouse	O
p120	B-Gene_or_gene_product
complementary	O
DNA	O
was	O
cloned	O
and	O
sequenced	O
,	O
comparison	O
with	O
the	O
human	O
p120	B-Gene_or_gene_product
complementary	O
DNA	O
showed	O
a	O
striking	O
conservation	O
of	O
85	O
%	O
of	O
the	O
nucleotide	O
sequence	O
and	O
96	O
%	O
of	O
the	O
amino	O
acid	O
sequence	O
.	O

The	O
two	O
ends	O
of	O
the	O
p120	O
molecule	O
had	O
less	O
homology	O
in	O
their	O
nucleotide	O
and	O
amino	O
acid	O
sequences	O
.	O

Based	O
on	O
this	O
homology	O
,	O
the	O
observed	O
inhibitory	O
effects	O
of	O
the	O
middle	O
portion	O
of	O
antisense	O
human	O
p120	O
RNA	O
may	O
be	O
related	O
to	O
suppression	O
of	O
mouse	O
p120	B-Gene_or_gene_product
expression	O
by	O
RNA	O
:	O
RNA	O
duplex	O
formation	O
.	O

The	O
high	O
evolutionary	O
conservation	O
of	O
the	O
middle	O
region	O
suggests	O
it	O
has	O
a	O
critical	O
role	O
for	O
the	O
function	O
of	O
this	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

Characterization	O
of	O
Spi	O
-	O
B	O
,	O
a	O
transcription	O
factor	O
related	O
to	O
the	O
putative	O
oncoprotein	B-Gene_or_gene_product
Spi	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
PU	I-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O

We	O
have	O
cloned	O
a	O
human	O
cDNA	O
from	O
a	O
new	O
gene	B-Gene_or_gene_product
,	O
spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
,	O
on	O
the	O
basis	O
of	O
its	O
homology	O
with	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
the	O
Spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
PU	I-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
putative	O
oncogene	O
product	O
.	O

spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
codes	O
for	O
a	O
protein	B-Gene_or_gene_product
of	O
262	O
amino	O
acids	O
presenting	O
43	O
%	O
overall	O
identity	O
with	O
Spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O

Its	O
highly	O
basic	O
carboxy	O
-	O
terminal	O
region	O
exhibits	O
34	O
%	O
sequence	O
identity	O
with	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
the	O
Ets	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

We	O
showed	O
that	O
the	O
Spi	O
-	O
B	O
protein	O
is	O
able	O
to	O
bind	O
the	O
purine	O
-	O
rich	O
sequence	O
(	O
PU	O
box	O
)	O
recognized	O
by	O
Spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
PU	I-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
to	O
activate	O
transcription	O
of	O
a	O
reporter	O
plasmid	O
containing	O
PU	O
boxes	O
.	O

Chromosome	O
in	O
situ	O
hybridization	O
allowed	O
us	O
to	O
map	O
spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
to	O
the	O
19q13	O
.	O
3	O
-	O
19q13	O
.	O
4	O
region	O
of	O
the	O
human	O
genome	O
.	O

spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
,	O
like	O
spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
was	O
found	O
to	O
be	O
expressed	O
in	O
various	O
murine	O
and	O
human	O
hematopoietic	O
cell	O
lines	O
except	O
T	O
lymphoid	O
cell	O
lines	O
.	O

A	O
member	O
of	O
the	O
Pyrin	B-Gene_or_gene_product
family	O
,	O
IFI16	B-Gene_or_gene_product
,	O
is	O
a	O
novel	O
BRCA1	B-Gene_or_gene_product
-	O
associated	O
protein	B-Gene_or_gene_product
involved	O
in	O
the	O
p53	B-Gene_or_gene_product
-	O
mediated	O
apoptosis	O
pathway	O
.	O

We	O
identified	O
IFI16	B-Gene_or_gene_product
as	O
a	O
BRCA1	B-Gene_or_gene_product
-	O
associated	O
protein	B-Gene_or_gene_product
involved	O
in	O
p53	B-Gene_or_gene_product
-	O
mediated	O
apoptosis	O
.	O

IFI16	B-Gene_or_gene_product
contains	O
the	O
Pyrin	O
/	O
PAAD	O
/	O
DAPIN	O
domain	O
,	O
commonly	O
found	O
in	O
cell	O
death	O
-	O
associated	O
proteins	B-Gene_or_gene_product
.	O

BRCA1	B-Gene_or_gene_product
(	O
aa	O
502	O
-	O
802	O
)	O
interacted	O
with	O
the	O
IFI16	B-Gene_or_gene_product
Pyrin	O
domain	O
(	O
aa	O
1	O
-	O
130	O
)	O
.	O

We	O
found	O
that	O
IFI16	B-Gene_or_gene_product
was	O
localized	O
in	O
the	O
nucleoplasm	O
and	O
nucleoli	O
.	O

Clear	O
nucleolar	O
IFI16	B-Gene_or_gene_product
localization	O
was	O
not	O
observed	O
in	O
HCC1937	O
BRCA1	O
mutant	O
cells	O
,	O
but	O
reintroduction	O
of	O
wild	B-Gene_or_gene_product
-	I-Gene_or_gene_product
type	I-Gene_or_gene_product
BRCA1	I-Gene_or_gene_product
restored	O
IFI16	B-Gene_or_gene_product
nuclear	O
relocalization	O
following	O
IR	O
(	O
ionizing	O
radiation	O
)	O
.	O

Coexpression	O
of	O
IFI16	B-Gene_or_gene_product
and	O
BRCA1	B-Gene_or_gene_product
enhanced	O
DNA	O
damage	O
-	O
induced	O
apoptosis	O
in	O
mouse	O
embryonic	O
fibroblasts	O
from	O
BRCA1	O
mutant	O
mice	O
expressing	O
wild	B-Gene_or_gene_product
-	I-Gene_or_gene_product
type	I-Gene_or_gene_product
p53	I-Gene_or_gene_product
,	O
although	O
mutant	O
IFI16	O
deficient	O
in	O
binding	O
to	O
BRCA1	O
did	O
not	O
induce	O
apoptosis	O
.	O

Furthermore	O
,	O
tetracycline	O
-	O
induced	O
IFI16	B-Gene_or_gene_product
collaborated	O
in	O
inducing	O
apoptosis	O
when	O
adenovirus	O
p53	B-Gene_or_gene_product
was	O
expressed	O
in	O
DNA	O
-	O
damaged	O
p53	B-Gene_or_gene_product
-	O
deficient	O
EJ	O
cells	O
.	O

These	O
results	O
indicate	O
a	O
BRCA1	B-Gene_or_gene_product
-	O
IFI16	B-Gene_or_gene_product
role	O
in	O
p53	B-Gene_or_gene_product
-	O
mediated	O
transmission	O
of	O
DNA	O
damage	O
signals	O
and	O
apoptosis	O
.	O

Regulation	O
of	O
aldehyde	O
reductase	O
expression	O
by	O
STAF	B-Gene_or_gene_product
and	O
CHOP	B-Gene_or_gene_product
.	O

Aldehyde	O
reductase	O
is	O
involved	O
in	O
the	O
reductive	O
detoxification	O
of	O
reactive	O
aldehydes	O
that	O
can	O
modify	O
cellular	O
macromolecules	O
.	O

To	O
analyze	O
the	O
mechanism	O
of	O
basal	O
regulation	O
of	O
aldehyde	O
reductase	O
expression	O
,	O
we	O
cloned	O
the	O
murine	O
gene	B-Gene_or_gene_product
and	O
adjacent	O
regulatory	O
region	O
and	O
compared	O
it	O
to	O
the	O
human	O
gene	B-Gene_or_gene_product
.	O

The	O
mouse	O
enzyme	O
exhibits	O
substrate	O
specificity	O
similar	O
to	O
that	O
of	O
the	O
human	O
enzyme	O
,	O
but	O
with	O
a	O
2	O
-	O
fold	O
higher	O
catalytic	O
efficiency	O
.	O

In	O
contrast	O
to	O
the	O
mouse	O
gene	B-Gene_or_gene_product
,	O
the	O
human	O
aldehyde	O
reductase	O
gene	B-Gene_or_gene_product
has	O
two	O
alternatively	O
spliced	O
transcripts	O
.	O

A	O
fragment	O
of	O
57	O
bp	O
is	O
sufficient	O
for	O
25	O
%	O
of	O
human	O
promoter	O
activity	O
and	O
consists	O
of	O
two	O
elements	O
.	O

The	O
3	O
'	O
element	O
binds	O
transcription	O
factors	O
of	O
the	O
Sp1	B-Gene_or_gene_product
family	I-Gene_or_gene_product
.	O

Gel	O
-	O
shift	O
assays	O
and	O
chromatin	O
immunoprecipitation	O
as	O
well	O
as	O
deletion	O
/	O
mutation	O
analysis	O
reveal	O
that	O
selenocysteine	O
tRNA	O
transcription	O
activating	O
factor	O
(	O
STAF	O
)	O
binds	O
to	O
the	O
5	O
'	O
element	O
and	O
drives	O
constitutive	O
expression	O
of	O
both	O
mouse	O
and	O
human	O
aldehyde	O
reductase	O
.	O

Aldehyde	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
thus	O
becomes	O
the	O
fourth	O
protein	B-Gene_or_gene_product
-	O
encoding	O
gene	B-Gene_or_gene_product
regulated	O
by	O
STAF	B-Gene_or_gene_product
.	O

The	O
human	O
,	O
but	O
not	O
the	O
mouse	O
,	O
promoter	O
also	O
binds	O
C	B-Gene_or_gene_product
/	I-Gene_or_gene_product
EBP	I-Gene_or_gene_product
homologous	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
CHOP	B-Gene_or_gene_product
)	O
,	O
which	O
competes	O
with	O
STAF	B-Gene_or_gene_product
for	O
the	O
same	O
binding	O
site	O
.	O

Transfection	O
of	O
the	O
human	O
promoter	O
into	O
ethoxyquin	O
-	O
treated	O
mouse	O
3T3	O
cells	O
induces	O
a	O
3	O
.	O
5	O
-	O
fold	O
increase	O
in	O
promoter	O
activity	O
and	O
a	O
CHOP	O
-	O
C	O
/	O
EBP	O
band	O
appears	O
on	O
gel	O
shifts	O
performed	O
with	O
the	O
5	O
'	O
probe	O
from	O
the	O
human	O
aldehyde	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
promoter	O
.	O

Induction	O
is	O
attenuated	O
in	O
similar	O
transfection	O
studies	O
of	O
the	O
mouse	O
promoter	O
.	O

Mutation	O
of	O
the	O
CHOP	O
-	O
binding	O
site	O
in	O
the	O
human	O
promoter	O
abolishes	O
CHOP	B-Gene_or_gene_product
binding	O
and	O
significantly	O
reduces	O
ethoxyquin	O
induction	O
,	O
suggesting	O
that	O
CHOP	B-Gene_or_gene_product
mediates	O
stimulated	O
expression	O
in	O
response	O
to	O
antioxidants	O
in	O
the	O
human	O
.	O

This	O
subtle	O
difference	O
in	O
the	O
human	O
promoter	O
suggests	O
a	O
further	O
evolution	O
of	O
the	O
promoter	O
toward	O
responsiveness	O
to	O
exogenous	O
stress	O
and	O
/	O
or	O
toxins	O
.	O

I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
/	I-Gene_or_gene_product
MAD	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
masks	O
the	O
nuclear	O
localization	O
signal	O
of	O
NF	O
-	O
kappa	O
B	O
p65	O
and	O
requires	O
the	O
transactivation	O
domain	O
to	O
inhibit	O
NF	O
-	O
kappa	O
B	O
p65	O
DNA	O
binding	O
.	O

The	O
active	O
nuclear	O
form	O
of	O
the	O
NF	O
-	O
kappa	O
B	O
transcription	O
factor	O
complex	O
is	O
composed	O
of	O
two	O
DNA	O
binding	O
subunits	O
,	O
NF	O
-	O
kappa	O
B	O
p65	O
and	O
NF	O
-	O
kappa	O
B	O
p50	O
,	O
both	O
of	O
which	O
share	O
extensive	O
N	O
-	O
terminal	O
sequence	O
homology	O
with	O
the	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
rel	I-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
product	O
.	O

The	O
NF	O
-	O
kappa	O
B	O
p65	O
subunit	O
provides	O
the	O
transactivation	O
activity	O
in	O
this	O
complex	O
and	O
serves	O
as	O
an	O
intracellular	O
receptor	O
for	O
a	O
cytoplasmic	O
inhibitor	O
of	O
NF	O
-	O
kappa	O
B	O
,	O
termed	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
.	O

In	O
contrast	O
,	O
NF	O
-	O
kappa	O
B	O
p50	O
alone	O
fails	O
to	O
stimulate	O
kappa	O
B	O
-	O
directed	O
transcription	O
,	O
and	O
based	O
on	O
prior	O
in	O
vitro	O
studies	O
,	O
is	O
not	O
directly	O
regulated	O
by	O
I	O
kappa	O
B	O
.	O

To	O
investigate	O
the	O
molecular	O
basis	O
for	O
the	O
critical	O
regulatory	O
interaction	O
between	O
NF	O
-	O
kappa	O
B	O
and	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
/	I-Gene_or_gene_product
MAD	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
,	O
a	O
series	O
of	O
human	O
NF	O
-	O
kappa	O
B	O
p65	O
mutants	O
was	O
identified	O
that	O
functionally	O
segregated	O
DNA	O
binding	O
,	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
-	O
mediated	O
inhibition	O
,	O
and	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
-	O
induced	O
nuclear	O
exclusion	O
of	O
this	O
transcription	O
factor	O
.	O

Results	O
from	O
in	O
vivo	O
expression	O
studies	O
performed	O
with	O
these	O
NF	O
-	O
kappa	O
B	O
p65	O
mutants	O
revealed	O
the	O
following	O
:	O
1	O
)	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
/	I-Gene_or_gene_product
MAD	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
completely	O
inhibits	O
NF	O
-	O
kappa	O
B	O
p65	O
-	O
dependent	O
transcriptional	O
activation	O
mediated	O
through	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
kappa	O
B	O
enhancer	O
in	O
human	O
T	O
lymphocytes	O
,	O
2	O
)	O
the	O
binding	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
/	I-Gene_or_gene_product
MAD	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
to	O
NF	O
-	O
kappa	O
B	O
p65	O
is	O
sufficient	O
to	O
retarget	O
NF	O
-	O
kappa	O
B	O
p65	O
from	O
the	O
nucleus	O
to	O
the	O
cytoplasm	O
,	O
3	O
)	O
selective	O
deletion	O
of	O
the	O
functional	O
nuclear	O
localization	O
signal	O
present	O
in	O
the	O
Rel	O
homology	O
domain	O
of	O
NF	O
-	O
kappa	O
B	O
p65	O
disrupts	O
its	O
ability	O
to	O
engage	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
/	I-Gene_or_gene_product
MAD	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
,	O
and	O
4	O
)	O
the	O
unique	O
C	O
-	O
terminus	O
of	O
NF	O
-	O
kappa	O
B	O
p65	O
attenuates	O
its	O
own	O
nuclear	O
localization	O
and	O
contains	O
sequences	O
that	O
are	O
required	O
for	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
-	O
mediated	O
inhibition	O
of	O
NF	O
-	O
kappa	O
B	O
p65	O
DNA	O
binding	O
activity	O
.	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
the	O
nuclear	O
localization	O
signal	O
and	O
transactivation	O
domain	O
of	O
NF	O
-	O
kappa	O
B	O
p65	O
constitute	O
a	O
bipartite	O
system	O
that	O
is	O
critically	O
involved	O
in	O
the	O
inhibitory	O
function	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
/	I-Gene_or_gene_product
MAD	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
.	O

Unexpectedly	O
,	O
our	O
in	O
vivo	O
studies	O
also	O
demonstrate	O
that	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
/	I-Gene_or_gene_product
MAD	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
binds	O
directly	O
to	O
NF	O
-	O
kappa	O
B	O
p50	O
.	O

This	O
interaction	O
is	O
functional	O
as	O
it	O
leads	O
to	O
retargeting	O
of	O
NF	O
-	O
kappa	O
B	O
p50	O
from	O
the	O
nucleus	O
to	O
the	O
cytoplasm	O
.	O

However	O
,	O
no	O
loss	O
of	O
DNA	O
binding	O
activity	O
is	O
observed	O
,	O
presumably	O
reflecting	O
the	O
unique	O
C	O
-	O
terminal	O
domain	O
that	O
is	O
distinct	O
from	O
that	O
present	O
in	O
NF	O
-	O
kappa	O
B	O
p65	O
.	O

MAZ	B-Gene_or_gene_product
,	O
a	O
zinc	B-Gene_or_gene_product
finger	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
binds	O
to	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MYC	I-Gene_or_gene_product
and	O
C2	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
sequences	O
regulating	O
transcriptional	O
initiation	O
and	O
termination	O
.	O

ME1a1	O
,	O
a	O
16	O
-	O
base	O
-	O
pair	O
nuclear	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
binding	O
site	O
residing	O
between	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MYC	I-Gene_or_gene_product
P1	O
and	O
P2	O
transcription	O
initiation	O
sites	O
,	O
is	O
required	O
for	O
P2	O
activity	O
.	O

A	O
cDNA	O
encoding	O
a	O
477	O
-	O
amino	O
acid	O
zinc	B-Gene_or_gene_product
finger	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
designated	O
MAZ	B-Gene_or_gene_product
(	O
MYC	O
-	O
associated	O
zinc	O
finger	O
protein	O
)	O
was	O
cloned	O
from	O
a	O
HeLa	O
lambda	O
gt11	O
library	O
by	O
screening	O
with	O
a	O
concatamerized	O
ME1a1	O
binding	O
site	O
probe	O
.	O

In	O
addition	O
to	O
six	O
potential	O
zinc	O
fingers	O
of	O
the	O
Cys2His2	O
type	O
,	O
MAZ	B-Gene_or_gene_product
contains	O
an	O
amino	O
-	O
terminal	O
proline	O
-	O
rich	O
domain	O
and	O
several	O
polyalanine	O
tracts	O
.	O

Its	O
mRNA	O
was	O
present	O
in	O
all	O
human	O
tissues	O
tested	O
except	O
for	O
kidney	O
,	O
as	O
a	O
doublet	O
of	O
approximately	O
2	O
.	O
5	O
and	O
2	O
.	O
7	O
kilobases	O
,	O
along	O
with	O
differentially	O
expressed	O
minor	O
species	O
.	O

MAZ	B-Gene_or_gene_product
bound	O
specifically	O
to	O
the	O
wild	O
-	O
type	O
ME1a1	O
sequence	O
but	O
not	O
to	O
a	O
ME1a1	O
mutant	O
that	O
also	O
failed	O
to	O
yield	O
P2	O
activity	O
.	O

When	O
expressed	O
as	O
a	O
fusion	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
in	O
a	O
pMAL	O
-	O
c	O
vector	O
,	O
MAZ	B-Gene_or_gene_product
binds	O
with	O
specificity	O
to	O
a	O
GA	O
box	O
sequence	O
(	O
GGGAGGG	O
)	O
found	O
in	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MYC	I-Gene_or_gene_product
P2	O
promoter	O
,	O
to	O
the	O
P2	O
attenuator	O
region	O
within	O
the	O
gene	B-Gene_or_gene_product
'	I-Gene_or_gene_product
s	I-Gene_or_gene_product
first	O
exon	O
,	O
and	O
to	O
a	O
related	O
sequence	O
involved	O
in	O
the	O
transcriptional	O
termination	O
of	O
the	O
C2	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

MAZ	B-Gene_or_gene_product
may	O
encode	O
a	O
transcription	O
factor	O
with	O
dual	O
roles	O
in	O
transcription	O
initiation	O
and	O
termination	O
.	O

PML	B-Gene_or_gene_product
regulates	O
p53	B-Gene_or_gene_product
stability	O
by	O
sequestering	O
Mdm2	O
to	O
the	O
nucleolus	O
.	O

The	O
promyelocytic	B-Gene_or_gene_product
leukaemia	I-Gene_or_gene_product
(	I-Gene_or_gene_product
PML	I-Gene_or_gene_product
)	I-Gene_or_gene_product
tumour	I-Gene_or_gene_product
-	I-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
potentiates	O
p53	B-Gene_or_gene_product
function	O
by	O
regulating	O
post	O
-	O
translational	O
modifications	O
,	O
such	O
as	O
CBP	B-Gene_or_gene_product
-	O
dependent	O
acetylation	O
and	O
Chk2	O
-	O
dependent	O
phosphorylation	O
,	O
in	O
the	O
PML	O
-	O
Nuclear	O
Body	O
(	O
NB	O
)	O
.	O

PML	B-Gene_or_gene_product
was	O
recently	O
shown	O
to	O
interact	O
with	O
the	O
p53	O
ubiquitin	O
-	O
ligase	O
Mdm2	O
(	O
refs	O
4	O
-	O
6	O
)	O
;	O
however	O
,	O
the	O
mechanism	O
by	O
which	O
PML	B-Gene_or_gene_product
regulates	O
Mdm2	O
remains	O
unclear	O
.	O

Here	O
,	O
we	O
show	O
that	O
PML	B-Gene_or_gene_product
enhances	O
p53	B-Gene_or_gene_product
stability	O
by	O
sequestering	O
Mdm2	O
to	O
the	O
nucleolus	O
.	O

We	O
found	O
that	O
after	O
DNA	O
damage	O
,	O
PML	B-Gene_or_gene_product
and	O
Mdm2	O
accumulate	O
in	O
the	O
nucleolus	O
in	O
an	O
Arf	B-Gene_or_gene_product
-	O
independent	O
manner	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
the	O
nucleolar	O
localization	O
of	O
PML	B-Gene_or_gene_product
is	O
dependent	O
on	O
ATR	O
activation	O
and	O
phosphorylation	O
of	O
PML	B-Gene_or_gene_product
by	O
ATR	O
.	O

Notably	O
,	O
in	O
Pml	O
(	O
-	O
/	O
-	O
)	O
cells	O
,	O
sequestration	O
of	O
Mdm2	O
to	O
the	O
nucleolus	O
was	O
impaired	O
,	O
as	O
well	O
as	O
p53	B-Gene_or_gene_product
stabilization	O
and	O
the	O
induction	O
of	O
apoptosis	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
PML	B-Gene_or_gene_product
physically	O
associates	O
with	O
the	O
nucleolar	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
L11	I-Gene_or_gene_product
,	O
and	O
that	O
L11	B-Gene_or_gene_product
knockdown	O
impairs	O
the	O
ability	O
of	O
PML	B-Gene_or_gene_product
to	O
localize	O
to	O
nucleoli	O
after	O
DNA	O
damage	O
.	O

These	O
findings	O
demonstrate	O
an	O
unexpected	O
role	O
of	O
PML	B-Gene_or_gene_product
in	O
the	O
nucleolar	O
network	O
for	O
tumour	O
suppression	O
.	O

A	O
membrane	O
protein	O
complex	O
mediates	O
retro	O
-	O
translocation	O
from	O
the	O
ER	O
lumen	O
into	O
the	O
cytosol	O
.	O

Elimination	O
of	O
misfolded	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
from	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
by	O
retro	O
-	O
translocation	O
is	O
an	O
important	O
physiological	O
adaptation	O
to	O
ER	O
stress	O
.	O

This	O
process	O
requires	O
recognition	O
of	O
a	O
substrate	O
in	O
the	O
ER	O
lumen	O
and	O
its	O
subsequent	O
movement	O
through	O
the	O
membrane	O
by	O
the	O
cytosolic	O
p97	O
ATPase	O
.	O

Here	O
we	O
identify	O
a	O
p97	B-Gene_or_gene_product
-	O
interacting	O
membrane	O
protein	O
complex	O
in	O
the	O
mammalian	O
ER	O
that	O
links	O
these	O
two	O
events	O
.	O

The	O
central	O
component	O
of	O
the	O
complex	O
,	O
Derlin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
is	O
a	O
homologue	O
of	O
Der1	B-Gene_or_gene_product
,	O
a	O
yeast	O
protein	B-Gene_or_gene_product
whose	O
inactivation	O
prevents	O
the	O
elimination	O
of	O
misfolded	O
luminal	O
ER	O
proteins	B-Gene_or_gene_product
.	O

Derlin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
associates	O
with	O
different	O
substrates	O
as	O
they	O
move	O
through	O
the	O
membrane	O
,	O
and	O
inactivation	O
of	O
Derlin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
in	O
C	O
.	O
elegans	O
causes	O
ER	O
stress	O
.	O

Derlin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
interacts	O
with	O
US11	B-Gene_or_gene_product
,	O
a	O
virally	O
encoded	O
ER	O
protein	B-Gene_or_gene_product
that	O
specifically	O
targets	O
MHC	B-Gene_or_gene_product
class	I-Gene_or_gene_product
I	I-Gene_or_gene_product
heavy	I-Gene_or_gene_product
chains	I-Gene_or_gene_product
for	O
export	O
from	O
the	O
ER	O
,	O
as	O
well	O
as	O
with	O
VIMP	B-Gene_or_gene_product
,	O
a	O
novel	O
membrane	O
protein	B-Gene_or_gene_product
that	O
recruits	O
the	O
p97	O
ATPase	O
and	O
its	O
cofactor	B-Gene_or_gene_product
.	O

A	O
novel	O
Ets	O
-	O
related	O
transcription	O
factor	O
,	O
Elf	O
-	O
1	O
,	O
binds	O
to	O
human	O
immunodeficiency	O
virus	O
type	O
2	O
regulatory	O
elements	O
that	O
are	O
required	O
for	O
inducible	O
trans	O
activation	O
in	O
T	O
cells	O
.	O

Human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV	O
-	O
1	O
)	O
and	O
HIV	O
-	O
2	O
are	O
structurally	O
related	O
retroviruses	O
which	O
both	O
cause	O
AIDS	O
in	O
humans	O
.	O

Although	O
both	O
viruses	O
establish	O
latency	O
in	O
quiescent	O
human	O
-	O
peripheral	O
-	O
blood	O
T	O
cells	O
,	O
the	O
asymptomatic	O
phase	O
of	O
HIV	O
-	O
2	O
infection	O
may	O
be	O
more	O
prolonged	O
than	O
that	O
of	O
HIV	O
-	O
1	O
.	O

The	O
latent	O
phases	O
of	O
both	O
HIV	O
-	O
1	O
and	O
HIV	O
-	O
2	O
infection	O
have	O
been	O
shown	O
to	O
be	O
disrupted	O
by	O
T	O
-	O
cell	O
activation	O
,	O
a	O
process	O
that	O
requires	O
host	O
cell	O
transcription	O
factors	O
.	O

In	O
the	O
case	O
of	O
HIV	O
-	O
1	O
,	O
the	O
transcription	O
factor	O
NF	O
-	O
kappa	O
B	O
is	O
sufficient	O
for	O
inducible	O
transcriptional	O
activation	O
.	O

In	O
contrast	O
,	O
factors	O
in	O
addition	O
to	O
NF	O
-	O
kappa	O
B	O
are	O
required	O
to	O
activate	O
HIV	O
-	O
2	O
transcription	O
in	O
infected	O
T	O
cells	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
a	O
novel	O
Ets	O
-	O
related	O
transcription	O
factor	O
,	O
Elf	O
-	O
1	O
,	O
binds	O
specifically	O
to	O
two	O
purine	O
-	O
rich	O
motifs	O
in	O
the	O
HIV	O
-	O
2	O
enhancer	O
.	O

Mutagenesis	O
experiments	O
demonstrated	O
that	O
these	O
Elf	O
-	O
1	O
binding	O
sites	O
are	O
required	O
for	O
induction	O
of	O
HIV	O
-	O
2	O
transcription	O
following	O
T	O
-	O
cell	O
-	O
receptor	B-Gene_or_gene_product
-	O
mediated	O
T	O
-	O
cell	O
activation	O
.	O

Moreover	O
,	O
Elf	O
-	O
1	O
is	O
the	O
only	O
factor	O
present	O
in	O
activated	O
T	O
-	O
cell	O
nuclear	O
extracts	O
that	O
binds	O
to	O
these	O
sites	O
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

Thus	O
,	O
Elf	O
-	O
1	O
is	O
a	O
novel	O
transcription	O
factor	O
that	O
appears	O
to	O
be	O
required	O
for	O
the	O
T	O
-	O
cell	O
-	O
receptor	B-Gene_or_gene_product
-	O
mediated	O
trans	O
activation	O
of	O
HIV	O
-	O
2	O
gene	O
expression	O
.	O

These	O
results	O
may	O
explain	O
differences	O
in	O
the	O
clinical	O
spectra	O
of	O
diseases	O
caused	O
by	O
HIV	O
-	O
1	O
and	O
HIV	O
-	O
2	O
and	O
may	O
also	O
have	O
implications	O
for	O
the	O
design	O
of	O
therapeutic	O
approaches	O
to	O
HIV	O
-	O
2	O
infection	O
.	O

The	O
BCL6	B-Gene_or_gene_product
proto	B-Gene_or_gene_product
-	I-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
suppresses	O
p53	B-Gene_or_gene_product
expression	O
in	O
germinal	O
-	O
centre	O
B	O
cells	O
.	O

The	O
human	O
proto	B-Gene_or_gene_product
-	I-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
BCL6	B-Gene_or_gene_product
encodes	O
a	O
BTB	O
/	O
POZ	O
-	O
zinc	O
-	O
finger	O
transcriptional	O
repressor	O
that	O
is	O
necessary	O
for	O
germinal	O
-	O
centre	O
formation	O
and	O
is	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
B	O
-	O
cell	O
lymphoma	O
.	O

The	O
precise	O
function	O
of	O
BCL6	B-Gene_or_gene_product
in	O
germinal	O
-	O
centre	O
development	O
and	O
lymphomagenesis	O
is	O
unclear	O
because	O
very	O
few	O
direct	O
BCL6	B-Gene_or_gene_product
target	O
genes	B-Gene_or_gene_product
have	O
been	O
identified	O
.	O

Here	O
we	O
report	O
that	O
BCL6	B-Gene_or_gene_product
suppresses	O
the	O
expression	O
of	O
the	O
p53	B-Gene_or_gene_product
(	O
also	O
known	O
as	O
tp53	B-Gene_or_gene_product
)	O
tumour	O
suppressor	O
gene	B-Gene_or_gene_product
and	O
modulates	O
DNA	O
damage	O
-	O
induced	O
apoptotic	O
responses	O
in	O
germinal	O
-	O
centre	O
B	O
cells	O
.	O

BCL6	B-Gene_or_gene_product
represses	O
p53	B-Gene_or_gene_product
transcription	O
by	O
binding	O
two	O
specific	O
DNA	O
sites	O
within	O
the	O
p53	B-Gene_or_gene_product
promoter	O
region	O
and	O
,	O
accordingly	O
,	O
p53	B-Gene_or_gene_product
expression	O
is	O
absent	O
in	O
germinal	O
-	O
centre	O
B	O
cells	O
where	O
BCL6	B-Gene_or_gene_product
is	O
highly	O
expressed	O
.	O

Suppression	O
of	O
BCL6	B-Gene_or_gene_product
expression	O
via	O
specific	O
short	O
interfering	O
RNA	O
leads	O
to	O
increased	O
levels	O
of	O
p53	B-Gene_or_gene_product
messenger	O
RNA	O
and	O
protein	B-Gene_or_gene_product
both	O
under	O
basal	O
conditions	O
and	O
in	O
response	O
to	O
DNA	O
damage	O
.	O

Most	O
notably	O
,	O
constitutive	O
expression	O
of	O
BCL6	B-Gene_or_gene_product
protects	O
B	O
cell	O
lines	O
from	O
apoptosis	O
induced	O
by	O
DNA	O
damage	O
.	O

These	O
results	O
suggest	O
that	O
an	O
important	O
function	O
of	O
BCL6	B-Gene_or_gene_product
is	O
to	O
allow	O
germinal	O
-	O
centre	O
B	O
cells	O
to	O
tolerate	O
the	O
physiological	O
DNA	O
breaks	O
required	O
for	O
immunoglobulin	O
class	O
switch	O
recombination	O
and	O
somatic	O
hypermutation	O
without	O
inducing	O
a	O
p53	B-Gene_or_gene_product
-	O
dependent	O
apoptotic	O
response	O
.	O

These	O
findings	O
also	O
imply	O
that	O
deregulated	O
BCL6	B-Gene_or_gene_product
expression	O
contributes	O
to	O
lymphomagenesis	O
in	O
part	O
by	O
functional	O
inactivation	O
of	O
p53	B-Gene_or_gene_product
.	O

The	O
human	O
T	O
cell	O
transcription	O
factor	O
-	O
1	O
gene	B-Gene_or_gene_product
.	O

Structure	O
,	O
localization	O
,	O
and	O
promoter	O
characterization	O
.	O

We	O
have	O
recently	O
isolated	O
cDNA	O
clones	O
representing	O
four	O
alternative	O
splice	O
forms	O
of	O
a	O
T	O
cell	O
-	O
specific	O
transcription	O
factor	O
,	O
TCF	O
-	O
1	O
.	O

Here	O
we	O
report	O
the	O
characterization	O
of	O
the	O
human	O
gene	B-Gene_or_gene_product
encoding	O
this	O
factor	O
.	O

The	O
TCF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
contained	O
in	O
10	O
exons	O
including	O
an	O
untranslated	O
first	O
exon	O
.	O

The	O
DNA	O
-	O
binding	O
high	O
mobility	O
group	O
(	O
HMG	O
)	O
box	O
of	O
TCF	O
-	O
1	O
is	O
encoded	O
by	O
the	O
closely	O
spaced	O
exons	O
VI	O
and	O
VII	O
.	O

Differential	O
splicing	O
involves	O
an	O
alternative	O
exon	O
(	O
IX	O
)	O
and	O
three	O
splice	O
acceptor	O
sites	O
in	O
exon	O
X	O
.	O

Based	O
on	O
comparison	O
of	O
sequence	O
and	O
on	O
the	O
placement	O
of	O
an	O
alternative	O
exon	O
,	O
TCF	O
-	O
1	O
appears	O
closely	O
related	O
to	O
the	O
recently	O
characterized	O
HMG	O
box	O
transcription	O
factor	O
TCF	O
-	O
1	O
alpha	O
/	O
LEF	O
.	O

In	O
particular	O
,	O
the	O
HMG	O
boxes	O
encoded	O
by	O
the	O
two	O
TCF	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
are	O
virtually	O
identical	O
.	O

The	O
TCF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
resides	O
on	O
chromosome	O
5	O
band	O
q31	O
.	O
1	O
.	O

The	O
TCF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
coincides	O
with	O
a	O
CpG	O
island	O
.	O

As	O
determined	O
by	O
chloramphenicol	O
acetyltransferase	O
analysis	O
,	O
the	O
promoter	O
is	O
preferentially	O
active	O
in	O
T	O
cells	O
.	O

The	O
promoter	O
does	O
not	O
contain	O
TCF	O
-	O
1	O
/	O
TCF	O
-	O
1	O
alpha	O
binding	O
sites	O
and	O
is	O
therefore	O
not	O
autoregulated	O
.	O

This	O
observation	O
implies	O
the	O
existence	O
of	O
yet	O
uncharacterized	O
T	O
cell	O
transcription	O
factors	O
that	O
are	O
active	O
during	O
early	O
T	O
cell	O
differentiation	O
.	O

CATERPILLER	O
16	O
.	O
2	O
(	O
CLR16	B-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
,	O
a	O
novel	O
NBD	B-Gene_or_gene_product
/	I-Gene_or_gene_product
LRR	I-Gene_or_gene_product
family	I-Gene_or_gene_product
member	O
that	O
negatively	O
regulates	O
T	O
cell	O
function	O
.	O

The	O
newly	O
discovered	O
mammalian	O
CATERPILLER	B-Gene_or_gene_product
(	I-Gene_or_gene_product
NOD	I-Gene_or_gene_product
,	I-Gene_or_gene_product
NALP	I-Gene_or_gene_product
,	I-Gene_or_gene_product
PAN	I-Gene_or_gene_product
)	I-Gene_or_gene_product
family	I-Gene_or_gene_product
of	O
proteins	B-Gene_or_gene_product
share	O
similarities	O
with	O
the	O
NBD	B-Gene_or_gene_product
-	I-Gene_or_gene_product
LRR	I-Gene_or_gene_product
superfamily	I-Gene_or_gene_product
of	O
plant	O
disease	B-Gene_or_gene_product
resistance	I-Gene_or_gene_product
(	I-Gene_or_gene_product
R	I-Gene_or_gene_product
)	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
and	O
are	O
predicted	O
to	O
mediate	O
important	O
immune	O
regulatory	O
function	O
.	O

This	O
report	O
describes	O
the	O
first	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
CATERPILLER	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
,	O
CLR16	B-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
that	O
is	O
located	O
on	O
human	O
chromosome	O
16	O
.	O

The	O
protein	B-Gene_or_gene_product
encoded	O
by	O
this	O
gene	B-Gene_or_gene_product
has	O
a	O
typical	O
NBD	B-Gene_or_gene_product
-	I-Gene_or_gene_product
LRR	I-Gene_or_gene_product
configuration	I-Gene_or_gene_product
.	O

Analysis	O
of	O
CLR16	B-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
suggests	O
the	O
highest	O
expression	O
among	O
T	O
lymphocytes	O
.	O

Cellular	O
localization	O
studies	O
of	O
CLR16	B-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
revealed	O
that	O
it	O
is	O
a	O
cytoplasmic	O
protein	B-Gene_or_gene_product
.	O

Querying	O
microarray	O
studies	O
in	O
the	O
public	O
data	O
base	O
showed	O
that	O
CLR16	B-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
was	O
significantly	O
(	O
>	O
90	O
%	O
)	O
down	O
-	O
regulated	O
6	O
h	O
after	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CD3	I-Gene_or_gene_product
and	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CD28	I-Gene_or_gene_product
stimulation	O
of	O
primary	O
T	O
lymphocytes	O
.	O

Its	O
reduction	O
upon	O
T	O
cell	O
stimulation	O
is	O
consistent	O
with	O
a	O
potential	O
negative	O
regulatory	O
role	O
.	O

Indeed	O
CLR16	B-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
decreased	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
,	O
NFAT	B-Gene_or_gene_product
,	O
and	O
AP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
induction	O
of	O
reporter	O
gene	O
constructs	O
in	O
response	O
to	O
T	O
cell	O
activation	O
by	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CD3	I-Gene_or_gene_product
and	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CD28	I-Gene_or_gene_product
antibodies	B-Gene_or_gene_product
or	O
PMA	B-Gene_or_gene_product
and	O
ionomycin	B-Gene_or_gene_product
.	O

Following	O
T	O
cell	O
stimulation	O
,	O
the	O
presence	O
of	O
CLR16	B-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
reduced	O
the	O
levels	O
of	O
the	O
endogenous	O
transcripts	O
for	O
the	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
CD25	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
that	O
are	O
central	O
in	O
maintaining	O
T	O
cell	O
activation	O
and	O
preventing	O
T	O
cell	O
anergy	O
.	O

This	O
reduction	O
was	O
accompanied	O
by	O
a	O
delay	O
of	O
IkappaBalpha	O
degradation	O
.	O

We	O
propose	O
that	O
CLR16	B-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
serves	O
to	O
attenuate	O
T	O
cell	O
activation	O
via	O
TCR	B-Gene_or_gene_product
and	O
co	O
-	O
stimulatory	O
molecules	O
,	O
and	O
its	O
reduction	O
during	O
T	O
cell	O
stimulation	O
allows	O
the	O
ensuing	O
cellular	O
activation	O
.	O

The	O
oxidative	O
stressor	O
arsenite	O
activates	O
vascular	B-Gene_or_gene_product
endothelial	I-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
mRNA	O
transcription	O
by	O
an	O
ATF4	O
-	O
dependent	O
mechanism	O
.	O

Aberrant	O
retinal	O
expression	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	B-Gene_or_gene_product
)	O
leading	O
to	O
neovascularization	O
is	O
a	O
central	O
feature	O
of	O
age	O
-	O
related	O
macular	O
degeneration	O
and	O
diabetic	O
retinopathy	O
,	O
two	O
leading	O
causes	O
of	O
vision	O
loss	O
.	O

Oxidative	O
stress	O
is	O
suggested	O
to	O
occur	O
in	O
retinal	O
tissue	O
during	O
age	O
-	O
related	O
macular	O
degeneration	O
and	O
diabetic	O
retinopathy	O
and	O
is	O
suspected	O
in	O
the	O
mechanism	O
of	O
VEGF	B-Gene_or_gene_product
expression	O
in	O
these	O
diseases	O
.	O

Arsenite	O
,	O
a	O
thiol	O
-	O
reactive	O
oxidative	O
stressor	O
,	O
induces	O
VEGF	B-Gene_or_gene_product
expression	O
by	O
a	O
HIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
-	O
independent	O
mechanism	O
.	O

Previously	O
,	O
we	O
demonstrated	O
that	O
homocysteine	O
,	O
an	O
endoplasmic	O
reticulum	O
stressor	O
,	O
increases	O
VEGF	B-Gene_or_gene_product
transcription	O
by	O
a	O
mechanism	O
dependent	O
upon	O
activating	O
transcription	O
factor	O
ATF4	O
.	O

Because	O
ATF4	O
is	O
expressed	O
in	O
response	O
to	O
oxidative	O
stress	O
,	O
we	O
hypothesized	O
that	O
ATF4	O
was	O
also	O
responsible	O
for	O
increased	O
VEGF	B-Gene_or_gene_product
transcription	O
in	O
response	O
to	O
arsenite	O
.	O

We	O
now	O
show	O
that	O
arsenite	O
increased	O
steady	O
state	O
levels	O
of	O
VEGF	B-Gene_or_gene_product
mRNA	O
and	O
activated	O
transcription	O
from	O
a	O
VEGF	B-Gene_or_gene_product
promoter	O
construct	O
.	O

Arsenite	O
induced	O
eIF2alpha	B-Gene_or_gene_product
phosphorylation	O
,	O
resulting	O
in	O
increased	O
ATF4	O
protein	O
levels	O
.	O

Inactivation	O
or	O
loss	O
of	O
ATF4	O
greatly	O
diminished	O
the	O
VEGF	B-Gene_or_gene_product
response	O
to	O
arsenite	O
treatment	O
.	O

Overexpression	O
of	O
ATF4	O
was	O
sufficient	O
to	O
activate	O
the	O
VEGF	B-Gene_or_gene_product
promoter	O
,	O
and	O
arsenite	O
cooperated	O
with	O
exogenous	O
ATF4	O
to	O
further	O
activate	O
the	O
promoter	O
.	O

A	O
complex	O
containing	O
ATF4	O
binds	O
a	O
DNA	O
element	O
at	O
+	O
1767	O
bp	O
relative	O
to	O
the	O
VEGF	O
transcription	O
start	O
site	O
,	O
and	O
DNA	O
binding	O
activity	O
is	O
increased	O
by	O
arsenite	O
treatment	O
.	O

In	O
addition	O
,	O
the	O
ability	O
of	O
a	O
thiol	O
antioxidant	O
,	O
N	O
-	O
acetylcysteine	O
,	O
to	O
inhibit	O
the	O
effect	O
of	O
arsenite	O
on	O
VEGF	B-Gene_or_gene_product
expression	O
coincided	O
with	O
its	O
ability	O
to	O
inhibit	O
phosphorylation	O
of	O
eIF2alpha	B-Gene_or_gene_product
and	O
ATF4	O
protein	O
expression	O
.	O

Thus	O
,	O
arsenite	O
-	O
induced	O
up	O
-	O
regulation	O
of	O
VEGF	B-Gene_or_gene_product
gene	O
transcription	O
occurs	O
by	O
an	O
ATF4	O
-	O
dependent	O
mechanism	O
.	O

Role	O
of	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
eta	I-Gene_or_gene_product
as	O
a	O
positive	O
regulator	O
of	O
the	O
glucocorticoid	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
transcriptional	O
activation	O
.	O

The	O
glucocorticoid	O
receptor	O
(	O
GR	B-Gene_or_gene_product
)	O
,	O
a	O
member	O
of	O
the	O
nuclear	O
receptor	B-Gene_or_gene_product
superfamily	I-Gene_or_gene_product
,	O
mediates	O
the	O
effects	O
of	O
glucocorticoids	O
.	O

It	O
is	O
known	O
that	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
family	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
interact	O
with	O
GR	B-Gene_or_gene_product
and	O
regulate	O
its	O
transcriptional	O
activity	O
.	O

They	O
also	O
bind	O
to	O
several	O
molecules	O
and	O
influence	O
many	O
cellular	O
events	O
by	O
altering	O
their	O
subcellular	O
localization	O
and	O
/	O
or	O
acting	O
as	O
a	O
chaperone	B-Gene_or_gene_product
.	O

Recently	O
,	O
it	O
has	O
been	O
proposed	O
that	O
ligand	O
-	O
activated	O
degradation	O
of	O
GR	B-Gene_or_gene_product
occurs	O
via	O
the	O
ubiquitin	O
-	O
proteasomal	O
degradation	O
pathway	O
and	O
that	O
inhibition	O
of	O
proteasomal	O
activity	O
induces	O
up	O
-	O
regulation	O
of	O
GR	B-Gene_or_gene_product
and	O
enhances	O
the	O
transcriptional	O
activity	O
of	O
GR	B-Gene_or_gene_product
.	O

To	O
examine	O
the	O
function	O
of	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3eta	I-Gene_or_gene_product
in	O
the	O
glucocorticoid	O
-	O
dependent	O
signal	O
pathway	O
,	O
we	O
studied	O
the	O
regulatory	O
role	O
of	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3eta	I-Gene_or_gene_product
in	O
ligand	O
-	O
induced	O
GR	B-Gene_or_gene_product
transcriptional	O
activation	O
.	O

14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3eta	I-Gene_or_gene_product
Enhanced	O
the	O
transcriptional	O
activity	O
of	O
GR	B-Gene_or_gene_product
,	O
and	O
the	O
levels	O
of	O
GR	B-Gene_or_gene_product
were	O
higher	O
in	O
cells	O
transfected	O
with	O
the	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3eta	I-Gene_or_gene_product
expression	O
vector	O
in	O
response	O
to	O
glucocorticoid	O
.	O

The	O
GR	B-Gene_or_gene_product
level	O
increased	O
in	O
both	O
cytosol	O
and	O
nucleus	O
,	O
and	O
endogenous	O
GR	B-Gene_or_gene_product
was	O
also	O
elevated	O
by	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3eta	I-Gene_or_gene_product
in	O
HeLa	O
cells	O
.	O

14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3eta	I-Gene_or_gene_product
Inhibited	O
ligand	O
-	O
induced	O
down	O
-	O
regulation	O
of	O
GR	B-Gene_or_gene_product
.	O

Proteasomal	O
inhibition	O
did	O
not	O
induce	O
any	O
synergistic	O
effect	O
on	O
the	O
14	O
-	O
3	O
-	O
3eta	O
-	O
induced	O
increase	O
in	O
GR	O
in	O
response	O
to	O
glucocorticoid	O
,	O
and	O
inhibition	O
of	O
translation	O
did	O
not	O
block	O
elevation	O
of	O
GR	O
by	O
14	O
-	O
3	O
-	O
3eta	O
,	O
indicating	O
that	O
14	O
-	O
3	O
-	O
3eta	O
induces	O
stabilization	O
of	O
GR	O
.	O

These	O
results	O
suggest	O
that	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3eta	I-Gene_or_gene_product
functions	O
as	O
a	O
positive	O
regulator	O
in	O
the	O
glucocorticoid	O
signal	O
pathway	O
by	O
blocking	O
the	O
degradation	O
of	O
GR	B-Gene_or_gene_product
and	O
inducing	O
an	O
elevation	O
of	O
GR	B-Gene_or_gene_product
,	O
thus	O
enhancing	O
the	O
transcriptional	O
activity	O
of	O
GR	B-Gene_or_gene_product
.	O

Transcriptional	O
repression	O
by	O
a	O
novel	O
member	O
of	O
the	O
bZIP	O
family	O
of	O
transcription	O
factors	O
.	O

We	O
describe	O
here	O
a	O
novel	O
member	O
of	O
the	O
bZIP	O
family	O
of	O
DNA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
designated	O
E4BP4	O
,	O
that	O
displays	O
an	O
unusual	O
DNA	O
-	O
binding	O
specificity	O
which	O
overlaps	O
that	O
of	O
the	O
activating	O
transcription	O
factor	O
family	O
of	O
factors	O
.	O

When	O
expressed	O
in	O
a	O
transient	O
transfection	O
assay	O
with	O
a	O
suitable	O
reporter	O
plasmid	O
,	O
E4BP4	O
strongly	O
repressed	O
transcription	O
in	O
a	O
DNA	O
-	O
binding	O
-	O
site	O
-	O
dependent	O
manner	O
.	O

Examination	O
of	O
a	O
series	O
of	O
deletion	O
mutants	O
revealed	O
that	O
sequences	O
responsible	O
for	O
the	O
repressing	O
potential	O
of	O
E4BP4	O
lie	O
within	O
the	O
carboxyl	O
-	O
terminal	O
region	O
of	O
the	O
protein	B-Gene_or_gene_product
.	O

No	O
similarity	O
was	O
found	O
between	O
this	O
region	O
and	O
the	O
repressing	O
domains	O
of	O
other	O
known	O
eukaryotic	O
transcriptional	O
repressors	O
.	O

Subunit	O
of	O
an	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
interferon	I-Gene_or_gene_product
-	O
responsive	O
transcription	O
factor	O
is	O
related	O
to	O
interferon	B-Gene_or_gene_product
regulatory	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
and	O
Myb	B-Gene_or_gene_product
families	I-Gene_or_gene_product
of	I-Gene_or_gene_product
DNA	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Alpha	B-Gene_or_gene_product
interferon	I-Gene_or_gene_product
stimulates	O
transcription	O
by	O
converting	O
the	O
positive	O
transcriptional	O
regulator	O
ISGF3	O
from	O
a	O
latent	O
to	O
an	O
active	O
form	O
.	O

This	O
receptor	B-Gene_or_gene_product
-	O
mediated	O
event	O
occurs	O
in	O
the	O
cytoplasm	O
,	O
with	O
subsequent	O
translocation	O
of	O
the	O
activated	O
factor	B-Gene_or_gene_product
to	O
the	O
nucleus	O
.	O

ISGF3	O
has	O
two	O
components	O
,	O
termed	O
ISGF3	O
alpha	O
and	O
ISGF3	O
gamma	O
.	O

ISGF3	O
gamma	O
serves	O
as	O
the	O
DNA	O
recognition	O
subunit	O
,	O
while	O
ISGF3	O
alpha	O
,	O
which	O
appears	O
to	O
consist	O
of	O
three	O
polypeptides	O
,	O
is	O
a	O
target	O
for	O
alpha	B-Gene_or_gene_product
interferon	I-Gene_or_gene_product
signaling	O
and	O
serves	O
as	O
a	O
regulatory	O
component	O
whose	O
activation	O
is	O
required	O
to	O
form	O
ISGF3	O
.	O

ISGF3	O
gamma	O
DNA	O
-	O
binding	O
activity	O
was	O
identified	O
as	O
a	O
48	O
-	O
kDa	O
polypeptide	O
,	O
and	O
partial	O
amino	O
acid	O
sequence	O
has	O
allowed	O
isolation	O
of	O
cDNA	O
clones	O
.	O

ISGF3	O
gamma	O
translated	O
in	O
vitro	O
from	O
recombinant	O
clones	O
bound	O
DNA	O
with	O
a	O
specificity	O
indistinguishable	O
from	O
that	O
of	O
ISGF3	O
gamma	O
purified	O
from	O
HeLa	O
cells	O
.	O

Sequencing	O
of	O
ISGF3	O
gamma	O
cDNA	O
clones	O
revealed	O
significant	O
similarity	O
to	O
the	O
interferon	O
regulatory	O
factor	O
(	O
IRF	B-Gene_or_gene_product
)	O
family	O
of	O
DNA	B-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
in	O
the	O
amino	O
-	O
terminal	O
117	O
residues	O
of	O
ISGF3	O
gamma	O
.	O

The	O
other	O
IRF	B-Gene_or_gene_product
family	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
bind	O
DNA	O
with	O
a	O
specificity	O
related	O
to	O
but	O
distinct	O
from	O
that	O
of	O
ISGF3	O
gamma	O
.	O

We	O
note	O
sequence	O
similarities	O
between	O
the	O
related	O
regions	O
of	O
IRF	B-Gene_or_gene_product
family	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
and	O
the	O
imperfect	O
tryptophan	O
repeats	O
which	O
constitute	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myb	I-Gene_or_gene_product
oncoprotein	I-Gene_or_gene_product
.	O

These	O
sequence	O
similarities	O
suggest	O
that	O
ISGF3	O
gamma	O
and	O
IRF	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
and	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myb	I-Gene_or_gene_product
oncoprotein	I-Gene_or_gene_product
use	O
a	O
common	O
structural	O
motif	O
for	O
DNA	O
recognition	O
.	O

Recombinant	O
ISGF3	O
gamma	O
,	O
like	O
the	O
natural	O
protein	O
,	O
interacted	O
with	O
HeLa	O
cell	O
ISGF3	O
alpha	O
to	O
form	O
the	O
mature	O
ISGF3	O
DNA	O
-	O
binding	O
complex	O
.	O

We	O
suggest	O
that	O
other	O
IRF	B-Gene_or_gene_product
family	I-Gene_or_gene_product
members	O
may	O
participate	O
in	O
signaling	O
pathways	O
by	O
interacting	O
with	O
as	O
yet	O
unidentified	O
regulatory	O
subunits	O
analogous	O
to	O
ISGF3	O
alpha	O
.	O

Expression	O
of	O
the	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
proto	I-Gene_or_gene_product
-	I-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
suppresses	O
p53	B-Gene_or_gene_product
activation	O
.	O

While	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
expression	O
in	O
cancer	O
was	O
originally	O
thought	O
to	O
be	O
limited	O
to	O
B	O
-	O
cell	O
lymphomas	O
with	O
a	O
14	O
;	O
19	O
chromosomal	O
translocation	O
,	O
more	O
recent	O
evidence	O
indicates	O
that	O
expression	O
of	O
this	O
presumptive	O
oncoprotein	B-Gene_or_gene_product
is	O
significantly	O
more	O
widespread	O
in	O
cancer	O
.	O

However	O
,	O
an	O
oncogenic	O
role	O
for	O
Bcl	O
-	O
3	O
has	O
not	O
been	O
clearly	O
identified	O
.	O

Experiments	O
presented	O
here	O
indicate	O
that	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
is	O
inducible	O
by	O
DNA	O
damage	O
and	O
is	O
required	O
for	O
the	O
induction	O
of	O
Hdm2	B-Gene_or_gene_product
gene	O
expression	O
and	O
the	O
suppression	O
of	O
persistent	O
p53	B-Gene_or_gene_product
activity	O
.	O

Furthermore	O
,	O
constitutive	O
expression	O
of	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
suppresses	O
DNA	O
damage	O
-	O
induced	O
p53	B-Gene_or_gene_product
activation	O
and	O
inhibits	O
p53	B-Gene_or_gene_product
-	O
induced	O
apoptosis	O
through	O
a	O
mechanism	O
that	O
is	O
at	O
least	O
partly	O
dependent	O
on	O
the	O
up	O
-	O
regulation	O
of	O
Hdm2	B-Gene_or_gene_product
.	O

The	O
results	O
provide	O
insight	O
into	O
a	O
mechanism	O
whereby	O
altered	O
expression	O
of	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
leads	O
to	O
tumorigenic	O
potential	O
.	O

Since	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
is	O
required	O
for	O
germinal	O
center	O
formation	O
,	O
these	O
results	O
suggest	O
functional	O
similarities	O
with	O
the	O
unrelated	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
oncoprotein	I-Gene_or_gene_product
in	O
suppressing	O
potential	O
p53	B-Gene_or_gene_product
-	O
dependent	O
cell	O
cycle	O
arrest	O
and	O
apoptosis	O
in	O
response	O
to	O
somatic	O
hypermutation	O
and	O
class	O
switch	O
recombination	O
.	O

Clone	O
pAT	O
133	O
identifies	O
a	O
gene	B-Gene_or_gene_product
that	O
encodes	O
another	O
human	O
member	B-Gene_or_gene_product
of	I-Gene_or_gene_product
a	I-Gene_or_gene_product
class	I-Gene_or_gene_product
of	I-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
induced	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
with	O
almost	O
identical	O
zinc	O
-	O
finger	O
domains	O
.	O

We	O
report	O
the	O
structure	O
and	O
regulation	O
of	O
a	O
gene	B-Gene_or_gene_product
represented	O
by	O
clone	O
pAT	O
133	O
,	O
which	O
is	O
induced	O
upon	O
transition	O
from	O
a	O
resting	O
state	O
(	O
G0	O
)	O
through	O
the	O
early	O
phase	O
of	O
the	O
cell	O
cycle	O
(	O
G1	O
)	O
.	O

The	O
pAT	O
133	O
gene	B-Gene_or_gene_product
is	O
immediately	O
induced	O
,	O
with	O
FOS	O
-	O
like	O
kinetics	O
,	O
in	O
human	O
T	O
cells	O
and	O
in	O
fibroblasts	O
.	O

Primary	O
structure	O
analysis	O
showed	O
that	O
the	B-Gene_or_gene_product
encoded	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
contains	O
three	O
tandem	O
zinc	O
-	O
finger	O
sequences	O
of	O
the	O
type	O
Cys2	O
-	O
Xaa12	O
-	O
His2	O
.	O

This	O
zinc	O
-	O
finger	O
region	O
,	O
which	O
is	O
thought	O
to	O
bind	O
DNA	O
in	O
a	O
sequence	O
-	O
specific	O
manner	O
,	O
is	O
similar	O
(	O
greater	O
than	O
80	O
%	O
on	O
the	O
amino	O
acid	O
level	O
)	O
to	O
two	O
previously	O
described	O
transcription	O
factors	O
pAT	O
225	O
/	O
EGR1	O
and	O
pAT	O
591	O
/	O
EGR2	O
.	O

Except	O
for	O
the	O
conserved	O
zinc	O
-	O
finger	O
domains	O
,	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
three	O
proteins	O
are	O
distinct	O
.	O

This	O
structural	O
similarity	O
suggests	O
that	O
the	O
pAT	O
133	O
gene	O
encodes	O
a	O
transcription	O
factor	O
with	O
a	O
specific	O
biological	O
function	O
.	O

Comparing	O
the	O
regulation	O
of	O
these	B-Gene_or_gene_product
related	I-Gene_or_gene_product
zinc	I-Gene_or_gene_product
-	I-Gene_or_gene_product
finger	I-Gene_or_gene_product
-	I-Gene_or_gene_product
encoding	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
showed	O
coordinate	O
induction	O
upon	O
mitogenic	O
stimulation	O
of	O
resting	O
T	O
lymphocytes	O
and	O
of	O
resting	O
fibroblasts	O
.	O

However	O
,	O
upon	O
transition	O
from	O
a	O
proliferating	O
(	O
G1	O
)	O
to	O
a	O
resting	O
state	O
of	O
the	O
cell	O
cycle	O
the	B-Gene_or_gene_product
three	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
were	O
differently	O
regulated	O
.	O

In	O
human	O
histiocytic	O
U937	O
cells	O
mRNA	O
of	O
clone	O
pAT	O
133	O
was	O
constitutively	O
expressed	O
,	O
whereas	O
mRNA	O
of	O
pAT	O
225	O
/	O
EGR1	O
was	O
induced	O
upon	O
induction	O
of	O
terminal	O
differentiation	O
.	O

In	O
contrast	O
mRNA	O
representing	O
pAT	O
591	O
/	O
EGR2	O
was	O
not	O
expressed	O
in	O
these	O
cells	O
.	O

This	O
difference	O
in	O
gene	O
regulation	O
suggests	O
distinct	O
biological	O
roles	O
in	O
the	O
control	O
of	O
cell	O
proliferation	O
for	O
the	B-Gene_or_gene_product
respective	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

A	O
conserved	O
MST	O
-	O
FOXO	O
signaling	O
pathway	O
mediates	O
oxidative	O
-	O
stress	O
responses	O
and	O
extends	O
life	O
span	O
.	O

Oxidative	O
stress	O
influences	O
cell	O
survival	O
and	O
homeostasis	O
,	O
but	O
the	O
mechanisms	O
underlying	O
the	O
biological	O
effects	O
of	O
oxidative	O
stress	O
remain	O
to	O
be	O
elucidated	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
the	O
protein	O
kinase	O
MST1	O
mediates	O
oxidative	O
-	O
stress	O
-	O
induced	O
cell	O
death	O
in	O
primary	O
mammalian	O
neurons	O
by	O
directly	O
activating	O
the	O
FOXO	O
transcription	O
factors	O
.	O

MST1	O
phosphorylates	O
FOXO	O
proteins	O
at	O
a	O
conserved	O
site	O
within	O
the	O
forkhead	O
domain	O
that	O
disrupts	O
their	O
interaction	O
with	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
promotes	O
FOXO	O
nuclear	O
translocation	O
,	O
and	O
thereby	O
induces	O
cell	O
death	O
in	O
neurons	O
.	O

We	O
also	O
extend	O
the	O
MST	O
-	O
FOXO	O
signaling	O
link	O
to	O
nematodes	O
.	O

Knockdown	O
of	O
the	O
C	O
.	O
elegans	O
MST1	O
ortholog	O
CST	O
-	O
1	O
shortens	O
life	O
span	O
and	O
accelerates	O
tissue	O
aging	O
,	O
while	O
overexpression	O
of	O
cst	O
-	O
1	O
promotes	O
life	O
span	O
and	O
delays	O
aging	O
.	O

The	O
cst	O
-	O
1	O
-	O
induced	O
life	O
-	O
span	O
extension	O
occurs	O
in	O
a	O
daf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
16	I-Gene_or_gene_product
-	O
dependent	O
manner	O
.	O

The	O
identification	O
of	O
the	O
FOXO	O
transcription	O
factors	O
as	O
major	O
and	O
evolutionarily	O
conserved	O
targets	O
of	O
MST1	O
suggests	O
that	O
MST	O
kinases	O
play	O
important	O
roles	O
in	O
diverse	O
biological	O
processes	O
including	O
cellular	O
responses	O
to	O
oxidative	O
stress	O
and	O
longevity	O
.	O

Identification	O
of	O
human	O
tRNA	O
:	O
m5C	O
methyltransferase	O
catalysing	O
intron	O
-	O
dependent	O
m5C	O
formation	O
in	O
the	O
first	O
position	O
of	O
the	O
anticodon	O
of	O
the	O
pre	O
-	O
tRNA	O
Leu	O
(	O
CAA	O
)	O
.	O

We	O
identified	O
a	O
human	O
orthologue	O
of	O
tRNA	O
:	O
m5C	O
methyltransferase	O
from	O
Saccharomyces	O
cerevisiae	O
,	O
which	O
has	O
been	O
previously	O
shown	O
to	O
catalyse	O
the	O
specific	O
modification	O
of	O
C34	O
in	O
the	O
intron	O
-	O
containing	O
yeast	O
pre	O
-	O
tRNA	O
Leu	O
(	O
CAA	O
)	O
.	O

Using	O
transcripts	O
of	O
intron	O
-	O
less	O
and	O
intron	O
-	O
containing	O
human	O
pre	O
-	O
tRNA	O
Leu	B-Gene_or_gene_product
(	I-Gene_or_gene_product
CAA	I-Gene_or_gene_product
)	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
as	O
substrates	O
,	O
we	O
have	O
shown	O
that	O
m5C34	O
is	O
introduced	O
only	O
in	O
the	O
intron	O
-	O
containing	O
tRNA	O
precursors	O
when	O
the	O
substrates	O
were	O
incubated	O
in	O
the	O
HeLa	O
extract	O
.	O

m5C34	O
formation	O
depends	O
on	O
the	O
nucleotide	O
sequence	O
surrounding	O
the	O
wobble	O
cytidine	O
and	O
on	O
the	O
structure	O
of	O
the	O
prolongated	O
anticodon	O
stem	O
.	O

Expression	O
of	O
the	O
human	O
Trm4	O
(	O
hTrm4	B-Gene_or_gene_product
)	O
cDNA	O
in	O
yeast	O
partially	O
complements	O
the	O
lack	O
of	O
the	O
endogenous	O
Trm4p	O
enzyme	O
.	O

The	O
yeast	O
extract	O
prepared	O
from	O
the	O
strain	O
deprived	O
of	O
the	O
endogenous	O
TRM4	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
and	O
transformed	O
with	O
hTrm4	B-Gene_or_gene_product
cDNA	O
exhibits	O
the	O
same	O
activity	O
and	O
substrate	O
specificity	O
toward	O
human	O
pre	O
-	O
tRNALeu	O
transcripts	O
as	O
the	O
HeLa	O
extract	O
.	O

The	O
hTrm4	O
MTase	O
has	O
a	O
much	O
narrower	O
specificity	O
against	O
the	O
yeast	O
substrates	O
than	O
its	O
yeast	O
orthologue	O
:	O
human	O
enzyme	O
is	O
not	O
able	O
to	O
form	O
m5C	O
at	O
positions	O
48	O
and	O
49	O
of	O
human	O
and	O
yeast	O
tRNA	O
precursors	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
showing	O
intron	O
-	O
dependent	O
methylation	O
of	O
humanpre	O
-	O
tRNA	O
Leu	O
(	O
CAA	O
)	O
and	O
identification	O
of	O
human	O
gene	B-Gene_or_gene_product
encoding	O
tRNA	O
methylase	O
responsible	O
for	O
this	O
reaction	O
.	O

A	O
human	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
fetoprotein	I-Gene_or_gene_product
enhancer	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
ATBF1	B-Gene_or_gene_product
,	O
contains	O
four	O
homeodomains	O
and	O
seventeen	O
zinc	O
fingers	O
.	O

We	O
have	O
isolated	O
a	O
full	O
-	O
length	O
cDNA	O
encoding	O
a	O
protein	B-Gene_or_gene_product
(	O
ATBF1	B-Gene_or_gene_product
)	O
that	O
binds	O
to	O
an	O
AT	O
-	O
rich	O
motif	O
in	O
the	O
human	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
fetoprotein	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
enhancer	O
.	O

The	O
amino	O
acid	O
sequence	O
deduced	O
from	O
the	O
cDNA	O
revealed	O
that	O
this	O
is	O
the	O
largest	O
DNA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
306	O
kDa	O
)	O
known	O
to	O
date	O
,	O
containing	O
four	O
homeodomains	O
,	O
17	O
zinc	O
finger	O
motifs	O
,	O
and	O
a	O
number	O
of	O
segments	O
potentially	O
involved	O
in	O
transcriptional	O
regulation	O
.	O

Although	O
the	O
exact	O
function	O
of	O
this	O
protein	O
has	O
not	O
been	O
determined	O
,	O
these	O
structural	O
features	O
suggest	O
that	O
ATBF1	B-Gene_or_gene_product
plays	O
a	O
transcriptional	O
regulatory	O
role	O
.	O

Identification	O
,	O
molecular	O
cloning	O
,	O
and	O
characterization	O
of	O
the	O
sixth	O
subunit	O
of	O
human	O
transcription	O
factor	O
TFIIIC	O
.	O

TFIIIC	O
in	O
yeast	O
and	O
humans	O
is	O
required	O
for	O
transcription	O
of	O
tRNA	O
and	O
5	O
S	O
RNA	O
genes	B-Gene_or_gene_product
by	O
RNA	O
polymerase	O
III	O
.	O

In	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
,	O
TFIIIC	O
is	O
composed	O
of	O
six	O
subunits	O
,	O
five	O
of	O
which	O
are	O
conserved	O
in	O
humans	O
.	O

We	O
report	O
the	O
identification	O
,	O
molecular	O
cloning	O
,	O
and	O
characterization	O
of	O
the	O
sixth	O
subunit	O
of	O
human	O
TFIIIC	O
,	O
TFIIIC35	O
,	O
which	O
is	O
related	O
to	O
the	O
smallest	O
subunit	O
of	O
yeast	O
TFIIIC	O
.	O

Human	O
TFIIIC35	O
does	O
not	O
contain	O
the	O
phosphoglycerate	O
mutase	O
domain	O
of	O
its	O
yeast	O
counterpart	O
,	O
and	O
these	O
two	O
proteins	B-Gene_or_gene_product
display	O
only	O
limited	O
homology	O
within	O
a	O
34	O
-	O
amino	O
acid	O
domain	O
.	O

Homologs	O
of	O
the	O
sixth	O
TFIIIC	O
subunit	O
are	O
also	O
identified	O
in	O
other	O
eukaryotes	O
,	O
and	O
their	O
phylogenic	O
evolution	O
is	O
analyzed	O
.	O

Affinity	O
-	O
purified	O
human	O
TFIIIC	O
from	O
an	O
epitope	O
-	O
tagged	O
TFIIIC35	O
cell	O
line	O
is	O
active	O
in	O
binding	O
to	O
and	O
in	O
transcription	O
of	O
the	O
VA1	B-Gene_or_gene_product
gene	B-Gene_or_gene_product
in	O
vitro	O
.	O

Furthermore	O
,	O
TFIIIC35	O
specifically	O
interacts	O
with	O
the	O
human	O
TFIIIC	O
subunits	O
TFIIIC63	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
TFIIIC90	O
in	O
vitro	O
.	O

Finally	O
,	O
we	O
determined	O
a	O
limited	O
region	O
in	O
the	O
smallest	O
subunit	O
of	O
yeast	O
TFIIIC	O
that	O
is	O
sufficient	O
for	O
interacting	O
with	O
the	O
yeast	O
TFIIIC	O
subunit	O
ScTfc1	O
(	O
orthologous	O
to	O
TFIIIC63	O
)	O
and	O
found	O
it	O
to	O
be	O
adjacent	O
to	O
and	O
overlap	O
the	O
34	O
-	O
amino	O
acid	O
domain	O
that	O
is	O
conserved	O
from	O
yeast	O
to	O
humans	O
.	O

B	O
cell	O
lymphoma	O
-	O
associated	O
chromosomal	O
translocation	O
involves	O
candidate	O
oncogene	B-Gene_or_gene_product
lyt	I-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
,	O
homologous	O
to	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
p50	I-Gene_or_gene_product
.	O

A	O
B	O
cell	O
lymphoma	O
-	O
associated	O
chromosomal	O
translocation	O
,	O
t	O
(	O
10	O
;	O
14	O
)	O
(	O
q24	O
;	O
q32	O
)	O
,	O
juxtaposes	O
the	O
immunoglobulin	O
C	O
alpha	O
1	O
locus	O
to	O
a	O
novel	O
gene	B-Gene_or_gene_product
,	O
lyt	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
.	O

The	O
normal	O
lyt	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
cDNA	O
codes	O
for	O
a	O
98	O
kd	O
protein	B-Gene_or_gene_product
which	O
displays	O
amino	O
-	O
terminal	O
homology	O
with	O
the	O
rel	O
(	O
DNA	O
-	O
binding	O
)	O
domain	O
of	O
the	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
-	I-Gene_or_gene_product
rel	I-Gene_or_gene_product
family	I-Gene_or_gene_product
of	O
transcription	O
factors	O
and	O
carboxy	O
-	O
terminal	O
homology	O
with	O
the	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
p50	I-Gene_or_gene_product
precursor	O
protein	B-Gene_or_gene_product
,	O
including	O
the	O
putative	O
proteolytic	O
cleavage	O
domain	O
(	O
poly	O
-	O
G	O
)	O
and	O
the	O
ankyrin	O
-	O
like	O
repeat	O
domains	O
.	O

The	O
lyt	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
can	O
bind	O
to	O
kappa	O
B	O
sequences	O
in	O
vitro	O
,	O
although	O
with	O
different	O
specificity	O
from	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
p50	I-Gene_or_gene_product
,	O
and	O
in	O
vitro	O
DNA	O
-	O
binding	O
is	O
activated	O
by	O
removal	O
of	O
the	O
ankyrin	O
domain	O
.	O

Chromosomal	O
translocation	O
generates	O
an	O
lyt	O
-	O
10	O
-	O
C	O
alpha	O
1	O
fusion	O
gene	O
coding	O
for	O
a	O
protein	B-Gene_or_gene_product
that	O
retains	O
the	O
rel	O
effector	O
domain	O
,	O
lacks	O
the	O
ankyrin	O
regulatory	O
domain	O
,	O
and	O
binds	O
kappa	O
B	O
sequences	O
in	O
vitro	O
,	O
suggesting	O
its	O
constitutive	O
activation	O
in	O
vivo	O
.	O

Analogous	O
rearrangements	O
of	O
the	O
lyt	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
have	O
been	O
found	O
in	O
an	O
additional	O
three	O
cases	O
of	O
lymphoid	O
neoplasia	O
.	O

The	O
lyt	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
defines	O
a	O
new	O
subfamily	O
(	O
rel	B-Gene_or_gene_product
/	I-Gene_or_gene_product
poly	I-Gene_or_gene_product
-	I-Gene_or_gene_product
G	I-Gene_or_gene_product
/	I-Gene_or_gene_product
ankyrin	I-Gene_or_gene_product
)	O
of	O
NF	O
-	O
kappa	O
B	O
-	O
rel	O
transcription	O
factors	O
with	O
potential	O
for	O
oncogenic	O
activation	O
in	O
human	O
cancer	O
.	O

Characterization	O
of	O
a	O
cofactor	B-Gene_or_gene_product
that	O
regulates	O
dimerization	O
of	O
a	O
mammalian	O
homeodomain	O
protein	B-Gene_or_gene_product
.	O

Dimerization	O
among	O
transcription	O
factors	O
has	O
become	O
a	O
recurrent	O
theme	O
in	O
the	O
regulation	O
of	O
eukaryotic	O
gene	O
expression	O
.	O

Hepatocyte	O
nuclear	O
factor	O
-	O
1	O
alpha	O
(	O
HNF	O
-	O
1	O
alpha	O
)	O
is	O
a	O
homeodomain	O
-	O
containing	O
protein	B-Gene_or_gene_product
that	O
functions	O
as	O
a	O
dimer	O
.	O

A	O
dimerization	O
cofactor	O
of	O
HNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
(	O
DCoH	B-Gene_or_gene_product
)	O
was	O
identified	O
that	O
displayed	O
a	O
restricted	O
tissue	O
distribution	O
and	O
did	O
not	O
bind	O
to	O
DNA	O
,	O
but	O
,	O
rather	O
,	O
selectively	O
stabilized	O
HNF	O
-	O
1	O
alpha	O
dimers	O
.	O

The	O
formation	O
of	O
a	O
stable	O
tetrameric	O
DCoH	B-Gene_or_gene_product
-	O
HNF	O
-	O
1	O
alpha	O
complex	O
,	O
which	O
required	O
the	O
dimerization	O
domain	O
of	O
HNF	O
-	O
1	O
alpha	O
,	O
did	O
not	O
change	O
the	O
DNA	O
binding	O
characteristics	O
of	O
HNF	O
-	O
1	O
alpha	O
,	O
but	O
enhanced	O
its	O
transcriptional	O
activity	O
.	O

However	O
,	O
DCoH	O
did	O
not	O
confer	O
transcriptional	O
activation	O
to	O
the	O
GAL4	O
DNA	O
binding	O
domain	O
.	O

These	O
results	O
indicate	O
that	O
DCoH	B-Gene_or_gene_product
regulates	O
formation	O
of	O
transcriptionally	O
active	O
tetrameric	O
complexes	O
and	O
may	O
contribute	O
to	O
the	O
developmental	O
specificity	O
of	O
the	O
complex	O
.	O

The	O
DNA	B-Gene_or_gene_product
binding	I-Gene_or_gene_product
parvulin	I-Gene_or_gene_product
Par17	B-Gene_or_gene_product
is	O
targeted	O
to	O
the	O
mitochondrial	O
matrix	O
by	O
a	O
recently	O
evolved	O
prepeptide	O
uniquely	O
present	O
in	O
Hominidae	O
.	O

The	O
parvulin	B-Gene_or_gene_product
-	O
type	O
peptidyl	O
prolyl	O
cis	O
/	O
trans	O
isomerase	O
Par14	O
is	O
highly	O
conserved	O
in	O
all	O
metazoans	O
.	O

The	O
recently	O
identified	O
parvulin	B-Gene_or_gene_product
Par17	B-Gene_or_gene_product
contains	O
an	O
additional	O
N	O
-	O
terminal	O
domain	O
whose	O
occurrence	O
and	O
function	O
was	O
the	O
focus	O
of	O
the	O
present	O
study	O
.	O

Based	O
on	O
the	O
observation	O
that	O
the	O
human	O
genome	O
encodes	O
Par17	B-Gene_or_gene_product
,	O
but	O
bovine	O
and	O
rodent	O
genomes	O
do	O
not	O
,	O
Par17	B-Gene_or_gene_product
exon	O
sequences	O
from	O
10	O
different	O
primate	O
species	O
were	O
cloned	O
and	O
sequenced	O
.	O

Par17	B-Gene_or_gene_product
is	O
encoded	O
in	O
the	O
genomes	O
of	O
Hominidae	O
species	O
including	O
humans	O
,	O
but	O
is	O
absent	O
from	O
other	O
mammalian	O
species	O
.	O

In	O
contrast	O
to	O
Par14	O
,	O
endogenous	O
Par17	B-Gene_or_gene_product
was	O
found	O
in	O
mitochondrial	O
and	O
membrane	O
fractions	O
of	O
human	O
cell	O
lysates	O
.	O

Fluorescence	O
of	O
EGFP	O
fusions	O
of	O
Par17	B-Gene_or_gene_product
,	O
but	O
not	O
Par14	O
,	O
co	O
-	O
localized	O
with	O
mitochondrial	O
staining	O
.	O

Par14	O
and	O
Par17	B-Gene_or_gene_product
associated	O
with	O
isolated	O
human	O
,	O
rat	O
and	O
yeast	O
mitochondria	O
at	O
low	O
salt	O
concentrations	O
,	O
but	O
only	O
the	O
Par17	B-Gene_or_gene_product
mitochondrial	O
association	O
was	O
resistant	O
to	O
higher	O
salt	O
concentrations	O
.	O

Par17	B-Gene_or_gene_product
was	O
imported	O
into	O
mitochondria	O
in	O
a	O
time	O
and	O
membrane	O
potential	O
-	O
dependent	O
manner	O
,	O
where	O
it	O
reached	O
the	O
mitochondrial	O
matrix	O
.	O

Moreover	O
,	O
Par17	B-Gene_or_gene_product
was	O
shown	O
to	O
bind	O
to	O
double	O
-	O
stranded	O
DNA	O
under	O
physiological	O
salt	O
conditions	O
.	O

Taken	O
together	O
,	O
the	O
DNA	B-Gene_or_gene_product
binding	I-Gene_or_gene_product
parvulin	I-Gene_or_gene_product
Par17	B-Gene_or_gene_product
is	O
targeted	O
to	O
the	O
mitochondrial	O
matrix	O
by	O
the	O
most	O
recently	O
evolved	O
mitochondrial	O
prepeptide	O
known	O
to	O
date	O
,	O
thus	O
adding	O
a	O
novel	O
protein	B-Gene_or_gene_product
constituent	O
to	O
the	O
mitochondrial	O
proteome	O
of	O
Hominidae	O
.	O

Human	O
MyoD	B-Gene_or_gene_product
:	O
cDNA	O
and	O
deduced	O
amino	O
acid	O
sequence	O
.	O

Structure	O
and	O
function	O
of	O
human	O
jun	B-Gene_or_gene_product
-	I-Gene_or_gene_product
D	I-Gene_or_gene_product
.	O

A	O
jun	O
related	O
cDNA	O
and	O
its	O
corresponding	O
genomic	O
fragment	O
were	O
cloned	O
from	O
human	O
cells	O
and	O
sequenced	O
.	O

Polymerase	O
chain	O
reaction	O
analysis	O
showed	O
that	O
this	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
the	O
human	O
homologue	O
of	O
the	O
mouse	O
jun	B-Gene_or_gene_product
-	I-Gene_or_gene_product
D	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
despite	O
the	O
fact	O
that	O
the	O
degree	O
of	O
amino	O
acid	O
sequence	O
conservation	O
between	O
the	O
two	O
is	O
much	O
poorer	O
(	O
77	O
.	O
3	O
%	O
)	O
than	O
that	O
found	O
between	O
the	O
homologues	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
jun	I-Gene_or_gene_product
and	O
jun	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	O
95	O
-	O
98	O
%	O
)	O
.	O

The	O
product	B-Gene_or_gene_product
of	O
this	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
binds	O
an	O
AP	O
-	O
1	O
site	O
and	O
upon	O
cotransfection	O
stimulates	O
the	O
activity	O
of	O
a	O
promoter	O
that	O
bears	O
an	O
AP	O
-	O
1	O
site	O
.	O

The	O
level	O
of	O
activation	O
is	O
comparable	O
to	O
that	O
of	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
jun	I-Gene_or_gene_product
and	O
the	O
activity	O
of	O
both	O
is	O
further	O
stimulated	O
by	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
fos	I-Gene_or_gene_product
.	O

Deletion	O
mutants	O
of	O
the	O
gene	O
that	O
lack	O
the	O
best	O
conserved	O
region	O
in	O
the	O
activating	O
domain	O
are	O
poorly	O
active	O
.	O

However	O
,	O
our	O
data	O
suggest	O
that	O
the	O
activating	O
domain	O
is	O
not	O
confined	O
exclusively	O
to	O
the	O
conserved	O
regions	O
.	O

Interestingly	O
,	O
at	O
high	O
concentrations	O
human	O
jun	B-Gene_or_gene_product
-	I-Gene_or_gene_product
D	I-Gene_or_gene_product
displays	O
decreased	O
activity	O
which	O
cannot	O
be	O
explained	O
by	O
a	O
simple	O
self	O
squelching	O
model	O
.	O

Localization	O
of	O
the	O
gene	B-Gene_or_gene_product
for	O
the	O
DNA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
AP	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
to	O
human	O
chromosome	O
6p22	O
.	O
3	O
-	O
pter	O
.	O

A	O
variety	O
of	O
cellular	O
proteins	B-Gene_or_gene_product
bind	O
to	O
cellular	O
and	O
viral	O
enhancer	O
elements	O
.	O

One	O
such	O
factor	O
,	O
known	O
as	O
AP	O
-	O
2	O
,	O
is	O
a	O
52	O
-	O
kDa	O
transcription	O
factor	O
identified	O
by	O
its	O
interaction	O
with	O
the	O
SV40	O
and	O
metallothionein	B-Gene_or_gene_product
enhancers	O
.	O

In	O
addition	O
,	O
it	O
has	O
been	O
found	O
that	O
AP	O
-	O
2	O
binds	O
to	O
the	O
SV40	O
T	B-Gene_or_gene_product
-	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
.	O

AP	O
-	O
2	O
activity	O
is	O
mediated	O
by	O
both	O
the	O
state	O
of	O
cellular	O
differentiation	O
and	O
changes	O
in	O
signal	O
transduction	O
pathways	O
,	O
suggesting	O
a	O
potential	O
role	O
of	O
AP	O
-	O
2	O
in	O
the	O
regulation	O
of	O
diverse	O
cellular	O
processes	O
.	O

As	O
part	O
of	O
an	O
effort	O
to	O
examine	O
the	O
chromosomal	O
organization	O
of	O
cellular	O
genes	B-Gene_or_gene_product
encoding	O
transcription	O
factors	O
,	O
we	O
report	O
the	O
mapping	O
of	O
the	O
gene	B-Gene_or_gene_product
encoding	O
AP	O
-	O
2	O
to	O
human	O
chromosome	O
6p22	O
.	O
3	O
-	O
24	O
by	O
analysis	O
of	O
somatic	O
cell	O
hybrids	O
and	O
in	O
situ	O
hybridization	O
to	O
chromosomes	O
.	O

Isolation	O
of	O
a	O
candidate	O
repressor	O
/	O
activator	O
,	O
NF	O
-	O
E1	O
(	O
YY	O
-	O
1	O
,	O
delta	O
)	O
,	O
that	O
binds	O
to	O
the	O
immunoglobulin	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
3	O
'	O
enhancer	O
and	O
the	O
immunoglobulin	B-Gene_or_gene_product
heavy	I-Gene_or_gene_product
-	I-Gene_or_gene_product
chain	I-Gene_or_gene_product
mu	O
E1	O
site	O
.	O

We	O
have	O
determined	O
that	O
the	O
developmental	O
control	O
of	O
immunoglobulin	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
3	O
'	O
enhancer	O
(	O
kappa	O
E3	O
'	O
)	O
activity	O
is	O
the	O
result	O
of	O
the	O
combined	O
influence	O
of	O
positive	O
-	O
and	O
negative	O
-	O
acting	O
elements	O
.	O

We	O
show	O
that	O
a	O
central	O
core	O
in	O
the	O
kappa	O
E3	O
'	O
enhancer	O
is	O
active	O
at	O
the	O
pre	O
-	O
B	O
-	O
cell	O
stage	O
but	O
is	O
repressed	O
by	O
flanking	O
negative	O
-	O
acting	O
elements	O
.	O

The	O
negative	O
-	O
acting	O
sequences	O
repress	O
enhancer	O
activity	O
in	O
a	O
position	O
-	O
and	O
orientation	O
-	O
independent	O
manner	O
at	O
the	O
pre	O
-	O
B	O
-	O
cell	O
stage	O
.	O

We	O
have	O
isolated	O
a	O
human	O
cDNA	O
clone	O
encoding	O
a	O
zinc	O
finger	O
protein	O
(	O
NF	O
-	O
E1	O
)	O
that	O
binds	O
to	O
the	O
negative	O
-	O
acting	O
segment	O
of	O
the	O
kappa	O
E3	O
'	O
enhancer	O
.	O

This	O
protein	O
also	O
binds	O
to	O
the	O
immunoglobulin	B-Gene_or_gene_product
heavy	I-Gene_or_gene_product
-	I-Gene_or_gene_product
chain	I-Gene_or_gene_product
enhancer	O
mu	O
E1	O
site	O
.	O

NF	O
-	O
E1	O
is	O
encoded	O
by	O
the	O
same	O
gene	B-Gene_or_gene_product
as	O
the	O
YY	O
-	O
1	O
protein	O
,	O
which	O
binds	O
to	O
the	O
adeno	O
-	O
associated	O
virus	O
P5	O
promoter	O
.	O

NF	O
-	O
E1	O
is	O
also	O
the	O
human	O
homologue	O
of	O
the	O
mouse	O
delta	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
which	O
binds	O
to	O
ribosomal	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
gene	B-Gene_or_gene_product
promoters	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
this	O
protein	O
contains	O
features	O
characteristic	O
of	O
transcriptional	O
activators	O
as	O
well	O
as	O
transcriptional	O
repressors	O
.	O

Cotransfection	O
studies	O
with	O
this	O
cDNA	O
indicate	O
that	O
it	O
can	O
repress	O
basal	O
promoter	O
activity	O
.	O

The	O
apparent	O
dual	O
function	O
of	O
this	O
protein	O
is	O
discussed	O
.	O

Two	O
distinct	O
transcription	O
factors	O
that	O
bind	O
the	O
immunoglobulin	B-Gene_or_gene_product
enhancer	O
microE5	O
/	O
kappa	O
2	O
motif	O
.	O

Activity	O
of	O
the	O
immunoglobulin	B-Gene_or_gene_product
heavy	O
and	O
kappa	O
light	O
chain	O
gene	B-Gene_or_gene_product
enhancers	O
depends	O
on	O
a	O
complex	O
interplay	O
of	O
ubiquitous	O
and	O
developmentally	O
regulated	O
proteins	B-Gene_or_gene_product
.	O

Two	O
complementary	O
DNAs	O
were	O
isolated	O
that	O
encode	O
proteins	B-Gene_or_gene_product
,	O
denoted	O
ITF	O
-	O
1	O
and	O
ITF	O
-	O
2	O
,	O
that	O
are	O
expressed	O
in	O
a	O
variety	O
of	O
cell	O
types	O
and	O
bind	O
the	O
microE5	O
/	O
kappa	O
2	O
motif	O
found	O
in	O
both	O
heavy	O
and	O
kappa	O
light	O
chain	O
enhancers	O
.	O

The	O
complementary	O
DNAs	O
are	O
the	O
products	O
of	O
distinct	O
genes	B-Gene_or_gene_product
,	O
yet	O
both	O
ITF	O
-	O
1	O
and	O
ITF	O
-	O
2	O
are	O
structurally	O
and	O
functionally	O
similar	O
.	O

The	O
two	O
proteins	B-Gene_or_gene_product
interact	O
with	O
one	O
another	O
through	O
their	O
putative	O
helix	O
-	O
loop	O
-	O
helix	O
motifs	O
and	O
each	O
possesses	O
a	O
distinct	O
domain	O
that	O
dictates	O
transcription	O
activation	O
.	O

The	O
tal	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
undergoes	O
chromosome	O
translocation	O
in	O
T	O
cell	O
leukemia	O
and	O
potentially	O
encodes	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
protein	B-Gene_or_gene_product
.	O

We	O
have	O
analyzed	O
t	O
(	O
1	O
;	O
14	O
)	O
(	O
p32	O
;	O
q11	O
)	O
chromosome	O
translocations	O
from	O
two	O
patients	O
with	O
T	O
cell	O
acute	O
lymphocytic	O
leukemia	O
.	O

The	O
chromosome	O
1	O
breakpoints	O
of	O
these	O
patients	O
lie	O
within	O
a	O
kilobasepair	O
of	O
each	O
other	O
,	O
and	O
thus	O
define	O
a	O
genetic	O
locus	O
(	O
designated	O
tal	B-Gene_or_gene_product
)	O
involved	O
in	O
T	O
cell	O
oncogenesis	O
.	O

Moreover	O
,	O
we	O
have	O
identified	O
sequences	O
within	O
tal	B-Gene_or_gene_product
that	O
potentially	O
encode	O
an	O
amphipathic	O
helix	O
-	O
loop	O
-	O
helix	O
motif	O
,	O
a	O
DNA	O
-	O
binding	O
domain	O
found	O
in	O
a	O
variety	O
of	O
proteins	B-Gene_or_gene_product
that	O
control	O
cell	O
growth	O
and	O
differentiation	O
.	O

The	O
homology	O
domain	O
of	O
tal	B-Gene_or_gene_product
is	O
especially	O
related	O
to	O
that	O
of	O
lyl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
a	O
gene	B-Gene_or_gene_product
on	O
chromosome	O
19	O
that	O
has	O
also	O
been	O
implicated	O
in	O
T	O
cell	O
oncogenesis	O
.	O

Hence	O
,	O
tal	B-Gene_or_gene_product
and	O
lyl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
encode	O
a	O
distinct	O
family	O
of	O
helix	O
-	O
loop	O
-	O
helix	O
proteins	O
involved	O
in	O
the	O
malignant	O
development	O
of	O
lymphocytes	O
.	O

Nucleolar	O
transcription	O
factor	O
hUBF	O
contains	O
a	O
DNA	O
-	O
binding	O
motif	O
with	O
homology	O
to	O
HMG	O
proteins	O
.	O

The	O
eukaryotic	O
upstream	O
binding	O
factor	O
(	O
UBF	O
)	O
,	O
recognizes	O
the	O
ribosomal	O
RNA	O
gene	B-Gene_or_gene_product
promoter	O
and	O
activates	O
transcription	O
mediated	O
by	O
RNA	O
polymerase	O
I	O
through	O
cooperative	O
interactions	O
with	O
the	O
species	O
-	O
specific	O
factor	O
,	O
SL1	B-Gene_or_gene_product
.	O

Isolation	O
of	O
complementary	O
DNA	O
clones	O
and	O
sequence	O
analysis	O
reveals	O
similarities	O
between	O
DNA	O
binding	O
domains	O
of	O
human	O
UBF	O
(	O
hUBF	O
)	O
and	O
high	O
mobility	O
group	O
(	O
HMG	O
)	O
protein	O
1	O
.	O

Expression	O
,	O
cellular	O
localization	O
and	O
in	O
vitro	O
transcription	O
studies	O
establish	O
that	O
cloned	O
hUBF	B-Gene_or_gene_product
encodes	O
a	O
nucleolar	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
that	O
binds	O
specifically	O
to	O
the	O
upstream	O
control	O
element	O
and	O
core	O
of	O
the	O
rRNA	O
gene	B-Gene_or_gene_product
promoter	O
to	O
activate	O
transcription	O
in	O
a	O
binding	O
site	O
-	O
dependent	O
manner	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
human	O
ribosomal	O
protein	B-Gene_or_gene_product
gene	B-Gene_or_gene_product
with	O
enhanced	O
expression	O
in	O
fetal	O
and	O
neoplastic	O
cells	O
.	O

Hepatocellular	O
carcinoma	O
is	O
strongly	O
associated	O
with	O
hepatitis	O
B	O
virus	O
carrier	O
patients	O
who	O
usually	O
have	O
HBV	O
sequences	O
integrated	O
in	O
the	O
chromosomal	O
DNA	O
of	O
liver	O
cells	O
.	O

To	O
assess	O
the	O
possible	O
effects	O
of	O
HBV	O
regulatory	O
sequences	O
(	O
e	O
.	O
g	O
.	O
,	O
the	O
enhancer	O
)	O
on	O
expression	O
of	O
neighboring	O
host	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
we	O
have	O
screened	O
for	O
cellular	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
that	O
are	O
both	O
overexpressed	O
and	O
adjacent	O
to	O
integrated	O
HBV	O
sequences	O
in	O
hepatocellular	O
carcinoma	O
cells	O
.	O

The	O
cloned	O
cDNA	O
for	O
one	O
such	O
gene	B-Gene_or_gene_product
encodes	O
a	O
protein	B-Gene_or_gene_product
similar	O
to	O
the	O
E	O
.	O
coli	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
ribosomal	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
which	O
is	O
thought	O
to	O
play	O
a	O
role	O
in	O
mRNA	O
binding	O
to	O
the	O
ribosome	O
.	O

The	O
protein	B-Gene_or_gene_product
encoded	O
by	O
the	O
cDNA	O
localizes	O
to	O
the	O
nucleolus	O
and	O
is	O
also	O
found	O
in	O
ribosomes	O
;	O
possibly	O
it	O
is	O
the	O
mammalian	O
homologue	O
of	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
(	O
MRL3	B-Gene_or_gene_product
)	O
.	O

The	O
expression	O
of	O
MRL3	B-Gene_or_gene_product
is	O
higher	O
in	O
colon	O
carcinoma	O
and	O
lymphoma	O
cell	O
lines	O
than	O
in	O
normal	O
liver	O
,	O
placenta	O
and	O
diploid	O
fibroblasts	O
,	O
and	O
is	O
also	O
higher	O
in	O
fetal	O
than	O
in	O
adult	O
liver	O
.	O

Therefore	O
,	O
MRL3	B-Gene_or_gene_product
overexpression	O
seems	O
to	O
be	O
a	O
property	O
of	O
rapidly	O
dividing	O
cells	O
and	O
is	O
not	O
directly	O
linked	O
to	O
oncogenesis	O
.	O

PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	I-Gene_or_gene_product
Spi	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	I-Gene_or_gene_product
autoregulates	O
its	O
expression	O
in	O
myeloid	O
cells	O
.	O

PU	O
.	O
1	O
(	O
Spi	O
-	O
1	O
)	O
,	O
a	O
member	O
of	O
the	O
Ets	O
transcription	O
factor	O
family	O
,	O
is	O
predominantly	O
expressed	O
in	O
myeloid	O
(	O
granulocytes	O
,	O
monocytes	O
and	O
macrophages	O
)	O
and	O
B	O
cells	O
.	O

PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
upregulated	O
early	O
during	O
commitment	O
of	O
multipotential	O
progenitors	O
to	O
the	O
myeloid	O
lineages	O
and	O
inhibition	O
of	O
PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
function	O
in	O
human	O
CD34	O
+	O
progenitors	O
prior	O
to	O
this	O
upregulation	O
blocks	O
myeloid	O
colony	O
formation	O
.	O

Since	O
PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
appears	O
to	O
play	O
a	O
role	O
in	O
hematopoietic	O
development	O
,	O
we	O
characterized	O
the	O
PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
.	O

Here	O
we	O
report	O
that	O
the	O
murine	O
PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
,	O
as	O
well	O
as	O
the	O
human	O
promoter	O
,	O
demonstrate	O
tissue	O
-	O
specific	O
reporter	O
gene	O
expression	O
in	O
myeloid	O
cell	O
lines	O
but	O
not	O
in	O
T	O
cells	O
and	O
HeLa	O
(	O
non	O
-	O
hematopoietic	O
cells	O
)	O
cells	O
.	O

Deletion	O
analysis	O
of	O
the	O
PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
indicates	O
that	O
tissue	O
-	O
specific	O
functional	O
elements	O
are	O
encoded	O
in	O
the	O
-	O
61	O
to	O
-	O
39	O
bp	O
and	O
-	O
7	O
to	O
+	O
34	O
bp	O
regions	O
.	O

The	O
first	O
region	O
contains	O
a	O
functional	O
octamer	O
(	O
Oct	O
)	O
site	O
at	O
-	O
54	O
bp	O
and	O
an	O
Sp1	O
site	O
at	O
-	O
39	O
bp	O
.	O

The	O
second	O
contains	O
a	O
binding	O
site	O
at	O
+	O
20	O
bp	O
for	O
both	O
PU	O
.	O
1	O
itself	O
and	O
the	O
related	O
ets	O
family	O
member	O
Spi	O
-	O
B	O
.	O

In	O
vivo	O
footprinting	O
assays	O
demonstrate	O
that	O
a	O
hypersensitive	O
band	O
was	O
detected	O
at	O
the	O
PU	O
.	O
1	O
site	O
in	O
myeloid	O
cells	O
but	O
not	O
in	O
HeLa	O
.	O

A	O
mutation	O
of	O
the	O
PU	O
.	O
1	O
site	O
which	O
abolished	O
PU	O
.	O
1	O
binding	O
caused	O
a	O
significant	O
decrease	O
in	O
promoter	O
activity	O
.	O

Mutation	O
of	O
the	O
Oct	O
and	O
/	O
or	O
Sp1	O
site	O
results	O
in	O
a	O
lesser	O
decrease	O
of	O
promoter	O
activity	O
in	O
myeloid	O
cells	O
.	O

Co	O
-	O
transfection	O
of	O
PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
or	O
Spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
in	O
cells	O
lacking	O
PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
Spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
specifically	O
transactivated	O
a	O
minimal	O
promoter	O
containing	O
the	O
PU	O
.	O
1	O
binding	O
site	O
,	O
indicating	O
that	O
PU	O
.	O
1	O
can	O
activate	O
its	O
own	O
promoter	O
elements	O
in	O
an	O
autoregulatory	O
loop	O
.	O

Positive	O
autoregulation	O
of	O
the	O
PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
function	O
of	O
PU	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
in	O
myeloid	O
cells	O
.	O

Calcium	O
signalling	O
in	O
T	O
cells	O
stimulated	O
by	O
a	O
cyclophilin	B-Gene_or_gene_product
B	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

The	O
immunosuppressant	O
drug	O
cyclosporin	O
A	O
blocks	O
a	O
calcium	O
-	O
dependent	O
signal	O
from	O
the	O
T	B-Gene_or_gene_product
-	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
TCR	B-Gene_or_gene_product
)	O
that	O
normally	O
leads	O
to	O
T	O
-	O
cell	O
activation	O
.	O

When	O
bound	O
to	O
cyclophilin	B-Gene_or_gene_product
,	O
cyclosporin	O
A	O
binds	O
and	O
inactivates	O
the	O
key	O
signalling	O
intermediate	O
calcineurin	O
.	O

To	O
identify	O
potential	O
cellular	O
homologues	O
of	O
cyclosporin	O
A	O
that	O
might	O
regulate	O
calcium	O
signalling	O
,	O
we	O
have	O
cloned	O
human	O
genes	B-Gene_or_gene_product
encoding	O
cyclophilin	B-Gene_or_gene_product
B	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
-	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O

One	O
gene	O
product	O
,	O
when	O
overexpressed	O
in	O
Jurkat	O
T	O
cells	O
,	O
specifically	O
induced	O
transcription	O
from	O
the	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
enhancer	O
,	O
by	O
activating	O
the	O
T	O
-	O
cell	O
-	O
specific	O
transcription	O
factors	O
NF	O
-	O
AT	O
and	O
NF	O
-	O
IL2A	O
.	O

This	O
protein	B-Gene_or_gene_product
,	O
termed	O
calcium	B-Gene_or_gene_product
-	I-Gene_or_gene_product
signal	I-Gene_or_gene_product
modulating	I-Gene_or_gene_product
cyclophilin	I-Gene_or_gene_product
ligand	I-Gene_or_gene_product
(	O
CAML	B-Gene_or_gene_product
)	O
,	O
acts	O
downstream	O
of	O
the	O
TCR	B-Gene_or_gene_product
and	O
upstream	O
of	O
calcineurin	O
by	O
causing	O
an	O
influx	O
of	O
calcium	O
.	O

CAML	B-Gene_or_gene_product
appears	O
to	O
be	O
a	O
new	O
participant	O
in	O
the	O
calcium	O
-	O
signal	O
transduction	O
pathway	O
,	O
implicating	O
cyclophilin	B-Gene_or_gene_product
B	I-Gene_or_gene_product
in	O
calcium	O
signalling	O
,	O
even	O
in	O
the	O
absence	O
of	O
cyclosporin	O
.	O

Identification	O
of	O
a	O
new	O
murine	O
runt	O
domain	O
-	O
containing	O
gene	B-Gene_or_gene_product
,	O
Cbfa3	B-Gene_or_gene_product
,	O
and	O
localization	O
of	O
the	O
human	O
homolog	O
,	O
CBFA3	B-Gene_or_gene_product
,	O
to	O
chromosome	O
1p35	O
-	O
pter	O
.	O

Core	O
binding	O
factor	O
(	O
CBF	O
)	O
is	O
a	O
heterodimeric	O
transcription	O
factor	O
composed	O
of	O
two	O
distinct	O
subunits	O
.	O

The	O
monomeric	O
beta	O
subunit	O
is	O
ubiquitously	O
expressed	O
,	O
whereas	O
expression	O
of	O
the	O
three	O
alpha	O
subunits	O
isolated	O
previously	O
seems	O
to	O
be	O
restricted	O
mainly	O
to	O
hematopoietic	O
tissues	O
.	O

To	O
isolate	O
additional	O
alpha	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
,	O
degenerate	O
oligonucleotides	O
derived	O
from	O
the	O
runt	O
domain	O
-	O
-	O
a	O
region	O
shared	O
by	O
all	O
alpha	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
-	O
-	O
were	O
used	O
for	O
screening	O
cDNA	O
libraries	O
.	O

A	O
228	O
-	O
bp	O
fragment	O
was	O
isolated	O
from	O
a	O
mouse	O
thymus	O
cDNA	O
library	O
,	O
which	O
showed	O
82	O
and	O
76	O
%	O
DNA	O
sequence	O
identity	O
to	O
the	O
previously	O
isolated	O
murine	O
alpha	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
,	O
Cbfa1	B-Gene_or_gene_product
and	O
Cbfa2	B-Gene_or_gene_product
.	O

This	O
novel	O
alpha	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
was	O
named	O
Cbfa3	B-Gene_or_gene_product
.	O

The	O
corresponding	O
sequence	O
from	O
the	O
human	O
homolog	O
CBFA3	B-Gene_or_gene_product
was	O
obtained	O
by	O
cosmid	O
cloning	O
and	O
sequencing	O
of	O
the	O
appropriate	O
restriction	O
fragment	O
.	O

The	O
corresponding	O
regions	O
of	O
mouse	O
Cbfa3	B-Gene_or_gene_product
and	O
human	O
CBFA3	B-Gene_or_gene_product
show	O
91	O
%	O
nucleotide	O
identity	O
and	O
100	O
%	O
protein	B-Gene_or_gene_product
identity	O
.	O

In	O
situ	O
hybridization	O
and	O
physical	O
mapping	O
of	O
somatic	O
cell	O
hybrids	O
localized	O
CBFA3	B-Gene_or_gene_product
to	O
chromosome	O
1p35	O
-	O
pter	O
.	O

Cell	O
-	O
cycle	O
-	O
dependent	O
alterations	O
of	O
a	O
highly	O
phosphorylated	O
nucleolar	O
protein	B-Gene_or_gene_product
p130	I-Gene_or_gene_product
are	O
associated	O
with	O
nucleologenesis	O
.	O

We	O
identified	O
a	O
novel	O
human	O
nucleolar	O
phosphoprotein	B-Gene_or_gene_product
p130	I-Gene_or_gene_product
(	O
130	O
kDa	O
)	O
using	O
a	O
strategy	O
for	O
selecting	O
monoclonal	O
antibodies	O
against	O
nuclear	O
proteins	B-Gene_or_gene_product
which	O
oscillate	O
in	O
the	O
cell	O
cycle	O
.	O

p130	B-Gene_or_gene_product
is	O
localized	O
in	O
interphase	O
nucleoli	O
in	O
a	O
dotted	O
manner	O
.	O

Complete	O
extraction	O
of	O
p130	B-Gene_or_gene_product
required	O
a	O
high	O
concentration	O
of	O
salt	O
(	O
0	O
.	O
5	O
M	O
NaCl	O
)	O
indicating	O
that	O
it	O
binds	O
firmly	O
to	O
the	O
nucleolar	O
components	O
via	O
ionic	O
interaction	O
.	O

p130	B-Gene_or_gene_product
is	O
heavily	O
phosphorylated	O
,	O
since	O
alkaline	O
phosphatase	O
treatment	O
converted	O
the	O
purified	O
p130	B-Gene_or_gene_product
into	O
a	O
95	O
kDa	O
product	O
;	O
this	O
was	O
further	O
supported	O
by	O
the	O
in	O
vitro	O
demonstration	O
that	O
cellular	O
phosphatase	O
and	O
casein	O
kinase	O
II	O
activities	O
were	O
responsible	O
for	O
the	O
interchange	O
of	O
these	O
two	O
forms	O
.	O

Extracts	O
of	O
mitotic	O
cells	O
had	O
lower	O
concentrations	O
of	O
p130	B-Gene_or_gene_product
compared	O
to	O
those	O
of	O
interphase	O
cells	O
suggesting	O
that	O
a	O
proportion	O
of	O
p130	B-Gene_or_gene_product
might	O
be	O
degraded	O
during	O
mitosis	O
.	O

Moreover	O
,	O
all	O
the	O
remaining	O
p130	B-Gene_or_gene_product
in	O
mitotic	O
cells	O
was	O
further	O
phosphorylated	O
,	O
likely	O
by	O
a	O
cdc2	O
kinase	O
,	O
resulting	O
in	O
increase	O
in	O
its	O
solubility	O
,	O
and	O
its	O
dispersion	O
throughout	O
the	O
entire	O
cytoplasm	O
.	O

Thus	O
,	O
p130	B-Gene_or_gene_product
in	O
metaphase	O
and	O
anaphase	O
cells	O
was	O
unable	O
to	O
be	O
detected	O
by	O
immunofluorescence	O
microscopy	O
.	O

At	O
telophase	O
,	O
p130	B-Gene_or_gene_product
reappeared	O
and	O
aggregated	O
into	O
a	O
granular	O
structure	O
,	O
resembling	O
the	O
prenucleolar	O
bodies	O
.	O

These	O
granules	O
migrated	O
from	O
the	O
nucleoplasm	O
to	O
the	O
nucleoli	O
in	O
early	O
G1	O
-	O
phase	O
.	O

Actinomycin	O
D	O
was	O
able	O
to	O
induce	O
segregation	O
of	O
p130	B-Gene_or_gene_product
-	O
containing	O
granules	O
into	O
the	O
nucleoplasm	O
,	O
similar	O
to	O
the	O
well	O
-	O
known	O
behavior	O
of	O
the	O
fibrillarin	O
-	O
containing	O
granules	O
,	O
indicating	O
that	O
p130	B-Gene_or_gene_product
is	O
localized	O
in	O
the	O
dense	O
fibrillar	O
component	O
,	O
a	O
subnucleolar	O
region	O
for	O
pre	O
-	O
rRNA	O
synthesis	O
and	O
processing	O
.	O

The	O
cDNA	O
sequence	O
of	O
p130	B-Gene_or_gene_product
revealed	O
a	O
remarkable	O
feature	O
,	O
that	O
a	O
serine	O
-	O
rich	O
stretch	O
interspersed	O
with	O
acidic	O
residues	O
is	O
repeated	O
ten	O
times	O
.	O

Such	O
a	O
characteristic	O
is	O
shared	O
with	O
a	O
rat	O
nucleolar	O
phosphoprotein	B-Gene_or_gene_product
Nopp140	I-Gene_or_gene_product
,	O
which	O
is	O
thought	O
to	O
shuttle	O
between	O
the	O
nucleolus	O
and	O
the	O
cytoplasm	O
.	O

Although	O
p130	B-Gene_or_gene_product
shows	O
74	O
%	O
identity	O
to	O
Nopp140	B-Gene_or_gene_product
,	O
our	O
observations	O
suggest	O
that	O
during	O
mitosis	O
the	O
functions	O
of	O
p130	B-Gene_or_gene_product
are	O
related	O
to	O
nucleologenesis	O
.	O

Acute	O
mixed	O
-	O
lineage	O
leukemia	O
t	O
(	O
4	O
;	O
11	O
)	O
(	O
q21	O
;	O
q23	O
)	O
generates	O
an	O
MLL	B-Gene_or_gene_product
-	O
AF4	B-Gene_or_gene_product
fusion	O
product	O
.	O

A	O
chromosomal	O
translocation	O
,	O
t	O
(	O
4	O
;	O
11	O
)	O
-	O
(	O
q21	O
;	O
q23	O
)	O
,	O
is	O
associated	O
with	O
an	O
aggressive	O
mixed	O
-	O
lineage	O
leukemia	O
.	O

A	O
yeast	O
artificial	O
chromosome	O
was	O
used	O
to	O
clone	O
the	O
chromosomal	O
breakpoint	O
of	O
this	O
translocation	O
in	O
the	O
RS4	O
;	O
11	O
cell	O
line	O
.	O

The	O
breakpoint	O
sequences	O
revealed	O
an	O
inverted	O
repeat	O
bordered	O
by	O
a	O
consensus	O
site	O
for	O
topoisomerase	O
II	O
binding	O
and	O
cleavage	O
as	O
well	O
as	O
chi	O
-	O
like	O
elements	O
.	O

The	O
der	O
(	O
11	O
)	O
chromosome	O
encodes	O
a	O
fusion	O
RNA	O
and	O
predicted	O
chimeric	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
between	O
the	O
11q23	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
MLL	B-Gene_or_gene_product
and	O
a	O
4q21	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
designated	O
AF4	B-Gene_or_gene_product
.	O

The	O
sequence	O
of	O
the	O
complete	O
open	O
reading	O
frame	O
for	O
this	O
fusion	O
transcript	O
reveals	O
the	O
MLL	B-Gene_or_gene_product
protein	B-Gene_or_gene_product
to	O
have	O
homology	O
with	O
DNA	O
methyltransferase	O
,	O
the	O
Drosophila	O
trithorax	O
gene	O
product	O
,	O
and	O
the	O
"	O
AT	O
-	O
hook	O
"	O
motif	O
of	O
high	O
-	O
mobility	O
-	O
group	O
proteins	O
.	O

An	O
alternative	O
splice	O
that	O
deletes	O
the	O
AT	O
-	O
hook	O
region	O
of	O
MLL	B-Gene_or_gene_product
was	O
identified	O
.	O

AF4	O
is	O
a	O
serine	O
-	O
and	O
proline	O
-	O
rich	O
putative	O
transcription	O
factor	O
with	O
a	O
glutamine	O
-	O
rich	O
carboxyl	O
terminus	O
.	O

The	O
composition	O
of	O
the	O
complete	O
MLL	B-Gene_or_gene_product
-	O
AF4	B-Gene_or_gene_product
fusion	O
product	O
argues	O
that	O
it	O
may	O
act	O
through	O
either	O
a	O
gain	O
-	O
of	O
-	O
function	O
or	O
a	O
dominant	O
negative	O
mechanism	O
in	O
leukemogenesis	O
.	O

Coupling	O
of	O
a	O
signal	O
response	O
domain	O
in	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
to	O
multiple	O
pathways	O
for	O
NF	O
-	O
kappa	O
B	O
activation	O
.	O

The	O
eukaryotic	O
transcription	O
factor	O
NF	O
-	O
kappa	O
B	O
plays	O
a	O
central	O
role	O
in	O
the	O
induced	O
expression	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
and	O
in	O
many	O
aspects	O
of	O
the	O
genetic	O
program	O
mediating	O
normal	O
T	O
-	O
cell	O
activation	O
and	O
growth	O
.	O

The	O
nuclear	O
activity	O
of	O
NF	O
-	O
kappa	O
B	O
is	O
tightly	O
regulated	O
from	O
the	O
cytoplasmic	O
compartment	O
by	O
an	O
inhibitory	O
subunit	O
called	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O

This	O
cytoplasmic	O
inhibitor	B-Gene_or_gene_product
is	O
rapidly	O
phosphorylated	O
and	O
degraded	O
in	O
response	O
to	O
a	O
diverse	O
set	O
of	O
NF	O
-	O
kappa	O
B	O
-	O
inducing	O
agents	O
,	O
including	O
T	O
-	O
cell	O
mitogens	O
,	O
proinflammatory	B-Gene_or_gene_product
cytokines	I-Gene_or_gene_product
,	O
and	O
viral	O
transactivators	O
such	O
as	O
the	O
Tax	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
of	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
1	O
.	O

To	O
explore	O
these	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
dependent	O
mechanisms	O
for	O
NF	O
-	O
kappa	O
B	O
induction	O
,	O
we	O
identified	O
novel	O
mutants	O
of	O
I	O
kappa	O
B	O
alpha	O
that	O
uncouple	O
its	O
inhibitory	O
and	O
signal	O
-	O
transducing	O
functions	O
in	O
human	O
T	O
lymphocytes	O
.	O

Specifically	O
,	O
removal	O
of	O
the	O
N	O
-	O
terminal	O
36	O
amino	O
acids	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
failed	O
to	O
disrupt	O
its	O
ability	O
to	O
form	O
latent	O
complexes	O
with	O
NF	O
-	O
kappa	O
B	O
in	O
the	O
cytoplasm	O
.	O

However	O
,	O
this	O
deletion	O
mutation	O
prevented	O
the	O
induced	O
phosphorylation	O
,	O
degradative	O
loss	O
,	O
and	O
functional	O
release	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
from	O
NF	O
-	O
kappa	O
B	O
in	O
Tax	B-Gene_or_gene_product
-	O
expressing	O
cells	O
.	O

Alanine	O
substitutions	O
introduced	O
at	O
two	O
serine	O
residues	O
positioned	O
within	O
this	O
N	O
-	O
terminal	O
regulatory	O
region	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
also	O
yielded	O
constitutive	O
repressors	O
that	O
escaped	O
from	O
Tax	B-Gene_or_gene_product
-	O
induced	O
turnover	O
and	O
that	O
potently	O
inhibited	O
immune	O
activation	O
pathways	O
for	O
NF	O
-	O
kappa	O
B	O
induction	O
,	O
including	O
those	O
initiated	O
from	O
antigen	O
and	O
cytokine	B-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O

In	O
contrast	O
,	O
introduction	O
of	O
a	O
phosphoserine	O
mimetic	O
at	O
these	O
sites	O
rectified	O
this	O
functional	O
defect	O
,	O
a	O
finding	O
consistent	O
with	O
a	O
causal	O
linkage	O
between	O
the	O
phosphorylation	O
status	O
and	O
proteolytic	O
stability	O
of	O
this	O
cytoplasmic	O
inhibitor	B-Gene_or_gene_product
.	O

Together	O
,	O
these	O
in	O
vivo	O
studies	O
define	O
a	O
critical	O
signal	O
response	O
domain	O
in	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
that	O
coordinately	O
controls	O
the	O
biologic	O
activities	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
NF	O
-	O
kappa	O
B	O
in	O
response	O
to	O
viral	O
and	O
immune	O
stimuli	O
.	O

OBF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
a	O
novel	O
B	O
cell	O
-	O
specific	O
coactivator	O
that	O
stimulates	O
immunoglobulin	B-Gene_or_gene_product
promoter	O
activity	O
through	O
association	O
with	O
octamer	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Recent	O
biochemical	O
and	O
genetic	O
studies	O
indicate	O
that	O
in	O
addition	O
to	O
the	O
octamer	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
other	O
B	O
cell	O
components	O
are	O
required	O
for	O
lymphoid	O
-	O
restricted	O
,	O
octamer	O
site	O
-	O
mediated	O
immunoglobulin	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
promoter	O
activity	O
.	O

Using	O
a	O
genetic	O
screen	O
in	O
yeast	O
,	O
we	O
have	O
isolated	O
B	O
cell	O
-	O
derived	O
cDNAs	O
encoding	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
OBF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
,	O
a	O
novel	O
protein	B-Gene_or_gene_product
that	O
specifically	O
associates	O
with	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O

Biochemical	O
studies	O
demonstrate	O
that	O
OBF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
has	O
no	O
intrinsic	O
DNA	O
-	O
binding	O
activity	O
and	O
recognizes	O
the	O
POU	O
domains	O
of	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
but	O
not	O
those	O
of	O
Oct	O
-	O
4	O
and	O
Oct	O
-	O
6	O
.	O

The	O
OBF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
mRNA	O
is	O
expressed	O
in	O
a	O
highly	O
cell	O
-	O
specific	O
manner	O
,	O
being	O
most	O
abundant	O
in	O
B	O
cells	O
and	O
essentially	O
absent	O
in	O
most	O
of	O
the	O
other	O
cells	O
or	O
tissues	O
tested	O
.	O

Furthermore	O
,	O
expression	O
of	O
OBF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
in	O
HeLa	O
cells	O
selectively	O
stimulates	O
the	O
activity	O
of	O
a	O
natural	O
immunoglobulin	B-Gene_or_gene_product
promoter	O
in	O
an	O
octamer	O
site	O
-	O
dependent	O
manner	O
.	O

Thus	O
,	O
OBF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
has	O
all	O
the	O
properties	O
expected	O
for	O
a	O
B	O
cell	O
-	O
specific	O
transcriptional	O
coactivator	O
protein	O
.	O

Isolation	O
of	O
cDNA	O
clones	O
for	O
42	O
different	O
Krueppel	O
-	O
related	O
zinc	O
finger	O
proteins	B-Gene_or_gene_product
expressed	O
in	O
the	O
human	O
monoblast	O
cell	O
line	O
U	O
-	O
937	O
.	O

To	O
study	O
the	O
complexity	O
and	O
structural	O
characteristics	O
of	O
zinc	O
finger	O
proteins	B-Gene_or_gene_product
expressed	O
during	O
human	O
hematopoiesis	O
and	O
to	O
isolate	O
novel	O
regulators	O
of	O
blood	O
cell	O
development	O
,	O
a	O
degenerate	O
oligonucleotide	O
probe	O
specific	O
for	O
a	O
consensus	O
zinc	O
finger	O
peptide	O
domain	O
was	O
used	O
to	O
isolate	O
63	O
cDNA	O
clones	O
for	O
Krueppel	O
-	O
related	O
zinc	O
finger	O
genes	B-Gene_or_gene_product
from	O
the	O
human	O
monoblast	O
cell	O
line	O
U	O
-	O
937	O
.	O

By	O
extensive	O
nucleotide	O
sequence	O
and	O
Northern	O
blot	O
analysis	O
,	O
these	O
cDNA	O
clones	O
were	O
found	O
to	O
originate	O
from	O
approximately	O
42	O
different	O
genes	B-Gene_or_gene_product
(	O
HZF	O
1	O
-	O
42	O
)	O
of	O
which	O
only	O
8	O
have	O
previously	O
been	O
described	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
a	O
majority	O
of	O
these	O
genes	B-Gene_or_gene_product
were	O
expressed	O
at	O
comparable	O
levels	O
in	O
U	O
-	O
937	O
and	O
HeLa	O
cells	O
.	O

The	O
large	O
number	O
of	O
individual	O
genes	B-Gene_or_gene_product
represented	O
among	O
the	O
63	O
clones	O
and	O
their	O
apparent	O
non	O
-	O
cell	O
-	O
type	O
-	O
specific	O
expression	O
suggest	O
that	O
the	O
majority	O
of	O
the	O
Krueppel	O
-	O
related	O
zinc	O
finger	O
genes	B-Gene_or_gene_product
are	O
likely	O
to	O
be	O
expressed	O
in	O
most	O
human	O
tissues	O
.	O

In	O
contrast	O
,	O
some	O
of	O
the	O
genes	B-Gene_or_gene_product
displayed	O
a	O
restricted	O
expression	O
pattern	O
,	O
indicating	O
that	O
they	O
represent	O
potential	O
regulators	O
of	O
monocyte	O
differentiation	O
or	O
proliferation	O
.	O

Detailed	O
structural	O
analysis	O
of	O
the	O
first	O
12	O
cDNAs	O
(	O
HZF	O
1	O
-	O
10	O
)	O
and	O
a	O
partial	O
characterization	O
of	O
HZF	O
11	O
-	O
42	O
revealed	O
that	O
a	O
common	O
feature	O
of	O
human	O
Krueppel	O
-	O
related	O
zinc	O
finger	O
proteins	B-Gene_or_gene_product
is	O
the	O
presence	O
of	O
tandem	O
arrays	O
of	O
zinc	O
fingers	O
ranging	O
in	O
number	O
from	O
3	O
to	O
over	O
20	O
that	O
are	O
preferentially	O
located	O
in	O
the	O
carboxy	O
-	O
terminal	O
regions	O
of	O
the	O
proteins	B-Gene_or_gene_product
.	O

In	O
addition	O
,	O
several	O
novel	O
KRAB	O
-	O
containing	O
zinc	O
finger	O
genes	B-Gene_or_gene_product
and	O
a	O
novel	O
conserved	O
sequence	O
element	O
were	O
identified	O
.	O

A	O
redox	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
ref1	B-Gene_or_gene_product
,	O
is	O
involved	O
in	O
negative	O
gene	B-Gene_or_gene_product
regulation	O
by	O
extracellular	O
calcium	O
.	O

A	O
rise	O
in	O
extracellular	O
calcium	O
(	O
Ca2	O
+	O
e	O
)	O
suppresses	O
not	O
only	O
secretion	O
of	O
parathyroid	O
hormone	O
(	O
PTH	O
)	O
but	O
also	O
expression	O
of	O
the	O
PTH	O
gene	B-Gene_or_gene_product
to	O
ensure	O
constant	O
plasma	O
Ca2	O
+	O
level	O
.	O

A	O
nuclear	O
protein	B-Gene_or_gene_product
(	I-Gene_or_gene_product
s	I-Gene_or_gene_product
)	I-Gene_or_gene_product
in	O
a	O
wide	O
variety	O
of	O
cells	O
bound	O
to	O
the	O
specific	O
DNA	O
elements	O
(	O
negative	O
Ca2	O
+	O
responsive	O
elements	O
,	O
nCaREs	O
)	O
in	O
the	O
human	O
PTH	O
gene	B-Gene_or_gene_product
in	O
sequence	O
-	O
specific	O
and	O
Ca2	O
+	O
e	O
concentration	O
-	O
dependent	O
manners	O
.	O

Our	O
Southwestern	O
cloning	O
revealed	O
that	O
a	O
redox	O
factor	O
protein	O
(	O
ref1	B-Gene_or_gene_product
)	O
,	O
which	O
was	O
known	O
to	O
activate	O
several	O
transcription	O
factors	O
via	O
alterations	O
of	O
their	O
redox	O
state	O
,	O
belonged	O
to	O
an	O
nCaRE	B-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

The	O
level	O
of	O
ref1	B-Gene_or_gene_product
mRNA	O
as	O
well	O
as	O
of	O
its	O
protein	B-Gene_or_gene_product
was	O
elevated	O
by	O
an	O
increase	O
in	O
Ca2	O
+	O
e	O
concentration	O
.	O

In	O
gel	O
shift	O
assay	O
,	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
ref1	I-Gene_or_gene_product
antibody	I-Gene_or_gene_product
eliminated	O
formation	O
of	O
the	O
nCaRE	O
-	O
protein	O
complex	O
.	O

We	O
also	O
found	O
that	O
there	O
was	O
another	O
protein	B-Gene_or_gene_product
(	I-Gene_or_gene_product
s	I-Gene_or_gene_product
)	I-Gene_or_gene_product
interacting	O
with	O
nCaREs	O
and	O
ref1	B-Gene_or_gene_product
.	O

Further	O
,	O
experiments	O
with	O
an	O
antisense	O
-	O
ref	B-Gene_or_gene_product
cDNA	O
expression	O
vector	O
introduced	O
into	O
cultured	O
cells	O
suggested	O
that	O
DNA	O
(	O
nCaRE	O
)	O
-	O
ref1	B-Gene_or_gene_product
interaction	O
led	O
to	O
Ca2	O
+	O
e	O
-	O
mediated	O
transcriptional	O
suppression	O
.	O

Thus	O
,	O
it	O
is	O
concluded	O
that	O
ref1	B-Gene_or_gene_product
possesses	O
transcription	O
repressor	O
activity	O
in	O
addition	O
to	O
its	O
function	O
as	O
a	O
transcriptional	O
auxiliary	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

A	O
new	O
orphan	O
member	O
of	O
the	O
nuclear	O
hormone	O
receptor	O
superfamily	O
closely	O
related	O
to	O
Rev	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Erb	I-Gene_or_gene_product
.	O

We	O
have	O
isolated	O
complementary	O
DNA	O
clones	O
encoding	O
a	O
novel	O
orphan	O
member	O
of	O
the	O
nuclear	O
receptor	O
superfamily	O
,	O
termed	O
BD73	B-Gene_or_gene_product
.	O

This	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
shows	O
strong	O
amino	O
acid	O
sequence	O
similarity	O
to	O
the	O
previously	O
described	O
Rev	B-Gene_or_gene_product
-	I-Gene_or_gene_product
ErbA	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O

Unlike	O
Rev	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Erb	I-Gene_or_gene_product
,	O
in	O
which	O
the	O
opposite	O
strand	O
of	O
the	O
C	O
-	O
terminal	O
coding	O
region	O
encodes	O
the	O
C	O
-	O
terminal	O
portion	O
of	O
a	O
variant	O
thyroid	O
hormone	O
receptor	O
isoform	O
,	O
the	O
opposite	O
strand	O
of	O
the	O
C	O
-	O
terminal	O
coding	O
region	O
of	O
BD73	B-Gene_or_gene_product
does	O
not	O
have	O
any	O
extensive	O
open	O
reading	O
frames	O
.	O

BD73	B-Gene_or_gene_product
messenger	O
RNA	O
is	O
expressed	O
in	O
a	O
wide	O
variety	O
of	O
tissues	O
and	O
cell	O
lines	O
.	O

In	O
quiescent	O
HepG2	O
cells	O
,	O
BD73	B-Gene_or_gene_product
messenger	O
RNA	O
levels	O
are	O
strongly	O
induced	O
by	O
planar	O
aromatic	O
antioxidants	O
.	O

Like	O
Rev	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Erb	I-Gene_or_gene_product
,	O
BD73	B-Gene_or_gene_product
binds	O
as	O
a	O
monomer	O
to	O
a	O
DNA	O
sequence	O
which	O
consists	O
of	O
a	O
specific	O
A	O
/	O
T	O
-	O
rich	O
sequence	O
upstream	O
of	O
the	O
consensus	O
hexameric	O
half	O
-	O
site	O
specified	O
by	O
the	O
P	O
box	O
of	O
the	O
DNA	O
-	O
binding	O
domain	O
.	O

Amino	O
acid	O
sequence	O
comparisons	O
suggest	O
that	O
the	O
A	O
box	O
sequence	O
,	O
which	O
has	O
been	O
suggested	O
to	O
mediate	O
monomer	O
binding	O
by	O
other	O
superfamily	O
members	O
,	O
lies	O
closer	O
to	O
the	O
DNA	O
-	O
binding	O
domain	O
in	O
BD73	B-Gene_or_gene_product
and	O
Rev	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Erb	I-Gene_or_gene_product
than	O
in	O
other	O
receptors	B-Gene_or_gene_product
.	O

Under	O
the	O
conditions	O
examined	O
,	O
neither	O
BD73	B-Gene_or_gene_product
nor	O
Rev	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Erb	I-Gene_or_gene_product
activated	O
reporters	O
containing	O
multiple	O
copies	O
of	O
their	O
common	O
binding	O
site	O
.	O

Thus	O
,	O
these	O
two	O
orphans	O
may	O
require	O
an	O
as	O
yet	O
unidentified	O
ligand	O
or	O
other	O
signal	O
for	O
such	O
activation	O
.	O

Together	O
,	O
BD73	B-Gene_or_gene_product
and	O
Rev	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Erb	I-Gene_or_gene_product
define	O
a	O
subgroup	O
of	O
orphan	B-Gene_or_gene_product
receptors	I-Gene_or_gene_product
that	O
bind	O
as	O
monomers	O
to	O
a	O
half	O
-	O
site	O
flanked	O
by	O
a	O
specific	O
and	O
extended	O
A	O
/	O
T	O
-	O
rich	O
sequence	O
.	O

Assignment	O
of	O
the	O
human	O
peroxisome	B-Gene_or_gene_product
assembly	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
gene	B-Gene_or_gene_product
(	O
PXMP3	B-Gene_or_gene_product
)	O
responsible	O
for	O
Zellweger	O
syndrome	O
to	O
chromosome	O
8q21	O
.	O
1	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O

Identification	O
of	O
a	O
novel	O
mammalian	O
member	O
of	O
the	O
NSF	O
/	O
CDC48p	O
/	O
Pas1p	O
/	O
TBP	O
-	O
1	O
family	O
through	O
heterologous	O
expression	O
in	O
yeast	O
.	O

Two	O
suppressors	O
of	O
the	O
growth	O
deficiency	O
of	O
a	O
potassium	O
transport	O
mutant	O
of	O
Saccharomyces	O
cerevisiae	O
were	O
isolated	O
from	O
a	O
mouse	O
cDNA	O
expression	O
library	O
.	O

These	O
suppressors	O
,	O
SKD1	B-Gene_or_gene_product
and	O
SKD2	B-Gene_or_gene_product
(	O
suppressor	O
of	O
K	O
+	O
transport	O
growth	O
defect	O
)	O
,	O
were	O
cDNAs	O
encoding	O
members	O
of	O
a	O
family	O
of	O
ATPases	O
involved	O
in	O
membrane	O
fusion	O
(	O
N	O
-	O
ethylmaleimide	O
-	O
sensitive	O
fusion	O
protein	O
,	O
NSF	B-Gene_or_gene_product
)	O
,	O
cell	O
division	O
cycle	O
regulation	O
(	O
CDC48p	B-Gene_or_gene_product
)	O
,	O
peroxisome	O
assembly	O
(	O
Pas1p	B-Gene_or_gene_product
)	O
,	O
and	O
transcriptional	O
regulation	O
(	O
TBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
.	O

The	O
SKD1	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
constitutes	O
a	O
novel	O
member	O
of	O
this	O
family	O
with	O
49	O
-	O
58	O
%	O
amino	O
acid	O
sequence	O
similarity	O
with	O
other	O
family	O
members	O
,	O
and	O
contains	O
a	O
single	O
ATP	O
binding	O
site	O
.	O

The	O
SKD2	O
polypeptide	O
is	O
the	O
mouse	O
homolog	O
of	O
NSF	B-Gene_or_gene_product
.	O

NF	O
-	O
kappa	O
B	O
controls	O
expression	O
of	O
inhibitor	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
:	O
evidence	O
for	O
an	O
inducible	O
autoregulatory	O
pathway	O
.	O

The	O
eukaryotic	O
transcription	O
factor	O
nuclear	O
factor	O
-	O
kappa	O
B	O
(	O
NF	O
-	O
kappa	O
B	O
)	O
participates	O
in	O
many	O
parts	O
of	O
the	O
genetic	O
program	O
mediating	O
T	O
lymphocyte	O
activation	O
and	O
growth	O
.	O

Nuclear	O
expression	O
of	O
NF	O
-	O
kappa	O
B	O
occurs	O
after	O
its	O
induced	O
dissociation	O
from	O
its	O
cytoplasmic	O
inhibitor	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O

Phorbol	O
ester	O
and	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
induction	O
of	O
nuclear	O
NF	O
-	O
kappa	O
B	O
is	O
associated	O
with	O
both	O
the	O
degradation	O
of	O
performed	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
the	O
activation	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
gene	O
expression	O
.	O

Transfection	O
studies	O
indicate	O
that	O
the	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
gene	B-Gene_or_gene_product
is	O
specifically	O
induced	O
by	O
the	O
65	O
-	O
kilodalton	O
transactivating	O
subunit	O
of	O
NF	O
-	O
kappa	O
B	O
.	O

Association	O
of	O
the	O
newly	O
synthesized	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
with	O
p65	B-Gene_or_gene_product
restores	O
intracellular	O
inhibition	O
of	O
NF	O
-	O
kappa	O
B	O
DNA	O
binding	O
activity	O
and	O
prolongs	O
the	O
survival	O
of	O
this	O
labile	O
inhibitor	O
.	O

Together	O
,	O
these	O
results	O
show	O
that	O
NF	O
-	O
kappa	O
B	O
controls	O
the	O
expression	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
by	O
means	O
of	O
an	O
inducible	O
autoregulatory	O
pathway	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
human	O
ERM	B-Gene_or_gene_product
,	O
a	O
new	O
member	O
of	O
the	O
Ets	B-Gene_or_gene_product
family	I-Gene_or_gene_product
closely	O
related	O
to	O
mouse	O
PEA3	O
and	O
ER81	O
transcription	O
factors	O
.	O

The	O
ets	B-Gene_or_gene_product
-	O
related	O
transcription	O
factors	O
PEA3	O
and	O
ER81	O
have	O
recently	O
been	O
isolated	O
and	O
characterized	O
in	O
the	O
mouse	O
.	O

They	O
share	O
95	O
%	O
identity	O
in	O
a	O
85	O
amino	O
acid	O
(	O
AA	O
)	O
domain	O
termed	O
the	O
ETS	O
domain	O
which	O
is	O
responsible	O
for	O
DNA	O
binding	O
,	O
and	O
therefore	O
they	O
form	O
an	O
Ets	B-Gene_or_gene_product
family	I-Gene_or_gene_product
group	I-Gene_or_gene_product
.	O

By	O
screening	O
a	O
human	O
testis	O
cDNA	O
library	O
with	O
a	O
probe	O
containing	O
the	O
mouse	O
PEA3	O
ETS	O
domain	O
,	O
we	O
isolated	O
a	O
2	O
.	O
2	O
kb	O
clone	O
containing	O
a	O
510	O
AA	O
open	O
reading	O
frame	O
.	O

Since	O
the	O
ETS	O
domain	O
,	O
which	O
is	O
localized	O
in	O
the	O
carboxy	O
terminal	O
region	O
of	O
the	O
encoded	O
protein	B-Gene_or_gene_product
,	O
is	O
95	O
%	O
and	O
96	O
%	O
identical	O
to	O
that	O
of	O
PEA3	O
and	O
ER81	O
,	O
respectively	O
,	O
we	O
named	O
this	O
new	O
member	O
'	B-Gene_or_gene_product
Ets	I-Gene_or_gene_product
Related	O
Molecule	O
PEA3	O
-	O
like	O
'	O
(	O
ERM	B-Gene_or_gene_product
)	O
.	O

Although	O
the	O
first	O
120	O
AA	O
in	O
the	O
amino	O
-	O
terminal	O
region	O
of	O
ERM	B-Gene_or_gene_product
share	O
47	O
%	O
identity	O
with	O
PEA3	O
and	O
66	O
%	O
with	O
ER81	O
,	O
ERM	B-Gene_or_gene_product
contains	O
a	O
central	O
region	O
of	O
approximately	O
35	O
AA	O
not	O
found	O
in	O
the	O
two	O
mouse	O
proteins	B-Gene_or_gene_product
.	O

Gel	O
shift	O
analysis	O
indicates	O
that	O
the	O
full	O
-	O
length	O
ERM	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
is	O
able	O
to	O
bind	O
specifically	O
to	O
an	O
oligonucleotide	O
containing	O
the	O
consensus	O
nucleotide	O
core	O
sequence	O
GGAA	O
recognized	O
by	O
the	O
Ets	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Moreover	O
,	O
in	O
vitro	O
translation	O
of	O
83	O
AA	O
of	O
the	O
ERM	B-Gene_or_gene_product
ETS	O
domain	O
led	O
to	O
the	O
production	O
of	O
a	O
truncated	O
protein	B-Gene_or_gene_product
which	O
also	O
binds	O
to	O
DNA	O
.	O

Though	O
differential	O
expression	O
is	O
observed	O
in	O
primary	O
tumors	O
and	O
normal	O
lymphocytes	O
do	O
not	O
express	O
ERM	B-Gene_or_gene_product
,	O
this	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
almost	O
ubiquitously	O
expressed	O
in	O
human	O
normal	O
tissues	O
.	O

ERM	B-Gene_or_gene_product
mRNA	O
is	O
highly	O
expressed	O
in	O
brain	O
as	O
well	O
as	O
in	O
placenta	O
and	O
,	O
to	O
a	O
lesser	O
degree	O
,	O
in	O
lung	O
,	O
pancreas	O
,	O
and	O
heart	O
.	O

Moreover	O
,	O
almost	O
all	O
human	O
cell	O
lines	O
tested	O
express	O
it	O
at	O
varying	O
levels	O
.	O

In	O
mouse	O
tissues	O
,	O
we	O
showed	O
that	O
PEA3	B-Gene_or_gene_product
and	O
ER81	B-Gene_or_gene_product
mRNAs	O
display	O
restricted	O
expression	O
,	O
whereas	O
ERM	B-Gene_or_gene_product
is	O
almost	O
ubiquitously	O
expressed	O
as	O
observed	O
for	O
human	O
tissues	O
.	O

Altogether	O
these	O
results	O
indicate	O
that	O
ERM	B-Gene_or_gene_product
is	O
clearly	O
a	O
new	O
ets	B-Gene_or_gene_product
family	I-Gene_or_gene_product
member	O
and	O
not	O
the	O
human	O
equivalent	O
of	O
PEA3	O
or	O
ER81	O
.	O

Characterization	O
of	O
the	O
genomic	O
structure	O
,	O
chromosomal	O
location	O
,	O
promoter	O
,	O
and	O
development	O
expression	O
of	O
the	O
alpha	O
-	O
globin	O
transcription	O
factor	O
CP2	O
.	O

We	O
recently	O
cloned	O
murine	O
and	O
human	O
cDNAs	O
that	O
encode	O
CP2	O
,	O
a	O
cellular	O
transcription	O
factor	O
that	O
interacts	O
with	O
the	O
alpha	O
-	O
globin	O
promoter	O
as	O
well	O
as	O
with	O
additional	O
cellular	O
and	O
viral	O
promoter	O
elements	O
.	O

We	O
have	O
now	O
characterized	O
the	O
genomic	O
structure	O
,	O
chromosome	O
location	O
,	O
promoter	O
,	O
and	O
expression	O
pattern	O
of	O
the	O
factor	O
.	O

Genes	B-Gene_or_gene_product
for	O
the	O
murine	O
and	O
human	O
mRNAs	O
contained	O
16	O
and	O
15	O
exons	O
,	O
respectively	O
.	O

Both	O
genes	B-Gene_or_gene_product
spanned	O
approximately	O
30	O
kilobases	O
of	O
chromosomal	O
DNA	O
,	O
and	O
among	O
coding	O
exons	O
,	O
all	O
exon	O
/	O
intron	O
boundaries	O
were	O
conserved	O
.	O

The	O
human	O
gene	B-Gene_or_gene_product
for	O
CP2	O
was	O
found	O
to	O
reside	O
on	O
chromosome	O
12	O
while	O
the	O
murine	O
gene	B-Gene_or_gene_product
mapped	O
to	O
the	O
distal	O
end	O
of	O
chromosome	O
15	O
,	O
near	O
Gdc	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
Wnt	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
and	O
Rarg	B-Gene_or_gene_product
,	O
a	O
region	O
syntenic	O
with	O
human	O
chromosome	O
12	O
.	O

The	O
murine	O
and	O
human	O
promoters	O
initiated	O
mRNAs	O
at	O
multiple	O
start	O
sites	O
in	O
a	O
conserved	O
region	O
that	O
spanned	O
more	O
than	O
450	O
nucleotides	O
.	O

Lastly	O
,	O
a	O
study	O
of	O
the	O
pattern	O
of	O
CP2	O
gene	O
expression	O
showed	O
that	O
the	O
factor	O
was	O
expressed	O
in	O
all	O
adult	O
and	O
fetal	O
murine	O
tissues	O
examined	O
from	O
at	O
least	O
day	O
9	O
.	O
5	O
of	O
development	O
.	O

Nuclear	O
receptor	O
steroidogenic	O
factor	O
1	O
regulates	O
the	O
muellerian	B-Gene_or_gene_product
inhibiting	I-Gene_or_gene_product
substance	I-Gene_or_gene_product
gene	B-Gene_or_gene_product
:	O
a	O
link	O
to	O
the	O
sex	O
determination	O
cascade	O
.	O

Normal	O
male	O
sex	O
differentiation	O
requires	O
that	O
Sertoli	O
cells	O
in	O
the	O
embryonic	O
testes	O
produce	O
muellerian	B-Gene_or_gene_product
inhibiting	I-Gene_or_gene_product
substance	I-Gene_or_gene_product
(	O
MIS	B-Gene_or_gene_product
)	O
,	O
a	O
TGF	B-Gene_or_gene_product
beta	I-Gene_or_gene_product
-	O
like	O
hormone	O
that	O
causes	O
muellerian	O
duct	O
regression	O
.	O

In	O
primary	O
Sertoli	O
cells	O
,	O
the	O
orphan	O
nuclear	O
receptor	O
,	O
steroidogenic	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
SF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
,	O
regulates	O
the	O
MIS	B-Gene_or_gene_product
gene	B-Gene_or_gene_product
by	O
binding	O
to	O
a	O
conserved	O
upstream	O
regulatory	O
element	O
.	O

In	O
heterologous	O
(	O
HeLa	O
)	O
cells	O
,	O
MIS	B-Gene_or_gene_product
gene	B-Gene_or_gene_product
activation	O
by	O
SF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
requires	O
removal	O
of	O
the	O
SF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
ligand	O
-	O
binding	O
domain	O
,	O
implicating	O
a	O
Sertoli	O
cell	O
-	O
specific	O
ligand	O
or	O
cofactor	O
.	O

Finally	O
,	O
the	O
sexually	O
dimorphic	O
expression	O
of	O
SF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
during	O
development	O
coincides	O
with	O
MIS	B-Gene_or_gene_product
expression	O
and	O
muellerian	O
duct	O
regression	O
.	O

We	O
propose	O
that	O
SF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
regulates	O
MIS	B-Gene_or_gene_product
in	O
vivo	O
and	O
participates	O
directly	O
in	O
the	O
process	O
of	O
mammalian	O
sex	O
determination	O
.	O

Smaller	O
isoform	O
of	O
human	O
mitochondrial	O
transcription	O
factor	O
1	O
:	O
its	O
wide	O
distribution	O
and	O
production	O
by	O
alternative	O
splicing	O
.	O

Mitochondrial	O
transcriptional	O
factor	O
1	O
(	O
mtTF1	O
)	O
is	O
required	O
for	O
both	O
transcription	O
and	O
replication	O
of	O
mammalian	O
mitochondrial	O
DNA	O
(	O
mtDNA	O
)	O
and	O
it	O
has	O
two	O
consensus	O
sequences	O
of	O
HMG	O
(	O
high	O
mobility	O
group	O
)	O
boxes	O
.	O

In	O
studies	O
on	O
the	O
regulation	O
of	O
gene	O
expression	O
of	O
mtTF1	O
,	O
we	O
examined	O
the	O
steady	O
state	O
level	O
of	O
the	O
mRNA	O
in	O
cultured	O
HeLa	O
cells	O
.	O

We	O
found	O
that	O
in	O
addition	O
to	O
the	O
major	O
mRNA	O
,	O
30	O
%	O
of	O
the	O
mRNA	O
of	O
mtTF1	O
in	O
the	O
cells	O
was	O
a	O
smaller	O
isoform	O
with	O
a	O
96	O
base	O
deletion	O
.	O

This	O
smaller	O
mRNA	O
was	O
also	O
found	O
in	O
most	O
human	O
tissues	O
.	O

The	O
region	O
of	O
the	O
deletion	O
corresponds	O
to	O
the	O
second	O
HMG	O
-	O
box	O
,	O
which	O
may	O
interact	O
directly	O
with	O
DNA	O
.	O

We	O
examined	O
the	O
structure	O
of	O
the	O
genomic	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
encoding	O
the	O
human	O
mtTF1	O
to	O
determine	O
the	O
mechanism	O
of	O
the	O
deletion	O
.	O

We	O
found	O
that	O
the	O
gene	B-Gene_or_gene_product
is	O
composed	O
of	O
7	O
exons	O
spanning	O
over	O
10	O
kilobase	O
-	O
pairs	O
and	O
that	O
its	B-Gene_or_gene_product
5th	O
exon	O
is	O
identical	O
to	O
the	O
96	O
bases	O
skipped	O
in	O
the	O
shorter	O
mRNA	O
.	O

Therefore	O
,	O
the	O
shorter	O
mtTF1	O
is	O
concluded	O
to	O
be	O
generated	O
by	O
alternative	O
splicing	O
.	O

Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
heterodimerizes	O
in	O
vivo	O
with	O
a	O
conserved	O
homolog	O
,	O
Bax	B-Gene_or_gene_product
,	O
that	O
accelerates	O
programmed	O
cell	O
death	O
.	O

Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
is	O
able	O
to	O
repress	O
a	O
number	O
of	O
apoptotic	O
death	O
programs	O
.	O

To	O
investigate	O
the	O
mechanism	O
of	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
'	I-Gene_or_gene_product
s	I-Gene_or_gene_product
effect	O
,	O
we	O
examined	O
whether	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
interacted	O
with	O
other	O
proteins	B-Gene_or_gene_product
.	O

We	O
identified	O
an	O
associated	O
21	O
kd	O
protein	B-Gene_or_gene_product
partner	O
,	O
Bax	B-Gene_or_gene_product
,	O
that	O
has	O
extensive	O
amino	O
acid	O
homology	O
with	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
focused	O
within	O
highly	O
conserved	O
domains	O
I	O
and	O
II	O
.	O

Bax	B-Gene_or_gene_product
is	O
encoded	O
by	O
six	O
exons	O
and	O
demonstrates	O
a	O
complex	O
pattern	O
of	O
alternative	O
RNA	O
splicing	O
that	O
predicts	O
a	O
21	O
kd	O
membrane	O
(	O
alpha	O
)	O
and	O
two	O
forms	O
of	O
cytosolic	O
protein	B-Gene_or_gene_product
(	O
beta	O
and	O
gamma	O
)	O
.	O

Bax	B-Gene_or_gene_product
homodimerizes	O
and	O
forms	O
heterodimers	O
with	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
in	O
vivo	O
.	O

Overexpressed	O
Bax	B-Gene_or_gene_product
accelerates	O
apoptotic	O
death	O
induced	O
by	O
cytokine	B-Gene_or_gene_product
deprivation	O
in	O
an	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	O
dependent	O
cell	O
line	O
.	O

Overexpressed	O
Bax	B-Gene_or_gene_product
also	O
counters	O
the	O
death	O
repressor	O
activity	O
of	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O

These	O
data	O
suggest	O
a	O
model	O
in	O
which	O
the	O
ratio	O
of	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
to	O
Bax	B-Gene_or_gene_product
determines	O
survival	O
or	O
death	O
following	O
an	O
apoptotic	O
stimulus	O
.	O

Chromosomal	O
localization	O
of	O
genes	B-Gene_or_gene_product
encoding	O
the	O
transcription	O
factors	O
,	O
c	O
-	O
rel	O
,	O
NF	O
-	O
kappa	O
Bp50	O
,	O
NF	O
-	O
kappa	O
Bp65	O
,	O
and	O
lyt	O
-	O
10	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O

We	O
have	O
used	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
to	O
perform	O
precise	O
chromosomal	O
mapping	O
of	O
the	O
genes	B-Gene_or_gene_product
encoding	O
the	O
transcription	O
factors	O
c	O
-	O
rel	O
,	O
NF	O
-	O
kappa	O
Bp50	O
,	O
NF	O
-	O
kappa	O
Bp65	O
,	O
and	O
lyt	O
-	O
10	O
.	O

The	O
previously	O
published	O
assignments	O
of	O
c	O
-	O
rel	O
and	O
NF	O
-	O
kappa	O
Bp50	O
have	O
been	O
refined	O
to	O
specific	O
bands	O
.	O

The	O
map	O
position	O
of	O
lyt	O
-	O
10	O
,	O
inferred	O
from	O
its	O
isolation	O
from	O
a	O
t	O
(	O
10	O
;	O
14	O
)	O
(	O
q24	O
;	O
q32	O
)	O
translocation	O
,	O
has	O
been	O
confirmed	O
.	O

NF	O
-	O
kappa	O
Bp65	O
has	O
now	O
been	O
mapped	O
to	O
11q13	O
,	O
a	O
site	O
of	O
frequent	O
involvement	O
in	O
aberration	O
in	O
multiple	O
tumor	O
types	O
.	O

Mad	B-Gene_or_gene_product
:	O
a	O
heterodimeric	O
partner	O
for	O
Max	B-Gene_or_gene_product
that	O
antagonizes	O
Myc	B-Gene_or_gene_product
transcriptional	O
activity	O
.	O

Myc	B-Gene_or_gene_product
family	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
appear	O
to	O
function	O
through	O
heterodimerization	O
with	O
the	O
stable	O
,	O
constitutively	O
expressed	O
bHLH	O
-	O
Zip	O
protein	B-Gene_or_gene_product
,	O
Max	B-Gene_or_gene_product
.	O

To	O
determine	O
whether	O
Max	B-Gene_or_gene_product
mediates	O
the	O
function	O
of	O
regulatory	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
other	O
than	O
Myc	B-Gene_or_gene_product
,	O
we	O
screened	O
a	O
lambda	O
gt11	O
expression	O
library	O
with	O
radiolabeled	O
Max	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

One	O
cDNA	O
identified	O
encodes	O
a	O
new	O
member	O
of	O
the	O
bHLH	O
-	O
Zip	O
protein	B-Gene_or_gene_product
family	I-Gene_or_gene_product
,	O
Mad	B-Gene_or_gene_product
.	O

Human	O
Mad	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
homodimerizes	O
poorly	O
but	O
binds	O
Max	B-Gene_or_gene_product
in	O
vitro	O
,	O
forming	O
a	O
sequence	O
-	O
specific	O
DNA	O
binding	O
complex	O
with	O
properties	O
very	O
similar	O
to	O
those	O
of	O
Myc	B-Gene_or_gene_product
-	O
Max	B-Gene_or_gene_product
.	O

Both	O
Myc	B-Gene_or_gene_product
-	O
Max	B-Gene_or_gene_product
and	O
Mad	B-Gene_or_gene_product
-	O
Max	B-Gene_or_gene_product
heterocomplexes	O
are	O
favored	O
over	O
Max	B-Gene_or_gene_product
homodimers	O
,	O
and	O
,	O
unlike	O
Max	B-Gene_or_gene_product
homodimers	O
,	O
the	O
DNA	O
binding	O
activity	O
of	O
the	O
heterodimers	B-Gene_or_gene_product
is	O
unaffected	O
by	O
CKII	O
phosphorylation	O
.	O

Mad	B-Gene_or_gene_product
does	O
not	O
associate	O
with	O
Myc	B-Gene_or_gene_product
or	O
with	O
representative	O
bHLH	O
,	O
bZip	O
,	O
or	O
bHLH	O
-	O
Zip	O
proteins	B-Gene_or_gene_product
.	O

In	O
vivo	O
transactivation	O
assays	O
suggest	O
that	O
Myc	B-Gene_or_gene_product
-	O
Max	B-Gene_or_gene_product
and	O
Mad	B-Gene_or_gene_product
-	O
Max	B-Gene_or_gene_product
complexes	O
have	O
opposing	O
functions	O
in	O
transcription	O
and	O
that	O
Max	B-Gene_or_gene_product
plays	O
a	O
central	O
role	O
in	O
this	O
network	O
of	O
transcription	O
factors	O
.	O

Dimerization	O
of	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
KB2	I-Gene_or_gene_product
with	O
RelA	B-Gene_or_gene_product
(	I-Gene_or_gene_product
p65	I-Gene_or_gene_product
)	I-Gene_or_gene_product
regulates	O
DNA	O
binding	O
,	O
transcriptional	O
activation	O
,	O
and	O
inhibition	O
by	O
an	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
(	I-Gene_or_gene_product
MAD	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
)	I-Gene_or_gene_product
.	O

Inducible	O
expression	O
of	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
is	O
regulated	O
by	O
a	O
cellular	O
transcription	O
factor	O
,	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
kappa	O
B	O
)	O
.	O

NF	O
-	O
kappa	O
B	O
is	O
composed	O
of	O
distinct	O
subunits	O
;	O
five	O
independent	O
genes	B-Gene_or_gene_product
,	O
NFKB1	B-Gene_or_gene_product
(	I-Gene_or_gene_product
p105	I-Gene_or_gene_product
)	I-Gene_or_gene_product
,	O
NFKB2	B-Gene_or_gene_product
(	I-Gene_or_gene_product
p100	I-Gene_or_gene_product
)	I-Gene_or_gene_product
,	O
RelA	B-Gene_or_gene_product
(	I-Gene_or_gene_product
p65	I-Gene_or_gene_product
)	I-Gene_or_gene_product
,	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
rel	I-Gene_or_gene_product
and	O
relB	B-Gene_or_gene_product
,	O
that	O
encode	O
related	O
proteins	B-Gene_or_gene_product
that	O
bind	O
to	O
kappa	O
B	O
DNA	O
elements	O
have	O
been	O
isolated	O
.	O

We	O
have	O
previously	O
found	O
that	O
NFKB2	B-Gene_or_gene_product
(	I-Gene_or_gene_product
p49	I-Gene_or_gene_product
/	I-Gene_or_gene_product
p52	I-Gene_or_gene_product
)	I-Gene_or_gene_product
acts	O
in	O
concert	O
with	O
RelA	B-Gene_or_gene_product
(	I-Gene_or_gene_product
p65	I-Gene_or_gene_product
)	I-Gene_or_gene_product
to	O
stimulate	O
the	O
HIV	O
enhancer	O
in	O
Jurkat	O
T	O
-	O
leukemia	O
cells	O
.	O

Here	O
we	O
examine	O
the	O
biochemical	O
basis	O
for	O
the	O
transcriptional	O
regulation	O
of	O
HIV	O
by	O
NFKB2	B-Gene_or_gene_product
.	O

Using	O
Scatchard	O
analysis	O
,	O
we	O
have	O
determined	O
the	O
dissociation	O
constants	O
of	O
homodimeric	O
p49	B-Gene_or_gene_product
and	O
heterodimeric	O
p49	B-Gene_or_gene_product
/	I-Gene_or_gene_product
p65	I-Gene_or_gene_product
for	O
binding	O
to	O
the	O
HIV	O
kappa	O
B	O
site	O
.	O

p49	B-Gene_or_gene_product
has	O
a	O
approximately	O
18	O
-	O
fold	O
-	O
lower	O
affinity	O
for	O
the	O
HIV	O
kappa	O
B	O
site	O
(	O
KD	O
=	O
69	O
.	O
1	O
pM	O
)	O
than	O
does	O
the	O
approximately	O
50	O
-	O
kDa	O
protein	B-Gene_or_gene_product
NFKB1	I-Gene_or_gene_product
(	I-Gene_or_gene_product
p50	I-Gene_or_gene_product
)	I-Gene_or_gene_product
derived	O
from	O
p105	B-Gene_or_gene_product
(	O
KD	O
=	O
3	O
.	O
9	O
pM	O
)	O
.	O

In	O
contrast	O
,	O
the	O
affinity	O
of	O
heterodimeric	O
NFKB2	O
(	O
p49	O
)	O
/	O
RelA	O
(	O
p65	O
)	O
for	O
this	O
site	O
is	O
approximately	O
6	O
-	O
fold	O
higher	O
(	O
KD	O
=	O
11	O
.	O
8	O
pM	O
)	O
than	O
that	O
of	O
p49	B-Gene_or_gene_product
alone	O
.	O

Consistent	O
with	O
these	O
findings	O
,	O
in	O
vitro	O
transcription	O
was	O
stimulated	O
18	O
-	O
fold	O
by	O
the	O
addition	O
of	O
preformed	O
,	O
heterodimeric	O
NFKB2	O
(	O
p49	O
)	O
/	O
RelA	O
(	O
p65	O
)	O
protein	O
.	O

Transcriptional	O
activation	O
of	O
the	O
HIV	O
enhancer	O
was	O
also	O
subject	O
to	O
regulation	O
by	O
recently	O
cloned	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
(	I-Gene_or_gene_product
MAD	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
)	I-Gene_or_gene_product
.	O

Recombinant	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
(	I-Gene_or_gene_product
MAD	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
)	I-Gene_or_gene_product
inhibited	O
the	O
DNA	O
binding	O
activity	O
of	O
p65	B-Gene_or_gene_product
,	O
p49	B-Gene_or_gene_product
/	I-Gene_or_gene_product
p65	I-Gene_or_gene_product
,	O
and	O
p50	B-Gene_or_gene_product
/	I-Gene_or_gene_product
p65	I-Gene_or_gene_product
but	O
stimulated	O
the	O
binding	O
of	O
NFKB2	B-Gene_or_gene_product
(	I-Gene_or_gene_product
p49	I-Gene_or_gene_product
)	I-Gene_or_gene_product
or	O
NFKB1	B-Gene_or_gene_product
(	I-Gene_or_gene_product
p50	I-Gene_or_gene_product
)	I-Gene_or_gene_product
.	O

Functional	O
activation	O
of	O
an	O
HIV	O
reporter	O
plasmid	O
by	O
p49	B-Gene_or_gene_product
/	I-Gene_or_gene_product
p65	I-Gene_or_gene_product
in	O
transiently	O
transfected	O
Jurkat	O
T	O
-	O
leukemia	O
cells	O
was	O
also	O
inhibited	O
by	O
coexpression	O
of	O
MAD	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
.	O

These	O
data	O
suggest	O
that	O
binding	O
of	O
the	O
NFKB2	B-Gene_or_gene_product
subunit	O
to	O
the	O
HIV	O
enhancer	O
is	O
facilitated	O
by	O
RelA	B-Gene_or_gene_product
(	I-Gene_or_gene_product
p65	I-Gene_or_gene_product
)	I-Gene_or_gene_product
and	O
that	O
this	O
NFKB2	O
(	O
p49	O
)	O
/	O
p65	O
heterodimeric	O
complex	O
mediates	O
transcriptional	O
activation	O
which	O
is	O
subject	O
to	O
regulation	O
by	O
MAD	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
.	O

cDNA	O
cloning	O
of	O
transcription	O
factor	O
E4TF1	O
subunits	O
with	O
Ets	O
and	O
notch	O
motifs	O
.	O

E4TF1	O
was	O
originally	O
identified	O
as	O
one	O
of	O
the	O
transcription	O
factors	O
responsible	O
for	O
adenovirus	O
E4	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
transcription	O
.	O

It	O
is	O
composed	O
of	O
two	O
subunits	O
,	O
a	O
DNA	B-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
with	O
a	O
molecular	O
mass	O
of	O
60	O
kDa	O
and	O
a	O
53	O
-	O
kDa	O
transcription	O
-	O
activating	O
protein	B-Gene_or_gene_product
.	O

Heterodimerization	O
of	O
these	O
two	O
subunits	O
is	O
essential	O
for	O
the	O
protein	B-Gene_or_gene_product
to	O
function	O
as	O
a	O
transcription	O
factor	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
a	O
new	O
E4TF1	O
subunit	O
,	O
designated	O
E4TF1	O
-	O
47	O
,	O
which	O
has	O
no	O
DNA	O
binding	O
activity	O
but	O
can	O
associate	O
with	O
E4TF1	O
-	O
60	O
.	O

We	O
then	O
cloned	O
the	O
cDNAs	O
for	O
each	O
of	O
the	O
E4TF1	O
subunits	O
.	O

E4TF1	O
was	O
purified	O
,	O
and	O
the	O
partial	O
amino	O
acid	O
sequence	O
of	O
each	O
subunit	O
was	O
determined	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
each	O
cDNA	O
clone	O
revealed	O
that	O
E4TF1	O
-	O
60	O
had	O
an	O
ETS	O
domain	O
,	O
which	O
is	O
a	O
DNA	O
binding	O
domain	O
common	O
to	O
ets	O
-	O
related	O
transcription	O
factors	O
.	O

E4TF1	O
-	O
53	O
had	O
four	O
tandemly	O
repeated	O
notch	O
-	O
ankyrin	O
motifs	O
.	O

The	O
putative	O
cDNA	O
of	O
E4TF1	O
-	O
47	O
coded	O
almost	O
the	O
same	O
amino	O
acid	O
sequences	O
as	O
E4TF1	O
-	O
53	O
.	O

Three	O
hundred	O
and	O
thirty	O
-	O
two	O
amino	O
acids	O
of	O
the	O
N	O
termini	O
of	O
E4TF1	O
-	O
47	O
and	O
-	O
53	O
were	O
identical	O
except	O
for	O
one	O
amino	O
acid	O
insertion	O
in	O
E4TF1	O
-	O
53	O
,	O
and	O
they	O
differ	O
from	O
each	O
other	O
at	O
the	O
C	O
terminus	O
.	O

These	O
three	O
recombinant	O
cDNA	O
clones	O
were	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
and	O
the	O
proteins	B-Gene_or_gene_product
behaved	O
in	O
the	O
same	O
manner	O
as	O
purified	O
proteins	O
in	O
a	O
gel	O
retardation	O
assay	O
.	O

Nucleotide	O
and	O
predicted	O
amino	O
acid	O
sequences	O
were	O
highly	O
homologous	O
to	O
GABP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
-	B-Gene_or_gene_product
beta	I-Gene_or_gene_product
,	O
which	O
is	O
further	O
supported	O
by	O
the	O
observation	O
that	O
GABP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
specific	I-Gene_or_gene_product
antibody	I-Gene_or_gene_product
can	O
recognize	O
human	O
E4TF1	O
.	O

The	O
human	O
Oct	O
-	O
6	O
POU	O
transcription	O
factor	O
lacks	O
the	O
first	O
50	O
amino	O
acids	O
of	O
its	O
murine	O
counterpart	O
.	O

Predominant	O
expression	O
of	O
human	O
zic	B-Gene_or_gene_product
in	O
cerebellar	O
granule	O
cell	O
lineage	O
and	O
medulloblastoma	O
.	O

Zic	B-Gene_or_gene_product
is	O
a	O
novel	O
zinc	O
finger	O
protein	O
which	O
displays	O
a	O
highly	O
restricted	O
expression	O
pattern	O
in	O
the	O
adult	O
and	O
developing	O
mouse	O
cerebellum	O
and	O
is	O
highly	O
homologous	O
to	O
the	O
recently	O
cloned	O
Drosophila	O
pair	O
-	O
rule	O
gene	B-Gene_or_gene_product
Opa	I-Gene_or_gene_product
.	O

To	O
clarify	O
the	O
mechanism	O
for	O
the	O
development	O
of	O
the	O
human	O
cerebellum	O
and	O
its	O
involvement	O
in	O
human	O
nervous	O
system	O
diseases	O
,	O
we	O
have	O
isolated	O
human	O
Zic	B-Gene_or_gene_product
cDNA	O
and	O
examined	O
its	O
expression	O
by	O
using	O
monoclonal	O
antibody	O
against	O
recombinant	O
Zic	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

The	O
nucleotide	O
sequence	O
of	O
human	O
Zic	B-Gene_or_gene_product
cDNA	O
is	O
85	O
%	O
homologous	O
to	O
that	O
of	O
mouse	O
Zic	B-Gene_or_gene_product
cDNA	O
.	O

Its	O
putative	O
amino	O
acid	O
sequence	O
is	O
highly	O
conserved	O
(	O
>	O
99	O
%	O
)	O
except	O
for	O
substitution	O
of	O
only	O
two	O
amino	O
acid	O
residues	O
.	O

In	O
situ	O
chromosome	O
hybridization	O
localized	O
the	O
human	O
Zic	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
to	O
chromosome	O
band	O
3q24	O
.	O

Human	O
Zic	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
was	O
immunohistochemically	O
detected	O
in	O
the	O
nuclei	O
of	O
the	O
cerebellar	O
granule	O
cell	O
lineage	O
from	O
the	O
progenitor	O
cells	O
of	O
the	O
external	O
germinal	O
layer	O
to	O
the	O
postmigrated	O
cells	O
of	O
the	O
internal	O
granular	O
layer	O
.	O

Furthermore	O
,	O
Zic	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
was	O
detected	O
in	O
medulloblastoma	O
(	O
26	O
/	O
29	O
cases	O
)	O
,	O
whereas	O
no	O
other	O
tumors	O
examined	O
(	O
over	O
70	O
cases	O
including	O
primitive	O
neuroectodermal	O
tumors	O
)	O
expressed	O
this	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

These	O
findings	O
suggest	O
that	O
Zic	B-Gene_or_gene_product
is	O
a	O
potential	O
biomarker	O
for	O
medulloblastoma	O
as	O
well	O
as	O
the	O
human	O
cerebellar	O
granule	O
cell	O
lineage	O
.	O

The	O
rearranged	B-Gene_or_gene_product
L	I-Gene_or_gene_product
-	I-Gene_or_gene_product
myc	I-Gene_or_gene_product
fusion	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
(	O
RLF	B-Gene_or_gene_product
)	O
encodes	O
a	O
Zn	O
-	O
15	O
related	O
zinc	B-Gene_or_gene_product
finger	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

We	O
have	O
previously	O
characterized	O
intrachromosomal	O
rearrangements	O
at	O
1p32	O
fusing	O
the	O
first	O
exon	O
of	O
the	O
RLF	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
with	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myc	I-Gene_or_gene_product
.	O

Here	O
we	O
present	O
the	O
full	O
-	O
length	O
cDNA	O
sequence	O
of	O
the	O
6251	O
bp	O
RLF	B-Gene_or_gene_product
mRNA	O
.	O

The	O
predicted	O
1914	O
amino	O
acid	O
Rlf	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
contains	O
sixteen	O
widely	O
spaced	O
zinc	O
finger	O
motifs	O
,	O
and	O
is	O
related	O
to	O
the	O
Zn	O
-	O
15	O
transcription	O
factor	O
.	O

RLF	B-Gene_or_gene_product
is	O
widely	O
expressed	O
in	O
fetal	O
and	O
adult	O
tissues	O
,	O
suggesting	O
that	O
it	O
has	O
a	O
general	O
role	O
in	O
transcriptional	O
regulation	O
.	O

The	O
zinc	O
fingers	O
are	O
not	O
contained	O
in	O
the	O
79	O
amino	O
acid	O
N	O
-	O
terminal	O
region	O
of	O
RLF	B-Gene_or_gene_product
involved	O
in	O
the	O
RLF	O
-	O
L	O
-	O
myc	O
fusions	O
,	O
and	O
the	O
transforming	O
ability	O
of	O
the	O
RLF	B-Gene_or_gene_product
-	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myc	I-Gene_or_gene_product
and	O
the	O
normal	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myc	I-Gene_or_gene_product
proteins	B-Gene_or_gene_product
is	O
indistinguishable	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
role	O
of	O
the	O
rearrangements	O
fusing	O
RLF	B-Gene_or_gene_product
and	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myc	I-Gene_or_gene_product
is	O
to	O
deregulate	O
the	O
tightly	O
controlled	O
expression	O
of	O
the	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myc	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

Activation	O
of	O
signalling	O
by	O
the	O
activin	O
receptor	O
complex	O
.	O

Activin	B-Gene_or_gene_product
exerts	O
its	O
effects	O
by	O
simultaneously	O
binding	O
to	O
two	O
types	O
of	O
protein	B-Gene_or_gene_product
serine	I-Gene_or_gene_product
/	I-Gene_or_gene_product
threonine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
,	O
each	O
type	O
existing	O
in	O
various	O
isoforms	O
.	O

Using	O
the	O
ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IB	I-Gene_or_gene_product
and	O
ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IIB	I-Gene_or_gene_product
receptor	O
isoforms	O
,	O
we	O
have	O
investigated	O
the	O
mechanism	O
of	O
activin	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
activation	O
.	O

ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IIB	I-Gene_or_gene_product
are	O
phosphoproteins	O
with	O
demonstrable	O
affinity	O
for	O
each	O
other	O
.	O

However	O
,	O
activin	B-Gene_or_gene_product
addition	O
strongly	O
promotes	O
an	O
interaction	O
between	O
these	B-Gene_or_gene_product
two	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Activin	B-Gene_or_gene_product
binds	O
directly	O
to	O
ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IIB	I-Gene_or_gene_product
,	O
and	O
this	O
complex	O
associates	O
with	O
ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IB	I-Gene_or_gene_product
,	O
which	O
does	O
not	O
bind	O
ligand	O
on	O
its	O
own	O
.	O

In	O
the	O
resulting	O
complex	O
,	O
ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IB	I-Gene_or_gene_product
becomes	O
hyperphosphorylated	O
,	O
and	O
this	O
requires	O
the	O
kinase	O
activity	O
of	O
ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IIB	I-Gene_or_gene_product
.	O

Mutation	O
of	O
conserved	O
serines	O
and	O
threonines	O
in	O
the	O
GS	O
domain	O
,	O
a	O
region	O
just	O
upstream	O
of	O
the	O
kinase	O
domain	O
in	O
ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IB	I-Gene_or_gene_product
,	O
abrogates	O
both	O
phosphorylation	O
and	O
signal	O
propagation	O
,	O
suggesting	O
that	O
this	O
domain	O
contains	O
phosphorylation	O
sites	O
required	O
for	O
signalling	O
.	O

ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IB	I-Gene_or_gene_product
activation	O
can	O
be	O
mimicked	O
by	O
mutation	O
of	O
Thr	O
-	O
206	O
to	O
aspartic	O
acid	O
,	O
which	O
yields	O
a	O
construct	O
,	O
ActR	O
-	O
IB	O
(	O
T206D	O
)	O
,	O
that	O
signals	O
in	O
the	O
absence	O
of	O
ligand	O
.	O

Furthermore	O
,	O
the	O
signalling	O
activity	O
of	O
this	O
mutant	O
construct	O
is	O
undisturbed	O
by	O
overexpression	O
of	O
a	O
dominant	O
negative	O
kinase	O
-	O
defective	O
ActR	O
-	O
IIB	O
construct	O
,	O
indicating	O
that	O
ActR	O
-	O
IB	O
(	O
T206D	O
)	O
can	O
signal	O
independently	O
of	O
ActR	O
-	O
IIB	O
.	O

The	O
evidence	O
suggests	O
that	O
ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IIB	I-Gene_or_gene_product
acts	O
as	O
a	O
primary	O
activin	O
receptor	O
and	O
ActR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IB	I-Gene_or_gene_product
acts	O
as	O
a	O
downstream	O
transducer	O
of	O
activin	O
signals	O
.	O

A	O
3	O
'	O
-	O
-	O
>	O
5	O
'	O
XPB	O
helicase	O
defect	O
in	O
repair	O
/	O
transcription	O
factor	O
TFIIH	O
of	O
xeroderma	O
pigmentosum	O
group	O
B	O
affects	O
both	O
DNA	O
repair	O
and	O
transcription	O
.	O

XPB	O
is	O
a	O
subunit	O
of	O
the	O
basal	O
transcription	O
factor	O
TFIIH	O
,	O
which	O
is	O
also	O
involved	O
in	O
nucleotide	O
excision	O
repair	O
(	O
NER	O
)	O
and	O
potentially	O
in	O
cell	O
cycle	O
regulation	O
.	O

A	O
frameshift	O
mutation	O
in	O
the	O
3	O
'	O
-	O
end	O
of	O
the	O
XPB	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
responsible	O
for	O
a	O
concurrence	O
of	O
two	O
disorders	O
:	O
xeroderma	O
pigmentosum	O
(	O
XP	O
)	O
and	O
Cockayne	O
'	O
s	O
syndrome	O
(	O
CS	O
)	O
.	O

We	O
have	O
isolated	O
TFIIH	O
from	O
cells	O
derived	O
from	O
a	O
patient	O
(	O
XP11BE	O
)	O
who	O
carries	O
this	O
frameshift	O
mutation	O
(	O
TFIIHmut	O
)	O
and	O
from	O
the	O
mother	O
of	O
this	O
patient	O
(	O
TFIIHwt	O
)	O
to	O
determine	O
the	O
biochemical	O
consequences	O
of	O
the	O
mutation	O
.	O

Although	O
identical	O
in	O
composition	O
and	O
stoichiometry	O
to	O
TFIIHwt	O
,	O
TFIIHmut	O
shows	O
a	O
reduced	O
3	O
'	O
-	O
-	O
>	O
5	O
'	O
XPB	O
helicase	O
activity	O
.	O

A	O
decrease	O
in	O
helicase	O
and	O
DNA	O
-	O
dependent	O
ATPase	O
activities	O
was	O
also	O
observed	O
with	O
the	O
mutated	O
recombinant	O
XPB	O
protein	O
.	O

The	O
XPB	O
mutation	O
causes	O
a	O
severe	O
NER	O
defect	O
.	O

In	O
addition	O
,	O
we	O
provide	O
evidence	O
for	O
a	O
decrease	O
in	O
basal	O
transcription	O
activity	O
in	O
vitro	O
.	O

The	O
latter	O
defect	O
may	O
provide	O
an	O
explanation	O
for	O
many	O
of	O
the	O
XP	O
and	O
CS	O
symptoms	O
that	O
are	O
difficult	O
to	O
rationalize	O
based	O
solely	O
on	O
an	O
NER	O
defect	O
.	O

Thus	O
,	O
this	O
work	O
presents	O
the	O
first	O
detailed	O
analysis	O
of	O
a	O
naturally	O
occurring	O
mutation	O
in	O
a	O
basal	O
transcription	O
factor	O
and	O
supports	O
the	O
concept	O
that	O
the	O
combined	O
XP	O
/	O
CS	O
clinical	O
entity	O
is	O
actually	O
the	O
result	O
of	O
a	O
combined	O
transcription	O
/	O
repair	O
deficiency	O
.	O

Recombinant	O
NFAT1	O
(	O
NFATp	O
)	O
is	O
regulated	O
by	O
calcineurin	B-Gene_or_gene_product
in	O
T	O
cells	O
and	O
mediates	O
transcription	O
of	O
several	O
cytokine	B-Gene_or_gene_product
genes	B-Gene_or_gene_product
.	O

Transcription	O
factors	O
of	O
the	O
NFAT	O
family	O
play	O
a	O
key	O
role	O
in	O
the	O
transcription	O
of	O
cytokine	B-Gene_or_gene_product
genes	B-Gene_or_gene_product
and	O
other	O
genes	B-Gene_or_gene_product
during	O
the	O
immune	O
response	O
.	O

We	O
have	O
identified	O
two	O
new	O
isoforms	O
of	O
the	O
transcription	O
factor	O
NFAT1	O
(	O
previously	O
termed	O
NFATp	O
)	O
that	O
are	O
the	O
predominant	O
isoforms	O
expressed	O
in	O
murine	O
and	O
human	O
T	O
cells	O
.	O

When	O
expressed	O
in	O
Jurkat	O
T	O
cells	O
,	O
recombinant	O
NFAT1	O
is	O
regulated	O
,	O
as	O
expected	O
,	O
by	O
the	O
calmodulin	B-Gene_or_gene_product
-	O
dependent	O
phosphatase	O
calcineurin	O
,	O
and	O
its	O
function	O
is	O
inhibited	O
by	O
the	O
immunosuppressive	O
agent	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
.	O

Transactivation	O
by	O
recombinant	O
NFAT1	O
in	O
Jurkat	O
T	O
cells	O
requires	O
dual	O
stimulation	O
with	O
ionomycin	O
and	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
;	O
this	O
activity	O
is	O
potentiated	O
by	O
coexpression	O
of	O
constitutively	O
active	O
calcineurin	O
and	O
is	O
inhibited	O
by	O
CsA	O
.	O

Immunocytochemical	O
analysis	O
indicates	O
that	O
recombinant	O
NFAT1	O
localizes	O
in	O
the	O
cytoplasm	O
of	O
transiently	O
transfected	O
T	O
cells	O
and	O
translocates	O
into	O
the	O
nucleus	O
in	O
a	O
CsA	O
-	O
sensitive	O
manner	O
following	O
ionomycin	O
stimulation	O
.	O

When	O
expressed	O
in	O
COS	O
cells	O
,	O
however	O
,	O
NFAT1	O
is	O
capable	O
of	O
transactivation	O
,	O
but	O
it	O
is	O
not	O
regulated	O
correctly	O
:	O
its	O
subcellular	O
localization	O
and	O
transcriptional	O
function	O
are	O
not	O
affected	O
by	O
stimulation	O
of	O
the	O
COS	O
cells	O
with	O
ionomycin	O
and	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
.	O

Recombinant	O
NFAT1	O
can	O
mediate	O
transcription	O
of	O
the	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
,	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
and	O
granulocyte	B-Gene_or_gene_product
-	I-Gene_or_gene_product
macrophage	I-Gene_or_gene_product
colony	I-Gene_or_gene_product
-	I-Gene_or_gene_product
stimulating	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
promoters	O
in	O
T	O
cells	O
,	O
suggesting	O
that	O
NFAT1	O
contributes	O
to	O
the	O
CsA	O
-	O
sensitive	O
transcription	O
of	O
these	O
genes	B-Gene_or_gene_product
during	O
the	O
immune	O
response	O
.	O

An	O
alternatively	O
spliced	O
isoform	O
of	O
the	O
Spi	O
-	O
B	O
transcription	O
factor	O
.	O

Spi	O
-	O
B	O
is	O
an	O
Ets	O
transcription	O
factor	O
related	O
to	O
the	O
oncoprotein	B-Gene_or_gene_product
Spi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
PU	I-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
highly	O
expressed	O
in	O
B	O
lymphoid	O
cells	O
.	O

The	O
Ets	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
share	O
a	O
conserved	O
Ets	O
domain	O
that	O
mediates	O
specific	O
DNA	O
binding	O
.	O

Spi	O
-	O
B	O
binds	O
DNA	O
sequences	O
containing	O
a	O
core	O
5	O
'	O
-	O
GGAA	O
-	O
3	O
'	O
and	O
activates	O
transcription	O
through	O
this	O
motif	O
.	O

Up	O
to	O
date	O
,	O
the	O
biological	O
function	O
of	O
Spi	O
-	O
B	O
remains	O
unknown	O
.	O

Here	O
,	O
we	O
describe	O
the	O
characterization	O
of	O
an	O
alternatively	O
spliced	O
variant	O
of	O
Spi	O
-	O
B	O
,	O
named	O
deltaSpi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
,	O
which	O
has	O
lost	O
the	O
Ets	O
domain	O
.	O

In	O
B	O
lymphoid	O
cells	O
,	O
deltaspi	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
and	O
spi	O
-	O
B	O
mRNAs	O
were	O
present	O
simultaneously	O
in	O
a	O
ratio	O
of	O
around	O
10	O
%	O
.	O

DeltaSpi	O
-	O
B	O
product	O
was	O
not	O
able	O
to	O
bind	O
DNA	O
and	O
was	O
recovered	O
in	O
cytoplasmic	O
cellular	O
extracts	O
.	O

We	O
raise	O
the	O
hypothesis	O
that	O
delta	B-Gene_or_gene_product
Spi	I-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
might	O
affect	O
Spi	O
-	O
B	O
function	O
by	O
recruiting	O
factors	B-Gene_or_gene_product
involved	O
in	O
Spi	O
-	O
B	O
activity	O
.	O

Characterization	O
of	O
a	O
new	O
isoform	O
of	O
the	O
NFAT	B-Gene_or_gene_product
(	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
)	O
gene	B-Gene_or_gene_product
family	O
member	O
NFATc	B-Gene_or_gene_product
.	O

The	O
cyclosporin	O
A	O
(	O
CsA	B-Gene_or_gene_product
)	O
/	O
FK506	O
-	O
sensitive	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	B-Gene_or_gene_product
)	O
plays	O
a	O
key	O
role	O
in	O
the	O
inducible	O
expression	O
of	O
cytokine	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
in	O
T	O
cells	O
.	O

Although	O
NFAT	B-Gene_or_gene_product
has	O
been	O
recently	O
shown	O
to	O
be	O
inducible	O
in	O
several	O
non	O
-	O
T	O
immune	O
cells	O
,	O
the	O
NFAT	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	O
members	O
characterized	O
to	O
date	O
have	O
been	O
isolated	O
only	O
from	O
T	O
cells	O
.	O

To	O
further	O
characterize	O
NFAT	B-Gene_or_gene_product
function	O
in	O
human	O
B	O
cells	O
and	O
to	O
demonstrate	O
cytokine	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
specificity	O
of	O
NFAT	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
we	O
report	O
here	O
the	O
isolation	O
and	O
characterization	O
of	O
a	O
cDNA	O
clone	O
from	O
the	O
Raji	O
B	O
cell	O
line	O
.	O

The	O
cDNA	O
clone	O
encodes	O
a	O
new	O
isoform	O
,	O
NFATc	B-Gene_or_gene_product
.	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
,	O
of	O
the	O
NFAT	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	O
member	O
NFATc	B-Gene_or_gene_product
(	O
designated	O
here	O
NFATc	B-Gene_or_gene_product
.	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
)	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
NFATc	B-Gene_or_gene_product
.	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
differs	O
from	O
that	O
of	O
NFATc	B-Gene_or_gene_product
.	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
in	O
the	O
first	O
NH2	O
-	O
terminal	O
29	O
residues	O
and	O
contains	O
an	O
additional	O
region	O
of	O
142	O
residues	O
at	O
the	O
COOH	O
terminus	O
.	O

Northern	O
analysis	O
using	O
a	O
probe	O
encompassing	O
a	O
common	O
region	O
of	O
both	O
isoforms	O
showed	O
two	O
mRNA	O
species	O
of	O
2	O
.	O
7	O
and	O
4	O
.	O
5	O
kilobase	O
pairs	O
,	O
while	O
an	O
NFATc	B-Gene_or_gene_product
.	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
-	O
specific	O
probe	O
detected	O
only	O
the	O
4	O
.	O
5	O
-	O
kilobase	O
pair	O
mRNA	O
which	O
was	O
preferentially	O
expressed	O
in	O
the	O
spleen	O
.	O

Transient	O
expression	O
of	O
NFATc	B-Gene_or_gene_product
.	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
was	O
capable	O
of	O
activating	O
an	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
NFAT	B-Gene_or_gene_product
-	O
driven	O
reporter	O
gene	O
in	O
stimulated	O
Jurkat	O
cells	O
in	O
a	O
CsA	O
-	O
sensitive	O
manner	O
.	O

However	O
,	O
NFATc	O
.	O
beta	O
neither	O
bound	O
to	O
the	O
kappa3	O
element	O
(	O
an	O
NFAT	O
-	O
binding	O
site	O
)	O
in	O
the	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
promoter	O
nor	O
activated	O
the	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
promoter	O
in	O
cotransfection	O
assays	O
.	O

These	O
data	O
suggest	O
that	O
different	O
members	O
or	O
isoforms	O
of	O
NFAT	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	O
may	O
regulate	O
inducible	O
expression	O
of	O
different	O
cytokine	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

Characterization	O
of	O
the	O
human	O
forkhead	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
FREAC	I-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
.	O

Evidence	O
for	O
regulation	O
by	O
Wilms	B-Gene_or_gene_product
'	I-Gene_or_gene_product
tumor	I-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
(	O
WT	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
and	O
p53	B-Gene_or_gene_product
.	O

We	O
describe	O
the	O
cloning	O
and	O
sequence	O
analysis	O
of	O
a	O
nearly	O
full	O
-	O
length	O
cDNA	O
as	O
well	O
as	O
a	O
corresponding	O
5	O
.	O
2	O
-	O
kilobase	O
pair	O
genomic	O
fragment	O
encoding	O
FREAC	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
,	O
a	O
member	O
of	O
the	O
forkhead	O
family	O
of	O
transcription	O
factors	O
.	O

The	O
cDNA	O
is	O
collinear	O
with	O
respect	O
to	O
the	O
coding	O
region	O
of	O
the	O
intronless	O
genomic	O
clone	O
.	O

The	O
conceptual	O
translation	O
product	O
predicts	O
a	O
protein	B-Gene_or_gene_product
of	O
465	O
amino	O
acids	O
with	O
a	O
hyperacidic	O
amino	O
-	O
terminal	O
end	O
,	O
a	O
DNA	O
binding	O
forkhead	O
domain	O
and	O
a	O
carboxyl	O
-	O
terminal	O
part	O
that	O
is	O
rich	O
in	O
homopolymeric	O
runs	O
of	O
prolines	O
and	O
alanines	O
.	O

The	O
transcription	O
start	O
is	O
identified	O
using	O
an	O
RNase	O
protection	O
assay	O
.	O

A	O
2	O
.	O
7	O
-	O
kilobase	O
pair	O
genomic	O
DNA	O
fragment	O
,	O
located	O
immediately	O
upstream	O
of	O
the	O
translation	O
start	O
,	O
was	O
fused	O
to	O
a	O
luciferase	O
reporter	O
gene	O
.	O

Significant	O
levels	O
of	O
luciferase	O
activity	O
were	O
detected	O
when	O
this	O
construct	O
was	O
transfected	O
into	O
two	O
kidney	O
-	O
derived	O
cell	O
lines	O
,	O
293	O
and	O
COS	O
-	O
7	O
cells	O
,	O
whereas	O
only	O
background	O
reporter	O
gene	O
expression	O
was	O
observed	O
in	O
a	O
cell	O
line	O
of	O
nonkidney	O
origin	O
.	O

Cotransfections	O
with	O
plasmids	O
expressing	O
WT	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
WTAR	O
(	O
a	O
mutated	O
form	O
of	O
WT	O
-	O
1	O
)	O
,	O
p53	B-Gene_or_gene_product
,	O
and	O
a	O
mutated	O
form	O
of	O
p53	O
revealed	O
a	O
complex	O
pattern	O
of	O
regulation	O
with	O
a	O
3	O
-	O
fold	O
induction	O
with	O
WT	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
a	O
7	O
-	O
fold	O
induction	O
with	O
mutated	O
p53	O
,	O
and	O
a	O
4	O
-	O
fold	O
repression	O
with	O
wild	O
-	O
type	O
p53	B-Gene_or_gene_product
.	O

A	O
5	O
'	O
-	O
promoter	O
deletion	O
series	O
delimits	O
a	O
DNA	O
fragment	O
necessary	O
for	O
WT	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
inducibility	O
in	O
cotransfection	O
experiments	O
.	O

This	O
fragment	O
is	O
shown	O
to	O
contain	O
at	O
least	O
one	O
cis	O
-	O
element	O
that	O
is	O
capable	O
of	O
interacting	O
with	O
recombinant	O
WT	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O

Characterization	O
of	O
NERF	O
,	O
a	O
novel	O
transcription	O
factor	O
related	O
to	O
the	O
Ets	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
ELF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O

We	O
have	O
cloned	O
the	O
gene	B-Gene_or_gene_product
for	O
a	O
novel	O
Ets	O
-	O
related	O
transcription	O
factor	O
,	O
new	O
Ets	O
-	O
related	O
factor	O
(	O
NERF	O
)	O
,	O
from	O
human	O
spleen	O
,	O
fetal	O
liver	O
,	O
and	O
brain	O
.	O

Comparison	O
of	O
the	O
deduced	O
amino	O
acid	O
sequence	O
of	O
NERF	O
with	O
those	O
of	O
other	O
members	O
of	O
the	O
Ets	B-Gene_or_gene_product
family	I-Gene_or_gene_product
reveals	O
that	O
the	O
level	O
of	O
homology	O
to	O
ELF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
which	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
several	O
T	B-Gene_or_gene_product
-	I-Gene_or_gene_product
and	I-Gene_or_gene_product
B	I-Gene_or_gene_product
-	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
-	I-Gene_or_gene_product
specific	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
,	O
is	O
highest	O
.	O

Homologies	O
are	O
clustered	O
in	O
the	O
putative	O
DNA	O
binding	O
domain	O
in	O
the	O
middle	O
of	O
the	O
protein	B-Gene_or_gene_product
,	O
a	O
basic	O
domain	O
just	O
upstream	O
of	O
this	O
domain	O
,	O
and	O
several	O
shorter	O
stretches	O
of	O
homology	O
towards	O
the	O
amino	O
terminus	O
.	O

The	O
presence	O
of	O
two	O
predominant	O
NERF	O
transcripts	O
in	O
various	O
fetal	O
and	O
adult	O
human	O
tissues	O
is	O
due	O
to	O
at	O
least	O
three	O
alternative	O
splice	O
products	O
,	O
NERF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1a	I-Gene_or_gene_product
,	O
NERF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1b	I-Gene_or_gene_product
,	O
and	O
NERF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
which	O
differ	O
in	O
their	O
amino	O
termini	O
and	O
their	O
expression	O
in	O
different	O
tissues	O
.	O

Only	O
NERF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
ELF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
and	O
not	O
NERF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1a	I-Gene_or_gene_product
and	O
NERF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1b	I-Gene_or_gene_product
,	O
function	O
as	O
transcriptional	O
activators	O
of	O
the	O
lyn	B-Gene_or_gene_product
and	O
blk	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
promoters	O
,	O
although	O
all	O
isoforms	O
of	O
NERF	O
bind	O
with	O
affinities	O
similar	O
to	O
those	O
of	O
ELF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
to	O
a	O
variety	O
of	O
Ets	O
binding	O
sites	O
in	O
,	O
among	O
others	O
,	O
the	O
blk	B-Gene_or_gene_product
,	O
lck	B-Gene_or_gene_product
,	O
lyn	B-Gene_or_gene_product
,	O
mb	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
and	O
immunoglobulin	B-Gene_or_gene_product
H	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
and	O
are	O
expressed	O
at	O
similar	O
levels	O
.	O

Since	O
NERF	O
and	O
ELF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
are	O
coexpressed	O
in	O
B	O
and	O
T	O
cells	O
,	O
both	O
might	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
the	O
same	O
genes	B-Gene_or_gene_product
.	O

Genomic	O
organization	O
and	O
chromosomal	O
localization	O
of	O
the	O
gene	B-Gene_or_gene_product
TCF15	I-Gene_or_gene_product
encoding	O
the	O
early	O
mesodermal	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
factor	O
bHLH	O
-	O
EC2	O
.	O

bHLH	O
-	O
EC2	O
is	O
a	O
recently	O
characterized	O
member	O
of	O
a	O
growing	O
family	O
of	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
transcription	O
factors	O
.	O

This	O
family	O
includes	O
bHLH	O
factors	O
such	O
as	O
twist	O
,	O
which	O
appear	O
to	O
be	O
primarily	O
involved	O
in	O
early	O
mesodermal	O
differentiation	O
,	O
and	O
bHLH	O
factors	O
such	O
as	O
TAL	O
-	O
1	O
,	O
which	O
have	O
been	O
characterized	O
through	O
their	O
association	O
with	O
chromosomal	O
breakpoints	O
associated	O
with	O
T	O
-	O
cell	O
leukemias	O
.	O

To	O
provide	O
for	O
studies	O
aimed	O
at	O
understanding	O
the	O
genetic	O
regulation	O
of	O
bHLH	O
-	O
EC2	O
,	O
we	O
have	O
characterized	O
the	O
organization	O
of	O
this	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
and	O
conducted	O
preliminary	O
studies	O
of	O
the	O
transcriptional	O
activity	O
of	O
the	O
upstream	O
promoter	O
region	O
.	O

The	O
mouse	O
bHLH	O
-	O
EC2	O
gene	B-Gene_or_gene_product
was	O
found	O
to	O
consist	O
of	O
two	O
exons	O
separated	O
by	O
a	O
5	O
-	O
kb	O
intron	O
,	O
an	O
organization	O
pattern	O
similar	O
to	O
the	O
mouse	O
twist	O
gene	B-Gene_or_gene_product
.	O

The	O
transcription	O
initiation	O
site	O
was	O
identified	O
by	O
RNase	O
protection	O
assay	O
and	O
primer	O
extension	O
analysis	O
.	O

Linked	O
promoter	O
-	O
reporter	O
gene	O
transfection	O
experiments	O
in	O
cultured	O
cells	O
indicated	O
that	O
while	O
the	O
identified	O
upstream	O
sequence	O
can	O
function	O
to	O
promote	O
transcription	O
,	O
it	O
does	O
not	O
function	O
in	O
a	O
cell	O
-	O
specific	O
fashion	O
.	O

To	O
investigate	O
the	O
possible	O
association	O
of	O
bHLH	B-Gene_or_gene_product
-	I-Gene_or_gene_product
EC2	I-Gene_or_gene_product
with	O
hematological	O
malignancy	O
,	O
the	O
chromosomal	O
location	O
of	O
this	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
in	O
the	O
human	O
was	O
mapped	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
and	O
assigned	O
to	O
chromosome	O
band	O
20p13	O
.	O

Identification	O
and	O
characterization	O
of	O
a	O
leukocyte	O
-	O
specific	O
component	O
of	O
the	O
nuclear	O
body	O
.	O

The	O
nuclear	O
body	O
(	O
NB	O
)	O
is	O
a	O
cellular	O
organelle	O
that	O
is	O
involved	O
in	O
the	O
pathogenesis	O
of	O
acute	O
promyelocytic	O
leukemia	O
and	O
viral	O
infection	O
.	O

The	O
NB	O
is	O
also	O
a	O
target	O
of	O
antibodies	B-Gene_or_gene_product
in	O
the	O
serum	O
of	O
patients	O
with	O
the	O
autoimmune	O
disease	O
primary	O
biliary	O
cirrhosis	O
.	O

In	O
this	O
study	O
,	O
serum	O
from	O
a	O
patient	O
with	O
primary	O
biliary	O
cirrhosis	O
was	O
used	O
to	O
identify	O
a	O
cDNA	O
encoding	O
a	O
novel	O
component	O
of	O
the	O
NB	O
,	O
a	O
140	O
-	O
kDa	O
protein	B-Gene_or_gene_product
designated	O
Sp140	B-Gene_or_gene_product
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
the	O
amino	O
-	O
terminal	O
portion	O
of	O
Sp140	B-Gene_or_gene_product
was	O
similar	O
to	O
Sp100	B-Gene_or_gene_product
,	O
a	O
previously	O
identified	O
NB	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

The	O
carboxyl	O
portion	O
of	O
Sp140	B-Gene_or_gene_product
contained	O
a	O
zinc	O
-	O
finger	O
domain	O
and	O
a	O
bromodomain	O
,	O
motifs	O
that	O
are	O
present	O
in	O
proteins	B-Gene_or_gene_product
regulating	O
gene	B-Gene_or_gene_product
transcription	O
.	O

High	O
levels	O
of	O
Sp140	B-Gene_or_gene_product
mRNA	O
were	O
detected	O
in	O
human	O
spleen	O
and	O
peripheral	O
blood	O
leukocytes	O
,	O
but	O
not	O
other	O
human	O
tissues	O
.	O

The	O
level	O
of	O
SP140	B-Gene_or_gene_product
mRNA	O
in	O
myeloid	O
precursor	O
cell	O
lines	O
HL60	O
and	O
NB4	O
markedly	O
increased	O
in	O
response	O
to	O
chemically	O
induced	O
cellular	O
differentiation	O
.	O

Immunohistochemical	O
techniques	O
were	O
used	O
to	O
demonstrate	O
that	O
SP140	B-Gene_or_gene_product
localized	O
to	O
the	O
NB	O
in	O
differentiated	O
HL60	O
and	O
NB4	O
cells	O
.	O

The	O
location	O
of	O
Sp140	B-Gene_or_gene_product
in	O
the	O
NB	O
,	O
and	O
expression	O
of	O
this	O
gene	B-Gene_or_gene_product
in	O
cells	O
involved	O
in	O
host	O
defense	O
,	O
suggest	O
that	O
Sp140	B-Gene_or_gene_product
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
acute	O
promyelocytic	O
leukemia	O
and	O
viral	O
infection	O
.	O

Characterization	O
of	O
EZH1	B-Gene_or_gene_product
,	O
a	O
human	O
homolog	O
of	O
Drosophila	O
Enhancer	B-Gene_or_gene_product
of	I-Gene_or_gene_product
zeste	I-Gene_or_gene_product
near	O
BRCA1	B-Gene_or_gene_product
.	O

Recent	O
transcription	O
mapping	O
efforts	O
within	O
chromosome	O
17q21	O
have	O
led	O
to	O
the	O
identification	O
of	O
a	O
human	O
homolog	O
of	O
the	O
Drosophila	O
gene	B-Gene_or_gene_product
Enhancer	I-Gene_or_gene_product
of	I-Gene_or_gene_product
zeste	I-Gene_or_gene_product
,	O
E	B-Gene_or_gene_product
(	I-Gene_or_gene_product
z	I-Gene_or_gene_product
)	I-Gene_or_gene_product
.	O

A	O
member	O
of	O
the	O
Polycomb	O
group	O
(	O
Pc	B-Gene_or_gene_product
-	I-Gene_or_gene_product
G	I-Gene_or_gene_product
)	O
of	O
proteins	O
,	O
Drosophila	O
E	B-Gene_or_gene_product
(	I-Gene_or_gene_product
z	I-Gene_or_gene_product
)	I-Gene_or_gene_product
acts	O
as	O
a	O
negative	O
regulator	O
of	O
the	O
segment	O
identity	O
genes	B-Gene_or_gene_product
of	O
the	O
Antennapedia	B-Gene_or_gene_product
and	O
Bithorax	B-Gene_or_gene_product
complexes	I-Gene_or_gene_product
.	O

Here	O
we	O
report	O
the	O
full	O
-	O
length	O
protein	B-Gene_or_gene_product
coding	O
sequence	O
of	O
human	O
EZH1	O
(	O
Enhancer	B-Gene_or_gene_product
of	I-Gene_or_gene_product
zeste	I-Gene_or_gene_product
homolog	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
and	O
compare	O
the	O
respective	O
protein	B-Gene_or_gene_product
sequences	O
in	O
both	O
species	O
.	O

EZH1	B-Gene_or_gene_product
encodes	O
a	O
protein	B-Gene_or_gene_product
of	O
747	O
amino	O
acids	O
that	O
displays	O
55	O
%	O
amino	O
acid	O
identity	O
overall	O
(	O
70	O
%	O
similarity	O
)	O
with	O
Drosophila	O
E	B-Gene_or_gene_product
(	I-Gene_or_gene_product
z	I-Gene_or_gene_product
)	I-Gene_or_gene_product
.	O

The	O
strongest	O
homology	O
was	O
noted	O
(	O
79	O
%	O
identity	O
,	O
89	O
%	O
similarity	O
)	O
within	O
the	O
carboxy	O
-	O
terminal	O
245	O
amino	O
acids	O
,	O
including	O
the	O
SET	O
domain	O
,	O
a	O
region	O
of	O
E	B-Gene_or_gene_product
(	I-Gene_or_gene_product
z	I-Gene_or_gene_product
)	I-Gene_or_gene_product
also	O
conserved	O
in	O
other	O
Drosophila	O
proteins	B-Gene_or_gene_product
with	O
roles	O
in	O
development	O
and	O
/	O
or	O
chromatin	O
structure	O
.	O

A	O
large	O
Cysrich	O
region	O
with	O
a	O
novel	O
spatial	O
pattern	O
of	O
cysteine	O
residues	O
was	O
also	O
conserved	O
in	O
both	O
EZH1	B-Gene_or_gene_product
and	O
E	B-Gene_or_gene_product
(	I-Gene_or_gene_product
z	I-Gene_or_gene_product
)	I-Gene_or_gene_product
.	O

The	O
strong	O
sequence	O
conservation	O
suggest	O
potential	O
roles	O
for	O
EZH1	B-Gene_or_gene_product
in	O
human	O
development	O
as	O
a	O
transcriptional	O
regulator	O
and	O
as	O
a	O
component	O
of	O
protein	O
complexes	O
that	O
stably	O
maintain	O
heterochromatin	O
.	O

EZH1	B-Gene_or_gene_product
is	O
expressed	O
as	O
two	O
major	O
transcripts	O
in	O
all	O
adult	O
and	O
fetal	O
human	O
tissues	O
surveyed	O
;	O
comparison	O
of	O
cloned	O
cDNAs	O
suggests	O
that	O
alternative	O
splicing	O
may	O
account	O
for	O
at	O
least	O
part	O
of	O
the	O
transcript	O
size	O
difference	O
.	O

Analysis	O
of	O
one	O
cDNA	O
revealed	O
an	O
unusual	O
splicing	O
event	O
involving	O
EZH1	B-Gene_or_gene_product
and	O
a	O
tandemly	O
linked	O
gene	O
GPR2	B-Gene_or_gene_product
and	O
suggests	O
a	O
potential	O
mechanism	O
for	O
modifying	O
the	O
EZH1	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
in	O
the	O
conserved	O
C	O
-	O
terminal	O
domain	O
.	O

The	O
sequence	O
and	O
isolated	O
cDNAs	O
will	O
provide	O
useful	O
reagents	O
for	O
determining	O
the	O
function	O
of	O
EZH1	B-Gene_or_gene_product
and	O
the	O
importance	O
of	O
the	O
evolutionarily	O
conserved	O
domains	O
.	O

Cloning	O
of	O
human	O
lymphocyte	O
-	O
specific	O
interferon	O
regulatory	O
factor	O
(	O
hLSIRF	B-Gene_or_gene_product
/	I-Gene_or_gene_product
hIRF4	I-Gene_or_gene_product
)	O
and	O
mapping	O
of	O
the	O
gene	B-Gene_or_gene_product
to	O
6p23	O
-	O
p25	O
.	O

The	O
interferon	O
regulatory	O
factor	O
(	O
IRF	B-Gene_or_gene_product
)	O
genes	O
encode	O
a	O
family	O
of	O
transcription	O
factors	O
involved	O
in	O
the	O
transcriptional	O
regulation	O
of	O
interferon	B-Gene_or_gene_product
and	O
the	O
interferon	B-Gene_or_gene_product
stimulated	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
through	O
recognition	O
of	O
the	O
interferon	O
stimulated	O
response	O
element	O
.	O

We	O
previously	O
reported	O
the	O
cloning	O
of	O
a	O
murine	O
lymphocyte	O
-	O
specific	O
IRF	O
(	O
mLSIRF	B-Gene_or_gene_product
)	O
,	O
which	O
was	O
rapidly	O
induced	O
following	O
B	B-Gene_or_gene_product
-	I-Gene_or_gene_product
or	I-Gene_or_gene_product
T	I-Gene_or_gene_product
-	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
crosslinking	O
.	O

To	O
study	O
the	O
role	O
of	O
LSIRF	B-Gene_or_gene_product
in	O
human	O
lymphocyte	O
development	O
,	O
we	O
have	O
cloned	O
the	O
complete	O
5	O
.	O
3	O
-	O
kb	O
cDNA	O
for	O
the	O
human	O
homolog	O
(	O
hLSIRF	B-Gene_or_gene_product
)	O
.	O

hLSIRF	B-Gene_or_gene_product
is	O
a	O
protein	B-Gene_or_gene_product
of	O
450	O
amino	O
acids	O
with	O
a	O
predicted	O
molecular	O
weight	O
of	O
51	O
.	O
6	O
kDa	O
and	O
possesses	O
92	O
%	O
identity	O
at	O
the	O
amino	O
acid	O
level	O
to	O
mLSIRF	B-Gene_or_gene_product
,	O
including	O
near	O
identity	O
in	O
the	O
DNA	O
-	O
binding	O
domain	O
.	O

In	O
Northern	O
blot	O
analysis	O
,	O
a	O
single	O
transcript	O
of	O
approximately	O
5	O
kb	O
was	O
highly	O
expressed	O
in	O
spleen	O
and	O
peripheral	O
blood	O
lymphocyte	O
.	O

hLSIRF	B-Gene_or_gene_product
mRNA	O
was	O
rapidly	O
induced	O
in	O
peripheral	O
T	O
cells	O
after	O
crosslinking	O
the	O
T	B-Gene_or_gene_product
-	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
.	O

Analysis	O
of	O
tumor	O
cell	O
lines	O
showed	O
that	O
hLSIRF	B-Gene_or_gene_product
mRNA	O
was	O
basally	O
expressed	O
in	O
most	O
B	O
-	O
but	O
not	O
T	O
-	O
cell	O
lines	O
.	O

Surprisingly	O
hLSIRF	B-Gene_or_gene_product
mRNA	O
was	O
also	O
found	O
in	O
the	O
melanoma	O
line	O
G361	O
and	O
is	O
expressed	O
in	O
normal	O
melanocytes	O
as	O
well	O
.	O

Sequence	O
from	O
a	O
genomic	O
clone	O
for	O
hLSIRF	B-Gene_or_gene_product
was	O
compared	O
to	O
that	B-Gene_or_gene_product
from	O
mouse	O
and	O
revealed	O
an	O
identical	O
exon	O
-	O
intron	O
structure	O
and	O
a	O
conserved	O
PU	O
-	O
1	O
-	O
binding	O
motif	O
in	O
the	O
promoter	O
.	O

By	O
FISH	O
analysis	O
,	O
hLSIRF	B-Gene_or_gene_product
was	O
mapped	O
to	O
6p23	O
-	O
p25	O
.	O

Stat2	O
is	O
a	O
transcriptional	O
activator	O
that	O
requires	O
sequence	O
-	O
specific	O
contacts	O
provided	O
by	O
stat1	B-Gene_or_gene_product
and	O
p48	B-Gene_or_gene_product
for	O
stable	O
interaction	O
with	O
DNA	O
.	O

Transcriptional	O
responses	O
to	O
interferon	O
(	O
IFN	B-Gene_or_gene_product
)	O
are	O
mediated	O
by	O
tyrosine	O
phosphorylation	O
and	O
nuclear	O
translocation	O
of	O
transcription	O
factors	O
of	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
(	O
Stat	O
)	O
family	O
.	O

The	O
Stat1	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
is	O
required	O
for	O
all	O
transcriptional	O
responses	O
to	O
IFN	B-Gene_or_gene_product
(	O
both	O
type	O
I	O
and	O
type	O
II	O
)	O
.	O

Responses	O
to	O
type	B-Gene_or_gene_product
I	I-Gene_or_gene_product
IFN	I-Gene_or_gene_product
(	O
alpha	O
and	O
beta	O
)	O
also	O
require	O
Stat2	O
and	O
the	O
IFN	B-Gene_or_gene_product
regulatory	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
family	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
p48	I-Gene_or_gene_product
,	O
which	O
form	O
a	O
heterotrimeric	O
transcription	O
complex	O
with	O
Stat1	B-Gene_or_gene_product
termed	O
ISGF3	O
.	O

Stat1	B-Gene_or_gene_product
homodimers	O
formed	O
in	O
response	O
to	O
IFN	B-Gene_or_gene_product
-	I-Gene_or_gene_product
gamma	I-Gene_or_gene_product
treatment	O
can	O
also	O
interact	O
with	O
p48	B-Gene_or_gene_product
and	O
function	O
as	O
transcriptional	O
activators	O
.	O

We	O
now	O
show	O
that	O
Stat2	O
is	O
capable	O
of	O
forming	O
a	O
stable	O
homodimer	O
that	O
interacts	O
with	O
p48	B-Gene_or_gene_product
,	O
can	O
be	O
recruited	O
to	O
DNA	O
,	O
and	O
can	O
activate	O
transcription	O
,	O
raising	O
a	O
question	O
of	O
why	O
Stat1	B-Gene_or_gene_product
is	O
required	O
.	O

Analysis	O
of	O
the	O
transcriptional	O
competence	O
,	O
affinity	O
,	O
and	O
specificity	O
of	O
Stat2	O
-	O
p48	B-Gene_or_gene_product
complexes	O
compared	O
with	O
other	O
Stat	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	O
containing	O
transcription	O
factor	O
complexes	O
suggests	O
distinct	O
roles	O
for	O
each	O
component	O
.	O

Although	O
Stat2	O
is	O
a	O
potent	O
transactivator	O
,	O
it	O
does	O
not	O
interact	O
stably	O
with	O
DNA	O
in	O
complex	O
with	O
p48	O
alone	O
.	O

Adding	O
Stat1	B-Gene_or_gene_product
increases	O
the	O
affinity	O
and	O
alters	O
the	O
sequence	O
selectivity	O
of	O
p48	B-Gene_or_gene_product
-	O
DNA	O
interactions	O
by	O
contacting	O
a	O
half	O
-	O
site	O
of	O
its	O
palindromic	O
recognition	O
motif	O
adjacent	O
to	O
a	O
p48	B-Gene_or_gene_product
interaction	O
sequence	O
.	O

Thus	O
,	O
ISGF3	O
assembly	O
involves	O
p48	B-Gene_or_gene_product
functioning	O
as	O
an	O
adaptor	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
to	O
recruit	O
Stat1	B-Gene_or_gene_product
and	O
Stat2	O
to	O
an	O
IFN	O
-	O
alpha	O
-	O
stimulated	O
response	O
element	O
,	O
Stat2	O
contributes	O
a	O
potent	O
transactivation	O
domain	O
but	O
is	O
unable	O
to	O
directly	O
contact	O
DNA	O
,	O
while	O
Stat1	B-Gene_or_gene_product
stabilizes	O
the	O
heteromeric	O
complex	O
by	O
contacting	O
DNA	O
directly	O
.	O

TRAMP	B-Gene_or_gene_product
,	O
a	O
novel	O
apoptosis	O
-	O
mediating	O
receptor	B-Gene_or_gene_product
with	O
sequence	O
homology	O
to	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
Fas	B-Gene_or_gene_product
(	I-Gene_or_gene_product
Apo	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
CD95	I-Gene_or_gene_product
)	I-Gene_or_gene_product
.	O

A	O
novel	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
(	O
TNF	B-Gene_or_gene_product
)	O
receptor	B-Gene_or_gene_product
family	O
,	O
designated	O
TRAMP	B-Gene_or_gene_product
,	O
has	O
been	O
identified	O
.	O

The	O
structural	O
organization	O
of	O
the	O
393	O
amino	O
acid	O
long	O
human	O
TRAMP	B-Gene_or_gene_product
is	O
most	O
homologous	O
to	O
TNF	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O

TRAMP	B-Gene_or_gene_product
is	O
abundantly	O
expressed	O
on	O
thymocytes	O
and	O
lymphocytes	O
.	O

Its	O
extracellular	O
domain	O
is	O
composed	O
of	O
four	O
cysteine	O
-	O
rich	O
domains	O
,	O
and	O
the	O
cytoplasmic	O
region	O
contains	O
a	O
death	O
domain	O
known	O
to	O
signal	O
apoptosis	O
.	O

Overexpression	O
of	O
TRAMP	B-Gene_or_gene_product
leads	O
to	O
two	O
major	O
responses	O
,	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
activation	O
and	O
apoptosis	O
.	O

TRAMP	B-Gene_or_gene_product
-	O
induced	O
cell	O
death	O
is	O
inhibited	O
by	O
an	O
inhibitor	B-Gene_or_gene_product
of	O
ICE	O
-	O
like	O
proteases	O
,	O
but	O
not	O
by	O
Bcl	O
-	O
2	O
.	O

In	O
addition	O
,	O
TRAMP	B-Gene_or_gene_product
does	O
not	O
appear	O
to	O
interact	O
with	O
any	O
of	O
the	O
known	O
apoptosis	O
-	O
inducing	O
ligands	O
of	O
the	O
TNF	B-Gene_or_gene_product
family	O
.	O

A	O
novel	O
genetic	O
system	O
to	O
isolate	O
a	O
dominant	O
negative	O
effector	O
on	O
DNA	O
-	O
binding	O
activity	O
of	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O

Recent	O
studies	O
have	O
revealed	O
that	O
interactions	O
between	O
transcription	O
factors	O
play	O
an	O
important	O
role	O
in	O
regulation	O
of	O
gene	O
expression	O
in	O
eukaryotic	O
cells	O
.	O

To	O
isolate	O
cDNA	O
clones	O
that	O
dominantly	O
inhibit	O
the	O
DNA	O
-	O
binding	O
activity	O
of	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
chosen	O
as	O
a	O
representative	O
factor	O
,	O
we	O
have	O
developed	O
a	O
novel	O
screening	O
system	O
.	O

This	O
employs	O
an	O
Escherichia	O
coli	O
tester	O
strain	O
carrying	O
a	O
modified	O
lac	O
operon	O
as	O
a	O
reporter	O
gene	O
,	O
with	O
the	O
lac	O
operator	O
sequence	O
replaced	O
by	O
an	O
octamer	O
sequence	O
.	O

Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
expressed	O
in	O
this	O
tester	O
strain	O
represses	O
the	O
expression	O
of	O
the	O
reporter	O
gene	O
and	O
changes	O
the	O
phenotype	O
of	O
the	O
cell	O
from	O
Lac	O
+	O
to	O
Lac	O
-	O
.	O

Introduction	O
of	O
a	O
cDNA	O
expression	O
library	O
prepared	O
from	O
a	O
human	O
T	O
-	O
cell	O
line	O
into	O
the	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	O
harboring	O
tester	O
strain	O
allowed	O
selection	O
of	O
three	O
Lac	O
+	O
clones	O
out	O
of	O
1	O
x	O
10	O
(	O
5	O
)	O
transformants	O
.	O

One	O
of	O
them	O
,	O
hT86	O
,	O
encoding	O
a	O
putative	O
zinc	O
finger	O
protein	B-Gene_or_gene_product
was	O
found	O
to	O
derepress	O
beta	O
-	O
galactosidase	O
activity	O
in	O
the	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	O
harboring	O
tester	O
strain	O
at	O
the	O
transcriptional	O
level	O
.	O

In	O
gel	O
mobility	O
shift	O
assays	O
,	O
hT86	O
attenuated	O
the	O
intensity	O
of	O
the	O
retarded	O
band	O
composed	O
of	O
the	O
octamer	O
probe	O
and	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
suggesting	O
a	O
dominant	O
negative	O
effect	O
on	O
the	O
DNA	O
-	O
binding	O
activity	O
of	O
Oct	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O

The	O
strategy	O
described	O
here	O
provides	O
a	O
new	O
approach	O
for	O
studying	O
protein	O
-	O
protein	O
interactions	O
that	O
govern	O
the	O
complex	O
regulation	O
of	O
gene	O
expression	O
.	O

BCL6	B-Gene_or_gene_product
can	O
repress	O
transcription	O
from	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
I	O
promoter	O
/	O
enhancer	O
region	O
.	O

The	O
gene	B-Gene_or_gene_product
BCL6	I-Gene_or_gene_product
encodes	O
a	O
zinc	B-Gene_or_gene_product
finger	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
with	O
similarities	O
to	O
transcription	O
factors	O
.	O

We	O
previously	O
reported	O
that	O
a	O
number	O
of	O
viral	O
genomes	O
,	O
including	O
human	O
immunodeficiency	O
virus	O
type	O
I	O
(	O
HIV	O
-	O
1	O
)	O
,	O
contain	O
sequences	O
which	O
are	O
similar	O
to	O
the	O
BCL6	B-Gene_or_gene_product
DNA	O
-	O
binding	O
consensus	O
in	O
their	O
promoter	O
regions	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
showed	O
that	O
the	O
full	O
-	O
length	O
BCL6	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
extracted	O
from	O
transfected	O
COS	O
cells	O
and	O
a	O
bacterially	O
expressed	O
truncated	O
protein	B-Gene_or_gene_product
containing	O
the	O
BCL6	O
zinc	O
fingers	O
can	O
bind	O
specifically	O
to	O
DNA	O
from	O
the	O
U3	O
promoter	O
/	O
enhancer	O
region	O
of	O
HIV	O
-	O
1	O
.	O

Transient	O
transfections	O
were	O
performed	O
to	O
analyze	O
the	O
effects	O
of	O
the	O
BCL6	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
on	O
luciferase	O
expression	O
driven	O
by	O
the	O
HIV	O
-	O
1	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
sequences	O
.	O

Full	O
-	O
length	O
BCL6	B-Gene_or_gene_product
significantly	O
repressed	O
luciferase	O
activity	O
compared	O
with	O
multiple	O
controls	O
.	O

We	O
conclude	O
that	O
the	O
BCL6	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
can	O
bind	O
to	O
the	O
HIV	O
-	O
1	O
promoter	O
-	O
enhancer	O
region	O
and	O
contains	O
a	O
domain	O
upstream	O
of	O
its	O
zinc	O
fingers	O
that	O
can	O
repress	O
transcription	O
from	O
the	O
HIV	O
-	O
1	O
LTR	O
.	O

The	O
class	O
II	O
trans	O
-	O
activator	O
CIITA	O
interacts	O
with	O
the	O
TBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
TAFII32	B-Gene_or_gene_product
.	O

The	O
class	O
II	O
trans	O
-	O
activator	O
(	O
CIITA	O
)	O
is	O
the	O
main	O
transcriptional	O
co	O
-	O
activator	O
for	O
the	O
expression	O
of	O
MHC	B-Gene_or_gene_product
class	I-Gene_or_gene_product
II	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Its	O
N	O
-	O
terminal	O
125	O
amino	O
acids	O
function	O
as	O
an	O
independent	O
transcriptional	O
activation	O
domain	O
.	O

Analyses	O
of	O
the	O
primary	O
amino	O
acid	O
sequence	O
of	O
the	O
activation	O
domain	O
predict	O
the	O
presence	O
of	O
three	O
alpha	O
-	O
helices	O
,	O
each	O
with	O
a	O
high	O
proportion	O
of	O
acidic	O
residues	O
.	O

Using	O
site	O
-	O
directed	O
mutagenesis	O
,	O
we	O
found	O
that	O
two	O
of	O
these	O
predicted	O
alpha	O
-	O
helices	O
are	O
required	O
for	O
full	O
transcriptional	O
activation	O
by	O
CIITA	O
.	O

Moreover	O
,	O
a	O
CIITA	O
protein	O
in	O
which	O
both	O
functional	O
alpha	O
-	O
helices	O
have	O
been	O
deleted	O
displays	O
a	O
dominant	O
negative	O
phenotype	O
.	O

This	O
activation	O
domain	O
of	O
CIITA	O
interacts	O
with	O
the	O
32	O
kDa	O
subunit	O
of	O
the	O
general	O
transcription	O
complex	O
TFIID	O
,	O
TAFII32	B-Gene_or_gene_product
.	O

Decreased	O
transcriptional	O
activation	O
by	O
N	O
-	O
terminal	O
deletions	O
of	O
CIITA	O
is	O
correlated	O
directly	O
with	O
their	O
reduced	O
binding	O
to	O
TAFII32	B-Gene_or_gene_product
.	O

We	O
conclude	O
that	O
interactions	O
between	O
TAFII32	B-Gene_or_gene_product
and	O
CIITA	O
are	O
responsible	O
for	O
activation	O
of	O
class	B-Gene_or_gene_product
II	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

Three	O
human	O
RNA	O
polymerase	O
III	O
-	O
specific	O
subunits	O
form	O
a	O
subcomplex	O
with	O
a	O
selective	O
function	O
in	O
specific	O
transcription	O
initiation	O
.	O

Transcription	O
by	O
RNA	O
polymerase	O
III	O
involves	O
recruitment	O
of	O
the	O
polymerase	O
by	O
template	B-Gene_or_gene_product
-	I-Gene_or_gene_product
bound	I-Gene_or_gene_product
accessory	I-Gene_or_gene_product
factors	I-Gene_or_gene_product
,	O
followed	O
by	O
initiation	O
,	O
elongation	O
,	O
and	O
termination	O
steps	O
.	O

An	O
immunopurification	O
approach	O
has	O
been	O
used	O
to	O
demonstrate	O
that	O
human	O
RNA	O
Pol	O
III	O
is	O
composed	O
of	O
16	O
subunits	O
,	O
some	O
of	O
which	O
are	O
apparently	O
modified	O
in	O
HeLa	O
cells	O
.	O

Partial	O
denaturing	O
conditions	O
and	O
sucrose	O
gradient	O
sedimentation	O
at	O
high	O
salt	O
result	O
in	O
the	O
dissociation	O
of	O
a	O
subcomplex	O
that	O
includes	O
hRPC32	O
,	O
hRPC39	O
,	O
and	O
hRPC62	O
.	O

Cognate	O
cDNAs	O
were	O
isolated	O
and	O
shown	O
to	O
encode	O
three	O
subunits	O
that	O
are	O
specific	O
to	O
RNA	O
Pol	O
III	O
and	O
homologous	O
to	O
three	O
yeast	O
subunits	O
.	O

The	O
human	O
RNA	O
Pol	O
III	O
core	O
lacking	O
the	O
subcomplex	O
functions	O
in	O
transcription	O
elongation	O
and	O
termination	O
following	O
nonspecific	O
initiation	O
on	O
a	O
tailed	O
template	O
,	O
but	O
fails	O
to	O
show	O
promoter	O
-	O
dependent	O
transcription	O
initiation	O
in	O
conjunction	O
with	O
accessory	B-Gene_or_gene_product
factors	I-Gene_or_gene_product
.	O

The	O
capability	O
for	O
specific	O
transcription	O
initiation	O
can	O
be	O
restored	O
either	O
by	O
the	O
natural	O
subcomplex	O
or	O
by	O
a	O
stable	O
subcomplex	O
composed	O
of	O
recombinant	O
hRPC32	O
,	O
hRPC39	O
,	O
and	O
hRPC62	O
polypeptides	O
.	O

One	O
component	O
(	O
hRPC39	O
)	O
of	O
this	O
subcomplex	O
interacts	O
physically	O
with	O
both	O
hTBP	O
and	O
hTFIIIB90	O
,	O
two	O
subunits	O
of	O
human	O
RNA	O
Pol	O
III	O
transcription	B-Gene_or_gene_product
initiation	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
IIIB	I-Gene_or_gene_product
.	O

These	O
data	O
strongly	O
suggest	O
that	O
the	O
hRPC32	O
-	O
hRPC39	O
-	O
hRPC62	O
subcomplex	O
directs	O
RNA	O
Pol	O
III	O
binding	O
to	O
the	O
TFIIIB	B-Gene_or_gene_product
-	O
DNA	O
complex	O
via	O
the	O
interactions	O
between	O
TFIIIB	B-Gene_or_gene_product
and	O
hRPC39	O
.	O

Tap	B-Gene_or_gene_product
:	O
a	O
novel	O
cellular	O
protein	B-Gene_or_gene_product
that	O
interacts	O
with	O
tip	B-Gene_or_gene_product
of	O
herpesvirus	O
saimiri	O
and	O
induces	O
lymphocyte	O
aggregation	O
.	O

Tip	B-Gene_or_gene_product
of	O
herpesvirus	O
saimiri	O
associates	O
with	O
Lck	B-Gene_or_gene_product
and	O
down	O
-	O
regulates	O
Lck	B-Gene_or_gene_product
-	O
mediated	O
activation	O
.	O

We	O
identified	O
a	O
novel	O
cellular	O
Tip	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
Tap	B-Gene_or_gene_product
)	O
by	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
.	O

Tap	B-Gene_or_gene_product
associated	O
with	O
Tip	B-Gene_or_gene_product
following	O
transient	O
expression	O
in	O
COS	O
-	O
1	O
cells	O
and	O
stable	O
expression	O
in	O
human	O
Jurkat	O
-	O
T	O
cells	O
.	O

Expression	O
of	O
Tip	B-Gene_or_gene_product
and	O
Tap	B-Gene_or_gene_product
in	O
Jurkat	O
-	O
T	O
cells	O
induced	O
dramatic	O
cell	O
aggregation	O
.	O

Aggregation	O
was	O
likely	O
caused	O
by	O
the	O
up	O
-	O
regulated	O
surface	O
expression	O
of	O
adhesion	B-Gene_or_gene_product
molecules	I-Gene_or_gene_product
including	O
integrin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
selectin	I-Gene_or_gene_product
,	O
ICAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
,	O
and	O
H	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CAM	I-Gene_or_gene_product
.	O

Furthermore	O
,	O
NF	O
-	O
kappaB	O
transcriptional	O
factor	O
of	O
aggregated	O
cells	O
had	O
approximately	O
40	O
-	O
fold	O
higher	O
activity	O
than	O
that	O
of	O
parental	O
cells	O
.	O

Thus	O
,	O
Tap	B-Gene_or_gene_product
is	O
likely	O
to	O
be	O
an	O
important	O
cellular	O
mediator	O
of	O
Tip	B-Gene_or_gene_product
function	O
in	O
T	O
cell	O
transformation	O
by	O
herpesvirus	O
saimiri	O
.	O

Human	O
TAF	O
(	O
II	O
)	O
135	O
potentiates	O
transcriptional	O
activation	O
by	O
the	O
AF	O
-	O
2s	O
of	O
the	O
retinoic	O
acid	O
,	O
vitamin	O
D3	O
,	O
and	O
thyroid	B-Gene_or_gene_product
hormone	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
in	O
mammalian	O
cells	O
.	O

We	O
report	O
for	O
the	O
first	O
time	O
the	O
cloning	O
of	O
a	O
complete	O
cDNA	O
encoding	O
the	O
human	O
TFIID	O
subunit	O
hTAF	O
(	O
II	O
)	O
135	O
(	O
hTAF	O
(	O
II	O
)	O
130	O
)	O
.	O

Full	O
-	O
length	O
hTAF	O
(	O
II	O
)	O
135	O
comprises	O
1083	O
amino	O
acids	O
and	O
contains	O
two	O
conserved	O
domains	O
present	O
also	O
in	O
dTAF	O
(	O
II	O
)	O
110	O
and	O
hTAF	O
(	O
II	O
)	O
105	O
.	O

We	O
show	O
that	O
expression	O
of	O
hTAF	O
(	O
II	O
)	O
135	O
in	O
mammalian	O
cells	O
strongly	O
and	O
selectively	O
potentiates	O
transcriptional	O
stimulation	O
by	O
the	O
activation	O
function	O
-	O
2	O
(	O
AF	O
-	O
2	O
)	O
of	O
the	O
retinoic	O
acid	O
,	O
thyroid	O
hormone	O
,	O
and	O
vitamin	O
D3	O
receptors	O
(	O
RAR	B-Gene_or_gene_product
,	O
TR	B-Gene_or_gene_product
,	O
and	O
VDR	B-Gene_or_gene_product
)	O
,	O
but	O
does	O
not	O
affect	O
the	O
AF	O
-	O
2s	O
of	O
the	O
estrogen	O
(	O
ER	B-Gene_or_gene_product
)	O
or	O
retinoid	O
X	O
(	O
RXR	B-Gene_or_gene_product
)	O
receptors	O
.	O

The	O
coactivator	O
activity	O
requires	O
an	O
hTAF	O
(	O
II	O
)	O
135	O
region	O
that	O
is	O
located	O
between	O
the	O
conserved	O
domains	O
but	O
is	O
itself	O
not	O
conserved	O
in	O
dTAF	O
(	O
II	O
)	O
110	O
and	O
hTAF	O
(	O
II	O
)	O
105	O
.	O

Expression	O
of	O
hTAF	O
(	O
II	O
)	O
135	O
also	O
stimulates	O
RAR	B-Gene_or_gene_product
AF	O
-	O
2	O
activity	O
when	O
a	O
promoter	O
with	O
a	O
low	O
-	O
affinity	O
TATA	O
element	O
(	O
TGTA	O
)	O
is	O
used	O
,	O
indicating	O
that	O
hTAF	O
(	O
II	O
)	O
135	O
overexpression	O
compensates	O
for	O
the	O
low	O
-	O
affinity	O
of	O
TBP	B-Gene_or_gene_product
for	O
this	O
promoter	O
and	O
may	O
facilitate	O
the	O
recruitment	O
of	O
TFIID	B-Gene_or_gene_product
by	O
the	O
RAR	B-Gene_or_gene_product
AF	O
-	O
2	O
.	O

A	O
new	O
protein	B-Gene_or_gene_product
containing	O
an	O
SH2	O
domain	O
that	O
inhibits	O
JAK	O
kinases	O
.	O

The	O
proliferation	O
and	O
differentiation	O
of	O
cells	O
of	O
many	O
lineages	O
are	O
regulated	O
by	O
secreted	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
known	O
as	O
cytokines	B-Gene_or_gene_product
.	O

Cytokines	B-Gene_or_gene_product
exert	O
their	O
biological	O
effect	O
through	O
binding	O
to	O
cell	O
-	O
surface	O
receptors	B-Gene_or_gene_product
that	O
are	O
associated	O
with	O
one	O
or	O
more	O
members	O
of	O
the	O
JAK	O
family	O
of	O
cytoplasmic	O
tyrosine	O
kinases	O
.	O

Cytokine	B-Gene_or_gene_product
-	O
induced	O
receptor	B-Gene_or_gene_product
dimerization	O
leads	O
to	O
the	O
activation	O
of	O
JAKs	O
,	O
rapid	O
tyrosine	O
-	O
phosphorylation	O
of	O
the	O
cytoplasmic	O
domains	O
,	O
and	O
subsequent	O
recruitment	O
of	O
various	O
signalling	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
including	O
members	O
of	O
the	O
STAT	B-Gene_or_gene_product
family	I-Gene_or_gene_product
of	O
transcription	O
factors	O
,	O
to	O
the	O
receptor	O
complex	O
.	O

Using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
,	O
we	O
have	O
now	O
isolated	O
a	O
new	O
SH2	O
-	O
domain	O
-	O
containing	O
protein	B-Gene_or_gene_product
,	O
JAB	B-Gene_or_gene_product
,	O
which	O
is	O
a	O
JAK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
that	O
interacts	O
with	O
the	O
Jak2	O
tyrosine	O
-	O
kinase	O
JH1	O
domain	O
.	O

JAB	B-Gene_or_gene_product
is	O
structurally	O
related	O
to	O
CIS	B-Gene_or_gene_product
,	O
a	O
cytokine	B-Gene_or_gene_product
-	I-Gene_or_gene_product
inducible	I-Gene_or_gene_product
SH2	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

Interaction	O
of	O
JAB	B-Gene_or_gene_product
with	O
Jak1	O
,	O
Jak2	O
or	O
Jak3	O
markedly	O
reduces	O
their	O
tyrosine	O
-	O
kinase	O
activity	O
and	O
suppresses	O
the	O
tyrosine	O
-	O
phosphorylation	O
and	O
activation	O
of	O
STATs	B-Gene_or_gene_product
.	O

JAB	B-Gene_or_gene_product
and	O
CIS	B-Gene_or_gene_product
appear	O
to	O
function	O
as	O
negative	O
regulators	O
in	O
the	O
JAK	O
signalling	O
pathway	O
.	O

RP1	B-Gene_or_gene_product
,	O
a	O
new	O
member	O
of	O
the	O
adenomatous	B-Gene_or_gene_product
polyposis	I-Gene_or_gene_product
coli	I-Gene_or_gene_product
-	O
binding	O
EB1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	I-Gene_or_gene_product
,	O
is	O
differentially	O
expressed	O
in	O
activated	O
T	O
cells	O
.	O

Cross	O
-	O
linking	O
of	O
the	O
CD3	B-Gene_or_gene_product
and	O
CD28	B-Gene_or_gene_product
molecules	O
on	O
T	O
lymphocytes	O
represents	O
one	O
of	O
the	O
most	O
effective	O
signals	O
for	O
T	O
lymphocyte	O
activation	O
and	O
triggering	O
of	O
their	O
cytotoxic	O
effector	O
function	O
.	O

To	O
identify	O
genes	B-Gene_or_gene_product
that	O
are	O
expressed	O
in	O
T	O
cells	O
after	O
stimulation	O
,	O
mRNA	O
from	O
T	O
lymphocytes	O
that	O
had	O
been	O
activated	O
by	O
the	O
simultaneous	O
stimulation	O
of	O
the	O
CD3	B-Gene_or_gene_product
and	O
CD28	B-Gene_or_gene_product
trigger	O
molecules	O
was	O
transcribed	O
for	O
a	O
differential	O
mRNA	O
display	O
analysis	O
into	O
cDNA	O
and	O
was	O
compared	O
with	O
cDNA	O
from	O
CD28	B-Gene_or_gene_product
-	O
or	O
CD3	B-Gene_or_gene_product
-	O
activated	O
or	O
resting	O
lymphocytes	O
.	O

Differential	O
expression	O
was	O
confirmed	O
subsequently	O
by	O
Northern	O
blot	O
analysis	O
.	O

One	O
of	O
the	O
cDNA	O
fragments	O
expressed	O
specifically	O
in	O
CD3	B-Gene_or_gene_product
-	O
and	O
CD28	B-Gene_or_gene_product
-	O
activated	O
T	O
cells	O
was	O
designated	O
RP1	B-Gene_or_gene_product
.	O

The	O
predictive	O
protein	O
-	O
coding	O
region	O
of	O
RP1	B-Gene_or_gene_product
had	O
a	O
significant	O
homology	O
to	O
members	O
of	O
the	O
recently	O
found	O
adenomatous	B-Gene_or_gene_product
polyposis	I-Gene_or_gene_product
coli	I-Gene_or_gene_product
(	O
APC	B-Gene_or_gene_product
)	O
protein	O
-	O
binding	O
EB1	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	I-Gene_or_gene_product
,	O
which	O
codes	O
for	O
yet	O
unknown	O
protein	B-Gene_or_gene_product
(	I-Gene_or_gene_product
s	I-Gene_or_gene_product
)	O
.	O

Bacterially	O
expressed	O
RP1	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
revealed	O
specific	O
binding	O
to	O
wild	B-Gene_or_gene_product
-	I-Gene_or_gene_product
type	I-Gene_or_gene_product
but	O
not	O
to	O
mutated	O
APC	O
protein	O
.	O

The	O
rapid	O
up	O
-	O
regulation	O
of	O
RP1	B-Gene_or_gene_product
mRNA	O
in	O
properly	O
activated	O
T	O
cells	O
suggests	O
that	O
this	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
might	O
belong	O
to	O
the	O
immediate	O
/	O
early	O
gene	B-Gene_or_gene_product
family	I-Gene_or_gene_product
,	O
which	O
controls	O
the	O
signal	O
transduction	O
cascade	O
downstream	O
of	O
the	O
TCR	B-Gene_or_gene_product
.	O

As	O
the	O
expression	O
level	O
of	O
the	O
RP1	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
in	O
activated	O
T	O
cells	O
and	O
a	O
spectrum	O
of	O
tumor	O
-	O
derived	O
cell	O
lines	O
correlates	O
with	O
the	O
proliferative	O
status	O
of	O
the	O
cells	O
,	O
members	O
of	O
the	O
EB1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	I-Gene_or_gene_product
may	O
not	O
only	O
be	O
involved	O
in	O
the	O
tumorigenesis	O
of	O
colorectal	O
cancers	O
but	O
may	O
also	O
play	O
a	O
role	O
in	O
the	O
proliferative	O
control	O
of	O
normal	O
cells	O
.	O

Human	O
gene	B-Gene_or_gene_product
for	O
the	O
RNA	O
polymerase	O
II	O
seventh	O
subunit	O
(	O
hsRPB7	O
)	O
:	O
structure	O
,	O
expression	O
and	O
chromosomal	O
localization	O
.	O

The	O
human	O
gene	B-Gene_or_gene_product
for	O
the	O
seventh	O
largest	O
subunit	O
of	O
RNA	O
polymerase	O
II	O
complex	O
,	O
hsRPB7	O
was	O
cloned	O
,	O
sequenced	O
and	O
mapped	O
.	O

This	O
complex	O
is	O
an	O
integral	O
part	O
of	O
the	O
transcription	O
-	O
coupled	O
DNA	O
repair	O
mechanism	O
and	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
several	O
human	O
genetic	O
diseases	O
and	O
implicated	O
in	O
many	O
others	O
.	O

The	O
hsRPB7	O
gene	B-Gene_or_gene_product
consists	O
of	O
8	O
exons	O
and	O
spans	O
approximately	O
5	O
.	O
1	O
kb	O
.	O

Southern	O
blots	O
of	O
genomic	O
and	O
cloned	O
DNA	O
suggest	O
that	O
hsRPB7	O
is	O
coded	O
for	O
by	O
a	O
single	O
gene	B-Gene_or_gene_product
.	O

Using	O
human	O
radiation	O
hybrids	O
and	O
YACs	O
,	O
the	O
gene	B-Gene_or_gene_product
was	O
localized	O
to	O
11q13	O
.	O
1	O
,	O
within	O
70	O
kb	O
of	O
marker	O
D11S1765	O
.	O

The	O
sequence	O
of	O
the	O
5	O
'	O
flanking	O
region	O
does	O
not	O
contain	O
a	O
TATA	O
element	O
,	O
but	O
does	O
contain	O
several	O
Sp1	O
binding	O
sites	O
,	O
an	O
AP	O
-	O
1	O
site	O
and	O
a	O
novel	O
inverted	O
polymorphic	O
GATA	O
tandem	O
repeat	O
.	O

This	O
novel	O
GATA	O
repeat	O
can	O
be	O
used	O
for	O
linkage	O
analysis	O
.	O

The	O
hsRPB7	O
gene	B-Gene_or_gene_product
seems	O
to	O
be	O
highly	O
conserved	O
among	O
eukaryotic	O
species	O
,	O
showing	O
general	O
sequence	O
conservation	O
to	O
yeast	O
and	O
Drosophila	O
.	O

Northern	O
blot	O
analysis	O
reveals	O
a	O
high	O
degree	O
of	O
tissue	O
-	O
specific	O
expression	O
.	O

For	O
example	O
,	O
adult	O
retina	O
,	O
brain	O
and	O
kidney	O
exhibit	O
a	O
relatively	O
high	O
level	O
of	O
expression	O
.	O

A	O
moderate	O
level	O
of	O
expression	O
is	O
observed	O
in	O
heart	O
,	O
lung	O
,	O
testis	O
,	O
cornea	O
,	O
retinal	O
pigmented	O
epithelium	O
/	O
choroid	O
and	O
placenta	O
with	O
a	O
lower	O
level	O
of	O
expression	O
in	O
the	O
uterus	O
,	O
small	O
intestine	O
and	O
skeletal	O
muscle	O
.	O

A	O
very	O
low	O
level	O
of	O
expression	O
was	O
observed	O
in	O
stomach	O
and	O
liver	O
.	O

Comparison	O
between	O
four	O
fetal	O
and	O
adult	O
tissues	O
also	O
demonstrate	O
a	O
surprising	O
level	O
of	O
developmental	O
specificity	O
.	O

Expression	O
in	O
fetal	O
retina	O
is	O
considerably	O
lower	O
than	O
fetal	O
brain	O
but	O
similar	O
to	O
adult	O
retina	O
.	O

